{
    "__type__": "Deck", 
    "children": [], 
    "crowdanki_uuid": "be5a4bc0-c495-11e8-a662-d481d727b8af", 
    "deck_config_uuid": "bbd22c61-371e-11e8-8e49-9cb6d0da61dc", 
    "deck_configurations": [
        {
            "__type__": "DeckConfig", 
            "autoplay": true, 
            "crowdanki_uuid": "bbd22c61-371e-11e8-8e49-9cb6d0da61dc", 
            "dyn": false, 
            "lapse": {
                "delays": [
                    10
                ], 
                "leechAction": 0, 
                "leechFails": 8, 
                "minInt": 1, 
                "mult": 0
            }, 
            "maxTaken": 60, 
            "name": "Default", 
            "new": {
                "bury": true, 
                "delays": [
                    1, 
                    10
                ], 
                "initialFactor": 2500, 
                "ints": [
                    1, 
                    4, 
                    7
                ], 
                "order": 1, 
                "perDay": 20, 
                "separate": true
            }, 
            "replayq": true, 
            "rev": {
                "bury": true, 
                "ease4": 1.3, 
                "fuzz": 0.05, 
                "ivlFct": 1, 
                "maxIvl": 36500, 
                "minSpace": 1, 
                "perDay": 100
            }, 
            "timer": 0
        }
    ], 
    "desc": "", 
    "dyn": 0, 
    "extendNew": 10, 
    "extendRev": 50, 
    "media_files": [
        "445e1ae2761d405fb6b7b389d7553e8f-ao-12-A.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-8-A.svg", 
        "c7156e55d7ad42bf9cd9efeb16e773d5-ao-3-Q.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-4-A.svg", 
        "paste-4196183048193.jpg", 
        "fca61051139d4a889aeec54c024fb10e-ao-5-Q.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-8-A.svg", 
        "tmp9pbyyc.png", 
        "40370c712deb41489d993bc97a4ed075-ao-3-A.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-5-Q.svg", 
        "7c80e20563554169bc5d5374388e47ec-ao-5-Q.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-4-Q.svg", 
        "paste-5510443040769.jpg", 
        "06769536f22b4e50b17c7572b9456594-ao-4-A.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-7-A.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-6-Q.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-7-A.svg", 
        "73a038139e5e45128883622fef3aa44a-ao-1-A.svg", 
        "476f0a43f1fc4b98a92ee0702a838030-ao-3-A.svg", 
        "f189765dde4e44018698a3425c30ac77-ao-3-A.svg", 
        "tmputftcr.png", 
        "ee0fa0f7a85046288699624d42bc3854-ao-1-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-9-A.svg", 
        "3aa7f3b019184787bb8b25d1e956abb2-ao-1-A.svg", 
        "47491ca45543444fb1b398bbb5eaafe6-ao-3-A.svg", 
        "637ed61baa4e4103aee250203de67264-ao-2-A.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-10-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-8-Q.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-5-A.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-12-Q.svg", 
        "paste-237172389052417.jpg", 
        "ad96db1f3c094851a73354db2488a812-ao-3-Q.svg", 
        "tmpwmj0ut.png", 
        "45752df80c334eaaa8be4bb49746d02b-ao-2-A.svg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-3-Q.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-10-Q.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-5-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-16-A.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-13-Q.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-3-A.svg", 
        "tmpix5qim.png", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-13-A.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-7-A.svg", 
        "57cb4863ccf945d598ce5f4518bda8c5-ao-5-A.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-9-A.svg", 
        "tmppcwibf.png", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-7-Q.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-O.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-19-Q.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-7-Q.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-1-Q.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-1-Q.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-4-Q.svg", 
        "4623716c49b34a94bc45e7c85e3078f3-ao-1-A.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-9-A.svg", 
        "5842a16355004d39af51ed18e1b30126-ao-3-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-8-Q.svg", 
        "f3efa4d2ad314d118abd95a70e76c66c-ao-1-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-3-Q.svg", 
        "a08cc10589774ec58d1813413c8b1b2d-ao-3-Q.svg", 
        "tmpbfn_ik.png", 
        "637ed61baa4e4103aee250203de67264-ao-4-A.svg", 
        "paste-224858717814785.jpg", 
        "cbb33d0be0b44b4c975bf5a8a97a6c52-ao-2-A.svg", 
        "d286a1e9ee6547779ed0e02926655795-ao-2-Q.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-10-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-7-A.svg", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-6-A.svg", 
        "tmpz08912.png", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-13-Q.svg", 
        "8b9d11e55af24760a2e902d9455c078b-ao-3-Q.svg", 
        "paste-633237093220353.jpg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-10-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-3-Q.svg", 
        "tmpsmqx_t.png", 
        "paste-102860171771905.jpg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-10-Q.svg", 
        "346af3bf3aba416dbf8f4f53ca163402-ao-2-A.svg", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-4-A.svg", 
        "988f2a4be17449eda5b5289d45856744-ao-1-Q.svg", 
        "3333092d7fa24648b826956283d014e6-ao-O.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-2-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-9-Q.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-8-Q.svg", 
        "52781e8155c04b6c82ee099b758e50c8-ao-5-Q.svg", 
        "tmppgl8oz.png", 
        "15439e09c73b4cc38607fdfcfa984152-ao-3-Q.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-5-A.svg", 
        "paste-20779051778049.jpg", 
        "e19ed494e6a347f6b02e0e386e0c73f0-oa-1-A.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-3-Q.svg", 
        "7c80e20563554169bc5d5374388e47ec-ao-2-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-10-A.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-4-A.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-O.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-13-A.svg", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-1-A.svg", 
        "21a562a5036b48af849ce3c068e827a6-ao-O.svg", 
        "tmp6jfgmf.png", 
        "2a9b029671cf45dcb4656aeeae293fc5-oa-2-A.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-9-A.svg", 
        "05e25644c8a34adda53563af5a11d2c9-ao-4-Q.svg", 
        "45752df80c334eaaa8be4bb49746d02b-ao-3-A.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-4-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-8-Q.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-5-Q.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-2-Q.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-O.svg", 
        "paste-711663196045313.jpg", 
        "a6ef346cdd714beeba506139f702194c-ao-6-A.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-9-A.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-1-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-7-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-1-A.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-3-Q.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-10-Q.svg", 
        "paste-590326074966017.jpg", 
        "fca61051139d4a889aeec54c024fb10e-ao-7-A.svg", 
        "tmpbtmppw.png", 
        "paste-94704028876801.jpg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-1-Q.svg", 
        "69244d8c59534607afd4989bfe43930a-ao-1-Q.svg", 
        "fca61051139d4a889aeec54c024fb10e-ao-6-A.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-6-Q.svg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-4-A.svg", 
        "tmpbdwfrq.png", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-O.svg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-1-Q.svg", 
        "73a038139e5e45128883622fef3aa44a-ao-2-A.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-12-A.svg", 
        "2edcc191e58a4bd297d1f6301de69416-ao-4-A.svg", 
        "fca61051139d4a889aeec54c024fb10e-ao-4-A.svg", 
        "8b9d11e55af24760a2e902d9455c078b-ao-O.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-8-Q.svg", 
        "f45f83152d654f7aadc09c78cee80025-ao-1-A.svg", 
        "paste-239770844266497.jpg", 
        "3aa7f3b019184787bb8b25d1e956abb2-ao-4-A.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-7-Q.svg", 
        "949eee3a93554fa5acd8acb1cdfdeb4d-ao-1-Q.svg", 
        "e4954af151fc4b6684eb3077e80ecd4d-ao-3-Q.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-5-Q.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-1-A.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-6-A.svg", 
        "346af3bf3aba416dbf8f4f53ca163402-ao-3-A.svg", 
        "d286a1e9ee6547779ed0e02926655795-ao-3-A.svg", 
        "tmpvftffn.png", 
        "tmpaczdmx.png", 
        "paste-19812684136449.jpg", 
        "3efad90d456742cb90056c92b0c13663-oa-5-A.svg", 
        "e19ed494e6a347f6b02e0e386e0c73f0-oa-2-Q.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-8-A.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-14-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-7-Q.svg", 
        "paste-752224867188737.jpg", 
        "paste-8710193676289.jpg", 
        "a08cc10589774ec58d1813413c8b1b2d-ao-1-A.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-7-Q.svg", 
        "7c80e20563554169bc5d5374388e47ec-ao-2-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-8-A.svg", 
        "05e25644c8a34adda53563af5a11d2c9-ao-1-A.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-5-A.svg", 
        "47491ca45543444fb1b398bbb5eaafe6-ao-1-A.svg", 
        "paste-84146999263233.jpg", 
        "paste-631536286171137.jpg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-4-Q.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-9-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-5-A.svg", 
        "tmpful3du.png", 
        "3333092d7fa24648b826956283d014e6-ao-4-Q.svg", 
        "e3faec01942d401cbe1516d280823959-ao-6-Q.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-1-A.svg", 
        "e3faec01942d401cbe1516d280823959-ao-8-Q.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-8-Q.svg", 
        "paste-40402757353473.jpg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-6-A.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-6-Q.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-6-A.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-13-A.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-3-Q.svg", 
        "69244d8c59534607afd4989bfe43930a-ao-2-A.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-3-A.svg", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-2-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-10-A.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-4-A.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-4-A.svg", 
        "tmpn_mh6p.png", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-7-Q.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-1-Q.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-O.svg", 
        "3aeee34ace0044d09a0ab2b02a98d121-ao-O.svg", 
        "949eee3a93554fa5acd8acb1cdfdeb4d-ao-2-Q.svg", 
        "40370c712deb41489d993bc97a4ed075-ao-5-Q.svg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-5-Q.svg", 
        "3333092d7fa24648b826956283d014e6-ao-5-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-1-A.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-1-A.svg", 
        "52781e8155c04b6c82ee099b758e50c8-ao-1-A.svg", 
        "paste-42601780609025.jpg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-4-A.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-3-A.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-O.svg", 
        "paste-44564580663297.jpg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-4-Q.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-5-A.svg", 
        "d286a1e9ee6547779ed0e02926655795-ao-2-A.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-2-Q.svg", 
        "7c80e20563554169bc5d5374388e47ec-ao-1-Q.svg", 
        "40370c712deb41489d993bc97a4ed075-ao-6-A.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-6-A.svg", 
        "paste-239942642958337.jpg", 
        "7c80e20563554169bc5d5374388e47ec-ao-6-A.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-8-A.svg", 
        "paste-20392504721409.jpg", 
        "86fcf23a5df443fe915a0c8d3b527216-ao-1-Q.svg", 
        "3aa7f3b019184787bb8b25d1e956abb2-ao-3-A.svg", 
        "paste-37701222924289.jpg", 
        "paste-297748607795201.jpg", 
        "05e25644c8a34adda53563af5a11d2c9-ao-3-A.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-17-A.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-5-A.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-2-A.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-6-Q.svg", 
        "tmp4uludv.png", 
        "3333092d7fa24648b826956283d014e6-ao-1-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-17-A.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-3-A.svg", 
        "637ed61baa4e4103aee250203de67264-ao-3-A.svg", 
        "05e25644c8a34adda53563af5a11d2c9-ao-2-A.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-3-A.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-9-A.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-4-A.svg", 
        "b567c1cf56b1497aad235bcca8a7d41b-aa-O.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-9-A.svg", 
        "tmpwfxdbh.png", 
        "tmp1c9ml9.png", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-6-Q.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-5-Q.svg", 
        "6218b815d3914801b563c39312b32585-ao-2-A.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg", 
        "paste-226220222447617.jpg", 
        "paste-729044928692225.jpg", 
        "7c80e20563554169bc5d5374388e47ec-ao-3-A.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-1-A.svg", 
        "9d75589dbb3049cab84de554edf0ee42-ao-2-Q.svg", 
        "ee0fa0f7a85046288699624d42bc3854-ao-3-Q.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-2-Q.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-4-Q.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-5-A.svg", 
        "86fcf23a5df443fe915a0c8d3b527216-ao-3-A.svg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-1-Q.svg", 
        "949eee3a93554fa5acd8acb1cdfdeb4d-ao-3-A.svg", 
        "paste-723706284343297.jpg", 
        "paste-240715737071617.jpg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-2-A.svg", 
        "tmpmgx4yb.png", 
        "424dcadad47a486fa57e864f7dc532b7-ao-1-A.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-11-Q.svg", 
        "paste-226245992251393.jpg", 
        "3efad90d456742cb90056c92b0c13663-oa-10-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-8-A.svg", 
        "7c80e20563554169bc5d5374388e47ec-ao-O.svg", 
        "tmpht4sim.png", 
        "paste-41158671597569.jpg", 
        "52781e8155c04b6c82ee099b758e50c8-ao-5-A.svg", 
        "f45f83152d654f7aadc09c78cee80025-ao-2-A.svg", 
        "45752df80c334eaaa8be4bb49746d02b-ao-4-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-3-Q.svg", 
        "paste-5785320947713.jpg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-O.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-5-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-3-Q.svg", 
        "fca61051139d4a889aeec54c024fb10e-ao-O.svg", 
        "paste-26938034880513.jpg", 
        "40370c712deb41489d993bc97a4ed075-ao-1-A.svg", 
        "fb9ac26aca0842e0a7bc0774c629ca27-ao-3-Q.svg", 
        "paste-723899557871617.jpg", 
        "Chest_radiograph_of_a_lung_with_Kerley_B_lines_-_annotated.jpg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-3-Q.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-5-A.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-6-A.svg", 
        "paste-90426241449985.jpg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-2-A.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-2-A.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-8-Q.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-3-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-1-Q.svg", 
        "9a47d52de5124cc2bacee1e11193bd5f-ao-3-A.svg", 
        "73a038139e5e45128883622fef3aa44a-ao-O.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-O.svg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-5-A.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-4-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-15-Q.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-3-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-7-A.svg", 
        "9b930ae4601b43c88953957edb11298b-ao-O.svg", 
        "tmpmmb5et.png", 
        "57cb4863ccf945d598ce5f4518bda8c5-ao-5-Q.svg", 
        "paste-15002320764929.jpg", 
        "e3faec01942d401cbe1516d280823959-ao-1-Q.svg", 
        "a577b6793bf04096a6769bb0dba3284b-ao-2-Q.svg", 
        "tmpcfvxvs.png", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-1-Q.svg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-5-A.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-1-A.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-3-A.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-10-A.svg", 
        "cbb33d0be0b44b4c975bf5a8a97a6c52-ao-2-Q.svg", 
        "tmphxefvd.png", 
        "f3efa4d2ad314d118abd95a70e76c66c-ao-3-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-6-A.svg", 
        "tmpuqgpds.png", 
        "2e166cc3270146619840bd9235d3d698-ao-7-Q.svg", 
        "2edcc191e58a4bd297d1f6301de69416-ao-1-A.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-4-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-12-A.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-4-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-5-Q.svg", 
        "gila_01.jpg", 
        "8ff6f95822174b37946fdecf76625f13-ao-1-Q.svg", 
        "45752df80c334eaaa8be4bb49746d02b-ao-1-Q.svg", 
        "7744f708601047169ef739ac6d185723-ao-O.svg", 
        "tmpmmpikh.png", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-3-A.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-6-A.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-4-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-3-Q.svg", 
        "7744f708601047169ef739ac6d185723-ao-2-A.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-6-Q.svg", 
        "21a562a5036b48af849ce3c068e827a6-ao-1-A.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-7-A.svg", 
        "paste-241076514324481.jpg", 
        "e4954af151fc4b6684eb3077e80ecd4d-ao-2-Q.svg", 
        "tmpf56ngg.png", 
        "a8274d6edc5a471594aeb61f643110c5-ao-9-Q.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-12-Q.svg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-2-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-1-Q.svg", 
        "e0fa02d1e96747fc9984d3d86fbb9041-ao-2-Q.svg", 
        "tmpcmpnvo.png", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-2-Q.svg", 
        "e3faec01942d401cbe1516d280823959-ao-3-A.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-1-A.svg", 
        "3333092d7fa24648b826956283d014e6-ao-2-Q.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-3-A.svg", 
        "476f0a43f1fc4b98a92ee0702a838030-ao-1-Q.svg", 
        "9a47d52de5124cc2bacee1e11193bd5f-ao-O.svg", 
        "a577b6793bf04096a6769bb0dba3284b-ao-1-Q.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-6-Q.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-7-Q.svg", 
        "f189765dde4e44018698a3425c30ac77-ao-1-A.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-4-Q.svg", 
        "346af3bf3aba416dbf8f4f53ca163402-ao-1-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-9-A.svg", 
        "f189765dde4e44018698a3425c30ac77-ao-5-A.svg", 
        "paste-631716674797569.jpg", 
        "a6ef346cdd714beeba506139f702194c-ao-8-A.svg", 
        "tmpmesev0.png", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-16-A.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-5-Q.svg", 
        "424dcadad47a486fa57e864f7dc532b7-ao-2-Q.svg", 
        "paste-102958956019713.jpg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-7-A.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-O.svg", 
        "da2f6aba7da7441d944fc99508e0d38f-ao-O.svg", 
        "ee0fa0f7a85046288699624d42bc3854-ao-3-A.svg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-2-Q.svg", 
        "9d75589dbb3049cab84de554edf0ee42-ao-2-A.svg", 
        "tmpbkq8c9.png", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-3-Q.svg", 
        "69244d8c59534607afd4989bfe43930a-ao-O.svg", 
        "8b9d11e55af24760a2e902d9455c078b-ao-1-A.svg", 
        "7c80e20563554169bc5d5374388e47ec-ao-1-A.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-3-Q.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-5-Q.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-6-Q.svg", 
        "637ed61baa4e4103aee250203de67264-ao-2-Q.svg", 
        "3333092d7fa24648b826956283d014e6-ao-3-Q.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-7-A.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-3-A.svg", 
        "paste-5153960755201.jpg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-7-Q.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-8-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-11-A.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-6-Q.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-11-Q.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-7-A.svg", 
        "86fcf23a5df443fe915a0c8d3b527216-ao-2-Q.svg", 
        "tmplwciiq.png", 
        "3aa7f3b019184787bb8b25d1e956abb2-ao-4-Q.svg", 
        "3aeee34ace0044d09a0ab2b02a98d121-ao-1-A.svg", 
        "57cb4863ccf945d598ce5f4518bda8c5-ao-1-Q.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg", 
        "476f0a43f1fc4b98a92ee0702a838030-ao-4-Q.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-1-A.svg", 
        "e19ed494e6a347f6b02e0e386e0c73f0-oa-3-Q.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-8-A.svg", 
        "52781e8155c04b6c82ee099b758e50c8-ao-2-Q.svg", 
        "52781e8155c04b6c82ee099b758e50c8-ao-4-A.svg", 
        "424dcadad47a486fa57e864f7dc532b7-ao-O.svg", 
        "e3faec01942d401cbe1516d280823959-ao-5-A.svg", 
        "949eee3a93554fa5acd8acb1cdfdeb4d-ao-2-A.svg", 
        "ad96db1f3c094851a73354db2488a812-ao-1-A.svg", 
        "3333092d7fa24648b826956283d014e6-ao-3-A.svg", 
        "988f2a4be17449eda5b5289d45856744-ao-2-Q.svg", 
        "988f2a4be17449eda5b5289d45856744-ao-5-Q.svg", 
        "32f45114f3f941aeaea0049234da3262-ao-2-A.svg", 
        "86fcf23a5df443fe915a0c8d3b527216-ao-3-Q.svg", 
        "paste-14534169329665.jpg", 
        "9a47d52de5124cc2bacee1e11193bd5f-ao-2-A.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-2-A.svg", 
        "paste-119541824749569.jpg", 
        "eb3e9520847748738c28835188fd95e4-ao-6-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-8-A.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-7-Q.svg", 
        "fca61051139d4a889aeec54c024fb10e-ao-1-Q.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-10-A.svg", 
        "73a038139e5e45128883622fef3aa44a-ao-3-Q.svg", 
        "40370c712deb41489d993bc97a4ed075-ao-5-A.svg", 
        "3333092d7fa24648b826956283d014e6-ao-5-A.svg", 
        "2a9b029671cf45dcb4656aeeae293fc5-oa-3-Q.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-2-A.svg", 
        "paste-38478612004865.jpg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-12-Q.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-2-Q.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-1-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-4-Q.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-6-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-8-A.svg", 
        "988f2a4be17449eda5b5289d45856744-ao-5-A.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-8-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-10-A.svg", 
        "e4954af151fc4b6684eb3077e80ecd4d-ao-1-A.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-12-Q.svg", 
        "45752df80c334eaaa8be4bb49746d02b-ao-O.svg", 
        "paste-42021960024065.jpg", 
        "paste-6665789243393.jpg", 
        "e3faec01942d401cbe1516d280823959-ao-O.svg", 
        "tmpxtuydd.png", 
        "06769536f22b4e50b17c7572b9456594-ao-1-A.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-6-Q.svg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-5-Q.svg", 
        "a08cc10589774ec58d1813413c8b1b2d-ao-3-A.svg", 
        "2edcc191e58a4bd297d1f6301de69416-ao-2-A.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-3-Q.svg", 
        "476f0a43f1fc4b98a92ee0702a838030-ao-2-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-1-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-9-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-14-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-2-Q.svg", 
        "79ea9babed5846b48cbd210dce585292-ao-1-Q.svg", 
        "paste-77133317668865.jpg", 
        "32f45114f3f941aeaea0049234da3262-ao-1-Q.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-7-A.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-7-A.svg", 
        "52781e8155c04b6c82ee099b758e50c8-ao-O.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-6-A.svg", 
        "tmpwthhra.png", 
        "paste-723852313231361.jpg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-O.svg", 
        "b567c1cf56b1497aad235bcca8a7d41b-aa-1-A.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-1-A.svg", 
        "2a9b029671cf45dcb4656aeeae293fc5-oa-2-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-12-Q.svg", 
        "paste-7425998454785.jpg", 
        "1bfd58a838f247ea8ca14a0345f18743-ao-1-A.svg", 
        "cbb33d0be0b44b4c975bf5a8a97a6c52-ao-3-A.svg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-5-A.svg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-1-A.svg", 
        "79ea9babed5846b48cbd210dce585292-ao-3-Q.svg", 
        "f933f4c7e73d09aede91c52d5a476c2d.jpg", 
        "ad96db1f3c094851a73354db2488a812-ao-O.svg", 
        "e3faec01942d401cbe1516d280823959-ao-9-A.svg", 
        "cbb33d0be0b44b4c975bf5a8a97a6c52-ao-1-Q.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-8-Q.svg", 
        "e3faec01942d401cbe1516d280823959-ao-10-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-4-Q.svg", 
        "paste-67976447393793.jpg", 
        "ad96db1f3c094851a73354db2488a812-ao-2-Q.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-1-A.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-11-A.svg", 
        "da2f6aba7da7441d944fc99508e0d38f-ao-1-A.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-2-A.svg", 
        "3333092d7fa24648b826956283d014e6-ao-6-Q.svg", 
        "7c80e20563554169bc5d5374388e47ec-ao-5-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-4-A.svg", 
        "9a47d52de5124cc2bacee1e11193bd5f-ao-1-Q.svg", 
        "69244d8c59534607afd4989bfe43930a-ao-3-A.svg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-3-A.svg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-6-A.svg", 
        "paste-625201209409537.jpg", 
        "2f9752605f61461fbc2f126347688db1-ao-1-Q.svg", 
        "8b9d11e55af24760a2e902d9455c078b-ao-2-A.svg", 
        "a08cc10589774ec58d1813413c8b1b2d-ao-2-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-17-Q.svg", 
        "paste-26688926777345.jpg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-7-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-2-A.svg", 
        "9a47d52de5124cc2bacee1e11193bd5f-ao-1-A.svg", 
        "5842a16355004d39af51ed18e1b30126-ao-4-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-10-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-2-Q.svg", 
        "424dcadad47a486fa57e864f7dc532b7-ao-3-A.svg", 
        "paste-13645111099393.jpg", 
        "paste-695694507638785.jpg", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-2-A.svg", 
        "paste-632008732573697.jpg", 
        "tmpzhc2ks.png", 
        "9a40f62570e4455db93b0f94a01effe6-ao-1-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-11-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-15-Q.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-7-A.svg", 
        "f45f83152d654f7aadc09c78cee80025-ao-3-A.svg", 
        "paste-631622185517057.jpg", 
        "476f0a43f1fc4b98a92ee0702a838030-ao-3-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-11-Q.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-1-A.svg", 
        "3aeee34ace0044d09a0ab2b02a98d121-ao-1-Q.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-O.svg", 
        "f45f83152d654f7aadc09c78cee80025-ao-O.svg", 
        "paste-710185727295489.jpg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-4-A.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-16-Q.svg", 
        "424dcadad47a486fa57e864f7dc532b7-ao-2-A.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-6-Q.svg", 
        "c7156e55d7ad42bf9cd9efeb16e773d5-ao-3-A.svg", 
        "79ea9babed5846b48cbd210dce585292-ao-O.svg", 
        "52781e8155c04b6c82ee099b758e50c8-ao-3-Q.svg", 
        "2edcc191e58a4bd297d1f6301de69416-ao-1-Q.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-4-A.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-10-A.svg", 
        "c7156e55d7ad42bf9cd9efeb16e773d5-ao-1-Q.svg", 
        "e3faec01942d401cbe1516d280823959-ao-7-Q.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-5-A.svg", 
        "paste-5308579577857.jpg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-5-A.svg", 
        "2a9b029671cf45dcb4656aeeae293fc5-oa-1-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-5-Q.svg", 
        "tmpzppauq.png", 
        "9a40f62570e4455db93b0f94a01effe6-ao-2-Q.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-9-Q.svg", 
        "3aa7f3b019184787bb8b25d1e956abb2-ao-1-Q.svg", 
        "paste-75896367087617.jpg", 
        "7380b5e4bfb04ae3aa341425dca3c2ae-ao-O.svg", 
        "tmplargxl.png", 
        "tmpy_vagu.png", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-1-A.svg", 
        "ee0fa0f7a85046288699624d42bc3854-ao-1-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-7-A.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-3-A.svg", 
        "fca61051139d4a889aeec54c024fb10e-ao-1-A.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-10-Q.svg", 
        "73a038139e5e45128883622fef3aa44a-ao-3-A.svg", 
        "e3faec01942d401cbe1516d280823959-ao-5-Q.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-2-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-3-A.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-2-A.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-4-Q.svg", 
        "86fcf23a5df443fe915a0c8d3b527216-ao-4-Q.svg", 
        "tmp7gtalh.png", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-3-A.svg", 
        "2a9b029671cf45dcb4656aeeae293fc5-oa-4-Q.svg", 
        "tmprztwtk.png", 
        "a8274d6edc5a471594aeb61f643110c5-ao-1-A.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg", 
        "f3efa4d2ad314d118abd95a70e76c66c-ao-O.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-1-A.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-4-Q.svg", 
        "9a47d52de5124cc2bacee1e11193bd5f-ao-4-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-16-Q.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-8-Q.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-1-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-14-Q.svg", 
        "e3faec01942d401cbe1516d280823959-ao-2-A.svg", 
        "9b930ae4601b43c88953957edb11298b-ao-2-A.svg", 
        "47491ca45543444fb1b398bbb5eaafe6-ao-1-Q.svg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-5-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-18-A.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-3-A.svg", 
        "988f2a4be17449eda5b5289d45856744-ao-3-A.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-6-A.svg", 
        "57cb4863ccf945d598ce5f4518bda8c5-ao-4-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-11-A.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-7-A.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-1-A.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-2-A.svg", 
        "d286a1e9ee6547779ed0e02926655795-ao-1-Q.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-5-A.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-11-A.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-6-Q.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-14-Q.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-1-A.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-6-A.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-5-A.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-4-A.svg", 
        "637ed61baa4e4103aee250203de67264-ao-4-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-3-Q.svg", 
        "32f45114f3f941aeaea0049234da3262-ao-1-A.svg", 
        "tmpkejhbc.png", 
        "fb9ac26aca0842e0a7bc0774c629ca27-ao-3-A.svg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-7-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-O.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-10-A.svg", 
        "paste-26014616911873.jpg", 
        "05e25644c8a34adda53563af5a11d2c9-ao-4-A.svg", 
        "fca61051139d4a889aeec54c024fb10e-ao-7-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-6-Q.svg", 
        "paste-70446053588993.jpg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-8-A.svg", 
        "7744f708601047169ef739ac6d185723-ao-1-A.svg", 
        "paste-241299852623873.jpg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-14-A.svg", 
        "57cb4863ccf945d598ce5f4518bda8c5-ao-3-Q.svg", 
        "tmpwk03le.png", 
        "paste-20963735371777.jpg", 
        "paste-704164183146497.jpg", 
        "e4954af151fc4b6684eb3077e80ecd4d-ao-1-Q.svg", 
        "ee0fa0f7a85046288699624d42bc3854-ao-2-A.svg", 
        "939d75215998468259a6ab7ca34f23_big_gallery.jpeg", 
        "3efad90d456742cb90056c92b0c13663-oa-13-A.svg", 
        "fb9ac26aca0842e0a7bc0774c629ca27-ao-O.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-9-Q.svg", 
        "e0fa02d1e96747fc9984d3d86fbb9041-ao-2-A.svg", 
        "988f2a4be17449eda5b5289d45856744-ao-1-A.svg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-3-A.svg", 
        "fca61051139d4a889aeec54c024fb10e-ao-3-Q.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-13-Q.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-3-Q.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-3-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-3-A.svg", 
        "e3faec01942d401cbe1516d280823959-ao-2-Q.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-6-Q.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-7-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-3-Q.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-5-A.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-19-A.svg", 
        "45752df80c334eaaa8be4bb49746d02b-ao-3-Q.svg", 
        "52781e8155c04b6c82ee099b758e50c8-ao-4-Q.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-7-A.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-10-A.svg", 
        "5842a16355004d39af51ed18e1b30126-ao-4-A.svg", 
        "e19ed494e6a347f6b02e0e386e0c73f0-oa-2-A.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-3-Q.svg", 
        "988f2a4be17449eda5b5289d45856744-ao-2-A.svg", 
        "7c80e20563554169bc5d5374388e47ec-ao-4-A.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-O.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-11-A.svg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-O.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-9-A.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-5-A.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-6-A.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-7-A.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-5-Q.svg", 
        "fca61051139d4a889aeec54c024fb10e-ao-3-A.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-13-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-8-Q.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-6-Q.svg", 
        "2a9b029671cf45dcb4656aeeae293fc5-oa-3-A.svg", 
        "tmpnqvtuo.png", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-6-Q.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-11-Q.svg", 
        "e3faec01942d401cbe1516d280823959-ao-3-Q.svg", 
        "paste-55074365636609.jpg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-4-Q.svg", 
        "paste-8985071583233.jpg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-14-A.svg", 
        "paste-26676041875457 (1).jpg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-6-A.svg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-1-A.svg", 
        "32f45114f3f941aeaea0049234da3262-ao-3-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-12-A.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-7-A.svg", 
        "paste-25941602467841.jpg", 
        "949eee3a93554fa5acd8acb1cdfdeb4d-ao-1-A.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-6-A.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-5-A.svg", 
        "988f2a4be17449eda5b5289d45856744-ao-4-A.svg", 
        "346af3bf3aba416dbf8f4f53ca163402-ao-3-Q.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-7-A.svg", 
        "paste-711792045064193.jpg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-2-A.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-9-Q.svg", 
        "47491ca45543444fb1b398bbb5eaafe6-ao-2-A.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-1-Q.svg", 
        "32f45114f3f941aeaea0049234da3262-ao-3-A.svg", 
        "tmpprdi4h.png", 
        "tmp0xchjr.png", 
        "paste-114804475822081.jpg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-3-A.svg", 
        "paste-47712791691265.jpg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-1-A.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-4-A.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-5-Q.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-1-Q.svg", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-4-Q.svg", 
        "e4954af151fc4b6684eb3077e80ecd4d-ao-O.svg", 
        "paste-36528696852481.jpg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-5-Q.svg", 
        "f45f83152d654f7aadc09c78cee80025-ao-1-Q.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-4-A.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-3-A.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-1-Q.svg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-4-A.svg", 
        "paste-42404212113409.jpg", 
        "paste-118803090374657.jpg", 
        "paste-38482906972161.jpg", 
        "988f2a4be17449eda5b5289d45856744-ao-3-Q.svg", 
        "e3faec01942d401cbe1516d280823959-ao-10-A.svg", 
        "637ed61baa4e4103aee250203de67264-ao-1-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-11-Q.svg", 
        "paste-119464515338241.jpg", 
        "paste-104191611633665.jpg", 
        "73a038139e5e45128883622fef3aa44a-ao-4-A.svg", 
        "paste-90537910599681.jpg", 
        "9d75589dbb3049cab84de554edf0ee42-ao-1-Q.svg", 
        "73a038139e5e45128883622fef3aa44a-ao-1-Q.svg", 
        "637ed61baa4e4103aee250203de67264-ao-3-Q.svg", 
        "f189765dde4e44018698a3425c30ac77-ao-3-Q.svg", 
        "79ea9babed5846b48cbd210dce585292-ao-2-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-2-A.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-5-A.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-6-Q.svg", 
        "da2f6aba7da7441d944fc99508e0d38f-ao-1-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-2-A.svg", 
        "paste-14667313315841.jpg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-10-A.svg", 
        "7380b5e4bfb04ae3aa341425dca3c2ae-ao-1-Q.svg", 
        "e19ed494e6a347f6b02e0e386e0c73f0-oa-4-A.svg", 
        "7c80e20563554169bc5d5374388e47ec-ao-6-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-6-A.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-3-Q.svg", 
        "3333092d7fa24648b826956283d014e6-ao-4-A.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-4-A.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-9-A.svg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-2-Q.svg", 
        "tmp3tqrgq.png", 
        "paste-25718264168449.jpg", 
        "f189765dde4e44018698a3425c30ac77-ao-2-Q.svg", 
        "2edcc191e58a4bd297d1f6301de69416-ao-O.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-1-A.svg", 
        "tmpsavpu1.png", 
        "416edf9b137c49ecb0752d56325dc86e-ao-1-Q.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-4-Q.svg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-3-Q.svg", 
        "cbb33d0be0b44b4c975bf5a8a97a6c52-ao-O.svg", 
        "45752df80c334eaaa8be4bb49746d02b-ao-4-Q.svg", 
        "8b9d11e55af24760a2e902d9455c078b-ao-3-A.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-2-A.svg", 
        "a577b6793bf04096a6769bb0dba3284b-ao-2-A.svg", 
        "paste-623453157720065.jpg", 
        "paste-320065257865217.jpg", 
        "2a9b029671cf45dcb4656aeeae293fc5-oa-O.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-2-Q.svg", 
        "ad96db1f3c094851a73354db2488a812-ao-1-Q.svg", 
        "3aa7f3b019184787bb8b25d1e956abb2-ao-3-Q.svg", 
        "f3efa4d2ad314d118abd95a70e76c66c-ao-2-Q.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-O.svg", 
        "4623716c49b34a94bc45e7c85e3078f3-ao-O.svg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-6-Q.svg", 
        "e0fa02d1e96747fc9984d3d86fbb9041-ao-1-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-5-Q.svg", 
        "paste-20388209754113.jpg", 
        "3efad90d456742cb90056c92b0c13663-oa-14-A.svg", 
        "05e25644c8a34adda53563af5a11d2c9-ao-3-Q.svg", 
        "fca61051139d4a889aeec54c024fb10e-ao-5-A.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-8-A.svg", 
        "40370c712deb41489d993bc97a4ed075-ao-O.svg", 
        "paste-225545912582145.jpg", 
        "40370c712deb41489d993bc97a4ed075-ao-3-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-15-A.svg", 
        "paste-52072183496705.jpg", 
        "f3efa4d2ad314d118abd95a70e76c66c-ao-2-A.svg", 
        "5842a16355004d39af51ed18e1b30126-ao-O.svg", 
        "5842a16355004d39af51ed18e1b30126-ao-3-A.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-8-A.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-9-A.svg", 
        "e3faec01942d401cbe1516d280823959-ao-4-Q.svg", 
        "tmpgqvkgb.png", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-2-A.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-5-Q.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-12-Q.svg", 
        "86fcf23a5df443fe915a0c8d3b527216-ao-4-A.svg", 
        "tmp3qsrby.png", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-1-Q.svg", 
        "f3efa4d2ad314d118abd95a70e76c66c-ao-1-A.svg", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-6-Q.svg", 
        "paste-88626650152961.jpg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-5-Q.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-7-A.svg", 
        "7c80e20563554169bc5d5374388e47ec-ao-4-Q.svg", 
        "tmp0e58ud.png", 
        "e19ed494e6a347f6b02e0e386e0c73f0-oa-4-Q.svg", 
        "tmp2ep58n.png", 
        "tmphzsimf.png", 
        "06769536f22b4e50b17c7572b9456594-ao-10-A.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-8-Q.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-3-Q.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-4-A.svg", 
        "ad96db1f3c094851a73354db2488a812-ao-3-A.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-2-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-9-Q.svg", 
        "79ea9babed5846b48cbd210dce585292-ao-3-A.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-7-A.svg", 
        "f189765dde4e44018698a3425c30ac77-ao-4-Q.svg", 
        "tmpaeujxg.png", 
        "476f0a43f1fc4b98a92ee0702a838030-ao-1-A.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-8-Q.svg", 
        "2edcc191e58a4bd297d1f6301de69416-ao-3-A.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-5-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-11-A.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-O.svg", 
        "paste-14813342203905.jpg", 
        "d286a1e9ee6547779ed0e02926655795-ao-1-A.svg", 
        "d286a1e9ee6547779ed0e02926655795-ao-O.svg", 
        "paste-147351737991169.jpg", 
        "paste-9942849290241.jpg", 
        "05e25644c8a34adda53563af5a11d2c9-ao-1-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-7-Q.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-14-A.svg", 
        "paste-7258494730241.jpg", 
        "paste-237430087090177.jpg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-O.svg", 
        "paste-633310107664385.jpg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-9-A.svg", 
        "346af3bf3aba416dbf8f4f53ca163402-ao-O.svg", 
        "tmp53sjtz.png", 
        "paste-5158255722497.jpg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-4-A.svg", 
        "tmpkhv23b.png", 
        "15439e09c73b4cc38607fdfcfa984152-ao-7-Q.svg", 
        "69244d8c59534607afd4989bfe43930a-ao-1-A.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-4-Q.svg", 
        "40370c712deb41489d993bc97a4ed075-ao-2-Q.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-2-A.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-7-A.svg", 
        "fb9ac26aca0842e0a7bc0774c629ca27-ao-1-Q.svg", 
        "476f0a43f1fc4b98a92ee0702a838030-ao-2-A.svg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-6-A.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-11-A.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-10-A.svg", 
        "b567c1cf56b1497aad235bcca8a7d41b-aa-2-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-7-Q.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-3-A.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-2-A.svg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-7-A.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-6-Q.svg", 
        "paste-23300197580801.jpg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-1-A.svg", 
        "paste-405539402022913.jpg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-5-Q.svg", 
        "6218b815d3914801b563c39312b32585-ao-1-A.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-4-Q.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-3-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-10-Q.svg", 
        "e19ed494e6a347f6b02e0e386e0c73f0-oa-3-A.svg", 
        "paste-744889063047169.jpg", 
        "paste-240818816286721.jpg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-1-Q.svg", 
        "57cb4863ccf945d598ce5f4518bda8c5-ao-1-A.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-5-Q.svg", 
        "paste-700586475388929.jpg", 
        "9b930ae4601b43c88953957edb11298b-ao-1-A.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-10-A.svg", 
        "c7156e55d7ad42bf9cd9efeb16e773d5-ao-2-A.svg", 
        "9d75589dbb3049cab84de554edf0ee42-ao-O.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-6-A.svg", 
        "f189765dde4e44018698a3425c30ac77-ao-5-Q.svg", 
        "4623716c49b34a94bc45e7c85e3078f3-ao-1-Q.svg", 
        "21a562a5036b48af849ce3c068e827a6-ao-1-Q.svg", 
        "637ed61baa4e4103aee250203de67264-ao-O.svg", 
        "tmpuxsxrr.png", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-7-Q.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-5-A.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-7-Q.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-3-A.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-2-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-9-Q.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-6-Q.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-3-A.svg", 
        "47491ca45543444fb1b398bbb5eaafe6-ao-2-Q.svg", 
        "paste-729023453855745.jpg", 
        "9b930ae4601b43c88953957edb11298b-ao-1-Q.svg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-6-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-5-A.svg", 
        "tmp73mfto.png", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-5-Q.svg", 
        "6218b815d3914801b563c39312b32585-ao-2-Q.svg", 
        "9a47d52de5124cc2bacee1e11193bd5f-ao-2-Q.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-2-Q.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-O.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-9-Q.svg", 
        "paste-5196910428161.jpg", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-O.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-5-Q.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-6-A.svg", 
        "paste-95764885798913.jpg", 
        "paste-147240068841473.jpg", 
        "73a038139e5e45128883622fef3aa44a-ao-2-Q.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-9-Q.svg", 
        "52781e8155c04b6c82ee099b758e50c8-ao-1-Q.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-5-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-5-A.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-9-Q.svg", 
        "949eee3a93554fa5acd8acb1cdfdeb4d-ao-O.svg", 
        "paste-9534827397121.jpg", 
        "tmpftfert.png", 
        "8b9d11e55af24760a2e902d9455c078b-ao-1-Q.svg", 
        "paste-710018223570945.jpg", 
        "fca61051139d4a889aeec54c024fb10e-ao-2-Q.svg", 
        "e3faec01942d401cbe1516d280823959-ao-8-A.svg", 
        "e0fa02d1e96747fc9984d3d86fbb9041-ao-O.svg", 
        "tmphfgmhw.png", 
        "fca61051139d4a889aeec54c024fb10e-ao-4-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-8-Q.svg", 
        "paste-13731010445313.jpg", 
        "9d75589dbb3049cab84de554edf0ee42-ao-1-A.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-7-Q.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-7-Q.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-3-Q.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-12-A.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-1-Q.svg", 
        "paste-227229539762177.jpg", 
        "f189765dde4e44018698a3425c30ac77-ao-4-A.svg", 
        "1bfd58a838f247ea8ca14a0345f18743-ao-1-Q.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-2-Q.svg", 
        "e3faec01942d401cbe1516d280823959-ao-6-A.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-3-A.svg", 
        "79ea9babed5846b48cbd210dce585292-ao-2-A.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-8-A.svg", 
        "14ab4892fd5a49bfb60774ff4d79b1db-ao-4-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-8-Q.svg", 
        "paste-13623636262913.jpg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-4-A.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-3-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-8-Q.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-7-A.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-2-A.svg", 
        "a08cc10589774ec58d1813413c8b1b2d-ao-1-Q.svg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-4-Q.svg", 
        "86fcf23a5df443fe915a0c8d3b527216-ao-1-A.svg", 
        "paste-698632265269249.jpg", 
        "40370c712deb41489d993bc97a4ed075-ao-6-Q.svg", 
        "f189765dde4e44018698a3425c30ac77-ao-2-A.svg", 
        "tmp3mhsu_.png", 
        "a6ef346cdd714beeba506139f702194c-ao-8-Q.svg", 
        "2edcc191e58a4bd297d1f6301de69416-ao-3-Q.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-4-Q.svg", 
        "2edcc191e58a4bd297d1f6301de69416-ao-2-Q.svg", 
        "32f45114f3f941aeaea0049234da3262-ao-2-Q.svg", 
        "tmphgkv4v.png", 
        "e3faec01942d401cbe1516d280823959-ao-11-A.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-1-A.svg", 
        "tmpwjvd9h.png", 
        "f45f83152d654f7aadc09c78cee80025-ao-2-Q.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-7-Q.svg", 
        "988f2a4be17449eda5b5289d45856744-ao-O.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-6-A.svg", 
        "79ea9babed5846b48cbd210dce585292-ao-1-A.svg", 
        "7c80e20563554169bc5d5374388e47ec-ao-3-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-4-A.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-2-Q.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-3-A.svg", 
        "637ed61baa4e4103aee250203de67264-ao-5-Q.svg", 
        "57cb4863ccf945d598ce5f4518bda8c5-ao-2-Q.svg", 
        "paste-90619514978305.jpg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-8-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-6-A.svg", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-5-Q.svg", 
        "paste-27346056773633.jpg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-4-A.svg", 
        "paste-633305812697089.jpg", 
        "tmpwyfkeh.png", 
        "45752df80c334eaaa8be4bb49746d02b-ao-1-A.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-4-A.svg", 
        "40370c712deb41489d993bc97a4ed075-ao-4-A.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-17-Q.svg", 
        "40370c712deb41489d993bc97a4ed075-ao-1-Q.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-8-A.svg", 
        "paste-104187316666369.jpg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-18-Q.svg", 
        "cbb33d0be0b44b4c975bf5a8a97a6c52-ao-1-A.svg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-6-Q.svg", 
        "949eee3a93554fa5acd8acb1cdfdeb4d-ao-3-Q.svg", 
        "tmpvtsoih.png", 
        "7380b5e4bfb04ae3aa341425dca3c2ae-ao-1-A.svg", 
        "69244d8c59534607afd4989bfe43930a-ao-2-Q.svg", 
        "cbb33d0be0b44b4c975bf5a8a97a6c52-ao-3-Q.svg", 
        "476f0a43f1fc4b98a92ee0702a838030-ao-O.svg", 
        "tmpnx3dnv.png", 
        "a08cc10589774ec58d1813413c8b1b2d-ao-O.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-O.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-11-Q.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-1-Q.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-4-Q.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-11-A.svg", 
        "9a47d52de5124cc2bacee1e11193bd5f-ao-5-Q.svg", 
        "3aa7f3b019184787bb8b25d1e956abb2-ao-2-A.svg", 
        "f3efa4d2ad314d118abd95a70e76c66c-ao-3-A.svg", 
        "424dcadad47a486fa57e864f7dc532b7-ao-1-Q.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-6-A.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-2-Q.svg", 
        "paste-723719169245185.jpg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-9-Q.svg", 
        "637ed61baa4e4103aee250203de67264-ao-1-A.svg", 
        "45752df80c334eaaa8be4bb49746d02b-ao-2-Q.svg", 
        "2a9b029671cf45dcb4656aeeae293fc5-oa-4-A.svg", 
        "52781e8155c04b6c82ee099b758e50c8-ao-3-A.svg", 
        "57cb4863ccf945d598ce5f4518bda8c5-ao-O.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-3-A.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-2-Q.svg", 
        "f189765dde4e44018698a3425c30ac77-ao-1-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-9-A.svg", 
        "346af3bf3aba416dbf8f4f53ca163402-ao-1-A.svg", 
        "a577b6793bf04096a6769bb0dba3284b-ao-1-A.svg", 
        "e3faec01942d401cbe1516d280823959-ao-4-A.svg", 
        "da2f6aba7da7441d944fc99508e0d38f-ao-2-A.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-1-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-5-A.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-9-A.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-8-A.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-1-Q.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-11-Q.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-2-Q.svg", 
        "f189765dde4e44018698a3425c30ac77-ao-O.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-6-Q.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-11-Q.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-7-Q.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-6-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-O.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-6-Q.svg", 
        "paste-48752173776897 (1).jpg", 
        "3333092d7fa24648b826956283d014e6-ao-6-A.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-O.svg", 
        "paste-48056389074945.jpg", 
        "69244d8c59534607afd4989bfe43930a-ao-3-Q.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-11-A.svg", 
        "3333092d7fa24648b826956283d014e6-ao-2-A.svg", 
        "a577b6793bf04096a6769bb0dba3284b-ao-O.svg", 
        "e3faec01942d401cbe1516d280823959-ao-7-A.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-1-A.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-11-Q.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-2-A.svg", 
        "57cb4863ccf945d598ce5f4518bda8c5-ao-4-A.svg", 
        "346af3bf3aba416dbf8f4f53ca163402-ao-2-Q.svg", 
        "6218b815d3914801b563c39312b32585-ao-O.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-2-A.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-5-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-7-Q.svg", 
        "1bfd58a838f247ea8ca14a0345f18743-ao-O.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-4-Q.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-6-A.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-4-A.svg", 
        "9a47d52de5124cc2bacee1e11193bd5f-ao-3-Q.svg", 
        "d3c837e1782a4d78bb9805eb54cc42ca-ao-6-A.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-10-A.svg", 
        "6218b815d3914801b563c39312b32585-ao-3-Q.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-9-Q.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-2-A.svg", 
        "40370c712deb41489d993bc97a4ed075-ao-2-A.svg", 
        "7744f708601047169ef739ac6d185723-ao-2-Q.svg", 
        "ee0fa0f7a85046288699624d42bc3854-ao-2-Q.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-5-A.svg", 
        "fb9ac26aca0842e0a7bc0774c629ca27-ao-1-A.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-2-A.svg", 
        "9b930ae4601b43c88953957edb11298b-ao-3-A.svg", 
        "tmpca8v12.png", 
        "6218b815d3914801b563c39312b32585-ao-3-A.svg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-3-Q.svg", 
        "b567c1cf56b1497aad235bcca8a7d41b-aa-2-A.svg", 
        "tmptwk7dg.png", 
        "f45f83152d654f7aadc09c78cee80025-ao-3-Q.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-2-Q.svg", 
        "tmpzmqz_c.png", 
        "a6ef346cdd714beeba506139f702194c-ao-3-Q.svg", 
        "c7156e55d7ad42bf9cd9efeb16e773d5-ao-2-Q.svg", 
        "86fcf23a5df443fe915a0c8d3b527216-ao-O.svg", 
        "e4954af151fc4b6684eb3077e80ecd4d-ao-2-A.svg", 
        "e3faec01942d401cbe1516d280823959-ao-9-Q.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-4-A.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-7-A.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-5-A.svg", 
        "3aa7f3b019184787bb8b25d1e956abb2-ao-2-Q.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-9-A.svg", 
        "a6ef346cdd714beeba506139f702194c-ao-2-Q.svg", 
        "paste-326207061098497.jpg", 
        "eb3e9520847748738c28835188fd95e4-ao-3-A.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-1-Q.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-2-Q.svg", 
        "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-5-Q.svg", 
        "paste-629650795528193.jpg", 
        "tmpdun3wp.png", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-6-A.svg", 
        "paste-623358668439553.jpg", 
        "06769536f22b4e50b17c7572b9456594-ao-5-Q.svg", 
        "ee0fa0f7a85046288699624d42bc3854-ao-O.svg", 
        "86fcf23a5df443fe915a0c8d3b527216-ao-2-A.svg", 
        "tmpw7n71m.png", 
        "paste-16423954939905.jpg", 
        "9a47d52de5124cc2bacee1e11193bd5f-ao-5-A.svg", 
        "tmpl9skhi.png", 
        "tmp1wkkew.png", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-5-A.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-2-Q.svg", 
        "47491ca45543444fb1b398bbb5eaafe6-ao-3-Q.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-1-Q.svg", 
        "paste-48567490183169.jpg", 
        "476f0a43f1fc4b98a92ee0702a838030-ao-4-A.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-7-A.svg", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-5-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-3-A.svg", 
        "8ff6f95822174b37946fdecf76625f13-ao-4-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-8-A.svg", 
        "paste-105621835743233.jpg", 
        "57cb4863ccf945d598ce5f4518bda8c5-ao-3-A.svg", 
        "3efad90d456742cb90056c92b0c13663-oa-4-Q.svg", 
        "9c0771cd971c48a299fcc0625e70d317-ao-2-A.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-10-Q.svg", 
        "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-2-A.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-10-Q.svg", 
        "bbf40be7fba14a59b224ab47ee07a4b5-ao-3-A.svg", 
        "tmpwzzqaz.png", 
        "a8274d6edc5a471594aeb61f643110c5-ao-2-A.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-5-Q.svg", 
        "tmpxnfucu.png", 
        "15439e09c73b4cc38607fdfcfa984152-ao-9-Q.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-10-A.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-6-Q.svg", 
        "fca61051139d4a889aeec54c024fb10e-ao-6-Q.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-6-A.svg", 
        "tmpt8_ojk.png", 
        "2edcc191e58a4bd297d1f6301de69416-ao-4-Q.svg", 
        "b567c1cf56b1497aad235bcca8a7d41b-aa-1-Q.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-7-Q.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-O.svg", 
        "9a47d52de5124cc2bacee1e11193bd5f-ao-4-A.svg", 
        "tmpxb_icv.png", 
        "tmpmrkxyw.png", 
        "tmpkvknuj.png", 
        "57cb4863ccf945d598ce5f4518bda8c5-ao-2-A.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-15-A.svg", 
        "paste-9247064588289.jpg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-10-Q.svg", 
        "6218b815d3914801b563c39312b32585-ao-1-Q.svg", 
        "9b930ae4601b43c88953957edb11298b-ao-2-Q.svg", 
        "e4954af151fc4b6684eb3077e80ecd4d-ao-3-A.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-1-Q.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-12-Q.svg", 
        "7744f708601047169ef739ac6d185723-ao-1-Q.svg", 
        "eb3e9520847748738c28835188fd95e4-ao-1-A.svg", 
        "d286a1e9ee6547779ed0e02926655795-ao-3-Q.svg", 
        "paste-13945758810113.jpg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-6-A.svg", 
        "paste-36704790511617.jpg", 
        "05e25644c8a34adda53563af5a11d2c9-ao-O.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-4-Q.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-2-A.svg", 
        "paste-227143640416257.jpg", 
        "paste-52145197940737.jpg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-13-Q.svg", 
        "tmptcmooy.png", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-1-A.svg", 
        "f15ba88647424e9fb28dc09e3b7e6cbe-ao-10-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-2-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-4-A.svg", 
        "fca61051139d4a889aeec54c024fb10e-ao-2-A.svg", 
        "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-6-Q.svg", 
        "52781e8155c04b6c82ee099b758e50c8-ao-2-A.svg", 
        "416edf9b137c49ecb0752d56325dc86e-ao-O.svg", 
        "416edf9b137c49ecb0752d56325dc86e-ao-1-A.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-2-Q.svg", 
        "05e25644c8a34adda53563af5a11d2c9-ao-2-Q.svg", 
        "e3faec01942d401cbe1516d280823959-ao-11-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-12-A.svg", 
        "988f2a4be17449eda5b5289d45856744-ao-4-Q.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-6-Q.svg", 
        "fb9ac26aca0842e0a7bc0774c629ca27-ao-2-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-3-Q.svg", 
        "e3faec01942d401cbe1516d280823959-ao-1-A.svg", 
        "445e1ae2761d405fb6b7b389d7553e8f-ao-13-A.svg", 
        "43af36f4a8a64c28a38d673fb8dab9e3-oa-6-A.svg", 
        "40370c712deb41489d993bc97a4ed075-ao-4-Q.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-4-Q.svg", 
        "paste-14632953577473.jpg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-2-A.svg", 
        "fd6504b24b0a4b67b23364682e33d2d0-ao-1-A.svg", 
        "a8274d6edc5a471594aeb61f643110c5-ao-4-A.svg", 
        "2e166cc3270146619840bd9235d3d698-ao-2-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-11-A.svg", 
        "8b9d11e55af24760a2e902d9455c078b-ao-2-Q.svg", 
        "06769536f22b4e50b17c7572b9456594-ao-1-Q.svg", 
        "a08cc10589774ec58d1813413c8b1b2d-ao-2-A.svg", 
        "e19ed494e6a347f6b02e0e386e0c73f0-oa-1-Q.svg", 
        "15439e09c73b4cc38607fdfcfa984152-ao-4-Q.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-2-A.svg", 
        "538a2fdd2a6a417e885e0d1b10853a49-ao-8-Q.svg", 
        "9b930ae4601b43c88953957edb11298b-ao-3-Q.svg", 
        "paste-29622389440513.jpg", 
        "2bc20057da4e4ec1b26538aea998a79d-ao-3-A.svg", 
        "c7156e55d7ad42bf9cd9efeb16e773d5-ao-O.svg", 
        "9a40f62570e4455db93b0f94a01effe6-ao-3-A.svg", 
        "21b949f0660f488bb7f4363b9c24d2a7-ao-5-A.svg", 
        "paste-8864812498945.jpg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-2-A.svg", 
        "paste-666578924339201.jpg", 
        "3aa7f3b019184787bb8b25d1e956abb2-ao-O.svg", 
        "paste-705048946409473.jpg", 
        "3efad90d456742cb90056c92b0c13663-oa-12-A.svg", 
        "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-8-A.svg", 
        "fb9ac26aca0842e0a7bc0774c629ca27-ao-2-A.svg", 
        "e19ed494e6a347f6b02e0e386e0c73f0-oa-O.svg", 
        "e0fa02d1e96747fc9984d3d86fbb9041-ao-1-Q.svg", 
        "paste-20929375633409.jpg", 
        "2a9b029671cf45dcb4656aeeae293fc5-oa-1-A.svg", 
        "2f9752605f61461fbc2f126347688db1-ao-1-A.svg", 
        "424dcadad47a486fa57e864f7dc532b7-ao-3-Q.svg", 
        "969e48d26b5f4730b6935dd6701f4d7b-oa-4-Q.svg", 
        "102e08bbf5a2406d9efaf24cd9912e39-ao-3-Q.svg", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-1-Q.svg", 
        "73a038139e5e45128883622fef3aa44a-ao-4-Q.svg", 
        "tmp5lxwog.png", 
        "83cf0965978e4f59a97e34b52ee7bcfb-ao-4-A.svg", 
        "2f55677a94fa48afbff2cf92bbd9c646-oa-4-Q.svg", 
        "ad96db1f3c094851a73354db2488a812-ao-2-A.svg", 
        "tmpffuqhp.png", 
        "eb3e9520847748738c28835188fd95e4-ao-5-Q.svg", 
        "47491ca45543444fb1b398bbb5eaafe6-ao-O.svg", 
        "da2f6aba7da7441d944fc99508e0d38f-ao-2-Q.svg", 
        "8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg", 
        "32f45114f3f941aeaea0049234da3262-ao-O.svg", 
        "3333092d7fa24648b826956283d014e6-ao-1-A.svg", 
        "paste-55070070669313.jpg", 
        "637ed61baa4e4103aee250203de67264-ao-5-A.svg", 
        "c7156e55d7ad42bf9cd9efeb16e773d5-ao-1-A.svg"
    ], 
    "mid": "1514613555313", 
    "name": "fracp-anki", 
    "note_models": [
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "css": "/* GENERAL CARD STYLE */\n.card {\n  font-family: \"Helvetica LT Std\", Helvetica, Arial, Sans;\n  font-size: 150%;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n\n/* OCCLUSION CSS START - don't edit this */\n#io-overlay {\n  position:absolute;\n  top:0;\n  width:100%;\n  z-index:3\n}\n\n#io-original {\n  position:relative;\n  top:0;\n  width:100%;\n  z-index:2\n}\n\n#io-wrapper {\n  position:relative;\n  width: 100%;\n}\n/* OCCLUSION CSS END */\n\n/* OTHER STYLES */\n#io-header{\n  font-size: 1.1em;\n  margin-bottom: 0.2em;\n}\n\n#io-footer{\n  max-width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.8em;\n  font-style: italic;\n}\n\n\n#io-extra-wrapper{\n  /* the wrapper is needed to center the\n  left-aligned blocks below it */\n  width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.5em;\n}\n\n#io-extra{\n  text-align:center;\n  display: inline-block;\n}\n\n.io-extra-entry{\n  margin-top: 0.8em;\n  font-size: 0.9em;\n  text-align:left;\n}\n\n.io-field-descr{\n  margin-bottom: 0.2em;\n  font-weight: bold;\n  font-size: 1em;\n}\n\n#io-revl-btn {\n  font-size: 0.5em;\n}\n\n/* ADJUSTMENTS FOR MOBILE DEVICES */\n\n.mobile .card, .mobile #content {\n  font-size: 120%;\n  margin: 0;\n}\n\n.mobile #io-extra-wrapper {\n  width: 95%;\n}\n\n.mobile #io-revl-btn {\n  font-size: 0.8em;\n}\n", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "ID (hidden)", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Header", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Image", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Question Mask", 
                    "ord": 3, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Footer", 
                    "ord": 4, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Remarks", 
                    "ord": 5, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Sources", 
                    "ord": 6, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Extra 1", 
                    "ord": 7, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Extra 2", 
                    "ord": 8, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Answer Mask", 
                    "ord": 9, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Original Mask", 
                    "ord": 10, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "Image Occlusion Enhanced", 
            "req": [
                [
                    0, 
                    "all", 
                    [
                        2
                    ]
                ]
            ], 
            "sortf": 1, 
            "tags": [], 
            "tmpls": [
                {
                    "afmt": "{{#Image}}\n<script>\n  // Toggle answer mask on clicking the image\n  var toggle = function() {\n    var amask = document.getElementById('io-overlay');\n    if (amask.style.display === 'block' || amask.style.display === '')\n      amask.style.display = 'none';\n    else\n      amask.style.display = 'block'\n  }\n</script>\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Answer Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n{{#Footer}}<div id=\"io-footer\">{{Footer}}</div>{{/Footer}}\n<button id=\"io-revl-btn\" onclick=\"toggle();\">Toggle Masks</button>\n<div id=\"io-extra-wrapper\">\n  <div id=\"io-extra\">\n    {{#Remarks}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Remarks</div>{{Remarks}}\n      </div>\n    {{/Remarks}}\n    {{#Sources}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Sources</div>{{Sources}}\n      </div>\n    {{/Sources}}\n    {{#Extra 1}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 1</div>{{Extra 1}}\n      </div>\n    {{/Extra 1}}\n    {{#Extra 2}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 2</div>{{Extra 2}}\n      </div>\n    {{/Extra 2}}\n  </div>\n</div>\n{{/Image}}\n", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "IO Card", 
                    "ord": 0, 
                    "qfmt": "{{#Image}}\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Question Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n<div id=\"io-footer\">{{Footer}}</div>\n{{/Image}}\n"
                }
            ], 
            "type": 0, 
            "vers": []
        }, 
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "css": ".card {\nfont-family: arial;\nfont-size: 16px;\nline-height: 1.4em;\ntext-align: left;\n color: #263238;\n background-color: #ECEFF1;\npadding: 20px;\n}\n\n.card-container{\nbackground-color: white;\npadding: 10px 15px 15px 15px;\nbox-shadow: 0 2px 2px 0 rgba(0,0,0,0.2);\nmargin-bottom: 20px;\nborder-radius: 2px;\n}\n\n.letter{\nfont-size: 20px;\ncolor:#37474F;\nmargin-bottom: 8px;\npadding-bottom: 8px;\nfont-family: Ebrima;\nborder-bottom: 1px solid #388E3C;\n}\n\nul{\n\tlist-style-position: inside;\n\tpadding-left: 0;\npadding-top: 0;\npadding-bottom: 0;\n}\n\n.references{\ncolor: #607D8B;\nfont-size: 14px;\n}", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Question", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Answer", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Reference", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "FRACP Type", 
            "req": [
                [
                    0, 
                    "all", 
                    [
                        0
                    ]
                ]
            ], 
            "sortf": 0, 
            "tags": [
                "InfectiousDiseases"
            ], 
            "tmpls": [
                {
                    "afmt": "<div class=\"card-container\">\n<div class=\"letter\">Q.</div>\n{{Question}}\n</div>\n\n<div class=\"card-container\">\n<div class=\"letter\">A.</div>\n{{Answer}}\n</div>\n\n<div class=\"card-container references\">\n<div>{{Tags}}</div>\n<div>{{Reference}}</div>\n</div>\n", 
                    "bafmt": "", 
                    "bfont": "Arial", 
                    "bqfmt": "", 
                    "bsize": 12, 
                    "did": null, 
                    "name": "Card 1", 
                    "ord": 0, 
                    "qfmt": "<div class=\"card-container\">\n<div class=\"letter\">Q.</div>\n{{Question}}\n</div>"
                }
            ], 
            "type": 0, 
            "vers": []
        }
    ], 
    "notes": [
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 major determinants of myocardial oxygen demand.", 
                "Heart rate<div>Myocardial contractility</div><div>Myocardial wall tension</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bwbW!=)aR/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "During which phase of the cardiac cycle is the majority of blood delivered to the myocardium?", 
                "Diastole", 
                ""
            ], 
            "flags": 0, 
            "guid": "KSl.C;_X:l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 3 vessel types which account for 75% of coronary blood flow resistance.", 
                "R1: Large epicardial arteries (trivial in the absence of IHD)<div>R2: Prearteriolar vessels</div><div>R3: Arteriolar and intra-myocardial capillary vessels</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p,6>Mz~Z@,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 non-atherosclerotic causes that limit coronary blood flow.", 
                "Spasm<div>Arterial thrombi (e.g. due to procoagulative state)</div><div>Coronary emboli</div><div>Ostial narrowing due to aortitis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kUtc$#HAf6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 5 major risk factors for coronary artery disease.", 
                "High LDL<div>Low HDL</div><div>Smoking</div><div>HTN</div><div>Diabetes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uWmoVg^O[z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 components of athersclerotic plaque.", 
                "Fat<div>Smooth muscle cells</div><div>Fibroblasts</div><div>Intracellular matrix</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tg64xDG_Hs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "At what degree of stenosis (%) does coronary luminal narrowing begin to limit the ability to increase flow to meet myocardial demand?", 
                "50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "A$,b*m1ZvD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe 2 processes which result in thrombus formation when an atherosclerotic plaque ruptures.", 
                "Platelet activation and aggregation<div>Activation of the coagulation cascade leading to deposition of fibrin strands</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tDtz&m5OU#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In the event of coronary occlusion, which portion of the myocardium is most affected by ischaemia?", 
                "Subendocarium", 
                ""
            ], 
            "flags": 0, 
            "guid": "CE$K/4i_(R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of mitral regurgitation in acute myocardial ischaemia.", 
                "Papillary muscle involvement in the setting of large left ventricular infarct", 
                ""
            ], 
            "flags": 0, 
            "guid": "FLX|6X+4W5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "After approximately what period of time does myocardial ischaemic damage become non-reversible?", 
                "20 minutes", 
                ""
            ], 
            "flags": 0, 
            "guid": "OT:9HyvO[#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 biochemical events which occur in the event of myocardial ischaemia", 
                "Fatty acids unable to be oxidised<div>Metabolism of glucose to lactate, causing pH drop<div>Reduce myocardial stores of high energy phosphates (ATP)</div><div>Potassium leak</div><div>Uptake of sodium</div><div>Increase in cytosolic calium</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BCo[$i#Nsv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ST elevation reflects ischaemia of what part of the myocardium?", 
                "Severe transmural ischaemia", 
                ""
            ], 
            "flags": 0, 
            "guid": "D$=NU95R}o", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe Levine's sign.", 
                "A clenched fist held over the chest to describe angina.", 
                ""
            ], 
            "flags": 0, 
            "guid": "GJ%%:#ggf+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe New York Heart Association class I functional status.", 
                "Patient has cardiac disease, but ordinary physical activity does not cause undue fatigue, palpitations, dyspnoea, or angina.", 
                ""
            ], 
            "flags": 0, 
            "guid": "x)-Bjm;t]G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe New York Heart Association class II functional status.", 
                "Patient has cardiac disease resulting in slight limitation of physical activity.&nbsp;<div>Comfortable at rest.&nbsp;<div>Ordinary physical activity results in fatigue, palpitations, dyspnoea, or angina.</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pN<:/->=A^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe New York Heart Association class III functional status.", 
                "Patient has cardiac disease resulting in marked limiation of physical activity.<div>Comfortable at rest.</div><div>Less than ordinary physical activity causes fatigue, palpitations, dyspnoea, or angina.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q,0fX9p&;$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe New York Heart Association class IV functional status.", 
                "Patient has cardiac disease resulting in inability to carry out any physical activity without discomfort.<div>Symptoms may be present at rest.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xq>z12*CH5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 blood investigations which may be ordered for a patient with suspected new stable ischaemic heart disease.", 
                "Lipid profile<div>HbA1c/fasting glucose</div><div>Renal function</div><div>Haemoglobin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sa.2Lp}ZI}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What ECG findings constitute a positive stress ECG test?", 
                "<div>Flat or downsloping ST depression &gt;0.1mV</div><div><br /></div><div>The following are NOT considered diagnostic:</div>T wave abnormalities<div>Conduction abnormalities<br /><div><div>Upsloping or junctional ST segment changes</div><div>Ventricular arrythmias</div><div>Failure to reach 85% predicted heart rate</div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "At|h#B5Lv2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 contraindications to exercise stress testing", 
                "<div>Rest angina within 48hours of the test</div>Unstable rhythm<div>Severe aortic stenosis</div><div>Acute myocarditis</div><div>Uncontrolled heart failure</div><div>Severe pulmonary hypertension</div><div>Active infective endocarditis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "/~88({tV{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the sensitivity of exercise stress testing?", 
                "75% (a&nbsp;negative test does not exclude coronary artery disease).", 
                ""
            ], 
            "flags": 0, 
            "guid": "wS)EVJwqI^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Histologically, the first phase of atherosclerosis is characterised by the accumulation of what cell type within intima?", 
                "Lipid-laden macrophages (foam cells) are the hallmark of early atheroma.", 
                ""
            ], 
            "flags": 0, 
            "guid": "YRD?mAdfE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pathophysiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The thickening of the intima by accumulation of lipid-laden macrophages (foam cells) and extracellular matrix represents the first phase of atherosclerosis and is known by what term?", 
                "Fatty streaks", 
                ""
            ], 
            "flags": 0, 
            "guid": "lNy!+VT83?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pathophysiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with suspected acute coronary syndrome, what is the recommendation regarding use of supplemental oxygen therapy?", 
                "Routine use of supplemental oxygen therapy for patient's with oxygen saturation &gt; 93% is not recommended.", 
                ""
            ], 
            "flags": 0, 
            "guid": "tr}tkpbJA,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pathophysiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for unstable angina.", 
                "Myocardial ischaemia at rest or with minimal exertion in the absence of myocardial necrosis.", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ic2L>g[p*1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 9 cardiac causes of elevated troponin.", 
                "<div>Acute coronary syndrome</div>Myocarditis<div>Aortic dissection</div><div>Takotsubocardiomyopathy</div><div>Tachyarrythmias</div><div>Heart failure</div><div>Coronary artery spasm</div><div>Aortic stenosis (structural heart disease)</div><div>Cardiac contusion/procedures</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g(&S(S8|g,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 antianginal medications used in the management of stable angina.", 
                "<ul><li>ß-blockers</li><li>Nitrates</li><li>Calcium channel blockers</li><li>Ranolazine</li></ul>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qz7,uLA)8e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The COURAGE trial compared PCI + medical therapy vs. medical therapy alone as an initial management strategy in patients with stable ischaemic heart disease. What was the main conclusion of this trial?", 
                "Although the addition of PCI to optimal medical therapy reduced the prevalence of angina, it did not reduce long-term rates of death, nonfatal myocardial infarction, and hospitalization for acute coronary syndromes.", 
                "https://www.ncbi.nlm.nih.gov/pubmed/17387127"
            ], 
            "flags": 0, 
            "guid": "s(&yGZmQc@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the only antianginal drug class proven to prevent reinfarction and to improve survival in patients who have sustained a myocardial infarction.", 
                "ß-blockers", 
                "https://www.ncbi.nlm.nih.gov/pubmed?term=8371471"
            ], 
            "flags": 0, 
            "guid": "kDEax2q{$r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name an appropriate first line investigation for suspected stable ischaemic heart disease.", 
                "Cardiac stress testing", 
                ""
            ], 
            "flags": 0, 
            "guid": "qqa`li!;E]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of aspirin.", 
                "Irreversible inhibition of cyclooxygenase and thereby inhibiting the formation of eicosanoids (thromboxane A<sub>2</sub>) via the oxygenation of arachidonic acid.", 
                "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/215618"
            ], 
            "flags": 0, 
            "guid": "BF>b>hG[t]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The CURE trial tested the efficacy of prolonged aspirin + clopidogrel compared to aspirin alone in ACS without STEMI. What were the key findings?", 
                "<ul><li>Dual antiplatelet therapy with clopidogrel and aspirin reduced cardiovascular mortality, non-fatal myocardial infarction or stroke</li><li>Superiority persisted throughout the 12 month study</li><li>Higher rates of major and minor bleeding, but no increase in life-threatening bleeding or intracranial haemorrhage</li></ul>", 
                "https://www.ncbi.nlm.nih.gov/pubmed/11519503"
            ], 
            "flags": 0, 
            "guid": "kTU/W:~zaZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the recommended time frame in which a patient presenting with acute chest pain or suspected acute coronary syndrome should undergo an ECG?", 
                "10 minutes", 
                "National Heart Foundation of Australia &amp; Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016"
            ], 
            "flags": 0, 
            "guid": "zk:f):Lwzl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 contraindications to the use of nitrate therapy.", 
                "<ul style=\"margin-left: 20px; \"><li>Allergy</li><li>Hypotension (&lt;90)</li><li>Bradycardia (&lt;50)</li><li>Tachycardia (&gt;100)</li><li>Phosphodiesterase inhibitor within the previous 24 hours</li><li>Hypertrophic cardiomyopathy</li><li>Severe aortic stenosis</li></ul>", 
                "ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction"
            ], 
            "flags": 0, 
            "guid": "iv0T$[op/3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of clopidogrel.", 
                "The active metabolite of the thienopyridines (clopidogrel, prasugrel) irreversibly binds to the platelet P2Y<sub>12</sub>&nbsp;receptor and inhibits platelet aggregation for the life of the platelet.", 
                "Australian Medicines Handbook"
            ], 
            "flags": 0, 
            "guid": "qV]MexO7Dl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of ticagrelor.", 
                "Ticagrelor, a nuceloside analogue,&nbsp;<b>reversibly</b> inhibits the adenosine diphosphate (ADP) receptor P2Y<sub>12</sub>. The thienopyridines (clopidogrel, prasugrel) irreversibly inhibit P2Y<sub>12</sub>.", 
                ""
            ], 
            "flags": 0, 
            "guid": "wf$J875j)7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The PLATO trial compared ticagrelor and clopidogrel in patients with acute coronary syndrome. What were the findings of this study?", 
                "<ul><li>Compared to clopidogrel, ticagrelor significantly reduced the rate of cardiovascular death, myocardial infarction, or stroke</li><li>Benefit &nbsp;persisted up to 12 months</li><li>No increase in overall major bleeding</li></ul>", 
                "https://www.ncbi.nlm.nih.gov/pubmed/19717846"
            ], 
            "flags": 0, 
            "guid": "J/Y5?d9ATR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name &nbsp;indications for coronary angiography in patients with stable ischaemic heart disease (SIHD).", 
                "<ul style=\"margin-left: 20px; \"><li>Angina that significantly interferes with a patient's lifestyle despite maximal tolerable medical therapy</li><li>Patients with high-risk criteria (survivors of cardiac arrest</li></ul>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ql~u/+/uOx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the preferred first line antianginal for patients with stable ischaemic heart disease (SIHD).", 
                "ß-blocker", 
                ""
            ], 
            "flags": 0, 
            "guid": "s~}U_}vu6{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism by which sudden withdrawal of ß-blocker therapy may precipitate exacerbation of ischaemic symptoms, including myocardial infarction.", 
                "Chronic use of ß-blocker therapy results in upregulation of adrenergic receptor density, and consequent increase in responsiveness to circulating catecholamines.", 
                ""
            ], 
            "flags": 0, 
            "guid": "Es2n>Rl*<`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the recommended duration of dual antiplatelet therapy for patients who have undergone stenting for acute coronary syndrome.", 
                "12 months<div>It may be reasonable to continue dual antiplatelet therapy for greater than 12 months in patients who have a low bleeding risk</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KkG0tzL>zS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Approximately what percentage of patients with left main coronary artery disease will also have multivessel coronary artery disease?", 
                "70%", 
                ""
            ], 
            "flags": 0, 
            "guid": "jq!suB@etw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with left main coronary disease with associated multivessel disease, what is the preferred revascularisation strategry?", 
                "Patients with significant left main coronary artery disease (≥50%) should undergo revascularisation with either CABG or PCI<div>CABG is preferred in multivessel disease</div><div>In other patients, which is preferable depends on clinician and patient.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pNn`0EyoEE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the preferred revascularisation strategry In patients with coronary artery disease with a ≥ 70% stenosis in ≥ 3 vessels, without proximal LAD involvement?", 
                "CABG", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pp12?~-%<o", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A \"small box\" on the ECG represents how many millimetres (mm), seconds or milivolts (mV)?", 
                "1mm<div>0.04 seconds</div><div>0.1mV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O<Pdk~4?M;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A narrow complex QRS complex on an ECG is defined as what duration of time/number of small boxes?", 
                "3 small boxes (small box = 0.04 seconds = 40 milliseconds)<div><div>120 milliseconds</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r8XL5XRpl0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The normal cardiac impulse in generated by pacemaker cells in what specialised area of the heart?", 
                "Sinoatrial node located at the juntion of the right atrium and superior vena cava.", 
                ""
            ], 
            "flags": 0, 
            "guid": "BcWf^ka0W%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Physiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The p wave on an ECG represents depolarisation of what cardiac structures?", 
                "Right and left atrial depolarisation. The right atrium depolarises before the left atrium and represents the first part of the p wave.", 
                ""
            ], 
            "flags": 0, 
            "guid": "r$V~,1LTwI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Physiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "First degree heart block is diagnoses by what finding on the ECG?", 
                "A PR interval greater than 200 milliseconds (5 \"small\" ECG squares).", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pl)F}xYf<D", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Physiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The T wave on an ECG represents repolarisation of what cardiac structures?", 
                "Ventricular repoarisation is represented by a T wave (normally) of the same polarity as the QRS complex.", 
                ""
            ], 
            "flags": 0, 
            "guid": "nTOawSt]9D", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Physiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the normal range of duration for the PR interval on an ECG?", 
                "120 milliseconds - 200 milliseconds (3 - 5 small squares)", 
                ""
            ], 
            "flags": 0, 
            "guid": "GAlG4CZxkE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for heart failure with reduced ejection fraction (HFrEF).", 
                "<ul><li>Symptoms ± signs of heart failure</li><li>Left ventircular ejection fracture (LVEF) &lt; 40%</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "NyBe]3JvMH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for heart failure with mildly reduced ejection fracture (HFmrEF).", 
                "<ul><li>Symptoms ± signs of heart failure</li><li>LVEF 40 - 49%</li><li>Elevated levels of natriuretic peptides</li><li>At least one additonal criterion:</li><ul><li>Relevant structural heart disease (left ventricular hypertrophy and/or left atrial enlargement)</li><li>Diastolic dysfunction</li></ul></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "d0},Em&j8T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for heart failure with preserved ejection fraction (HFpEF).", 
                "<ul><li>Symptoms ± signs of heart failure</li><li>Left ventricular ejection fraction &gt; 50%</li><li>Elevated levels of natriuretic peptids</li><li>At least one additional criterion:</li><ul><li>Relevant structural heart disease (left ventricular hypertrophy and/or left atrial enlargement)<br /></li><li>Diastolic dysfunction</li></ul></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "e:8,EAr=hc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The Killip classification is a system used to stratify risk of death following acute myocardial infarction. What is Killip class I?", 
                "Individuals with no clinical signs of heart failure.", 
                ""
            ], 
            "flags": 0, 
            "guid": "xI,.^.$AK^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 recreational substances which may cause heart failure.", 
                "<ul><li>Alcohol</li><li>Cocaine</li><li>Amphetamine</li><li>Anabolic steroids</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "hy+,k.6+&4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 heavy metals which may cause heart failure.", 
                "<ul><li>Copper</li><li>Iron</li><li>Lead</li><li>Cobalt</li></ul>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c#3+o|=d.U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the recommended technique for measurement of left ventricular ejection fraction using echocardiography.", 
                "Modified biplane Simpson's rule", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "g7(<g~3c&{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 which should be considered in the initial assessment of a patient with newly diagnosed heart failure.", 
                "<ul><li>FBE</li><li>UEC</li><li>LFTs</li><li>Hba1c/fasting glucose</li><li>Lipid profile</li><li>TSH</li><li>Iron studies</li><li>Natriuretic peptics</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "jyr~Vtc~Ug", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 echocardiographic measurements which are important in determining right ventricular systolic function.", 
                "<ul style=\"margin-left: 20px; \"><li>Tricuspid annular plane systolic excursion</li><li>Tricuspid lateral annular systolic velocity</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "cC+>C->wK,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 causes of heart failure where genetic testing is recommended.", 
                "<ul style=\"margin-left: 20px; \"><li>Hypertrophic cardiomyopathy (HCM)</li><li>Idiopathic dilated cardiomyopathy (DCM)</li><li>Arrhythmogenic right ventricular cardiomyopathy (ARVC)</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "y5K`eg:PB[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The SPRINT trial compared intensive blood pressure control (target systolic blood pressure &lt; 120 mm Hg) in patients at high risk for cardiovascular disease without stroke or diabetes to standard treatment (target systolic blood pressure 135 - 139 mm Hg). What were the key findings?", 
                "In patients at high risk for CVD (without previous stroke or diabetes), intensive BP control (target systolic blood pressure &lt;120mm Hg) improved cardiovascular outcomes and overall survival compared to standard therapy (target SBP 135 - 139mm Hg).", 
                "https://www.ncbi.nlm.nih.gov/pubmed/26551272"
            ], 
            "flags": 0, 
            "guid": "epu@[&:i4v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of empagliflozin.", 
                "Inhibition of&nbsp;sodium-glucose co-transporter 2", 
                "Australian Medicines Handbook"
            ], 
            "flags": 0, 
            "guid": "u~qTf>;-G~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 treatments (or combination of treatments) that may cause harm in patients with symptomatic (NYHA Class II - IV) heart failure with reduced ejection fraction (HFrEF)", 
                "<ul style=\"margin-left: 20px; \"><li>Thiazolidinediones (glitazones)</li><li>NSAIDs or COX-2 inhibitors</li><li>Diltiazem or verapamil</li><li>Adding an ARB to an ACE-I + MRA (risk of hyperkalaemia and renal dysfunction)</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "qemdtRQ>Dc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the universal definition of myocardial infarction.", 
                "A combination of criteria is required to meet the diagnosis of acute myocardial infarction:<div><ul style=\"margin-left: 20px; \"><li>Abnormal cardiac biomarker (value above 99th percentile reference limit)</li></ul><div>Plus at least one of the following:</div></div><div><ul style=\"margin-left: 20px; \"><li>Symptoms of ischaemia</li><li>New significant ST-T wave changes or left bundle branch block</li><li>Pathological Q waves</li><li>Imaging evidence of new loss of viable myocardium or regional wall motion abnormality</li><li>Intracoronary thrombus detected on angiography or autopsy</li></ul></div>", 
                "https://academic.oup.com/eurheartj/article/37/3/267/2466099"
            ], 
            "flags": 0, 
            "guid": "ksVT,9e:5>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for type 1 myocardial infarction.", 
                "Myocardial necrosis due to disruption of an atherosclerotic plaque, consequent intraluminal thrombus and reduced myocardial blood flow.", 
                "https://academic.oup.com/eurheartj/article/37/3/267/2466099"
            ], 
            "flags": 0, 
            "guid": "h+lZaCOha;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for type 2 myocardial infarction.", 
                "Myocardial necrosis in which a condition other than coronary plaque disruption results in an imbalance between myocardial oxygen supply and demand. Mechanisms include tachyarrythmias, coronary artery spasm, anaemia, etc.", 
                "https://academic.oup.com/eurheartj/article/37/3/267/2466099"
            ], 
            "flags": 0, 
            "guid": "PV.qw~m&O>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 non-cardiac causes of troponin elevation.", 
                "Hypertensive emergency<div>Critical illness (e.g. shock/sepsis/burns)</div><div>Pulmonary embolsim</div><div>Pulmonary hypertension</div><div>Renal failure</div><div>Acute neurological event (stroke/subarachnoid haemorrhage)</div><div>Thyroid disease</div><div>Infiltrative diseases (amyloidosis, haemchromatosis)</div>", 
                "https://academic.oup.com/eurheartj/article/37/3/267/2466099#42049200"
            ], 
            "flags": 0, 
            "guid": "hq@G3LYFXK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which cardiac biomarker is most useful in the detection of early reinfarction.", 
                "CK-MB<div>Has a more rapid decline after MI, as compared with cardiac troponin.</div>", 
                "https://academic.oup.com/eurheartj/article/37/3/267/2466099#42049200"
            ], 
            "flags": 0, 
            "guid": "i94E|9pzYO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the most common cause of left ventricular outflow obstruction.", 
                "Aortic stenosis", 
                ""
            ], 
            "flags": 0, 
            "guid": "m[~]~OkaA5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 symptoms of aortic stenosis.", 
                "Exertional dyspnoea or reduced exercise tolerance<div>Exertional presyncope or syncope</div><div>Exertional angina</div><div><br /></div><div>Symptoms rarely occur before stenosis is severe.</div><div>If these symptoms occur in mild-mod AS, seek other causes.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mpF+L9y(xm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the only 2 effective treatments for severe aortic stenosis.", 
                "Surgical aortic valve replacement (SAVR)<div>Transcatheter aortic valve implantation (TAVI)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "la,QsIW8%w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 4 main parameters used to identity severe aortic stenosis.", 
                "Aortic jet velocity (≥4.0m/s)<div>Mean transvalvular pressure gradient (≥40mmHg)</div><div>Valve area &lt;1cm</div><div>DVI &lt; 0.25</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bE`*2(,S;s", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the valvular anatomy in Stage A aortic stenosis.", 
                "Stage A refers to patients who are at risk of developing aortic stenosis.<br /><div>Bicuspid aortic valve (or other)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LD,oFn|c2l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the valvular anatomy in Stage B aortic stenosis.", 
                "Mild - moderate leaflet calcification with some reduction in systolic motion<div>OR</div><div>Rheumatic valve changes with commisural fusion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BPsw1L{3x?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 4 key steps in determining whether a patient with aortic stenosis has an indication for valve replacement.", 
                "Patient symptoms status<div>Determine severity of aortic stenosis (echocardiogram)</div><div>Assess left ventricular ejection fraction</div><div><div>Determination of whether other cardiac surgery is indicated</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N8,p^f4BCX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 2 factors which lead to exertional dyspnoea in aortic stenosis.", 
                "Diastolic dysfunction with an increase in left ventricular filling pressures with exercise<div>Left ventricle unable to increase cardiac output with exercise</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y#9xr+kSF2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the histological features of achalasia.", 
                "Reduced neurons/ganglion cells in the myeteric plexus.<div>Remaining ganglion cells are surrounded by lymphocytes.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k2p#F9^*bH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What investigation is required to diagnose achalasia.", 
                "Oesophageal manometry.", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q[el[p{6GB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Using conventional manometry, what findings are suggestive achalasia.", 
                "Incomplete relaxation of oesophageal sphincter (LES pressure &gt; 8mmHg above gastric pressure at nadir)<div>Aperistalsis in the distal oesophagus</div><div>Elevated resting lower oesophageal sphincter pressure (hypertensive LES &gt; 45 mmHg)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B;b=532Al@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the current theory regarding the aetiology of primary achalasia.", 
                "Primary achalasia is idiopathic but is thought to result from inflammation and degeneration of neurons in the oesophageal wall possibly due to an autoimmune disorder.<div>May be triggered by HSV-1 infection but this is inconclusive.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B)BVfNS*!O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of endoscopy in the investigation of suspected achalasia.", 
                "Endoscopy should be performed to exclude malignancy at the oesophago-gastric junction.", 
                ""
            ], 
            "flags": 0, 
            "guid": "qcAb2QYO&K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name &nbsp;endoscopic features suggestive of achalasia.", 
                "Dilated oesophagus containing residual material<div>Unusually increased resistance to passage of endoscopy through oesophagogastric junction</div><div><br /></div><div>Oesophageal mucosa is usually normal in appearance.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gP7oYYP#O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Using high-resolution oesophageal manometry, a diagnosis of achalasia is suggested by what finding?", 
                "Elevated integrated relaxation pressure (&gt;15mmHg).<div>Integrated relaxation pressure represents the median of the maximal relaxation pressures in four seconds during the 10-second window of the oesophagogastric junction relaxation that follows a swallow.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F^*FPZA;LS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<img src=\"paste-5158255722497.jpg\" /><div>What are the findings and diagnosis demonstrated in this barium oesophagram?</div>", 
                "Dilated oesophagus<div>Bird's beak appearance of distal oesophagus</div><div>Retained food</div><div>Appearance typical of achalasia.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hqyBbeF8jl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<img src=\"paste-5510443040769.jpg\" /><div>What are the findings and diagnosis?</div>", 
                "Simple columnar epithelium extending well above oesophagogastric junction (instead of normal stratified squamous epithelium)<div>Barret's oesophagus</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NugeQH%7{`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 10 manifestations of IgG4 related disease.", 
                "Lymphadenopathy<div>Type 1 autoimmune pancreatitis</div><div>Sclerosing cholangitis</div><div>Dacryoadenitis</div><div>Sclerosing sialedinitis<br /><div>Retroperitoneal fibrosis</div></div><div>Aortitis</div><div>Thyroiditis (Riedel's thyroiditis)</div><div>Lung nodules</div><div>Tubulointerstitial nephritis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M7Va0fygF@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how a diagnosis of IgG4 related disease is usually made.", 
                "Biopsy demonstrating characteristic histopathological findings and immunohistochemical staining.<div>Supported by elevated serum IgG4 levels (although these are not diagnostic).</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hs7srfcz)8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 studies which are part of the postdiagnostic evaluation for IgG4 related disease.", 
                "CT chest, abdomen and pelvis<div>Urinalysis (proteinuria in subclinical tubulointerstitial nephritis)</div><div>Serum complement levels (often profoundly low in tubulointerstitial nephritis)</div><div>Serum IgE (marker of allergic disease)</div><div>FBE (eosinophil count)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jUcOWLi2>C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 histological features of IgG4 related disease.", 
                "Storiform fibrosis<div>Dense lymphoplasmacytic infiltration with predominantly IgG4 positive plasma cells</div><div>Obliterative phlebitis</div><div>Tissue eosinophilia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H+]vjJV5?Q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the most common demongraphic affected by IgG4 related disease.", 
                "Middle-aged and older men.<div>The gender discrepancy normalises for disease involving the head and neck.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A_3:ix~;{!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why are biopsies of lymph nodes inadequate for diagnosis IgG4 related disease?", 
                "Lymph nodes usually do not demonstrate the hallmark histological feature of IgG4 related disease: storiform fibrosis.<div>Dense infiltration of IgG positive plasma cells is not unique to IgG4 related disease.</div><div>Fine-needle aspirates do not provide adequate tissue.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ay_5Y4(%hN", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for IgG4 related disease", 
                "An immune mediated disease comprising a collection of disorders that share pathological, serological and clincial features:<div>Tumour-like swelling of involved organs</div><div>Lymphoplasmacytic infiltrate enriched in IgG4 positive plasma cells</div><div>Fibrosis with characteristic storiform pattern</div><div>Elevated serum IgG4</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fEx8a%*-sg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common presentation of autoimmune pancreatitis?", 
                "Obstructive jaundice", 
                ""
            ], 
            "flags": 0, 
            "guid": "nI2.Zn<:y6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for primary sclerosing cholangitis.", 
                "Chronic progressive disorder of unknown aetiology characterised by inflammation, fibrosis and stricturing of medium and large ducts in the intrahepatic and/or extrahepatic biliary trees.", 
                ""
            ], 
            "flags": 0, 
            "guid": "d2gtl:`U;u", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the diagnostic approach for patients with suspected primary sclerosing cholangitis.", 
                "IgG4 level (to identify patients with IgG4 related disease)<div>Antimitochondrial antibodies (to differentiate from primary biliary cirrhosis)</div><div>Cholangiography (usually MRCP is first line investigation)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r9Fgz{6|53", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of liver biopsy in the diagnosis of patients with primary sclerosing cholangitis?", 
                "Liver biopsy is seldom diagnostic.<div>Can be performed in patients with suspected small duct primary sclerosing cholangitis (i.e. patients with normal cholangiography).</div><div>Histology is often non-specific and similar to primary biliary cirrhosis.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lH5uKckKa*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In a patient with primary sclerosing cholangitis and a gallbladder mass, what is the most appropriate next step?", 
                "Cholecystectomy<div>Gallbladder mass in patients with PSC may represent gallbladder carcinoma.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hnW}7]sY#:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Patients diagnosed with primary sclerosing cholangitis should be screened for what strongly associated disease?", 
                "Ulcerative colitis", 
                ""
            ], 
            "flags": 0, 
            "guid": "KTd81BXNAD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Disease progression in arrhythmogenic right ventricular cardiomyopathy may be accelerated by?", 
                "Endurance exercise", 
                ""
            ], 
            "flags": 0, 
            "guid": "ee#{[G)N5t", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Arrhythmogenic right ventricular cardiomyopathy is usually caused by mutations in genes which encode what type of proteins?", 
                "Desmosomal proteins", 
                ""
            ], 
            "flags": 0, 
            "guid": "ilRV$LcUBV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the hallmark histological finding in arrhythmogenic right ventricular cardiomyopathy?", 
                "Fibrofatty infiltration of the myocardium", 
                ""
            ], 
            "flags": 0, 
            "guid": "mX,;-)/{][", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the most common pattern of inheritance for arrhythmogenic right ventricular cardiomyopathy.", 
                "Autosomal dominant", 
                ""
            ], 
            "flags": 0, 
            "guid": "b+g[PatJp1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the average age of presentation for arrhythmogenic right ventricular cardiomopathy?", 
                "30 years", 
                ""
            ], 
            "flags": 0, 
            "guid": "smF$L1p3BM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the most common cause of sudden cardiac arrest in patients less than 35 years of age.", 
                "Hypertrophic obstructive cardiomyopathy (HOCM)", 
                ""
            ], 
            "flags": 0, 
            "guid": "z8k3?,>(0R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for primary sclerosing cholangitis", 
                "Chronic progressive disorder of unknown aetiology characterised by inflammation, fibrosis and stricturing of medium and large ducts in the intrahepatic and/or extra hepatic biliary trees", 
                ""
            ], 
            "flags": 0, 
            "guid": "u%oBw|NM&5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of primary sclerosing cholangitis patients have concomittant ulcerative colitis?", 
                "90% (if routine rectal and sigmoid biopsies taken)", 
                ""
            ], 
            "flags": 0, 
            "guid": "EZ-P~)4YR9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of ulcerative colitis patients have concomittant primary sclerosing cholangitis?", 
                "5%<div><br /></div><div>Only UC patients with abnormal LFTs should undergo evaluation for PSC</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D{UCx~1AlM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "First-degree relatives of patients with primary sclerosing cholangitis are at increased risk of which two diseases?", 
                "Primary sclerosing cholangitis<div>Ulcerative colitis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GuZVw%YrMR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 symptoms of primary sclerosing cholangitis", 
                "Fatigue<div>Prutitis</div><div>Less common: fevers/chills, night sweats, right upper quadrant pain</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C,hSptzs(e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of patients diagnosed with primary sclerosing cholangitis are asymptomatic?", 
                "50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "if7498Zn&G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Pruritis in primary sclerosing cholangitis is often debilitating. Would you expect an elevated bilirubin in such patients?", 
                "No<div><br /></div><div>Pruritis of cholestasis in patients with PSC is often occurs with normal bilirubin.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LEJ6QA{cJH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 indications for liver transplantation in patients with primary sclerosing cholangitis", 
                "MELD score &gt; 15<div>Recurrent or refractory cholangitis</div><div>Intractable pruritis</div><div><br /></div><div>The usual indications for liver transplantation (e.g. acute liver failure) also apply.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ECL3Y&d0Ku", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 clinical signs that may be present at diagnosis in patients with primary sclerosing cholangitis", 
                "Jaundice<div>Hepatomegaly</div><div>Splenomegaly</div><div>Excoriations</div><div><br /></div><div>50% of patients will have no findings</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LB3?,3uiJ%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the expected LFT abnormalities in patients with primary sclerosing cholangitis", 
                "<div>Cholestatic pattern.</div>Elevated ALP (most patients)<div>Elevated bilirubin</div><div>Hypoalbuminaemia (late stage)</div><div><br /></div><div>Elevations in ALP and bilirubin fluctuate, possibly indicating transient blockage of stricture bile ducts by sludge or small stones</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Bsv2IWQSu}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with primary sclerosing cholangitis has a persistently elevated bilirubin on serial LFTs. This is indicative of what disease stage?", 
                "Advanced disease", 
                ""
            ], 
            "flags": 0, 
            "guid": "D=06I!9K%L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 autoantibodies that may be positive in patients with primary sclerosing cholangitis", 
                "ANA (75%)<div>Anti smooth muscle (75%)</div><div>P-ANCA against nuclear envelope protein (80%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bcrC8e*y|O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which immunoglobulin may be elevated in patients with primary sclerosing cholangitis?", 
                "IgM (50%)", 
                ""
            ], 
            "flags": 0, 
            "guid": "bOyq9#%qv5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 diagnostic investigations that may be useful in patients with suspected primary sclerosing cholangitis", 
                "MRCP (best)<div>ERCP (if MRI contraindicated)</div><div>Percutaneous transhepatic cholangiography (PTC)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i{;B*ENpzl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why would an antimitochondrial antibody (AMA) test be ordered for a patient with suspected primary sclerosing cholangitis?", 
                "To exclude a differential diagnosis of primary biliary cholangitis", 
                ""
            ], 
            "flags": 0, 
            "guid": "QBzXY0l%?S", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the features of primary sclerosing cholangitis seen on cholangiography", 
                "Multifocal stricturing and dilation of intrahepatic and/or extrahepatic bile ducts", 
                ""
            ], 
            "flags": 0, 
            "guid": "v:Ed4fh!uM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 pathology investigations that may be ordered in a patient with suspected primary sclerosing cholangitis", 
                "LFTs<div>ANA</div><div>P-ANCA<br /><div>IgM level</div><div>Anti-smooth muscle antibodies</div><div>IgG4 level (screen for IgG4 associated disease)<br /><div>Anti-mitochondrial antibodies (exclude prmary biliary cholangitis)</div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u6U}Z+{DdV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the difference between classic and small duct primary sclerosing cholangitis?", 
                "Classic: findings present on cholangiography<div>Small duct: normal cholangiography, diagnosis made on liver biopsy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jw]8n?X.Qb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the pattern of bile duct involvement in classic primary biliary cirrhosis", 
                "Majority intrahepatic and extrahepatic ducts (87%)<div>May involve gallbladder and cystic duct</div><div><br /><div>Intrahepatic alone (11%) and extrahepatic alone (2%) rare</div><div><br /></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z;V}W@|]VX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is liver biopsy recommended for patients with suspected primary sclerosing cholangitis?", 
                "No.<div><br /></div><div>Liver biopsy is rarely diagnostic of PSC</div><div><div>Histology demonstrates fibrous obliteration of small bile ducts with concentric replacement by connective tissue in an \"onion skin\" pattern.</div><div>Seen in less than 25% of liver biopsies.</div></div><div><br /></div><div>Biopsy is indicated if small duct PSC is suspected</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "OE.:b>|8-[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Of classic and small duct primary sclerosing cholangitis, which has the better prognosis?", 
                "Small duct PSC has a far better prognosis<div>It may progress to classic PSC</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h*ap[=tHI1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the median survival from diagnosis with primary sclerosing cholangitis?", 
                "10 - 12 years", 
                ""
            ], 
            "flags": 0, 
            "guid": "y6Kao%aCJc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is ultrasound a useful investigation for patients with suspected primary sclerosing cholangitis?", 
                "No<div><br /></div><div><div>May reveal abnormal bile ducts, but the examination may be normal.</div><div>Findings include bile duct wall thickening, enlargement, cholelithiasis, cholecystitis.</div><div><br /></div><div><br /></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cG5>gPO>2[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is poststreptococcal glomerulonephritis caused by?", 
                "A specific nephritogenic strain of group A beta-haemolytic streptococcus", 
                ""
            ], 
            "flags": 0, 
            "guid": "z$}>|_h)k-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,", 
                "Renal"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most comon cause of nephritic syndrome in children globally?", 
                "Poststreptococcal glomerulonephritis", 
                ""
            ], 
            "flags": 0, 
            "guid": "l9S<@UDdZB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,", 
                "Renal"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the pathogenesis of poststreptococcal glomerulonephritis (3)", 
                "<div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>- Patient&nbsp;nephritogenic strains of group A beta-haemolytic streptococcus (GAS)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>- Forms immune complexes (antigen antibody complexes)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>- Deposition of complexes as subepithelial humps within the glomeruli, complement activation</div><div>Influx of inflammatory cells into the glomerulus --&gt; proliferative GN</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P~5A7zd7w!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,", 
                "Renal"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the the expected light microscopy findings in poststreptococcal glomerulonephritis (5)", 
                "Diffuse proliferative glomerulonephritis<div>Prominent endocapillary proliferation</div><div>Numerous neutrophils</div><div>Trichrome stain: small subepithelial hump-shaped deposits</div><div>Crescents uncommon, confer poor prognosis</div><div><br /></div><div>Severity correlates with clinical findings</div><div><br /></div><div><img src=\"paste-6665789243393.jpg\" /></div><div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>(A) Light microscopy showing a proliferative (exudative) glomerulonephritis. Note numerous neutrophils within glomerular capillaries (Periodic acid Schiff, 40x).</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>(B) Immunofluorescence microscopy showing bright granular capillary wall staining for C3 (40x).</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>(C) Immunofluorescence microscopy showing bright granular capillary wall staining for IgG (40x).</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>(D) Electron microscopy showing a subepithelial electron dense deposit (subepithelial hump, 79900x).</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K`85QGsb[L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What disease is shown below? Describe the findings shown, and the expected findings in this disease.<div><br /></div><div><img src=\"paste-8710193676289.jpg\" /></div>", 
                "Poststreptococcal glomerulonephritis light microscopy.<div><br /></div><div>Findings shown: marked cellular proliferation and neutrophillic infiltration within the glomerular tuft. Few open capillary lumens.</div><div>Expected findings: Diffuse proliferative GN (as described above) with prominent endocapillary proliferation and numerous neutrophils.</div><div>Severity correlates with clinical findings.</div><div><br /></div><div>Below is a normal glomerulus for comparison.</div><div><img src=\"paste-8864812498945.jpg\" /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MVm`~x-/P5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Describe what is shown below.</div><div><br /></div><img src=\"paste-8985071583233.jpg\" />", 
                "Renal biopsy immunofluorescence microscopy showing bright granular capillary wall staining for C3 in a patient with poststreptococcal glomerulonephritis.", 
                ""
            ], 
            "flags": 0, 
            "guid": "GYiQC&D|87", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Describe what is shown below.</div><div><br /></div><img src=\"paste-9247064588289.jpg\" />", 
                "Renal biopsy immunofluorescene microscopy showing bright granular capillary wall staining for IgG in a patient with poststreptococcal glomerulonephritis.", 
                ""
            ], 
            "flags": 0, 
            "guid": "ttW8zr.2}x", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>What is shown below?</div><div><br /></div><img src=\"paste-9534827397121.jpg\" />", 
                "Electron microscopy showing a subepithelial electron dense deposit (subepithelial 'hump') in a patient with poststreptococcal glomerulonephritis.<div>Hump contains immune complexes, IgG, C3</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yZNg|b60g#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe what you would expect to find on immunofluorescence microscopy in a patient with poststreptococcal glomerulonephritis", 
                "IgG and C3 in diffuse granular pattern within the mesangium and glomarular capillary walls<div>Granular pattern is called 'starry sky' pattern</div><div>May also see IgN, IgA, fibrin</div><div><br /></div><div><img src=\"paste-9942849290241.jpg\" /></div><div><br /></div><div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>(A) Light microscopy showing a proliferative (exudative) glomerulonephritis. Note numerous neutrophils within glomerular capillaries (Periodic acid Schiff, 40x).</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>(B) Immunofluorescence microscopy showing bright granular capillary wall staining for C3 (40x).</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>(C) Immunofluorescence microscopy showing bright granular capillary wall staining for IgG (40x).</div><div>(D) Electron microscopy showing a subepithelial electron dense deposit (subepithelial hump, 79900x).</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e9UTT[jl?D", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe what you would expect to see on electron microscopy in a patient with poststreptococcal glomerulonepritis", 
                "<div>Dome shaped subepithelial electron-dense deposits called humps</div><div>These are deposits of immune complexes, IgG, and C3</div><div><br /></div><div><img src=\"paste-9534827397121.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D[j2}v/r!3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the clinical manifestations of poststreptococcal glomerulonephritis", 
                "Asymptomatic with microscopic haematuria (most patients)<div>Acute nephritic syndrome&nbsp;</div><div>- Hypertension, haematuria, red cell casts, pyuria, mild-mod proteinuria</div><div>Oedema</div><div>Elevated creatinine</div><div>Antecedent history of group A streptococcal skin (3 - 6 weeks ago) or throat infection (1 - 3 weeks ago)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P.>ltYwAuf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 5 components of acute nephritic syndrome", 
                "Hypertension, haematuria, red cell casts, pyuria, mild-mod proteinuria", 
                ""
            ], 
            "flags": 0, 
            "guid": "c7{`U.z4(`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe what may be seen on urinalysis in a patient with poststreptococcal glomerulonephritis", 
                "Haematuria - dysmorphic red cells<div>+/- red cell casts,&nbsp;</div><div>Variable proteinuria (may be nephrotic range in 5% of patients)</div><div>White cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ty<n:/Ky{E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 investigations which may be ordered for a patient with suspected poststreptococcal glomerulonephritis", 
                "UEC - elevated creatinine<div>Urinalysis - haematuria, red cell casts, proteinuria, white cells</div><div>C3 - low</div><div>Blood cultures</div><div>Streptozyme test (contains 5 streptococcal antibodies)</div><div><br /></div><div>Renal biopsy seldom required.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r,)w#|e+n_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When might a renal biopsy be required for a patient with suspected poststreptococcal glomerulonephritis? (6)", 
                "Significant renal imapirment progressing towards dialysis, to confirm diagnosis&nbsp;<div>- patients with &gt;30% crescents on biopsy are often treated with immunosuppression via pulsed methylpred<div><div>Disease course deviates from expected</div><div>Presents late without clear history of group A strep infection</div><div>Persistently low C3 beyond 6 weeks (suggestive of membranous GN)</div><div>Recurrent episodes of haematuria (suggetive of IgA)</div><div>Persistent or progressive increase increase in serum creatinine (uncharacteristic of post-strep GN)</div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JF#T}C55se", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of poststreptococcal glomerulonephritis", 
                "Management is supportive care.<div>- Manage complications of fluid overload such as hypertension or pulmonary oedema, via sodium restriction and loop diuretics</div><div>- Dialysis rarely required</div><div>- Antibiotics not required as postinfective</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z4ds1cyR7l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for membranous glomerulonephritis", 
                "<div>Glomerular basement membrane thickening with little or no cellular proliferation or infiltration on light microscopy</div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CviODN6);4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the two most common causes for nephrotic syndrome in adults", 
                "Membranous glomerulonephritis (20 - 30% cases caucasians)<div>Focal segmental glomerulonephritis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x}-&4I~5pI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the association between malignancy and membranous glomerulonephritis", 
                "Associated with malignancy in 25 - 30% of cases<div>Most commonly solid organ tumours<br /><div>Malignancy is usually diagnosed before the membranous GN</div></div><div>A diagnosis of MN should not prompt an extensive search for occult malignancy in the absence of a suggestive clinical finding. Age appropriate screening should be implemented.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HU1o>5]E,%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What age is the peak incidence of membranous glomerulonephritis?", 
                "30 - 50", 
                ""
            ], 
            "flags": 0, 
            "guid": "MKY@whf!CN", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the male:female ratio for membranous glomerulonephritis?", 
                "Male to female 2:1", 
                ""
            ], 
            "flags": 0, 
            "guid": "LK_At`Da)>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the characteristic findings on light microscopy in membranous glomerulonephritis.", 
                "Thickening of the glomerular basement membrane throughout all glomeruli<div>Absence of significant hypercellularity</div><div><br /></div><div><img src=\"paste-13623636262913.jpg\" /></div><div><br /></div><div>Normal:</div><div><img src=\"paste-13645111099393.jpg\" /></div><div><br /></div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g<97CXe@l=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the findings seen on immunofluoresence in patients with membranous glomerulonephritis", 
                "Diffuse granular pattern of IgG and C3 along the GBM/along the capillary walls (same thing)<div><br /></div><div><img src=\"paste-13731010445313.jpg\" /></div><div><br /></div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r%B/x}Y,{L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the electron microscopy findings seen in membranous glomerulonephritis (3)", 
                "Subepithelial electron dense deposits on the outer aspect of the GBM&nbsp;<div>Effacement of foot processes of the overlying podocyte,</div><div>Expansion of the GBM by deposition of new extracellular matrix between the immune deposits</div><div><br /></div><div><img src=\"paste-13945758810113.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c0*tWjHA{+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the pathogenesis of membranous glomerulonephritis", 
                "Glomerular basement membrane expansion occurs due to immune deposits (IgG, C3) within the glomerular basement membrane, causing diffuse thickening", 
                ""
            ], 
            "flags": 0, 
            "guid": "BgH4clx-37", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Membranous glomerulonephritis is said to have a 'spike' appearance on silver stain. Why is this so?", 
                "Basement membrane takes up the silver stain; immune deposits do not.<div>In membranous GN, the thickened basement membrane is interdispersed with immune deposits which do not stain.</div><div>This makes it look like the basement membrane has projections or 'spikes' on the stain.</div><div><br /></div><div><img src=\"paste-14534169329665.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rci!Drii%_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Label this glomerulus.</div><img src=\"paste-14667313315841.jpg\" />", 
                "<img src=\"paste-14632953577473.jpg\" />", 
                ""
            ], 
            "flags": 0, 
            "guid": "zx5;eHZZqa", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>What is the diagnosis? Name two characteristic findings seen here.&nbsp;</div><div><br /></div><img src=\"paste-14813342203905.jpg\" />", 
                "Membranous glomerulonephritis<div><div>-Capillary loops are thickened and prominent</div><div>-Cellularity is not increased</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zq}Kqw)Uim", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the diagnosis? Describe the findings below.<br /><div><img src=\"paste-15002320764929.jpg\" /></div>", 
                "Electron microscopy of membranous glomerulonephritis.<div>Electron dense deposits (D) seen in the subepithelial space across the GBM and under the epithelial cells (Ep). There is new basement membrane growing between the deposits, which will give a spike appearance on silver stain.</div><div><br /></div><div>(Top left box - urinary space. Bottom right box - capillary lumen)<br /><div><br /></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kaFmDk3R~[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Membranous glomerulonephritis may be broadly catagorised into two categories. What are they?", 
                "Idiopathic (75%)<div>Secondary</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uAHhF!L3c/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the significance of phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous glomerulonephritis", 
                "Thought to be a possible cause of idiopathic MN<div>PLA2R is a transmembrane receptor expressed in glomerular podocytes</div><div>Anti-PLA2R identified in 70% of patients with idiopathic MN and 0% controls in one study</div><div>May also be useful for monitoring clinical status; higher titres correlate with poorer outcome</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I$r??v1IE2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 causes of secondary membranous glomerulonephritis", 
                "SLE<div>Drugs</div><div>Infections</div><div>Malignancy</div><div>IgG4 related disease</div><div>Haematopoietic cell transplant and graft-vs-host disease</div><div>Post renal transplantation (recurrent or de novo)</div><div>Sarcoidosis (rare)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wc9~Q!l08E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 infections associated with membranous glomerulonephritis", 
                "Hepatitis B - may have low complement<div>Hepatitis C (chronic) (uncommon)</div><div>Syphilis</div><div>HIV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F9?2zJW!M{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 drugs that may cause membranous nephropathy", 
                "NSAIDs<div>Penicillamine</div><div>Gold salts</div><div>Bucillamine</div><div>Anti-TNF</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I_s+xSAaY#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the significance of thrombospondin type-1 domain-containing 7A (THSD7A) in membranous glomerulonephritis", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>A transmembrane receptor expressed on glomerular podocytes</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Antibodies expressed in 10% of idiopathic MN patients who are also negative for PLA2R</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>May be more prevalent in Japanese, less in North American and European populations</div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mL2h_#SKT7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the type of liver metastases that may be amenable to resection", 
                "Colorectal or GI neuroendocrine origin<div>Can be resected completely, leaving adequate liver</div><div>Extrahepatic disease not an absolute contraindication, so long as complete resection (margin negative) is possible</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h5hiXqJdvE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of metastatic colorectal cancer patients with liver metastases are amenable to resection?", 
                "20%", 
                ""
            ], 
            "flags": 0, 
            "guid": "MK+!hn9aH*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of unresectable liver metastases in colorectal cancer", 
                "Consider neoadjuvant chemo to attempt to downstage to resectable, or<div>Radiofrequency ablation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hF~f1$V}z(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What kind of colorectal liver metastases are most appropriate for radiofrequency ablation?", 
                "Unresectable<div>&lt;3 lesions</div><div>&lt;3cm size</div><div>Not near major vascular structures</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oCmMi)wLYs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 2 most common histological types of prostate cancer", 
                "Adenocarcinoma (95%)<div>Small cell (neuroendocrine)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n;2?dg4%N%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of androgen production and regulation in men", 
                "<div>GnRH released from hypothalamus</div><div>Stimulates release of LH and FSH from anterior pituitary</div><div>LH stimulates androgens production by testes (Leydig cells) (90 - 95%) and the adrenals (5%)</div><div>Testosterone has negative feedback effect on anterior pituitary and hypothalamus</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "o9P0aUX5~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where is PSA produced?", 
                "Prostate cells<div>Not produced anywhere else</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "riX%N]UNT+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 causes of an elevated PSA", 
                "Prostate cancer<div>BPH</div><div>Prostatitis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BCt`iCg)?M", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is PSA specific for prostate cancer?", 
                "No.<div>Specific for prostate but not for prostate cancer, can be elevated due to benign prostate pathology.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c9Q(hC!XDB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is PSA density?", 
                "<div>Ratio of prostate size to PSA (usually via CT or MRI; DRE inaccurate)</div><div>High density is bad</div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HmX)><tX*-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is fractionated PSA?", 
                "<div>Percentage of PSA present as&nbsp;conjugated or free</div><div>High free PSA (&gt;30%) is favourable, low (&lt;10%) associated with cancer</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Hdv.|%<O-3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the utility of DRE in diagnosing prostate cancer.", 
                "Detects cancer in posterior and lateral glans aspects<div>Does not detect tumours in other parts of the prostate (25 - 35%)<br /><div>Cannot detect small (T1) tumours</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fE1[CB0<83", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A digital rectal examination is performed in a patient with a normal PSA. Findings are considered suspicious for prostate cancer. Is a biopsy indicated?", 
                "Yes.<div><div>Biopsy indicated for concerning findings on DRE, regardless of PSA or other risk factors</div></div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "t5GT;{S<dW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with an abnormal digital rectal examination and normal PSA has a transrectal ultrasound performed. The ultrasound is reported as normal. Is biopsy indicated?", 
                "Yes.<div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Biopsy indicated for concerning findings on DRE, regardless of PSA or other risk factors</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Biopsy cannot be avoided by obtaining a normal transrectal ultrasound in patients with abnormal DRE (possibility of false negatives)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "t//u|6Wn`Q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is transrectal ultrasound recommended as part of the diagnostic workup for prostate cancer?", 
                "No.<div>Possibility of false negatives.</div><div>Useful during biopsies to target lesions for biopsy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "eSKe%$T/)P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe Gleason grade.", 
                "<div>Based on the architectural features of prostate cancer cells</div><div>Correlates well with clinical behaviour</div><div>Grade 1 - 5 from most to least differentiated</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "unl;@)P;Mw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe composite Gleason score.", 
                "<div>Derived from adding together the two most prominent Gleason grades</div><div>E.g. A biopsy is predominantly grade 3 with secondary grade 4 disease; the composite score is \"3+4\" or 7.</div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EA0?3soka8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe Gleason grade group", 
                "<div>Updated way of stratifying composite Gleason scores into risk groups.</div><div>Correlates well with prognosis</div><div><br /></div><div>Grade group 1: composite Gleason score &lt;6</div><div>Grade group 2: score 3+4 = 7</div><div>Grade group 3: score 4+3 = 7</div><div>Grade group 4: score 8&nbsp;</div><div>Grade group 5: score 9 - 10&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O)Oo2A|0w#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 histopathological factors that correlate with poor prognosis in prostate cancer", 
                "Higher Gleason grade, composite Gleason score, and grade group<div>Perineural invasion</div><div>Higher percentage of positive biopsies</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h0|xAC~XZe", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 factors used to determine clinical stage of prostate cancer", 
                "TNM stage<div>Grade group</div><div>Preoperative PSA</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hz+Jqnt50n", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe pathological T staging of prostate cancer", 
                "T2 - organ confined<div>T3 - extraprostatic extension</div><div>T4 - tumour is fixed or invdes adjacent structures other than semial vesicles</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s=TDd/XFK~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of prostate cancer patients are upgraded to a higher stage following radical prostatectomy?", 
                "34%", 
                ""
            ], 
            "flags": 0, 
            "guid": "bY/?(9IUV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe clinical T staging of prostate cancer", 
                "T1 - clinically inapparent tumour that is not palpable<div>T2 - Tumour palpable, confined within prostate</div><div>T3 - extraprostatic tumour that is not fixed or does not invade surrounding structures</div><div>T4 - tumour is fixed or invades surrounding structures other than seminal vesicles</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oF_HifWV_(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe clinical N staging of prostate cancer", 
                "<div>Nx - not assessed</div>N0 - no positive regional nodes<div>N1 - metastases in regional node(s)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zRc,+YhbPu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe clinical M staging of prostate cancer", 
                "M0 - no distant mets<div>M1 - distant metastasis<br /><div>&nbsp; &nbsp;M1a - nonregional lymph nodes</div><div>&nbsp; &nbsp;M1b - bone(s)</div><div>&nbsp; &nbsp;M1c - other sites with or without bone disease</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uQ-:TfHAH<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the criteria for NCCN very low risk prostate cancer", 
                "<div>Detected by elevated PSA</div><div>No abnormalities on DRE</div><div>Histologic grade group 1 (Gleason score &lt;6)</div><div>PSA &lt;10</div><div>&lt;3 biopsy cores positive, less than 50% involvement per core</div><div>PSA density less than 0.15ng/mL</div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Fa&>#qaNTU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of NCCN very low risk prostate cancer", 
                "<div>Life expectancy &lt; 20 years:&nbsp;Active surveillance</div><div>Life expectancy &gt; 20 years: Active surveilance OR radiation therapy (external beam or brachytherapy) OR radical prostatectomy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "eP63k#LK0<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the criteria for NCCN low risk prostate cancer", 
                "<div>Normal DRE or disease limited to one lobe only (T0 - T2a)</div><div>Histologic grade group 1 (Gleason score &lt;6)</div><div>PSA &lt;10</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r8}uC}de,e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management for NCCN low risk prostate cancer", 
                "<div>Active surveillance, or</div><div>Radiation therapy (external beam or brachytherapy), or</div><div>Radical prostatectomy (lymph node dissection optional)</div><div><br /></div><div>Very little data on which of the above is preferable; one large randomised trial (ProtecT) showed no significant difference in 10 year survival between the three</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q3>#3..`UB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the criteria for NCCN intermediate risk prostate cancer.", 
                "<div>At least one of the following:</div><div><br /></div><div>T2b (involving more than one half of one lobe) or&nbsp;T2c (bilateral disease)</div><div>Gleason score 7</div><div>PSA 10 - 20</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h.}!wcPR}i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management for NCCN intermediate risk prostate cancer.", 
                "<div>Active surveillance (if life expectancy &lt;10 years), or</div><div>External beam RT +/- ADT (4 - 6 months), or</div><div>Radical prostatectomy with pelvic lymph node dissection</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mlwW7$$Uep", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the criteria for high risk prostate cancer", 
                "<div>T3a, or</div><div>Gleason score 8 - 10, or</div><div>PSA &gt;20</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gef+P~NPv9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management for high risk prostate cancer", 
                "<div>RT (external beam or brachytherapy) + ADT, or</div><div>RT (external beam) + docetaxel, or</div><div>Radical prostatectomy with extended pelvic lymph node dissection</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sY]Jh~Ju#}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the NCCN criteria for very high risk prostate cancer", 
                "<div>T3b or T4 with seminal vesicle involvement, tumor fixation, or invasion of adjacent organs, or</div><div>Primary Gleason grade 5, or</div><div>Gleason grade group 4 or 5 (score 8 - 10)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zQ2eBucZF(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of NCCN very high risk prostate cancer", 
                "<div>RT (external beam) +/- brachytherapy + long term ADT, or</div><div>RT (external beam) + docetaxel, or</div><div>Radical prostatectomy with extended pelvic node dissection</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xBH4~0V^Yz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of prostate cancer with nodal metastasis", 
                "RT (external beam) + ADT, or<div>ADT alone</div><div><br /></div><div>Nodal mets denote stage IV disease.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q1N:8qu:nc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe NCCN recommendations for ongoing monitoring post definitive therapy for early prostate cancer", 
                "PSA every 6 - 12 months for 5 years, then every year<div>DRE every year (may be omitted if PSA undetectable)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tUgBGJ_-1R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of failure of PSA to fall to undetectable levels post definitive therapy", 
                "Check PSA doubling time<div>Imaging to seek distant metastases</div><div>- If present, ADT + RT (external beam) to metastases if weight bearing/symptomatic</div><div>- if not present, ADT +/- RT</div><div><br /></div><div>In both cases, can observe instead and institute treatment when symptoms develop of PSA changes to suggest symptoms are imminent</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "we{Xh]aR2<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of goserelin", 
                "<div>Used for prostate cancer</div>Gonadotropin-releasing hormone agonist (also leuprolide, buserelin)<div>Bind to GnRH receptor on pituitary gonadotropin-releasing cells, causing release of FSH and LH, and increased testosterone from Leydig cells</div><div><div>After 1 week GnRH receptors are downregulated on GnRH-producing cells, causing fall in LH and FSH. Fall in LH leads to fall in testosterone</div><div>Castrate levels achieved after 3 - 4 weeks (&lt;1.7nmol/L)</div></div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D]H+E?q<$&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the 'flare phenomenon' seen with GnRH agonist ADT", 
                "GnRH agonists initially cause rise in LH (and FSH), and hence testosterone<div>Downregulation of GnRH receptors occurs 1 week later, causing fall in LH and hence testosterone</div><div>In meantime increased testosterone can cause transient worsening of disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jYA=%uzah3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How can the 'flare phenomenon' seen with GnRH agonist ADT be prevented?", 
                "Antiandrogens commenced 1 week prior (if high risk) or concurrently<div>- flutamide, bicalutamide, nilutamide</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MgV3FPUV,.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In which patients in GnRH agonist ADT alone contraindicated?", 
                "<div>Patients in whom transient worsening of prostate cancer could have dire consequences:</div>Impending cord compression<div>Severe urinary tract obstruction</div><div>Painful bony metastases</div><div><br /></div><div>Can be given with antiandrogens (e.g. flutamide, bicalutamide, nilutamide) to mitigate risk.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j)R/m!n7F0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of Degarelix", 
                "GnRH antagonist used for prostate cancer (ADT)<div>Avoids flare phenomenon seen in GnRH agonists</div><div>Suppresses testosterone faster (within 3 days vs 3 - 4 weeks)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u95:DJ}}pI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 side effects of ADT", 
                "<div>Sexual dysfunction</div><div>Loss of bone mineral density (increased bone turnover)</div><div>Hot flashes</div><div>Gynaecomastia</div><div>Fatigue</div><div>Increased cardiovascular disease and diabetes</div><div></div><div>Decreased muscle with increased fat</div><div>Anaemia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dfaT_:rBB{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechism of action of antiandrogens", 
                "<div>Bind to androgen receptors and competitively inhibit their binding to testosterone</div><div>No role in treatment of prostate cancer except to prevent flare phenomenon with GnRH agonist ADT</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C=+>TCf/=l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of castrate sensitive metastatic prostate cancer", 
                "ADT alone, or<div>ADT + abiraterone, or</div><div>ADT + docetaxel</div><div><br /></div><div>Significant survival benefit with addition of abiraterone or docetaxel to ADT in high risk/high volume disease</div><div>May also be used in low risk/low volume disease (grade 2B)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "euc<([x/R~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of abiraterone", 
                "<div>Used for treatment of metastatic prostate cancer</div><div>Inhibits products of the CYP17 gene, resulting in block of synthesis of androgens in the tumour, testes, and adrenal glands</div><div>Risk of adrenal insufficiency, hence given with prednisolone</div><div>Contraindicated in severe hepatic dysfunction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GzE;:~oDYU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 side effects of abiraterone", 
                "<div>Hypertriglyceridaemia (most common)</div><div>Hypokalaemia<div><div>hypertension</div><div>oedema</div><div>hepatotoxicity</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uM5/9.N8S#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is a diagnosis of castrate resistance determined in patients with previously castrate-sensitive prostate cancer?", 
                "Evidence of disease progression on ADT", 
                ""
            ], 
            "flags": 0, 
            "guid": "cBRn08VwFa", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of castrate-resistant prostate cancer", 
                "<div>Continue ADT, then add one of the following:</div>Abiraterone + predisolone<div>Enzalutamide</div><div>Taxane chemotherapy (docetaxel)</div><div><br /></div><div>Less common: immunotherapy (Sipuleucel-T), radium-223</div><div><br /></div><div>All confer a survival benefit.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w`G:hc1zi/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of enzalutamide", 
                "<div>Used in metastatic castrate-resistant prostate cancer</div><div>Blocks binding of androgens to androgen receptors, inhibits nuclear translocation of the androgen receptor, inhbits association of the androgen receptor with nuclear DNA</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jL9pea)j!2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Once a patient with castrate resistant prostate cancer has progressed on either abiraterone or enzalutamide, is there evidence for switching to the other agent?", 
                "No.<div>Should choose another modality, e.g. taxane chemotherapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m<>OIpIL|b", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 oral medications used in metastatic castrate-resistant prostate cancer thatn interfere with androgenic stimulation", 
                "Abiraterone<div>Enzalutamide</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wzM&R6cTuQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most important prognostic factor in metastatic castrate-resistant prostate cancer?", 
                "Site of metastatic involvement<div>- Lymph node only is best (31.6 months)</div><div>- Bone (21 months)</div><div>- Lung (19 months)</div><div>- Liver (13 months)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j^*fY$u}%v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient is commenced on ADT for castrate-sensitive metastatic prostate cancer. What primary prevention is needed to maintain bone health?", 
                "Calcium 1000 - 1200mg/day (food or supplements)<div>Vitamin D supplement</div><div>Lifestyle modification</div><div>Baseline + periodic DEXA</div><div><br /></div><div>No role for bisphosphonates in castrate-sensitive disease.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cDb@Wary8a", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient is on ADT for castrate-resistant prostate cancer with bony metastases. Is therapy required to prevent fractures? What would be used?", 
                "<div>Bisphosphonates or denosumab indicated in CRPC with bony mets for fracture prevention</div><div>- Not indicated in castrate-sensitive disease</div><div><br /></div><div>Should also have usual recommendations for patients on ADT:</div><div><div>calcium 1000 - 1200mg/day (food or supplements) + vitamin D supplements + lifestyle modificiations + baseline &amp; periodic DEXA</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i.T+>IFdP#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with metastatic prostate cancer is found to have a falling PSA in the setting of worsening clinical and radiological disease. What might explain this, and how should it be managed?", 
                "Transformation to small cell carcinoma<div>Biopsy, and if confirmed cease ADT and treat with platinum-based chemotherapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hBwSVs%Fa{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of pain due to bony metastases in prostate cancer", 
                "Radiotherapy<div>Analgesia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DT=.;kszq9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of bony metastases are seen in prostate cancer?", 
                "Osteoblastic<div>Axial skeleton</div><div><br /></div><div>Note can also have other leson types but less common</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PwdR~57kZm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of localised small cell prostate cancer", 
                "Treat as per high or very high risk prostate cancer guidelines, regardless of actual grade:<div><br /></div><div><div>RT (external beam or brachytherapy) + ADT, or</div><div>RT (external beam) + docetaxel, or</div><div>Radical prostatectomy with extended pelvic lymph node dissection</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yDjHXnwLU/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of small cell prostate cancer", 
                "High grade disease but low PSA, often &lt;2.5&nbsp;<div>60% metastatic at presentation</div><div>Paraneoplastic syndromes (cushing's syndrome, peripheral neuropathy, membranous nephropathy, hypercalcaemia)</div><div>Poor prognosis, 1 year survival 48%, 5 year survival 14%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GDls9Q$wKg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is single strongest factor for poor survival in breast cancer?", 
                "Lymph node involvement<div>In node-negative patients: tumour size</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MI$VI}<^RX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the primary prevention guidelines for colorectal cancer?", 
                "<div>2 yearly FOBT from age 50 - 74</div><div>Lifestyle advice for everyone</div><div>Chemoprophylaxis with low dose aspirin should be considered in patients 50 - 70 of average risk</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vC,uA_d!mx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of bevacizumab?", 
                "Class: antiangiogenic<div>Mechanism: Vascular endothelial growth factor (VEGF) ligand inhibitor</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pv&N)/MD6[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of sunitinib, pazopanib, sorafenib?", 
                "Tyrosine kinase inhibitors, antiangiogensis agents<div>Inhibit &nbsp;VEGF receptor tyrosine kinases 1-3 (sorafebin only types 2-3), hence blocking VEGF signalling</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l?F(Ql^Rv,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 adverse effect of antiangiogenesis agents", 
                "<div>Hypertension (most common)</div><div>Proteinuria/nephrotic syndrome</div><div>Aterial and venous thrombosis</div><div>Bleeding</div><div>Heart failure</div><div>LV dysfunction/Myocardial ischaemia</div><div><br /></div><div></div>Antiangiogenesis agents block vascular endothelial growht factor signalling", 
                ""
            ], 
            "flags": 0, 
            "guid": "bgwHU%RZzU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of colorectal cancers are metastatic at presentation?", 
                "20%", 
                ""
            ], 
            "flags": 0, 
            "guid": "EKSva]3J#g", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of colorectal cancers are identfied due to suspicious symptoms (as opposed to screening)?", 
                "70 - 80%", 
                ""
            ], 
            "flags": 0, 
            "guid": "k&0u|;dS.G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 primary tumour-related symptoms that may be present in patients with colorectal cancer", 
                "<div>Change in bowel habit (74%) (more common with left than right sided CRC)</div><div>Rectal bleeding + change in bowel habit (51%)</div><div>Rectal mass (24.5%)</div><div>Abdominal mass (12.5%)</div><div>Iron deficiency anaemia (9.6 - 23%) (Right sided CRCs more likely to cause iron deficiency anaemia from unrecognized blood loss)</div><div>Abdominal pain alone (3.8%)</div><div>Bowel obstruction</div><div>Peritonitis/perforation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x!%O1qyXqp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which site of colorectal cancer is associated with the highest mean daily blood loss?", 
                "Right sided colorectal cancer - fourfold higher mean daily blood loss (approx 9ml/day) than other colonic sites", 
                ""
            ], 
            "flags": 0, 
            "guid": "JG`~DF:vUp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 6 most common sites of metastases from colorectal cancer", 
                "<div>Regional lymph nodes</div><div>Liver (1st site of haematogenous spread - as venous drainage of intestinal tract is via portal system&nbsp;</div><div>Lungs (2nd haematogenous site)</div><div>Peritoneum</div><div>Bone</div><div>Brain</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G^zhVS3W@!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 clinical features that may be seen in patients with metastatic colorectal cancer", 
                "RUQ pain<div>Abdominal distension</div><div>Early satiety</div><div>Supraclavicular lymphadenopathy</div><div>Periumbilical nodules</div><div>Malignant fistula</div><div>Strep gallolyticus (formerly bovis) or clostridium septicum sepsis</div><div><br /></div><div>Symptomatic at diagnosis confers worse prognosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rQ?q8v.=5l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the best diagnostic test for suspected colorectal cancer?", 
                "Colonoscopy<div>Can localise, biopsy, detect synchronous cancers, remove polyps</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "QOuwu:<=af", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the miss rate for colorectal cancer in asymptomatic patients?", 
                "2 - 6%", 
                ""
            ], 
            "flags": 0, 
            "guid": "w-|BFiGqJ=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the appearance of colorectal cancer on colonoscopy", 
                "<div>Vast majority of CRCs protrude into the bowel lumen</div><div>May be exophytic or polypoid</div><div>May involve the whole circumference of the bowel wall (correlates with apple core on imaging).</div><div>Small number of lesions are flat or depressed</div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "OsmO0E4Qf5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of CEA in screening, diagnosis, and management of colorectal cancer?", 
                "No role in screening or diagnosis<div>Role in monitoring disease:</div><div>- Check pre-op level, if ongoing elevation postop this implies residual disease</div><div>- Rising CEA after resection implies recurrence and imaging should be obtained</div><div>Role in prognosis: preop CEA &gt; 5 confers poorer prognosis (independent of TNM stage)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tV<G7MueU3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 tumour markers that may be helpful in monitoring patients with colorectal cancer", 
                "CEA<div>CA19-9</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Qp^.ytWz7Y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the T staging (of TNM) used for colorectal cancers.", 
                "<div><div>Tis: carcinoma in situ</div><div>T1: tumour invades submucosa</div><div>T2: invades muscularis propria</div><div>T3: invades through muscularis propria into pericolorectal tissues</div><div>T4: invades through the visceral peritoneum, or invades or adheres to adjacent organs or structures</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j<9?kUgsK<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the N staging (of TNM) used for colorectal cancers.", 
                "<div>N1: 1 -3 regional lymph nodes</div><div>N2: four or more regional nodes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d%u.P#A[Zb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the M staging (of TNM) for colorectal cancer", 
                "<div>M0: no mets</div><div>M1: mets to one or more distant sites or organs, or peritoneal mets</div><div>- M1a: one site or organ without peritoneal mets</div><div>- M1b: two or more sites without peritoneal mets</div><div>- M1c: peritoneal mets alone or with other sites</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qIP5Jw;Q3`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the difference between clinical and pathologic staging of colorectal cancer", 
                "<div>Radiographic, endoscopic (including biopsy), and intraoperative findings are used to assign the clinical stage (TNM)</div><div>Histological examination is used to assign pathologic stage (pT, pN, pM)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j@Lm){O,+>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the effect of neoadjuvant treatment on colorectal cancer TNM staging", 
                "May significantly alter (improve) stage", 
                ""
            ], 
            "flags": 0, 
            "guid": "c;>kqxtlWl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are mismatch repair genes, and what is their significance in colorectal cancer?", 
                "<div>MMR genes code for proteins that correct DNA mismatches generated during DNA replication</div><div>Defects in MMR therefore increase spontaneous mutation rate, resulting in a high number of DNA replication errors - accumulation of abnormalities in short sequences of neucleotide bases that are repeated dozens to hundreds of times ('microsatellites').&nbsp;</div><div>Accumulation of these changes is called microsatellite instability (MSI).&nbsp;</div><div><br /></div><div>MMR-deficient results in MSI-high</div><div>MMR-proficient results in MSI-low</div><div><br /></div><div>Mutations in one of several DNA MMR genes &nbsp;resulting in failure to produce MMR proteins&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HI>&*%%/57", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 MMR genes", 
                "<div>MLH1</div><div>MSH2</div><div>MSH6</div><div>PMS2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dbDy8n>V$#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In which patient populations might MMR proteins be absent?", 
                "<div>Found in Lynch syndrome and 15 - 20% of sporadic colorectal cancers</div><div>- Lynch syndrome have germline mutations</div><div>- Sporadic CRCs have epigenetic genes (methylation) that silence gene expression</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rP#1@%+8v@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which confers the better prognosis, MSI-high or MSI-low colorectal cancer?", 
                "MSI-high<div><br /></div><div><div>MMR deficient (MSI-H, or microsatellite unstable) tumours have longer survival than MMR proficient tumours that are MSI-low (MSI-L, showing microsat instability in &lt;30-40% of loci) or MSI stable, both in Lynch and sporadic CRC</div><div>- We don't know why</div><div>-&nbsp;This is despite these tumours often being poorly differentiated</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kz+2_Xt;S#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the significance of KRAS mutation in colorectal cancer", 
                "<div>Activating mutation of the RAS-RAF-ERK pathway</div><div>40% of CRC</div><div>Good concordance of primary and mets (but not lymph node mets)</div><div>Poor prognostic marker</div><div>KRAS is downstream of EGFR, so KRAS mutant CRC is unresponsive to anti-EGFR therapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pX!lyM407>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the significance of NRAS mutation in colorectal cancer", 
                "<div>Poor prognosis</div><div>Downstream of EGFR, so unresponsive to anti-EGFR therapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hi3>(l~byB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the significance of BRAF mutation in colorectal cancer", 
                "<div>Activating mutation, most occur in codon 600 (V600E)</div><div>10% sporadic CRC</div><div>Associated with smoking</div><div>Strong negative prognostic marker regardless of TNM in MSI stable patients (less so in MSI unstable patients)</div><div>Unlikely to respond to anti-EGFR therapy unless together with a BRAF inhibit</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PVYfM@{?/B", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the significance of EGFR in colorecal cancer", 
                "<div>Epidermal growth factor receptor</div><div>Inhibition prevents cell growth</div><div>Can be targeted with anti-EGFR agents - cetuximab,&nbsp;panitumumab</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k?7hZl9FIV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patient population, of those with metastatic colorectal cancer, are candidates for anti-EGFR therapy (cetuximab)?", 
                "Patients without mutant RAS (KRAS, NRAS)<div><br /><div>BRAF mutation also makes response unlikely</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r_o.{S:9!z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the chemotherapy management of metastatic colorectal cancer", 
                "<div>FOLFOX (oxaliplatin + leucovorin + fluorouracil), or&nbsp;</div><div>XELOX (oxaliplatin + capecitabine), or&nbsp;</div><div>FOLFIRI (irinotecan + leucovorin + fluorouracil)</div><div><br /></div><div>Plus (add to any of the above):</div><div>- Bevacizumab (if KRAS/BRAF mutant, OR right sided)</div><div>- Cetuximab (if KRAS/BRAF wild type AND left sided)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NSl;j0S/x{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define seizure", 
                "Sudden change in behaviour caused by electrical hypersynchonisation of neural networks in the cerebral cortex", 
                ""
            ], 
            "flags": 0, 
            "guid": "pg7dZ<0xNs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define acute symptomatic seizure", 
                "Seizure occurring at the time of a systemic insult, e.g. Traumatic brain injury, stroke, SDH, CNS infection, severe metabolic derangement", 
                ""
            ], 
            "flags": 0, 
            "guid": "cEC}3/uH`$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define unprovoked seizure", 
                "Seizure due to unknown aetiology OR&nbsp;<div>pre-existing brain lesion OR&nbsp;</div><div>progressive nervous system disorder&nbsp;</div><div><br /></div><div>(i.e. not an acute symptomatic seizure)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lMJ-}&V~OW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for epilepsy, including diagnostic criteria (3)", 
                "<div>Epilepsy is a disease of the brain defined by:</div><div>At least two unprovoked seizures more than 24hrs apart, OR</div><div>One unprovoked seizure with estimated recurrence similar to that following two unprovoked seizures (around &gt;60%), OR</div><div>Diagnosis of an epilepsy syndrome</div><div><br /></div>", 
                "International league against epilepsy"
            ], 
            "flags": 0, 
            "guid": "vQs>2AOYR2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for resolved epilepsy", 
                "<div>Patient with age-dependent epilepsy who is older than age which syndrome is active, OR</div><div>Seizure free for &gt;10 years, and off medication &gt;5 years</div>", 
                "International league against epilepsy"
            ], 
            "flags": 0, 
            "guid": "F7NFXk+Y}.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 3 broad seizure types", 
                "Focal seizures with retained awareness<div>Focal seizures with impaired awareness</div><div>Generalised seizures</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oV+H}Fac:q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for focal seizure with retained awareness", 
                "Seizure occuring in one part of the brain (i.e. focal) with retained awareness<div>May have motor or nonmotor onset</div><div>May progress to bilateral (focalto bilateral tonic-clonic)</div><div><br /></div><div><img src=\"paste-4196183048193.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O}z4##B}7#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What kind of seizure is an 'aura'?", 
                "Focal seizure with retained awareness", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q|}FTv_%Gt", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A focal seizure with retained awareness where the patient sees flashing lights indicates seizure activity in which part of the brain?", 
                "occipital cortex", 
                ""
            ], 
            "flags": 0, 
            "guid": "e+gZ98-A2>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A focal seizure with retained awareness where the patient has sudden fear or anxiety, epigastric 'rising', gustatory or olfactor hallucinations, and deja-vu indicates seizure activity in which part of the brain?", 
                "Temporal lobe", 
                ""
            ], 
            "flags": 0, 
            "guid": "zU^kk`kSYs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What symptoms might you expect in a patient with focal seizure with retained awareness arising from the temporal lobe?", 
                "sudden fear or anxiety<div>epigastric 'rising'</div><div>gustatory or olfactor hallucinations</div><div>deja-vu</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "FZ~E7#^kHo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of temporal lobe epilepsy", 
                "Begins with aura (focal seizure with retained awarenss) with&nbsp;sudden fear or anxiety, epigastric 'rising', gustatory or olfactor hallucinations, and deja-vu<div>Seizure progresses to focal seizure with impaired awareness and automatisms</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O}&kZOi#M]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the commonest focal epilepsy syndrome in adults?", 
                "Temporal lobe epilepsy", 
                ""
            ], 
            "flags": 0, 
            "guid": "efq&kl%zP9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the EEG and MRI findings in temporal lobe epilepsy", 
                "May be normal<div>MRI: mesian temporal sclerosis or hippocampal sclerosis</div><div>EEG: epileptiform activity in temporal lobe</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I8YT)|k6t=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the antiepleptic of choice in temporal lobe epilepsy?", 
                "Carbamazepine", 
                ""
            ], 
            "flags": 0, 
            "guid": "g2%zE]{)BW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A focal seizure with retained awareness where the patient has hemiclonic activity in the contralateral face, arm, or leg indicates seizure activity in which part of the brain?", 
                "Primary motor cortex (frontal lobe)&nbsp;<div><div>Seizures may be quite focal (isolated to one limb or face) or may spread (or march) to adjacent areas (Jacksonian seizure)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e~$O5?q:-1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 antibiotics that cover pseudomonas", 
                "Pip/taz<div>Meropenen<br /><div>Ceftazidime</div><div>Cefepime</div></div><div>Gentamicin</div><div>Amikacin</div><div><br /></div><div>Only oral option: ciprofloxacin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ezuUwkwf7c", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 features that suggest primary (as opposed to secondary) membranous nephropathy", 
                "<div>Exclusively subepithelial and intramembranous electron-dense deposits</div><div>Positive for IgG and C3 on immunofluoresence, nothing else</div><div>IgG deposits are predominantly IgG4&nbsp;</div><div>Presence of antigen phospholipase A2 receptor (PLA2R) or thrombospondin type-` domain-containing 7A (THSD7A) within immune deposits&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Kh|GK9a8Ga", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 feature that may be seen in membranous glomerulonephritis that strongly suggests SLE as a cause", 
                "Tubuloreticular structures in the glomerular endothelial cells<div><br /></div><div><img src=\"paste-147240068841473.jpg\" /></div><div><img src=\"paste-147351737991169.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yXMqGe5eQ{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 features of membranous glomerulonephritis that suggests secondary MN", 
                "Mesangial and/or subendothelial deposits (suggests a circulating immune complex)<div>Presence of IgA, IgM, C1q, and IgG other than IgG4</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "prQ%=bA?PT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the clinical presentation of membranous glomerunonephritis (3)", 
                "Nephrotic syndrome (80%)&nbsp;<div>Asymptomatic proteinuria (20%)</div><div><div>Normotensive (70%)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Gu9cO_K3_F", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the typical onset of membranous glomeruloneprhtis (i.e. days, weeks, or months)", 
                "<div>Usually subacute/slow onst due to slow buildup of deposits in subepithelium (FSGS and minimal change are more rapid); proteinuria may be present for months prior to diagnosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rv24gv(ZFy", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define nephrotic syndrome", 
                "<div>Proteinuria, hypoalbuminaemia, oedema, hyperlipidaemia (some people also include hypertension)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rM[XoCt).N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the expected urinalysis results in a patient with membranous glomerulonephritis (3)", 
                "Nephrotic range proteinuria<div>Microscopic haematuria (50%)</div><div>Glucose</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i9ca?9,5A$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the expected urine microscopy results in a patient with membranous glomerulonephritis (3)", 
                "Oval fat bodies<div>Lipid droplets</div><div>Fatty casts</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Qx7p/W0E5a", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the expected pathology results in a patient with membranous glomerulonephritis", 
                "Hypoalbuminaemia<div>Hyperlipidaemia</div><div>Normal eGFR (70%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ov;r=YHKU5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 investigations that may be ordered in a patient with membranous glomerulonephritis, (excluding investigations seeking primary or secondary cause)", 
                "UEC<div>LFT</div><div>FBE</div><div>Urinalysis and sediment</div><div>24hr urine collection for protein quantification (or spot protein:creatinine ratio)</div><div>C3/C4</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lu&$UaNB>N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 9 investigations that may be ordered in a patient with membranous glomerulonephritis, seeking a primary or secondary cause", 
                "Anti-PLA2R ELISA assay<div>ANA, and if positive dsDNA, anti-Sm, anti-Ro/SSA, anti-La-SSB</div><div>RF and anti-CCP</div><div>Hepatitis B and C serology</div><div>HIV testing</div><div>IgG4</div><div>SPEP and serum free light chains</div><div>CXR (for cancer and sarcoid)</div><div>Consider PSA, FOBT, mammography, other cancer screening as age-appropriate</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Nb71Ql-%Uj", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When might a renal biopsy be avoided in patients with suspected membranous glomerulonephritis?", 
                "Anti-PLA2R positive patients AND normal kindey function AND no evidence of secondary cause<div><br /></div><div>If do not fulfil all three, kidney biopsy is indicated.</div><div><br /></div><div><img src=\"paste-20392504721409.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cCdKc,1eRM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A renal biopsy is performed in a patient with suspected membranous glomerunonephritis. Light microscopy and immunofluorescence are consistent with MN.<div>Describe subsequent antibody/antigen testing to establish primary vs secondary MN</div>", 
                "Stain for PLA2R antigen<div>If positive - diagnosis of PLA2R associated MN established</div><div>If negative - stain for IgG subclasses</div><div><br /></div><div>If IgG4 dominant - stain for THSD7A antibody/antigen</div><div>If positive - THSD7A-associated MN established</div><div>If negative - non-PLA2R, non THSD7A MN established</div><div><br /></div><div>If IgG1, IgG2, or IgG3 dominant - secondary MN</div><div><br /></div><div><img src=\"paste-20388209754113.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A.`1P(T2:y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In which patients with membranous glomerunonephritis is aggressive cancer screening indicated?", 
                "THSD7A-associated MN<div>Secondary MN</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qMn7!#[hUo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with suspected membranous glomerulonephritis is PLA2R negative. Renal biopsy is contraindicated. What would you do?", 
                "Repeat anti-PLA2R assay in 3-4 months<div>If still negative, biopsy if possible</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ur(w77q9I:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name tests that you would perform on a renal biopsy of a patient with suspected membranous glomerulonephritis", 
                "light microscopy<div>immunofluorescence</div><div>electron microscopy</div><div>+/- PLA2R antigen</div><div>+/- IgG subclasses</div><div>+/- THSD7A antibody/antigen</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mJ>@<fk]ZC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Nephrology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The vast majority of myasthenia gravis patients have autoantibodies against what?", 
                "Acetylcholine receptor (80 - 90%)", 
                ""
            ], 
            "flags": 0, 
            "guid": "N]5>~Sr%.=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Myasthenia gravis paraneoplastic syndrome is associated with which malignancies (5)?", 
                "Thymoma/invasive thymic carcinoma<div>SCLC</div><div>Thyroid</div><div>Breast</div><div>Hodgkin's lymphoma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Mpsd*{IsGW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 paraneoplastic muscle function syndromes", 
                "Myasthenia gravis<div>Lambert-Eaton syndrome</div><div>Dematomyositis/polymyositis</div><div>Paraneoplastic neuromyotonia</div><div>Acute necrotizing myopathy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i`xiC*V}p@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 antibodies which may be positive in myasthenia gravis", 
                "Acetylcholine receptor antibodies (85%)<div>MuSK (muscle specific receptor tyrosine kinase) antibodies (38 - 50%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BNv-#}2}(u", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of myasthenia gravis patients will have no detectable autoantibodies?", 
                "6-12% of patients are seronegative (no antibodies)", 
                ""
            ], 
            "flags": 0, 
            "guid": "blqx;a:%C^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the ice pack test, and how does it work?", 
                "Bedside test for myasthenia gravis<div>Ice pack is applied to the upper eyelid for 5 minutes, then ptosis is reassessed</div><div>Positive if ptosis improves by &gt;2mm or more</div><div>Positive in 80% of MG</div><div>Improvement is due to cold decreasing breakdown of acetylcholine by ancetylcholinesterase at the neuromuscular junction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zee^h,J/S7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the clinical presentations of myasthenia gravis", 
                "Cardinal feature: fluctuating skeletal muscle weakness with true muscle fatigue<div><br /></div><div>Two varients:<br /><div>Ocular: weakness limited to eyelids and extraocular muscles</div><div>Generalised: may affect ocular muscles, but also inovles combination of bulbar, limb, and respiratory muscles</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u!F`[7>5A|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the clinical features of ocular myasthenia gravis (2)", 
                "Ptosis<div>Diplopia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HyoEjn7NV!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of patients with ocular myasthenia gravis at presentation will remain purely ocular?", 
                "50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "hm/<bZkX+T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 bulbar manifestations of myasthenia gravis", 
                "Muscle of jaw closure weakness (fatigueable chewing)<div>Oropharyngeal muscle weakness (dysarthria, dysphagia)</div><div><br></div><div>Symptoms worsen with prolonged use</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y?z^I#@oOu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of patients with myasthenia gravis present with proximal muscle weakness alone?", 
                "&lt;5%", 
                ""
            ], 
            "flags": 0, 
            "guid": "bZIZ@I-,4/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What will occur when a patient with myasthenia gravis diplopia closes one eye?", 
                "Diplopia will disappear", 
                ""
            ], 
            "flags": 0, 
            "guid": "xS%L2%VEUg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name sites of extraocular involvement in myasthenia gravis", 
                "Bulbar muscles (chewing fatigue, dysarthria, dysphagia)<div>Facial muscles (expressionless)</div><div>Neck and limb muscles (neck flexor and extensor weakness causing dropped head syndrome, proximal muscle weakness, can have distal muscle weakness)</div><div>Respiratory muscles (can have respiratory failure)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "t+#-c0.WYf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the natural history/disease course of myasthenia gravis", 
                "Symptoms may be transient with hours, days, or weeks free of symptoms<div>New symptoms often develop weeks to months later</div><div>Maximal disease after 3 years in 77%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "iTZ~`tz0P!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the major limitation of the ice pack test", 
                "Test for myasthenia gravis<div>Does not work in patients with extraocular muscle weakness</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "t7?dN=FU}W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the edrophonium test, and how does it work?", 
                "Test for myasthenia gravis<div>Edrophonium is an acetylcholinesterase inhibitor, rapid onset and short duration</div><div>Prolongs presence of acetylcholine in NMJ and thus results in immediate symptom improvement<br /><div>Used in patients with obvious ptosis or ophthalmoparesis in whom an improvement can be easily observed</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KtjjGp!YCQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the sensitivity of the edrophonium test for myasthenia gravis?", 
                "80 - 90%", 
                ""
            ], 
            "flags": 0, 
            "guid": "yZXWW<u+Q%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In which patients is the endrophonium test relatively contraindicated?", 
                "Cardiac disease/arrythmia - symptomatic bradycardia may occur<div>Bronchial asthma - bronchospasm may occur</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Lb%}#cP0g/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is the edrophonium test specific for myasthenia gravis?", 
                "No<div><br />May be positive in motor neuron disease, brainstem tumours, compressive cranial neuropathies</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A}R(I<6X_p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name two bedside tests that may be performed in a patient with suspected myasthenia gravis", 
                "Ice pack test<div>Edrophonium test</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "duL{e5yF;U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of patients with thymoma and myasthenia gravis would you expect to have&nbsp;Acetylcholine receptor positive disease?", 
                "98 - 100%", 
                ""
            ], 
            "flags": 0, 
            "guid": "bU#n.ISBid", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of patients with generalised myasthenia gravis would you expect to have MuSK positive disease?", 
                "38 - 50%<div>MuSK rare in patients with purely ocular disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ABw4eKnZWG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the predominant cell type involved in Stephen-Johnson syndrome?", 
                "T cells", 
                ""
            ], 
            "flags": 0, 
            "guid": "pC(+(XLSQs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 tests or interventions that may be performed in a patient with suspected food allergy", 
                "Skin testing for food-specific IgE (sensitive, not specific) - good first test<div>IgE immunoassay for food-specific IgE in serum</div><div>- good for peanut, wheat</div><div>Diagnostic elimination diet</div><div>Food diary</div><div>Supervised food challenge (gold standard)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oAn,3co6jt", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mean time to cardiac arrest in iatrogenic (drug-induced) anaphylaxis?", 
                "5 minutes", 
                ""
            ], 
            "flags": 0, 
            "guid": "AP~s3ZZtsY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mean time to cardiac arrest in insect sting anaphylaxis?", 
                "15 minutes", 
                ""
            ], 
            "flags": 0, 
            "guid": "bU(otlw-^N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mean time to cardiac arrest in food induced anaphylaxis?", 
                "30 minutes", 
                ""
            ], 
            "flags": 0, 
            "guid": "njTs|&e)H=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with anaphylaxis, is there a different degree of response to adrenaline in early vs late phase?", 
                "Anaphylaxis is most responsive to treatment in early phase, prior to development of shock<div>Delay is associated with increased mortality</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GAHNN}CBaz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does adrenaline work when used as treatment for anaphylaxis?", 
                "<div>Decreases mediator release from mast cells</div><div>Prevents or reverses obstruction to airflow in upper and lower respiratory tracts</div><div>Prevents or reverses cardiovascular collapse</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q!Z<9F$vc;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the supportive care management of anaphylaxis (6)", 
                "<div>Manage the airway - intubate immediately if marked stridor or respiratory arrest</div><div>Stop the offending drug/cause</div><div>Call for help</div><div>Position supine with legs elevated (unless prominent airway swelling, in which case sit upright. Pregnant patients should like on left side)</div><div>2 large bore IVCs – if normotensive, 125ml/hr NaCl to TKVO</div><div>Continuous monitoring</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f,>KA4Iv3y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the treatment of choice for anaphylaxis?&nbsp;", 
                "Adrenaline, all patients, all severities", 
                ""
            ], 
            "flags": 0, 
            "guid": "z&N[%n5rOd", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the dose and route of administration of adrenaline in patients with anaphylaxis without shock/hypotension", 
                "Adrenaline 0.5mg IM outer thigh<div>Subsequent dose in 5 - 15min if required (can give sooner if necessary)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JVKfxh92S8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the dose and route of administration of adrenaline in anaphylatic patients who do not respond to IM adrenaline or have shock/hypotension not responding IM adrenaline and fluid resus", 
                "<div>IV adrenaline by slow continuous infusion (not intermittent bolus – can cause extreme hypertension, ventricular arrythmias)</div><div>Use 0.1mcg/kg/min, increase every 2-3min by 0.05microg until BP and perfusion improve. Rare to need more than 1microg/kg/min but no known max dose.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M/yFD[7^Eb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the IV fluid you would give a hypotensive anaphylaxis patient", 
                "At least 2L normal saline stat<div>If still hypotensive give ongoing fluids - may need up to 7L</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b7.XL)EUtB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which anaphylaxis patients should receive supplemental O2?", 
                "Hypoxic patients", 
                ""
            ], 
            "flags": 0, 
            "guid": "gkh7r5f=JF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the significance of a history of beta blocker therapy in anaphylaxis patients? How is this managed?", 
                "<div>Beta-blockers can cause treatment-resistance to adrenaline.&nbsp;</div><div>Glucagon should be given if no response to adrenaline because it has inotropic and chronotropic effects that are not mediated through beta receptors.</div><div>Glucagon 1-5mg IV slow bolus over 5min. Can then give infusion of 5-15microg/min titrated to effect (not weight)</div><div>Beware glucagon-induced vomiting (airway)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A%uSlh!?*R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 things you may use to treat hypoxia in the setting of anaphylaxis (other than adrenaline)", 
                "Supplemental O2<div>Bronchodilators</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L+l51Wn9YJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the characteristic defect in common variable immunodeficiency (CVID)?", 
                "Impaired B cell differentiation with defective production of immunoglobulin, despite presence of B cells", 
                ""
            ], 
            "flags": 0, 
            "guid": "B`Sk_vq!&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 3 diagnostic criteria for common variable immunodeficiency", 
                "<div>Markedly reduced serum concentrations of IgG, plus low IgA and/or IgM</div><div>Poor or absent response to immunisation</div><div>Absence of any other defined immunodeficiency state</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ci|MOZKArb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common severe antibody deficiency?", 
                "Common variable immunodeficiency", 
                ""
            ], 
            "flags": 0, 
            "guid": "bGz{T]xB.0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "At what age are most diagnoses of common variable immunodeficiency made?", 
                "20 - 40", 
                ""
            ], 
            "flags": 0, 
            "guid": "Lv/9[i4dXW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the pathogenesis of common variable immunodeficiency (4)", 
                "<div>Arises from a number of gene defects, may be recessive or autosomal dominant with variable penetrance</div><div>Normal overall B cell numbers in 90% of cases</div><div>Low percentage of isotype-switched memory B cells (and also plasma cells) capable of producing antigen-specific IgG and IgM which are critical for recall (secondary) antibody responses</div><div>T cell abnormalities including low CD4/CD8 cell ratio in some patients</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "IMFT7$eli", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 9 clinical manifestations of common variable immunodeficiency syndrome", 
                "Infections<div>Chronic pulmonary disease</div><div>Gastrontestinal</div><div>Autoimmune</div><div>Granulomatous infiltration</div><div>Allergic disease</div><div>Lymphadenopathy/splenomegaly</div><div>Liver disease</div><div>Malignancy (typically Non Hodgkins lymphoma)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z9N]-@bs3b", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Describe the shunt below and calculate the Qp:Qs ratio</div><img src=\"paste-44564580663297.jpg\" />", 
                "VSD&nbsp;<div>Normal saturations in SVC, IVC, RA, then step up &gt;7% in saturations in the RV indicates oxygenated blood flowing from left ventricle to right ventricle<div>Qp: Qs =&nbsp;(Aorta - MV) / (PV - PA)</div><div>= 97 - 64 / 97 - 88 = 33 / 9 = around 4:1</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h.qilxs7A$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the indications for closure of a VSD (5)", 
                "<div>Haemodynamically significant shunt, as indicated by:</div><div>Symptoms, OR</div><div>LV enlargement, OR</div><div>Qp:Qs &gt; 2:1</div><div><br /></div><div>Pulmonary hypertension with net L -&gt; R shunt</div><div>Endocarditis</div><div>AR</div><div>RV outflow tract obstruction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vp;?{S4N>J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of a VSD (4)", 
                "Murmur<div>Heart failure with LV dilation</div><div>Endocarditis</div><div>Cyanosis (pulmonary hypertension/flow reversal)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vI:<fDN;Zg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 4 types of VSD", 
                "<div>Membranous (80%)</div><div>Subarterial (6% total 30% asians)</div><div>Muscular (20%)</div><div>AV canal type (aka inlet) - complete AVSD</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A$N26MWi&2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of VSD will commonly spontaneously close?", 
                "Muscular", 
                ""
            ], 
            "flags": 0, 
            "guid": "OIx$(qZIPw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of VSD is unlikely to close spontaneously?", 
                "Subarterial", 
                ""
            ], 
            "flags": 0, 
            "guid": "w]>1~>Fo7m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name one absolute contraindication to closure of an ASD or VSD", 
                "Eisenmenger syndrome", 
                ""
            ], 
            "flags": 0, 
            "guid": "E|A:Bigaz-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name three types of ASD", 
                "<div>Ostium primum (15 - 20%) (partial AVSD- more common in Down syndrome &nbsp;</div><div>Ostium secundum (75%)&nbsp;</div><div>Sinus venosus (5 - 10%) (not technically actually ASDs but have left to right shunt, behave similarly)&nbsp;</div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mYj.U^8f;!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 indictions for closure of an ASD", 
                "<div>Haemodynamically significant shunt</div><div>- Symptoms, OR</div><div>- RV enlargement, OR</div><div>- Qp:Qs &gt; 1.5</div><div>Paradoxical embolism</div><div>Platypnea/orthodeoxia syndrome</div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BtYojP=*&@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 complications of an ASD", 
                "<div>Arrhythmia</div><div>Heart failure with RV and RA dilation</div><div>Pulmonary hypertension</div><div>Tricuspid regurgitation</div><div>Paradoxical embolism</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KrPs^^aR9$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the formula use to detect and evaluate shunts on cardiac catheterisation", 
                "<div>Pulmonary circulation (Qp) and systemic circulation (Qs) should be equal in absence of a shunt</div><div>Qp and Qs are calculated using oxygen saturations of aorta, mixed venous, pulmonary vein and pulmonary artey.&nbsp;This gives Qp:Qs ratio, which in normal hearts should be 1:1</div><div><br /></div><div>Qp:Qs = (Aorta - MV)/ (PV - PA)</div><div><br /></div><div>Greater than 7% 'step up' in oxygen saturations is abnormal</div><div><br /></div><div>Example:</div><div>Mixed venous 65%</div><div>RA 80%</div><div>PA 80%</div><div>Pulmonary vein 95%</div><div>Aorta 95%</div><div><br /></div><div>There is a 15% step up from mixed venous to RA, indicating an atrial level shunt</div><div>Qp:Qs = 95 - 65 / 95 - 80 = 30 / 15 = 2:1</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ed_8k3[qC_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the formula for calculating Qp:Qs?", 
                "Qp:Qs = (Aorta - MV)/ (PV - PA)", 
                ""
            ], 
            "flags": 0, 
            "guid": "jbrvfLNQ/,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where would you expect to see a 'step up' in oxygen saturations in an ASD?", 
                "Step up in the right atrium (i.e. RA O2 is at least 7% higher than mixed venous O2)", 
                ""
            ], 
            "flags": 0, 
            "guid": "P|C?E`J%6F", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where would you expect to see a 'step up' in oxygen saturations in a patient with VSD?", 
                "Step up in RV&nbsp;<div>- RV O2 saturations at least 7% higher than in the RA, indicating a ventricular-level shunt</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D3D2Q?KytZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where would you expect to see a 'step up' in oxygen saturations in a patient with a PDA?", 
                "Step up in pulmonary artery<div>- O2 sats in the pulmonary artery at least 7% higher than the RV, due to extra oxygenated blood entering from the aorta)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ij[le&iDM8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How much higher does the O2 saturation have to be to constitute a 'step up' in patients being evaulated for a cardiac shunt?", 
                "7%", 
                ""
            ], 
            "flags": 0, 
            "guid": "FKF3fsvqvP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>A patient undergoes cardiac catheterisation for suspected shunt. These are their oxygen saturations:</div><div>Mixed venous 65%</div><div>RA 80%</div><div>RV 80%</div><div>PA 80%</div><div>Aorta 95%</div><div>Pulmonary vein 95%</div><div><br /></div><div>Describe where the shunt is and calculate the Qp:Qs ratio</div>", 
                "Step up of 15% from MV to RA indicates flow of oxygenated blood from left to right at the atrial level - an ASD<div>Qp:Qs = (Aorta - MV)/ (PV - PA)</div><div>95 - 65 / 95 - 80 = 30 / 15 = 2:1 shunt</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s<+FLiue`#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 methods used to close a VSD", 
                "Surgical closure<div>Percutaneous device closure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y7PeLU3QD.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which types of VSD are suitable for percutaneous device closure?", 
                "Muscular<div>Post surgical</div><div>Post infarct</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O`/Y&dS%1/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which types of VSD are NOT suitable for percutaneous device closure?", 
                "Membranous - risk of heart block", 
                ""
            ], 
            "flags": 0, 
            "guid": "x!]ndpK=sz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Where is the shunt? Calculate the Qp:Qs ratio.</div><img src=\"paste-47712791691265.jpg\" />", 
                "Patent ductus arteriosus - consistent saturations in mixed venous, RA, RV, then 15% step up in pulmonary artery (oxygenated blood flowing from aorta into pulmonary artery)<div>Qp:Qs = aorta - MV / PV - PA</div><div>98 - 75 / 99 - 90 = 23 / 9 = around 3:1</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s?P4C3[4I3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients with patent ductus arteriosus develop endocarditis at some point in their life?", 
                "10%", 
                ""
            ], 
            "flags": 0, 
            "guid": "GtVq=h+[.M", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 complications of a patent ductus arteriosus", 
                "Heart failure<div>Endocarditis</div><div>Pulmonary hypertention</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pV3,_`0Q12", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the criteria for closure of a patent ductus arteriosus?", 
                "<div>Left chamber enlargement</div><div>Pulmonary hypertension (need net left to right shunt, can test occlude)</div><div>Previous endocarditis</div><div>Audible murmur</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d[905]TR#F", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When would you not close a patent ductus arteriosus?", 
                "Eisenmenger syndrome, or<div>Asymptomatic and inaudible</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h_*tF)B1%;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why is there a low threshold to close patent ductus arteriosus?", 
                "Risk of endocarditis<div>Risk of heart failure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C5WZU~KDU}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Describe the shunt below and calcualte the Qp:Qs</div><img src=\"paste-48752173776897 (1).jpg\" />", 
                "Right to left shunt at atrial level - ASD with Eisenmenger syndrome)<div>Qp:Qs = aorta - MV / PV - PA</div><div>89 - 75 / 99 - 75 = 14 / 24 = approx 1:2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j~fP(IE6JT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the formula used to calculate pulmonary vascular resistance", 
                "(Pulmonary artery pressure - left atrial pressure) / pulmonary blood flow<div>Pulmonary blood flow equals cardiac output unless there is a shunt or other abnormality<br /><div><br /></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zdpnqAYSy", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A 35 year old with dilated cardiomyopathy is assessed for candidacy for heart transplant. He undergoes a right heart catheter.&nbsp;<div>Pulmonary artery pressure 70/30 (mean 45)</div><div>mean pulmonary capillary wedge pressure 30</div><div>cardiac output 5.0L/min</div><div><br /></div><div>Calculate the pulmonary vascular resistance and explain why this is important.</div>", 
                "<div>PVR =&nbsp;(Pulmonary artery pressure - left atrial pressure) / pulmonary blood flow</div><div>Pulmonary blood flow = cardiac output unless there is a shunt or some other abnormality</div>PVR = (45 - 30)/5 = 3<div>(PVR normal range 1 - 3)</div><div><br /></div><div>Pulmonary vascular resistance is used to differentiate between pulmonary hypertension due to left heart disease (normal PVR) vs other causes (elevated PVR)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K`!eBAlt~N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Would you expect normal or elevated pulmonary vascular resistance in a patient with class 2 pulmonary hypertension?", 
                "Normal<div>Class 2 is PTH due to left heart disease; normal PVR differentiates this class from all others.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "znV(X?gG.#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the pathophysiology of Eisenmenger syndrome (6)", 
                "<div>Left to right shunt (usually large and longstanding)</div><div>Increased pulmonary blood flow with shear stress and circumferential stretch</div><div>Endothelial dysfunction and vascular remodelling - smooth muscle cell proliferation, increase in extracellular matrix, intravascular thrombosis</div><div>Increased pulmonary vascular resistance</div><div>Reversal of shunt when pulmonary pressures equal/exceed systemic pressures</div><div>Cyanosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Es5mgtEZB4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 complications of Eisenmenger syndrome", 
                "<div>Erythrocytosis +/- hyperviscosity syndrome</div><div>Bleeding (abnormal haemostasis)</div><div>Gallstones, gout</div><div>Stroke, cerebral abscess (paradoxical emboli)</div><div>Heart failure (late)</div><div>Sudden cardiac death</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C/FP5CDO0f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the indication for intervention in patients with aortic coarctation", 
                "<div><div>Infant, children, and adult patients with coarctation with peak to peak (or maximum instantaneous) gradient ≥20 mmHg&nbsp;</div><div>or&nbsp;</div><div>a gradient &lt;20 mmHg with anatomic imaging evidence of significant coarctation and collateral flow.</div></div><div><br /></div><div>The peak to peak gradient is a measurement derived from catheterization data in which the peak pressure beyond the coarctation is subtracted from the peak pressure proximal to the coarctation.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gzK9_zmFW;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "45752df80c334eaaa8be4bb49746d02b-ao-1", 
                "Name the 4 types of VSD", 
                "<img src=\"tmpkejhbc.png\" />", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-1-A.svg\" />", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "oT)0]Z`b1@", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "45752df80c334eaaa8be4bb49746d02b-ao-2", 
                "Name the 4 types of VSD", 
                "<img src=\"tmpkejhbc.png\" />", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-2-A.svg\" />", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "rGY.Ud85A!", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "45752df80c334eaaa8be4bb49746d02b-ao-3", 
                "Name the 4 types of VSD", 
                "<img src=\"tmpkejhbc.png\" />", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-3-A.svg\" />", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "fSIsLIl&b)", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "45752df80c334eaaa8be4bb49746d02b-ao-4", 
                "Name the 4 types of VSD", 
                "<img src=\"tmpkejhbc.png\" />", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-4-A.svg\" />", 
                "<img src=\"45752df80c334eaaa8be4bb49746d02b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "h#x49|Gj:)", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 4 anatomical abnormalities seen in the tetralogy of fallot", 
                "<div>Pulmonary stenosis</div><div>VSD</div><div>Overriding aorta (deviation of the origin of the aorta to the right)</div><div>Concentric right ventricular hypertrophy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gh+>,Ur[I^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>What is the name of this collection of findings?</div><img src=\"paste-19812684136449.jpg\" />", 
                "Tetralogy of Fallot", 
                ""
            ], 
            "flags": 0, 
            "guid": "FQ$E#>w_FQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3aa7f3b019184787bb8b25d1e956abb2-ao-1", 
                "Name the findings seen in tetralogy of fallot.", 
                "<img src=\"tmpy_vagu.png\" />", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-1-A.svg\" />", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "G){R{*2lPU", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3aa7f3b019184787bb8b25d1e956abb2-ao-2", 
                "Name the findings seen in tetralogy of fallot.", 
                "<img src=\"tmpy_vagu.png\" />", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-2-A.svg\" />", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "u.M@JkPN@G", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3aa7f3b019184787bb8b25d1e956abb2-ao-3", 
                "Name the findings seen in tetralogy of fallot.", 
                "<img src=\"tmpy_vagu.png\" />", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-3-A.svg\" />", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q2t`{:d4vl", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3aa7f3b019184787bb8b25d1e956abb2-ao-4", 
                "Name the findings seen in tetralogy of fallot.", 
                "<img src=\"tmpy_vagu.png\" />", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-4-A.svg\" />", 
                "<img src=\"3aa7f3b019184787bb8b25d1e956abb2-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "lM#k!^9-bf", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div><br /></div><div>What is the pathology below?</div><img src=\"paste-29622389440513.jpg\" />", 
                "Transposition of the great arteries", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ri%{e,M;P.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 cardiac conditions that result in very high maternal risk", 
                "<div>Severe pulmonary hypertension</div><div>Eisenmenger syndrome</div><div>Cardiomyopathy with NYHA2+ or EF &lt;40%</div><div>Severe obstructive cardiac lesions (AS, PS, MS)</div><div>Marfan syndrome with aortic root &gt; 40mm</div><div>Previous severe peripartum cardiomyopathy</div><div><br /></div><div>College lecturer says pregnancy is 'contraindicated' in the first two.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G)R%_@2Fq!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "73a038139e5e45128883622fef3aa44a-ao-1", 
                "Which parts of the trace below correspond to which structures on a normal right heart catheter?", 
                "<img src=\"tmpmmpikh.png\" />", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-1-A.svg\" />", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Dn~ulqDEq;", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "73a038139e5e45128883622fef3aa44a-ao-2", 
                "Which parts of the trace below correspond to which structures on a normal right heart catheter?", 
                "<img src=\"tmpmmpikh.png\" />", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-2-A.svg\" />", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "pd&mU/[i~E", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "73a038139e5e45128883622fef3aa44a-ao-3", 
                "Which parts of the trace below correspond to which structures on a normal right heart catheter?", 
                "<img src=\"tmpmmpikh.png\" />", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-3-A.svg\" />", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "DGoywn@(#4", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "73a038139e5e45128883622fef3aa44a-ao-4", 
                "Which parts of the trace below correspond to which structures on a normal right heart catheter?", 
                "<img src=\"tmpmmpikh.png\" />", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-4-A.svg\" />", 
                "<img src=\"73a038139e5e45128883622fef3aa44a-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Odq7MA?D`x", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "1bfd58a838f247ea8ca14a0345f18743-ao-1", 
                "Draw the expected trace for a normal right heart catheter", 
                "<img src=\"tmpxtuydd.png\" />", 
                "<img src=\"1bfd58a838f247ea8ca14a0345f18743-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"1bfd58a838f247ea8ca14a0345f18743-ao-1-A.svg\" />", 
                "<img src=\"1bfd58a838f247ea8ca14a0345f18743-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "IGt4e]&i(e", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the normal pressure in the right ventricle?", 
                "15 - 28mmHg, mean 24 (systole)<div>0 - 8 mmHg, mean 4 (diastole)</div><div><br /></div><div>RV systolic pressure should be around 25% of systemic pressure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Lr$SL4{D@>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the normal pressure in the right atrium?", 
                "2 - 14mmHg (systole)<div>-2 to +6 (diastole)</div><div>Mean pressure is 4mmHg</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Bs$PRc2,rj", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the normal systolic pressure in the left ventricle?", 
                "130 (range 90 - 140) mmHg", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q|!ebt`PyR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the normal end diastolic pressure in the left ventricle?", 
                "7mmHg (range 4 - 12)", 
                ""
            ], 
            "flags": 0, 
            "guid": "D~@jHZe-:>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the normal stroke volume index", 
                "47 (range 30 - 65) mL/m2/beat", 
                ""
            ], 
            "flags": 0, 
            "guid": "cKKOv]raqz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is normal mean pulmonary artery wedge pressure?", 
                "Mean = 9mmHg<div><br /></div><div>Normal &lt; 15</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kMQ>tArX8@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is normal mean pulmonary artery pressure?", 
                "<div>Mean 16mmHg</div><div><br /></div><div>Normal mean &lt; 22</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "QhW[?3uc2j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the normal end diastolic volume index of the left ventricle?", 
                "70ml/m2", 
                ""
            ], 
            "flags": 0, 
            "guid": "K4*~Eum=YF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the changes you would see in the pulmonary artery pressure trace in the setting of severe pulmonary regurgitation", 
                "The pulmonary artery pressure will be wider or 'ventricularised' (i.e. more similar to the RV, which has the same systolic pressure but a lower diastolic pressure than the PA)<div><br /></div><div><img src=\"paste-37701222924289.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AL}rHm<q|A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is pulmonary artery wedge pressure?", 
                "A balloon is inflated in the pulmonary artery<div>The pressure distal to the balloon should equal the left atrial pressure in the absence of abnormal lung vasculature</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CmQCh&j^ZW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is Kussmal's sign, and what does it indicate?", 
                "Failure of right atrial pressure to drop with inspiration, as observed by a failure of the JVP to fall in inspiration, or a rise of JVP in inspiration<div><br /></div><div>Classically associated with constrictive pericarditis or restrictive cardiomyopathy</div><div>Also in RV infarction, severe RV dysfunction, massive PE, severe TR</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kUv[h_L)zW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the waves seen in a normal JVP, and what they indicate (5)", 
                "<div>a = atrial contraction</div><div>c = closing and bulging of the tricuspid valve</div><div>x = atrial relaxation</div><div>v = passive filling of atrium</div><div>y = opening of the tricuspid valve</div><div><br /></div><div><img src=\"paste-38482906972161.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EUliRr2[jr", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<img src=\"paste-38478612004865.jpg\" /><div>What does each wave in this normal JVP trace mean?</div>", 
                "<div><div><div>a = atrial contraction</div><div>c = closing and bulging of the tricuspid valve</div><div>x = atrial relaxation</div><div>v = passive filling of atrium</div><div>y = opening of the tricuspid valve</div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l(ZKs3bWUa", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "637ed61baa4e4103aee250203de67264-ao-1", 
                "What events do all the waves in this normal JVP trace represent?", 
                "<img src=\"tmp0e58ud.png\" />", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-1-A.svg\" />", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "fQSAQN-v,B", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "637ed61baa4e4103aee250203de67264-ao-2", 
                "What events do all the waves in this normal JVP trace represent?", 
                "<img src=\"tmp0e58ud.png\" />", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-2-A.svg\" />", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "FWwZ9$Q=-.", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "637ed61baa4e4103aee250203de67264-ao-3", 
                "What events do all the waves in this normal JVP trace represent?", 
                "<img src=\"tmp0e58ud.png\" />", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-3-A.svg\" />", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Me%@/c|?=H", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology", 
                "marked"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "637ed61baa4e4103aee250203de67264-ao-4", 
                "What events do all the waves in this normal JVP trace represent?", 
                "<img src=\"tmp0e58ud.png\" />", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-4-A.svg\" />", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q@Lv/+COxt", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "637ed61baa4e4103aee250203de67264-ao-5", 
                "What events do all the waves in this normal JVP trace represent?", 
                "<img src=\"tmp0e58ud.png\" />", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-5-A.svg\" />", 
                "<img src=\"637ed61baa4e4103aee250203de67264-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "j7vX!!Q)z=", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should LA and LV pressure be equal?", 
                "During diastole, when the mitral valve is open<div>If not equal, implies an obstruction between them such as mitral stenosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Fk9M#_z)S/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What pressure across the mitral valve and what valve area would indicate severe mitral stenosis?", 
                "Gradient &gt; 10mmHg<div>Valve area &lt; 1cm2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y6VtU4&y5^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What difference in pressure would you expect between the pulmonary wedge pressure and the left ventricular end diastolic pressure?", 
                "They should be the same<div>PCWP should equal left atrial pressure</div><div>Left atrial diastolic pressure should equal left ventricular end diastolic pressure, as the mitral valve is open.</div><div><br /></div><div>If not equal, implies obstruction between LA and &nbsp;LV (e.g. mitral stenosis) or abnormal pulmonary vasculature interfering with using wedge pressure to accurately estmate LA pressure (e.g. pulmonary vein stenosis)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cc4CE`U+@d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What difference would you expect in left ventricular systolic pressure and aortic systolic pressure?", 
                "They should be the same<div><br /></div><div>If not, implies left ventricular outflow tract obstruction - e.g. aortic stenosis, HOCM</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D;RreR/l8T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the difference between constrictive pericarditis and restrictive cardiomyopathy? Why is differentiating between the two important?", 
                "Constrictive pericarditis is a disease of the pericardium (e.g. TB pericarditis, connective tissue disease)<div>Restrictive pericarditis is disease of the myocardium (e.g. idiopathic, post RT, infiltrative)</div><div><br /></div><div>Both present similarly, but important to differentiate due to different management</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Cf[~V&Epk-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What two 'critical' features of constrictive pericarditis are responsible for the physical examination, haemodynamic, and imaging findings?", 
                "Greatly enhanced ventricular interaction/interdependance<div>Dissociation of intracardiac and intrathoracic pressures</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wj$%CE*dJi", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is ventricular interdependance?", 
                "The haemodynamics of the left and right ventricles are directly influenced by each other to a much greater degree than normal. A major feature of constrictive pericarditis.", 
                ""
            ], 
            "flags": 0, 
            "guid": "MX{k!nSQ#n", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the pathophysiology of ventricular interdependence seen in constrictive pericarditis", 
                "<div>In constrictive pericarditis the upper limit of cardiac volume is constrained by the inelastic pericardium.&nbsp;</div><div>The thickened, rigid pericardium prevents the normal inspiratory decrease in intrathoracic pressure from being transmitted to the heart chambers. It also does not expand to accommodate increased venous return in inspiration.</div><div>Pulmonary venous pressure declines in inspiration but LV pressure does not, leading to reduced LV volume (lower transpulmonary gradient)</div><div>RV volume expands by shifting the interventricular septum, instead of by stretching the pericardium - on catheter seen as a decrease in LV pressure with a rise in RV pressure (remember RV pressure was supposed to fall with inspiration)</div><div><br /></div><div><img src=\"paste-55074365636609.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B^IacSjtxi", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is systolic area index, and how is it important?", 
                "SAI = ratio of RV pressure to LV pressure in inspiration versus expiration<div>i.e. a marker of ventricular interdependance<br /><div>&gt;1.1&nbsp;is the most sensitive, specific, and best PPV and NPV for constrictive pericarditis</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "brIf3E_|T,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<img src=\"paste-55070070669313.jpg\" /><div>This trace shows LV pressure (yellow) and RV pressure (orange) in inspiration and expiration. What is the above phenomenon called, and what disease does it indicate?</div>", 
                "Fall in LV pressure due to a rise in RV pressure with inspiration (remember RV pressure should fall with inspiration due to fall in intrathoracic pressure which brings increased venous return)<div>This is interventricular dependance seen in constrictive pericarditis</div><div>Due to 'fixed shell'-like pericardium, the increased venous return causes a rise in RV pressure. As the pericardium cannot stretch to accommodate the extra blood, it must expand by shifting the interventricular septum towards the LV, and LV pressure falls.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w6ft&edyg(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What sign will be significantly absent in restrictive cardiomyopathy, when LV and RV pressures are measured?", 
                "<div>There will NOT be evidence of ventricular interdependance (seen in constritive pericarditis)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x@v@Wue~TZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is e' (e prime)?", 
                "<div>Mitral annular early diastolic velocity</div>Measurement of LV myocardial relaxation&nbsp;<div><div>Early in diastole blood is sucked into the ventricle by the active process of myocardial relaxation (as opposed to being pushed in by LA contraction)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g2Jx]5NFR+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What does E represent in echocardiography?", 
                "LV passive filling", 
                ""
            ], 
            "flags": 0, 
            "guid": "Hf(p6fk`=+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is E/e' used for, what what is the normal range?", 
                "Ratio between early mitral inflow velocity and mitral annular early diastolic velocity<div>Used to estmate LV filling pressure</div><div>Useful in HFpEF as a marker of diastolic dysfunction</div><div>E/e' &lt;10 is normal</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fr,9IrbwD^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 5 'groups' in pulmonary hypertension", 
                "<div>Group 1 – Pulmonary arterial hypertension (PAH)</div><div>Group 2 – PH due to left heart disease</div><div>Group 3 – PH due to chronic lung disease and/or hypoxemia</div><div>Group 4 – PH due to chronic thromboembolic pulmonary hypertension</div><div>Group 5 – PH due to unclear multifactorial mechanisms</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h=!a}-P3?=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the causes of group 1 pulmonary hypertension (8)?", 
                "<div>Group 1 is idopathic, hertiable, and diseases that localise to the small pulmonary arterioles.</div><div><br /></div>Idiopathic<div>Heritable</div><div>Drugs/toxins</div><div>Connective tissue disease</div><div>HIV</div><div>Portal hypertension</div><div>Congenital heart disease (i.e. shunts)</div><div>Schistosomiasis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J#9Hx0qjkj", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 connective tissue diseases associated with group 1 pulmonary hypertension", 
                "Scleroderma<div>RA</div><div>SLE</div><div>Raynaud</div><div>Mixed connective tissue disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cjl)e#Z[*$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is cor pulmonale?", 
                "A complication of group 3 pulmonary hypertension<div>Refers to PH group 3-induced altered structure (e.g. hypertrophy or dilation) or function of the right ventricle</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H+sRx2Sr=E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 conditions which may result in group 3 pulmonary hypertension", 
                "Group 3 is PH due to chronic lung disease or hypoxaemia<div><br /></div><div>COPD</div><div>Interstitial lung disease</div><div>OSA</div><div>Hypoventilation syndromes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lsZqKVYezf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 conditions associated with group 5 pulmonary hypertension", 
                "Chronic haemolytic anaemia (e.g. sickle cell, thalassemia)<div>Myeloproliferative disorders</div><div>Systemic disorders (sarcoidosis, lymphangioleiomyomatosis, pulmonary Langerhans histiocytosis X)</div><div>Metabolic disorders (e.g. glycogen storage disease)</div><div>Chronic kidney disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I6pO<j:zpZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the definition of pulmonary hypertension?", 
                "Mean pulmonary artery pressure &gt; 25mmHg", 
                ""
            ], 
            "flags": 0, 
            "guid": "W+B%H5$bN", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What echo findings would one expect in pulmonary hypertension (5)?", 
                "RV enlargement<div>RV hypertrophy</div><div>RA enlargement</div><div>Functional tricuspid regurgitation with high jet velocity</div><div>Pulmonary artery midsystolic notch</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yG8ft[X)SK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How can pulmonary artery wedge pressure be used to differentiate between group 2 and group 1/3/4/5 pulmonary hypertension?", 
                "<div>Group 2 is PH due to left heart disease</div><div><br /></div>If PCWP is low or normal (&lt;15), likely not group 2<div>If PCWP is elevated, indicates elevated LA pressure - likely left heart disease is present</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mzKvuVvL[*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management pulmonary hypertension", 
                "Diuretics if fluid retention<div>Exercise training<br /><div>Oxygen if group 3 and resting or excercise hypoxia</div><div><div>Anticoagulation if group 4</div></div><div>Advanged therapy in selected patients (see other card)&nbsp;</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DbKd!?*Gi%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with pulmonary hypertension are candidates for 'advanced therapy' (pulmonary vasodilators)?", 
                "<div>NYHA class II - IV despite treatment of underlying cause and:</div><div>- group 1, or</div><div>- on case by case basis for group 3, 4, or 5</div><div>- NOT used in most patients in group 2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vjS=!g;^y_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Pulmonary arterial hypertension refers to which group of patients with pulmonary hypertension?", 
                "Group 1", 
                ""
            ], 
            "flags": 0, 
            "guid": "o!WmGbs?X2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 'advanced therapy' in pulmonary hypertension?", 
                "Therapy directed at the pulmonary hypertension itself, rather than the underlying cause", 
                ""
            ], 
            "flags": 0, 
            "guid": "lls?=@9dJx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What test should be performed in patients with group 1 pulmonary hypertension to assist with selecting an appropriate 'advanced therapy' agent?", 
                "Vasoreactivity test", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ehu!FnVuT+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "If a patient with group 1 pulmonary hypertension has a positive vasoreactivity test, what advanced therapy agent should be used?", 
                "Trial of calcium channel blocker - dihydropyriudine or diltiazem", 
                ""
            ], 
            "flags": 0, 
            "guid": "p.T,!bFg:f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How might one distinguish between hypertrophic cardiomyopathy and Fabry's disease?", 
                "Cardiac MRI: inferolateral late gadolinium enhancement and low native T1 time on mapping<div><br /></div><div>Fabry disease is a potential cause of unexplained LVH or hypertrophic cardiomyopathy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LGH!}M(h;J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the formula for calculating the Duke treadmill score?", 
                "<div>Exercise time (minutes based on the Bruce protocol) -&nbsp;(5 x maximum ST segment deviation in mm) - (4 x exercise angina [0 = none, 1 = nonlimiting, and 2 = exercise limiting])</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jKv$jb{gLT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What scores constitute low, moderate, and high risk Duke scores?", 
                "<div>Low risk – score ≥+5</div><div>Moderate risk – score from -10 to +4</div><div>High risk – score ≤-11</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O}n&idb-f{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which noninvasive investigation modality has the highest sensitivity for detecting flow-limiting stenosis in ischaemic heart disease?", 
                "CTCA", 
                ""
            ], 
            "flags": 0, 
            "guid": "vB`dh=z^,x", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients whom stable angina cannot be excluded by clinical assessment alone, what diagnostic testing should be used if there is no history of confirmed CAD?", 
                "CTCA<div><br /></div><div>Should be done in patients where clinical assessment indicates typical or atypical angina, or</div><div>clinical assessment indicates non-anginal chest pain but ECG shows ST segment changes or Q waves</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P)@8#t(O?q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients whom stable angina cannot be excluded by clinical assessment alone, what diagnostic testing should be used if there is a history of confirmed CAD?", 
                "Non-invasive functional imaging (usualy stress echo or nuclear stress test)", 
                ""
            ], 
            "flags": 0, 
            "guid": "fVn},N5mi/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with a left bundle branch block requires stress testing for evaluation of chest pain. Should they have an exercise stress test (echo or nuc med), or a pharmacologic stress test (echo or nuc med), and why?", 
                "Presence of LBBB confounds exercise stress testing - causes false positive<div>Need to use pharmacologic stress</div><div><br></div><div>This applies to both nuclear medicine and echocardiography</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rS]z&$u0T(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the second most common dementia type", 
                "Vascular dementia (10 - 20%)", 
                ""
            ], 
            "flags": 0, 
            "guid": "pqBji}9)c4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 risk factors for vascular dementia", 
                "Age<div>Stroke/silent infarctions</div><div>Cerebral amyloid angiopathy</div><div>Cerebral autosomal dominant arteriopathy</div><div>Weak association with metabolic syndrome</div><div><br /></div><div>No proven association with hypertension, dyslipidaemia, diabetes, IHD</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H,:@dR+Q]{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define vascular dementia", 
                "Multiple infarctions and chronic ischemia leading to dementia", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q6PC3mx}6h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the expected disease course of vascular dementia (3)", 
                "Abrupt onset<div>Stepwise deterioration</div><div>Fluctuating course</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yr1^oslYXM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 clinical features (as opposed to disease course features) of vascular dementia that are worth points on the Hachinski ischaemic score for diagnosis of vascular dementia", 
                "Nocturnal confusion<div>Preservation of personality</div><div>Depression</div><div>Emotional incontinence</div><div>Somatic complaints</div><div>Focal neurological symptoms</div><div>Focal neurological signs</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JD_Cp-iz%U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Vascular dementia is divided into two types based on presentation. These are...", 
                "Cortical<div>Subcortical</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b!@,jmtvF.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 clinical features of subcortical vascular dementia", 
                "<div>Focal motor signs</div><div>Early gait disturbance (marche a petit pas, magnetic gait, apraxic gait, Parkinsonian gait)</div><div>Falls</div><div>Early urinary frequency, urgency</div><div>Pseudobulbar palsy</div><div>Personality and mood changes, abulia, apathy, depression</div><div>Mild memory deficit, psychomotor retardation, abnormal executive function</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mTo~p97LOO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Subcortical vascular dementia arises due to what disease process?", 
                "Lacunar infarctions and chronic ischemia affecting the deep cerebral nuclei and white matter pathways", 
                ""
            ], 
            "flags": 0, 
            "guid": "rRI@d/POZK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What clincial features would you expect in a patient with cortical vascular dementia with medial frontal involvement? (3)", 
                "executive dysfunction<div>abulia</div><div>apathy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "iE,oXlc9^_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What clincial features would you expect in a patient with cortical vascular dementia with left parietal involvement? (3)", 
                "aphasia<div>apraxia</div><div>agnosia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s(Pk~/0f8G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What clincial features would you expect in a patient with cortical vascular dementia with right parietal involvement? (4)", 
                "hemineglect<div>confusion</div><div>agitation</div><div>visuospatial and constructional difficulty</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i!a#$1>sP*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What clincial features would you expect in a patient with cortical vascular dementia with medial temporal involvement? (1)", 
                "anterograde amnesia", 
                ""
            ], 
            "flags": 0, 
            "guid": "M;kT~NK_y#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name two sets of diagnostic criteria for vascualr dementia", 
                "Hachinski ischaemic score<div>DSM-5</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q_Dx^5Ndx2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 imaging investigations that may be performed in a patient with suspected vascular dementia. Why would you choose one over the other?", 
                "CT brain<div>MRI brain</div><div><br /></div><div>MRI is more sensitive, but if evidence of vascular pathology evident on CT it may not be necessary</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jH/gt9Z%kR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can MRI distinguish between post-stroke patients with and without vascular dementia?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "wJO_uKo}y&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What findings might one expect to see on MRI brain of a patient with vascular dementia?", 
                "cortical and subcortical infarctions<div>subcortical ischemic changes</div><div>leukoaraiosis (white matter lesions near the lateral ventricles)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "huR@S3Aaws", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can&nbsp;leukoaraiosis on MRI brain be seen in healthy controls?", 
                "Yes, however is more common and more severe in patients with stroke", 
                ""
            ], 
            "flags": 0, 
            "guid": "yG{}5X[GnR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What did the Framingham study findings show with regards to leukoaraiosis and stroke risk?", 
                "Presence of severe leukoaraiosis at baseline doubles risk of future stroke", 
                ""
            ], 
            "flags": 0, 
            "guid": "e>aY(E4Vuq", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the benefits of neuropsychological testing in patients with vascular dementia?", 
                "Provide baseline for monitoring<div>Quantify degree of impairment</div><div>Detect pattern of impairment consistent with vascular dementia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dGGB2W;&or", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What findings would you expect on neuropsychological testing in a patient with vascular dementia, compared with a patient with Alzheimer's?", 
                "Similar to Alzheimer's, but with much less memory impairment and much more impaired executive function", 
                ""
            ], 
            "flags": 0, 
            "guid": "rz4s=QVK+t", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the DSM-5 criteria for Alzheimer's dementia?", 
                "Evidence of significant cognitive decline from a previous level of performance in one or more cognitive domains<div>Cognitive deficits interfere with ADLs</div><div>Not due to delirium</div><div>Not better explained by another mental health disorder</div><div>Insidious onset and gradual progression in at least two cognitive domains</div><div>And either:</div><div>- a causitive genetic mutation, or</div><div>- all three of:&nbsp;</div><div>---decline in memory and learning plus one other cognitive domain,&nbsp;</div><div>---AND steadly progressive gradual decline in function without extended plateaus,&nbsp;</div><div>---AND no evidence of mixed aetiology</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D8;1F{ik%+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Aged", 
                "Care"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What were the findings of the PRAMI trial with regards to stenting only culprit lesions vs complete revascularisation (stenting all significant lesions) in STEMI patients?", 
                "PRAMI looked at stenting only 'culprit lesions' on PCI vs stenting all anatomically significant disease in STEMI patients<div>Stenting all anatomically significant lesions was superior with lower mortality, cardiac mortality, refractory angina</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pgze[$OlP`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What were the findings of the CvLPRIT trial, with regards to stenting only the culprit lesions vs full revascularisation in STEMI patients?", 
                "Treating all anatomically significant lesions on PCI during index admission for STEMI patients was superior to stenting the culprit lesion alone + medical therapy<div>Stenting all lesions did not have to occur during index procedure so long as it was in the same admission</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q$:6v4HFVZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the proposed mechanism of benefit to stenting non-culprit lesions (as well as the culprit lesion) in STEMI patients during the index admission?", 
                "Complete revascularisation has significant mortality benefit<div>Thought to be due to</div><div>- reduced ischaemic burden</div><div>- stabilises multiple 'vulnerable' plaques that are at risk of rupture in this patient population with generalised inflammaiton and endothelial dysfunction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h.AD>&ToE$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the benefits of complete revascularisation (stenting culprit and non-culprit lesions) during index admission for STEMI patients?", 
                "Reduced cardiac death, refractory angina, nonfatal MI", 
                ""
            ], 
            "flags": 0, 
            "guid": "J+5<M<129;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which approach, radial or femoral, has a lower risk of major adverse cardiac event and all-cause mortality?", 
                "No statistically significant difference for stable angina or NSTEMI<div>Radial is superior in STEMI</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q|>,1]hE;i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which approach, radial or femoral, has a lower risk of major bleeding and major vascular complications?", 
                "Radial approach<div><br /></div><div>This is thought to contribute to the lower mortality in STEMI patients with radial approach (as these patients require aggresive anticoagulation)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y3c<t61W>E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 benefits to a radial approach for PCI", 
                "Less bleeding/major vascular complications<div>Lower mortality in STEMI patients</div><div>Earlier ambulation</div><div>Patient comfort</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f61kC^_0_-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is one drawback of using a radial access approach for PCI in STEMI?", 
                "You are 'using up' a potential graft if the patient requires CAGS down the track", 
                ""
            ], 
            "flags": 0, 
            "guid": "P@5g96>TH`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What were the findings of the ORBITA trial for optimal medical therapy vs optimal medical therapy + PCI for stable angina?", 
                "Optimal medical therapy vs same + PCI for stable angina. 200 patients.<div>Included sham procedure and blinded follow up</div><div><br /></div><div>PCI reduced ischaemic burden on stress echo</div><div>No statistically significant difference in other outcomes (exercise time, angina)</div><div><br /></div><div>Summary: no symptom benefit to PCI in stable angina in this trial</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "IcW^,:IQ&9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What FFR result indicates functionally significant stenosis on PCI?", 
                "&gt; 0.8 no functionally significant stenosis (no ischaemia on functional testing)<div>&lt; 0.8 functionally significant stenosis</div><div><br /></div><div>If FFR &lt; 0.8, revascularisation is recommended.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m1~anr%@;8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is FFR (Frational Flow Reserve)?", 
                "FFR is a single highly reliable and reproducible invasive method to assess the ischemia producing potential of a lesion with accuracy of more than 90% (88% sensitivity, 100% specificity, 100% positive predictive value, 88% negative predictive value)", 
                ""
            ], 
            "flags": 0, 
            "guid": "wYs@{}0a9h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is FFR measured?", 
                "A pressure wire is passed beyond a coronary artery lesion&nbsp;<div>Ratio between coronary pressure distal to the stenosis and aortic pressure under conditions of maximum myocardial hyperemia is calculated</div><div><br /></div><div>1.0 is normal</div><div>&gt; 0.80 is not functionally significant</div><div>&lt; 0.80 is functionally significant</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H^dQRTO5AZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e0fa02d1e96747fc9984d3d86fbb9041-ao-1", 
                "What is under the box?", 
                "<img src=\"tmpprdi4h.png\" />", 
                "<img src=\"e0fa02d1e96747fc9984d3d86fbb9041-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e0fa02d1e96747fc9984d3d86fbb9041-ao-1-A.svg\" />", 
                "<img src=\"e0fa02d1e96747fc9984d3d86fbb9041-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "xZ[i/as7-Q", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e0fa02d1e96747fc9984d3d86fbb9041-ao-2", 
                "What is under the box?", 
                "<img src=\"tmpprdi4h.png\" />", 
                "<img src=\"e0fa02d1e96747fc9984d3d86fbb9041-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e0fa02d1e96747fc9984d3d86fbb9041-ao-2-A.svg\" />", 
                "<img src=\"e0fa02d1e96747fc9984d3d86fbb9041-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "F]3xU[3@!]", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long is DAPT indicated for post DES insertion?", 
                "12 months", 
                ""
            ], 
            "flags": 0, 
            "guid": "v,_zrMpC?*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "After what time period can one consider stopping DAPT in patients with DES insertion for ACS and significant reasons to stop e.g. &nbsp;need for major surgery?", 
                "<div>General recommendation is for 12 months, but if significant indication to stop, after 6 months there is less evidence of benefit</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J_2!JYE&<_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the recommendation in triple vessel disease - PCI or CABG?", 
                "<div>SYNTAX and SYNTAX II trials</div><div>Looked at multivessel PCI vs CABG in patients with functionally significant triple vessel disease</div><div><br /></div>If syntax score &lt;23 (not anatomically complex): either procedure<div>If syntax score &gt;23 (anatomically complex): CABG</div><div><br /></div><div>Syntax score analyses anatomy of the coronary artery lesion(s) with points awarded based on location, tortuosity, calcification, thrombus, etc .</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kp%tA,.xd{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Look at this</div><img src=\"paste-16423954939905.jpg\" />", 
                "I looked at it.", 
                ""
            ], 
            "flags": 0, 
            "guid": "JoUh%@890g", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What steps may be taken to mitigate bleeding risk in patients on DAPT (5)?", 
                "Access site selection<div>Modulation of modifiable risk factors for bleeding</div><div>Low dose aspirin</div><div>Low dose of P2Y12 inhibitor as appropriate</div><div>Routine use of PPI.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M*%vs3Oggl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients who require triple therapy (dual antiplatelet plus anticoagulation), which P2Y12 inhibitor should be used?", 
                "Clopidogrel", 
                ""
            ], 
            "flags": 0, 
            "guid": "O~+NYWX-E~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Regarding dual antiplatelet therapy, which P2Y12 inhibitor should be used in ACS patients?", 
                "Ticagrelor or prasugrel is recommended in ACS patients unless drug-specific contraindications exist", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pv}B^^Y6]~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What duration of DAPT is recommended in stable CAD patients treated with PCI?", 
                "6 months if low bleeding risk<div>1 - 2 months if high bleeding risk</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HO0DkPoi50", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-1", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-1-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "k0PO&^kb@(", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-2", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-2-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "b?pe6<)uE1", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-3", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-3-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "hkI6.e)iyn", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-4", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-4-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "on?rg>M|)_", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-5", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-5-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "AxZ)4i&,/T", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-6", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-6-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "BMe}7p.O;{", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-7", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-7-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "G_PV8Js:vu", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-8", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-8-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "BmWp_gswO=", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-9", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-9-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": ")q00s?XoC", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-10", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-10-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Hedq1g(*1>", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-11", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-11-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "uUPPHRxt-*", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d3c837e1782a4d78bb9805eb54cc42ca-ao-12", 
                "What is under the box?", 
                "<img src=\"tmpuxsxrr.png\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-12-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-12-A.svg\" />", 
                "<img src=\"d3c837e1782a4d78bb9805eb54cc42ca-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "QQ@pNn+<vO", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does duration of DAPT vary by stent type (DES vs BMS)?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "r9?GAj4{P<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long should DAPT be continued in ACS patients managed medically?", 
                "Irrespective of the final revascularization strategy (e.g. medical therapy, PCI, or CABG), the default DAPT duration in these patients is 12 months.&nbsp;<div>Six-month therapy duration should be considered in high bleeding risk patients, whereas &gt;12-month therapy may be considered in ACS patients who have tolerated DAPT without a bleeding complication.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Dm=`6S@D=!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long should DAPT be continued in ACS patients managed with PCI?", 
                "Irrespective of the final revascularization strategy (e.g. medical therapy, PCI, or CABG), the default DAPT duration in these patients is 12 months.&nbsp;<div>Six-month therapy duration should be considered in high bleeding risk patients, whereas &gt;12-month therapy may be considered in ACS patients who have tolerated DAPT without a bleeding complication.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DrESN1x9;;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long should DAPT be continued in ACS patients managed with CABG?", 
                "Irrespective of the final revascularization strategy (e.g. medical therapy, PCI, or CABG), the default DAPT duration in these patients is 12 months.&nbsp;<div>Six-month therapy duration should be considered in high bleeding risk patients, whereas &gt;12-month therapy may be considered in ACS patients who have tolerated DAPT without a bleeding complication.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "isaVhg;;]o", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How much is bleeding risk increased by giving oral anticoagulation + DAPT vs oral anticoagulation alone?", 
                "2 - 3 fold risk of bleeding", 
                ""
            ], 
            "flags": 0, 
            "guid": "qyeN}!RnAS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the maximum acceptable duration of triple therapy", 
                "6 months", 
                ""
            ], 
            "flags": 0, 
            "guid": "qpQ%DVz.H}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Are bioresorbable stents superior to drug eluting and bare metal stents?", 
                "<div>No</div><div>Worse outcomes</div>Increased stent thrombosis and recurrent MI<div>Not used in Australia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m[z$ldFZ]2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with left main disease, should &nbsp;PCI or CABG be used?", 
                "<div>CABG if high syntax score &gt;32 (highly complex anatomy/high risk lesion(s)</div><div>Either may be used in low and intermediate syntax scores<br /></div><div><br /></div><div>EXCEL trial - 3000 patients with syntax score &lt;32: no difference in outcomes at 3 years</div><div>Increased risk of repeat procedures with PCI group</div><div>Lower 30 day complication rate with PCI</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jq]{a0&x30", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "After what period can cessation of the P2Y12 inhibitor component of DAPT be considered for post-PCI patients who require elective noncardiac surgery?", 
                "1 month, if aspirin can be continued<div><br /><div>If both aspirin and P2Y12 need to be stopped, or if prior to 1 month, consider bridging with cangrelor, tirofiban, or eptifibatide</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i*SwqUGnYf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients should be considered for prolonged DAPT (&gt;12 months)?", 
                "History of stent thrombosis<div>Lower extremities artery disease</div><div>Complex PCI</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ykkMY1yYw;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mean age of diagnosis of breast cancer?", 
                "60", 
                ""
            ], 
            "flags": 0, 
            "guid": "vns~RPIK5.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the mortality and incidence of breast cancer doing?", 
                "Increasing incidence<div>Decreasing mortality</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gnmV?ky}h}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the breast cancer screening mammogram program", 
                "Women aged 50 - 74 are invited for 2 yearly mammograms<div>Women aged &gt;40 can access screening mammogram</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rDd((m>S>=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mortality relative risk with screening mammograms vs no screening?", 
                "RR 0.80 breast cancer specific mortality", 
                ""
            ], 
            "flags": 0, 
            "guid": "lmm&(vg}3_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common mutation associated with breast cancer?", 
                "BRCA", 
                ""
            ], 
            "flags": 0, 
            "guid": "N6K,F_p6lP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism behind BRCA mutations increase breast cancer risk?", 
                "BRCA1 and 2 code for proteins responsible for repair of double strand DNA breaks via homologous recombination<div>Defect in one copy is sufficient to cause disease state (autosomal dominant inheritance)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y0E2wnC?hg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why do PARP inhibitors work well in BRCA mutant cancers?", 
                "PARP1 is most abundant member of the PARP family<div>When inhibited, double-strand DNA breaks accumulate and under normal conditions are repaired via the BRCA pathway-dependent homologous recombination mechanism</div><div>In BRCA mutant cancers, damage cannot be repaired</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "FKS/kORTy@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the difference between the 'genetic era' and the mutations it allowed us to identify, vs the genomic era.", 
                "Genetic era found single mutations &nbsp;via classic linkage analysis that were high penetrance and high risk (monogenetic syndromes) e.g. BRCA raising breast and ovarian cancer risk<div>Genomic era now focuses on whole genome sequencing to find multiple low risk alleles (polygenetic inheritance) that cumulatively result in high risk of disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "o32hMV?KLJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The 'genetic era' identified what types of mutations? (3)", 
                "<div>Pathogeneic variant in one gene,&nbsp;resulting in high predisposition for disease</div><div>Often protein-truncating varients (frameshifts common)</div><div>Genetic tests for these have well-established clinical utility</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "$~#nV%=4J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The 'genomic era' has led to identification of what types of mutations?", 
                "Multiple common gene varients (multiple alleles) that together contribute to risk of disease<div>Genetic variation modified by environment</div><div>Still not well-established in clinical practice</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "QxOaZsv-Nx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are tumour suppressor genes?", 
                "<div>Monitor and prevent DNA replication of damaged genome:</div>- Act as cell cycle checkpoints<div>- Recognise DNA damage and promote repair</div><div>- Cause apoptosis if cannot be accurately repaired</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sj0=cFaDWJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is a loss or gain of function required for mutation in tumour suppressor genes to cause cancer?", 
                "Loss of function", 
                ""
            ], 
            "flags": 0, 
            "guid": "gk{.n^&W4Z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do mutations in tumour suppressor genes lead to malignancy?", 
                "<div>Loss of function mutations lead to inability to recognise or repair damaged DNA, or cause apoptosis in cells with damaged DNA</div><div>This leads to accumulation of further mutation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CzX<1,$[!4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the 'two hit hypothesis'", 
                "Both tumour suppresor gene alleles within a single cell must be crippled for total loss of function<div>- Either both germline (autosomal recessive inheritance), or</div><div>- One germline and one somatic (autosomal dominant inheritance)</div><div>e.g. BRCA, APC, MMR, p53</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KX&t_TxW^?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "BRCA, APC, MMR, and p53 are all examples of what kind of gene?", 
                "Tumour suppressor gene", 
                ""
            ], 
            "flags": 0, 
            "guid": "Msutod`H5i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 tumour suppressor genes implicated in familial cancer syndromes", 
                "BRCA<div>APC</div><div>MMR</div><div>TP53</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CP1k7V/`Y=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutations in what types of gene are responsible for the majority of inherited cancer syndromes?", 
                "Tumour suppressor genes", 
                ""
            ], 
            "flags": 0, 
            "guid": "qqU8G^6[xR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in what gene results in retinoblastoma?", 
                "RB1", 
                ""
            ], 
            "flags": 0, 
            "guid": "B]$A5:h4IJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What kind of gene is RB1?", 
                "Tumour suppressor gene (mutation results in retinoblastoma)", 
                ""
            ], 
            "flags": 0, 
            "guid": "P;Sf5Je4.d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "RB1 mutation is associated with retinoblastoma. What type of inheritance pattern does it follow?", 
                "Autosomal dominant", 
                ""
            ], 
            "flags": 0, 
            "guid": "hkrd0~ns,>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "RB1 mutation is seen in what proportion of familial or bilateral retinoblastoma?", 
                "92%", 
                ""
            ], 
            "flags": 0, 
            "guid": "h@SO5M_09{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "RB1 mutation is seen in what proportion of unilateral or nonfamilial retinoblastoma?", 
                "10%", 
                ""
            ], 
            "flags": 0, 
            "guid": "b;1_X3<!u+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 3 most common cancers, other than retinoblastoma, seen in patients with familial retinoblastoma", 
                "Osteosarcoma (RR 314)<div>Soft tissue sarcoma (RR 243)</div><div>Melanoma (RR 50)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AID_Vs#P<t", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Are patients with nonfamilial retinoblastoma at risk of other malignancies?", 
                "Yes, not not nearly as much as familial retinoblastoma<div>Risk of soft tissue sarcoma (RR 21) and&nbsp;melanoma (RR 1.97)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rGa@Jj]8]f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mean age at diagnosis of familial or bilateral retinoblastoma?", 
                "12 months", 
                ""
            ], 
            "flags": 0, 
            "guid": "HWqm0-9l>|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mean age at diagnosis of unilateral retinoblastoma?", 
                "2 years", 
                ""
            ], 
            "flags": 0, 
            "guid": "PDtKuw)+lk", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how inheritance of one non functioning allele of a tumour suppressor gene leads to increased cancer risk, using the two hit hypothesis", 
                "Inactivation of both alleles within the same cell is required to cause disease<div>Usually this takes a very long time (cancers diagnosed in old age)</div><div>If one allele is inactivated from birth (germline mutation), only one further mutation is required to cause disease. This leads to cancer developing and younger age, and multiple primaries</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ox2/G;^b=]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are proto-oncogenes?", 
                "Normal genes that regulate cell growth<div>Cause cancer if mutated resulting in overexpression - they are then called oncogenes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A/hgCl//%O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in how many alleles (one or two) of a proto-oncogene are required to cause disease?", 
                "One<div>Gain of function in a single mutant allele increases malignant potential</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ja[^(JxuY8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does gain of function in a proto-oncogene (which then becomes an oncogene) result in increased malignant potential?", 
                "Proto-oncogenes regulate cell growth<div>Overexpression can result in&nbsp;</div><div>- DNA missense mutations</div><div>- Chromosomal translocation causing abberant protein or expression</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ok4|36zqM)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why are mutations in proto-oncogenes almost never seen in familial cancer sydromes?", 
                "Mutation causes overexpression<div>These constitutively active mutations are generally not tolerated during embryogenesis/do not survive to term</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H_h!?26$_p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name one proto-oncogene which, when mutated, causes a familial cancer syndrome", 
                "RET<div>Mutation causes multiple endocrine neoplasia type 2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CMg3S9jxVK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutations in proto-oncogenes are usually germline or somatic?", 
                "Somatic<div>Usually not tolerated during embryogenesis so germline is rare</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l`)!QK@Od.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the Philadelphia chromosome?", 
                "Fusion of parts of chromosomes 9 and 22, causing BCR (from 22) and ABL (from 9) gene fusion<div>BCR promotor causes high expression of the aberrant ABL proto-oncogene, a tyrosine kinase</div><div>Results in leukaemia (usually CML)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Gafao^^WvG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 clinical features of multiple endocrine neoplasia type 1 (MEN 1)", 
                "Parathyroid adenomas (90%)<div>Pancreatic islet cell/GI adenomas (65%)<br /><div>Pituitary adenomas (15%)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ft5z@hda0Q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 clinical features of Multiple Endocrine Neoplasia type 2A", 
                "Medullary thyroid cancer (90%)<div>Pheochromocytoma (45%)</div><div>Parathyroid hyperplasia (15%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s98_!RG{,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in the RET proto-oncogene results in what clinical syndrome?", 
                "Multiple endocrine neoplasia type 2 (MEN 2)", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ny#9^QaxeX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What inheritance pattern does RET follow?", 
                "<div>Autosomal dominant</div><div><br /></div>RET is a proto-oncogene. Mutation results in MEN2.", 
                ""
            ], 
            "flags": 0, 
            "guid": "iYQ*T4Tu.?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 clinical features of multiple endocrine neoplasia type 2B", 
                "Medullary thyroid cancer<div>Pheochromocytoma</div><div>Mucosal neuromas</div><div>Marfinoid body habitus</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CQSi4BAGl+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in what gene results in multiple endocrine neoplasia type 2?", 
                "RET", 
                ""
            ], 
            "flags": 0, 
            "guid": "gxL2PlmJun", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in the MENIN tumour suppressor gene results in what clinical syndrome?", 
                "Multiple endocrine neopalsia type 1", 
                ""
            ], 
            "flags": 0, 
            "guid": "ID{NUQ0,wG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What mutation results in multiple endocrine neoplasia type 1?", 
                "MENIN (tumour suppressor gene)", 
                ""
            ], 
            "flags": 0, 
            "guid": "AqG!!gEq=A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in the MENIN tumour suppressor gene results in multiple endocrine neoplasia type 1. What pattern of inheritance does it follow?", 
                "Autosomal dominant", 
                ""
            ], 
            "flags": 0, 
            "guid": "yk9+0erbdv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of breast cancers are associated with germline high risk gene mutations?", 
                "5%", 
                ""
            ], 
            "flags": 0, 
            "guid": "qO9rg.-lvZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of breast cancer patients will have a family history of breast or ovarian cancer?", 
                "30%", 
                ""
            ], 
            "flags": 0, 
            "guid": "IUm}toBn-S", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 genes associated with familial breast/ovarian cancer, and their syndromes", 
                "Hereditary breast and ovarian cancer syndrome - BRCA 1 and 2<div>Li Fraumeni syndrome - TP53</div><div>Cowden syndrome - PTEN</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Dx#C.H:N~A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Li Fraumeni Syndrome results from mutation in what gene?", 
                "TP53 (missense mutation)", 
                ""
            ], 
            "flags": 0, 
            "guid": "lf[IDoZj<5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in TP53 results in what syndrome?", 
                "Li Fraumeni syndrome", 
                ""
            ], 
            "flags": 0, 
            "guid": "HTpBsXVly9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in PTEN results in what syndrome?", 
                "Cowden syndrome", 
                ""
            ], 
            "flags": 0, 
            "guid": "B5N<~/|pYe", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Cowden syndrome arises due to mutation in what gene?", 
                "PTEN", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q>NetX_:jP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do all patients with a germline mutation associated with high breast and ovarian cancer risk have a family history of those diseases?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "G(<)L=aj!f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why don't all patients with a germline mutation associated with high breast and ovarian cancer risk have a family history of those diseases?", 
                "<div>This may be due to:</div><div><br /></div>De novo mutation<div>Small, male-enriched paternal family history</div><div>Not 100% cancer penetrance</div><div>Adoption</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Bq+`p8y.+U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 features that are seen in families with heriditary breast and ovarian cancer syndrome (HBOC)?", 
                "Young, premenopausal onset of breast cancer (age &lt;35)<div>Breast and ovarian cancers within the family</div><div>Triple negative breast cancer</div><div>High grade serous ovarian cancer or primary peritoneal cancer</div><div>&gt;1 generation affected</div><div>Male breast cancer at any age</div><div>Ashkenazi Jewish or Icelandic heritage</div><div>Breast cancer in a patient with a 1st or 2nd degree relative with ovarian cancer, or relative with breast cancer age &lt;50</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qw)f~J{%sJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the incidence of BRCA1 and 2 in the population?", 
                "1 in 500", 
                ""
            ], 
            "flags": 0, 
            "guid": "di4&ylUYp4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "BRCA 1 and 2 are what type of genes?", 
                "Tumour suppressor genes", 
                ""
            ], 
            "flags": 0, 
            "guid": "rIW@?idWO=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "BRCA 1 and 2 mutations follow what pattern of inheritance?", 
                "Autosomal dominant", 
                ""
            ], 
            "flags": 0, 
            "guid": "hG^PWLr&nh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do all BRCA1 and 2 families have the same mutations?", 
                "No<div>&gt;1000 different BRCA mutations have been reported</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ap+lICJb~v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how mutations in BRCA 1 and 2 result in malignancy", 
                "BRCA are responsible for repair of breaks in double stranded DNA via the error-free homologous recombination pathway (BRCA 1 and 2 act at different points along the same pathway)<div>If unable to use this pathway due to BRCA nonfunctioning, cells switch to using non-homologous end joining, an error-prone method</div><div>This gives rise to mutations</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P.@]zG~5LX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Biallelic mutations in BRCA2 result in what disease?", 
                "Fanconi anaemia", 
                ""
            ], 
            "flags": 0, 
            "guid": "HQ;qSb}4!S", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a biallelic mutation?", 
                "Mutation on both copies of a particular allele - may be homozygous (the same mutation) or compound heterozygous (a different mutation on each allele)", 
                ""
            ], 
            "flags": 0, 
            "guid": "x>aJz[F8.i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of high risk familities will have a BRCA 1 or 2 mutation?", 
                "20%", 
                ""
            ], 
            "flags": 0, 
            "guid": "to[K2bY~Bg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutations in BRCA 1 are found in what percentage of triple negative breast cancer?", 
                "12%", 
                ""
            ], 
            "flags": 0, 
            "guid": "ls>[HCTTJM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of high grade serous ovarian cancer have BRCA 1 or 2 mutation?", 
                "15%", 
                ""
            ], 
            "flags": 0, 
            "guid": "PxGaWiwu8T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in what genes account for the vast majority of famila breast cancer in Ashkenazi Jewish women?", 
                "BRCA 1 and 2 - 96%", 
                ""
            ], 
            "flags": 0, 
            "guid": "G_-V?]]rEn", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should genetic testing for BRCA 1 and 2 be considered? (6)", 
                "Diagnosis of breast cancer age &lt; 35<div>Male breast cancer at any age</div><div>High grade serous ovarian cancer or primary peritoneal cancer</div><div>Ashkenazi Jewish background</div><div>Triple negative breast cancer</div><div>Very strong family history</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wx_K+/W|ml", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Government funded testing for BRCA 1 and 2 is provided when...", 
                "Risk of BRCA mutatation &gt;10%", 
                ""
            ], 
            "flags": 0, 
            "guid": "JRF:9A?l5L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 differences between BRCA1 and 2 clinical syndromes", 
                "BRCA 1:&nbsp;<div>- higher risk of breast cancer (73 vs 69%)</div><div>- higher risk of ovarian or fallopian tube cancer (44 vs 17%)</div><div>BRCA 2:</div><div>- higher risk of male breast cancer (5-6% vs 2-3%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Kk%[2dZ?~O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the recommended risk reduction strategies in patiens with BRCA mutation? (3)", 
                "<div>Prophylactic bilateral mastectomy OR annual mammography and breast MRI from age 25 until mastectomy</div><div>Salpingo-oophorectomy after completing family or at age 40<div><div>Tamoxifen (if premenopausal) or raloxifene (if postmenopausal) for 5 years (reduces risk by 40%)</div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P?qhs,s/d$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is screening for ovarian cancer recommended in patients with BRCA 1 and 2 mutation?", 
                "No - it does not work.<div>Salpingo-oophorectomy at age 40 is recommended</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NeolL0Q%]~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the other name for Li Fraumeni syndrome?", 
                "SBLA (sarcoma, breast, leukaemia, adrenal gland) cancer syndrome", 
                ""
            ], 
            "flags": 0, 
            "guid": "py.rQ]ahN]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 clinical features of Li Fraumeni syndrome", 
                "Breast cancer, often before age 30, 66% HER2 positive<div>Sarcoma - osteosarcoma, other soft tissue sarcoma</div><div>Childhood brain, leukaemia, adrenal cancers</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HyI)!,`KSt", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of Li Fraumeni syndrome patients will have a tumour by ages 30 and 70?", 
                "50% by age 30<div>95% by age 70</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F:ohX78DI{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with Li Fraumeni syndrome who develop a malignancy, what percentage will develop a second malignancy?", 
                "15%", 
                ""
            ], 
            "flags": 0, 
            "guid": "q$1/^!W{Vc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should testing for Li Fraumeni syndrome be considered?", 
                "HER2 positive cancer age &lt;35<div>Family history of cancer aged less than 45 AND sarcoma at any age</div><div>Childhood adrenal adenocarcinoma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wi|t]|bfi:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of Li Fraumeni patients will develop a HER2 positve breast cancer?", 
                "Two thirds", 
                ""
            ], 
            "flags": 0, 
            "guid": "nI/Uqyuk-g", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient presents with breast cancer aged 25. Her mother had breast cancer diagnosed at age 30, and her aunt had a sarcoma aged 10. Her brother, two uncles, grandmother and grandfather are healthy. What is the most likely familial cancer syndrome and mutation?", 
                "Li Fraumeni, TP53", 
                ""
            ], 
            "flags": 0, 
            "guid": "Fz2xnMeE;3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the function of the TP53 gene?", 
                "Tumour suppressor gene, mutation causes Li Fraumeni syndrome<div>Produces Tumour Protein 53, which delays cell cycle progression, can allow cell to initiate DNA repair, can initiate apoptosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n=5XyK?]#D", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "TP53 follows what pattern of inheritance?", 
                "Autosomal dominant (Li Fraumeni syndrome)", 
                ""
            ], 
            "flags": 0, 
            "guid": "sbC$I)c@M`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in how many alleles of TP53 within a single cell is required for malignant transformation?", 
                "Both must be mutated - two hit hypothesis, as it is a tumour suppressor gene.<div>One inherited as mutant (germline mutation)</div><div>Second allele mutates during life (somatic mutation) resulting in no gene to produce functional TP53</div><div>Usually missense mutation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "&,>;t:x[(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do all Li Fraumeni patients have an identifiable mutation in TP53?", 
                "No, but the majority do.", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q53ZuUFj7H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What screening should be offered to patients with Li Fraumeni syndrome?", 
                "Annual breast MRI or prophylactic mastectomy<div>No other effective screening for the other cancers - whole body MRI is being trialled.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pp,fL$&*1X", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 clinical features of Cowden syndrome", 
                "<div>Large head circumference</div><div>Tricholemminomas (tumour of outer root sheath of hair follicle, benign, usually head and neck, may be described as skin tags)</div><div>Lhermitte Duclos (dysplatic cerebellar gangliocytoma, benign, may have cerebellar signs)</div>Breast cancer and benign breast changes (fibrocystic disease)&nbsp;<div>Endometrial cancer</div><div>Follicular thyroid cancer</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hd^abaTj?!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of gene is PTEN?", 
                "Tumour suppressor gene, seen in Cowden syndrome", 
                ""
            ], 
            "flags": 0, 
            "guid": "G{StP|qf1C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What pattern of inheritance is seen in Cowden syndrome?", 
                "Autosomal dominant (PTEN tumour suppressor gene)", 
                ""
            ], 
            "flags": 0, 
            "guid": "j{4b/-9u]c", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is Cowden syndrome?", 
                "An autosomal dominant condition characterised by multiple hamartomas, large head, trichilemmomas, white flat mucosal lesions (papillomatous papules), increase cancer risk (breast, follicular thyroid, endometrial)", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pw+O.@F^y$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of Cowden syndrome patients have an identifiable PTEN mutation?", 
                "Around 1/3", 
                ""
            ], 
            "flags": 0, 
            "guid": "Kd85<0sU*L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Hereditary breast and ovararian cancer syndrome (HBOC) due to BRCA 1 and 2 mutation increases risk of breast and ovarian cancer. Name 1 other malignancy associated with this syndrome.", 
                "Pancreatic cancer", 
                ""
            ], 
            "flags": 0, 
            "guid": "N`930Op}65", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 genes seen in polyp-associated familial colorectal cancer", 
                "APC (familial adenomatous polyposis)<br /><div>MUTYH (MUTYH-associated polyposis)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mH4<1ZD<=]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name two non polyp-associated familial colorectal cancer syndromes, and their genes", 
                "Hereditary nonpolyposis colorectal cancer (HNPCC) - MMR genes MLH1, MSH2, MSH6, PMS2<div>Familial CRC Syndrome X - no genes identified yet</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tfqOa?TR0r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How many polyps are typically seen on colonoscopy of an adult patient with classic familial adenomatous polyposis", 
                "100s to 1000s", 
                ""
            ], 
            "flags": 0, 
            "guid": "NJ_3rOH?>0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How many polyps are typically seen on colonoscopy of an adult patient with attenuated familial adenomatous polyposis", 
                "10 - 99", 
                ""
            ], 
            "flags": 0, 
            "guid": "QBm^[G,-wU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of polyp is seen in patients with familial adenomatous polyposis?", 
                "Tubulous villus adenomas", 
                ""
            ], 
            "flags": 0, 
            "guid": "rwS-Ceb]ph", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 types of neoplastic colorectal polyp", 
                "<div>Tubular adenomas (0–25% villous tissue)</div><div>Tubulovillous adenomas (25–75% villous tissue)<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span></div><div>Villous adenoma (75–100% villous tissue)</div><div><br /></div><div>All of these are termed 'adenomas' and have potential for malignant transformation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "RcY?Y5e.9_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What histopathological features of an adenomatous colorectal polyp confer increased risk of malignant transformation?", 
                "Size &gt; 1cm<br /><div>Higher grade of dysplasia</div><div>Higher percentage of villous tissue</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pF;Ea?y(i*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mean age of onset of colonic polyp formation in patients with FAP?", 
                "16", 
                ""
            ], 
            "flags": 0, 
            "guid": "k3Yf{9^)w_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Familial adenomatous polyposis arises due to what mutation", 
                "Autosomal dominant syndrome&nbsp;<div>Germline mutations in the adenomatous polyposis coli (APC) gene on chromosome 5q21-q22</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "RcA3K[B,!e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What symptoms may a patient with familial adenomatous polyposis present with?", 
                "Usually asymptomatic until cancer diagnosis - present with symptoms of colorectal cancer<div>May have GI bleeding, abdo pain, diarrhoea</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "o~ZW7{SCVw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 extracolonic manifestations of familial adenomatous polyposis", 
                "Fundic gland polyps&nbsp;<div>Gastric adenomas&nbsp;</div><div>Duodenal cancer 5% (2nd most common cause of death)</div><div>Adenomas of other upper GI tract sites (rare)</div><div>Desmoid tumours 10 -15%</div><div>Thyroid cancer (12%)&nbsp;</div><div>Congenital hypertrophy of the retinal pigment epithelium (CHRPE)</div><div><div>Osteomas, cysts</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K+db]_GH?U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of thyroid cancer is typically seen in FAP?", 
                "Papillary thyroid cancer", 
                ""
            ], 
            "flags": 0, 
            "guid": "cU?,u6_,D[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 2nd most common cause of death in FAP?<br />", 
                "Duodenal malignancy", 
                ""
            ], 
            "flags": 0, 
            "guid": "zi;vilx~yh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the features of fundic gland polyps seen in patients with FAP", 
                "Occur in most patients<div>&lt;1cm size</div><div>In fundus or body of stomach</div><div>May have 100s</div><div>Rarely progress to cancer</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fhy8Pf&*?<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the features of gastric adenomas seen in FAP", 
                "Uncommon<div>Typically isolated and located in the antrum</div><div>May progress to cancer</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "foa<fnV2a3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of desmoid tumours in patients with FAP", 
                "<div>Occur in 10 - 15%</div><div>Arise from fibroblasts, usually in the abdomen&nbsp;</div><div>Slow growing (rapid progression in 10%)&nbsp;</div><div>Do not metastasise, can cause morbidity and mortality due to compression of surrounding structures</div><div>Recur after resection</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "IsW_K4EeU9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the penetrance of FAP in patients with APC gene mutation?", 
                "100%", 
                ""
            ], 
            "flags": 0, 
            "guid": "G#(W/kTI0R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients with FAP have de novo mutations in the APC gene?", 
                "25%", 
                ""
            ], 
            "flags": 0, 
            "guid": "rMa5zCbxa7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How many different APC gene mutations associated with FAP have been described?", 
                "&gt;1000 different mutations", 
                ""
            ], 
            "flags": 0, 
            "guid": "myi-D([X/<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should total colectomy be considered in patients with FAP?", 
                "Eventually required in all patients<div>Typically performed between age 15 - 25, once adenomas have been observed</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b1UDue;Eyz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the lifetime risk of colorectal cancer in patients with FAP if untreated?", 
                "100%&nbsp;<div>Genetics course claims 100% mortality by age 45 if untreated</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ES!a]_6DZp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When shuold APC testing be considered", 
                "Cumulative count of ≥ 10 colorectal adenomas before 30 years of age or&nbsp;<div>≥ 20 colorectal adenomas at any age</div><div>Known APC mutation in a relative (children should be tested at age 10)</div><div><br /></div><div>APC mutation is seen in familial adenomatous polyposis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h-WQsH5AS2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "With regards to FAP, which patients should have colonic surveillance?", 
                "<div>Patients with a diagnosis of FAP</div><div>Individuals found on genetic testing to carry a pathogenic APC mutation</div><div>First-degree relatives of patients with FAP or AFAP in whom genetic testing has been declined or is not possible because the family mutation has not been identified.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x]5a_)oe^h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In AFAP, should surveillance be by colonoscopy or flexible sigmoidoscopy?", 
                "Colonoscopy - first adenomas may only be present in the proximal colon<div><br /><div>This is unlike FAP, where flexisig is sufficient as adenomas appear simultanously throughout the colorectum.</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d:Z=rh2L<_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for MutYH associated polyposis", 
                "MUTYH-associated polyposis is an autosomal recessive polyposis syndrome.&nbsp;<div>Patients typically have 100 - 1000 polyps (less than FAP)</div><div>Onset at age 45 (later than FAP)</div><div>Can get FAP-like extracolonic manifestations but no desmoid disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Bh}j^j,HU2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of the population have a mutation in one MUTYH allele?", 
                "1-2%", 
                ""
            ], 
            "flags": 0, 
            "guid": "zZ=BLb^pvr", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of colorectal cancer patients have biallelic MUTYH mutations?", 
                "1%", 
                ""
            ], 
            "flags": 0, 
            "guid": "IF%RW!kFp:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients with multiple colorectal adenomas and no APC mutation have biallelic MUTYH mutations?", 
                "15%", 
                ""
            ], 
            "flags": 0, 
            "guid": "Na2>:{Uy=)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the function of the MUTYH gene?", 
                "MUTYH protein repairs oxidative damage to DNA<div><br /></div><div>Mutation results in MUTYH associated polyposis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kSI)kd7,L7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What pattern of inheritance does MUTYH associated polyposis follow?", 
                "Autosomal recessive", 
                ""
            ], 
            "flags": 0, 
            "guid": "v>DY9`-k51", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the recommended surveillance for patients with biallelic MUTYH mutations?", 
                "These patients have MUTYH associated polyposis<div>Colonoscopy every 2 years from age 18 - 20</div><div>Once polyps are detected, annual colonoscopy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z?%Q|N_,5R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should colectomy be considered in patients with MUTYH associated polyposis?", 
                "When polyps cannot be easily managed colonoscopically", 
                ""
            ], 
            "flags": 0, 
            "guid": "B(B.(v]gs^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do carriers of MUTYH gene have increased risk of colorectal cancer?", 
                "Carrier state increases risk of colorectal cancer in age &gt; 60", 
                ""
            ], 
            "flags": 0, 
            "guid": "njO&XJfN5b", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for Peutz-Jeghers syndrome", 
                "Autosomal dominant syndrome&nbsp;characterized by&nbsp;<div>- multiple hamartomatous polyps in the gastrointestinal tract (low malignant potential) - may present with intussusception</div><div>- lip, buccal, and palm pigmentation</div><div>- increased risk of colorectal, breast, and other cancers (lifetime cancer risk 37 - 93%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ys8aIr$nhV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in what gene is responsible for Peutz-Jegher syndrome?", 
                "STK11", 
                ""
            ], 
            "flags": 0, 
            "guid": "r-hPz6p$q3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Mutation in&nbsp;STK11 results in what syndrome?", 
                "Peutz-Jegher syndrome", 
                ""
            ], 
            "flags": 0, 
            "guid": "KAbZ+f6f&-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 non-colorectal cancers seen in patients with hereditary non-polyposis colorectal cancer (HNPCC)", 
                "Endometrial cancer (most common) 40-50%<div>Ovarian cancer 10%</div><div>Stomach cancer 5 - 15%</div><div>Small bowel 1 - 5%</div><div>Ureter and renal pelvis 3-4%</div><div>Brain 3 - 6%</div><div>(multiple others)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D8X`WE!Cd7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the lifetime colorectal cancer risk in HNPCC?", 
                "10 - 47% (depending on sex and which MMR gene is mutated)", 
                ""
            ], 
            "flags": 0, 
            "guid": "jm8<Plx6?2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the average age of diagnosis of colorectal cancer in HNPCC?", 
                "45 - 60 (median age 48)", 
                ""
            ], 
            "flags": 0, 
            "guid": "yq}|~:Z0WY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common inherited colorectal cancer susceptibility syndrome?", 
                "Hereditary nonpolyposis colorectal cancer", 
                ""
            ], 
            "flags": 0, 
            "guid": "L>96#Aw&Xu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Hereditary nonpolyposis colorectal cancer accounts for what percentage of colorectal and endometrial cancer diagnoses?", 
                "3% of colorectal cancers<div>2% of endometrial cancers</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hwhWiO~PRS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Hereditary nonpolyposis colorectal cancer follows what pattern of inheritance", 
                "Autosomal dominant", 
                ""
            ], 
            "flags": 0, 
            "guid": "e=@oEAgref", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the Amsterdam criteria for diagnosis of&nbsp;hereditary nonpolyposis colorectal cancer?", 
                "3-2-1 rule:<div><div>- Three or more relatives with histologically verified Lynch syndrome-associated cancers, one of whom is a first-degree relative of the other two and FAP has been excluded</div><div>- At least 2 generations affected</div><div>- One (or more) cancers diagnosed age &lt; 50</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ic5OyiOUWW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should surveillance be commenced for patients with hereditary non polyposis colorectal cancer syndrome (HNPCC)?", 
                "Surveillance colonoscopy every 1 to 2 years<div>Commence at age 25 or 5 years younger than the youngest affected family member (whichever is earlier)</div><div>Annual surveillance is preferred in confirmed mutation carriers</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N0[whlA@7v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the frequency of germline mutations in a MMR-gene in unselected individuals with colorectal cancers?", 
                "&nbsp;2-4%<div><br /></div><div>This refers to hereditary non polyposis colorectal cancer syndrome.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rUuMuJUNP2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is tumour testing in patients with suspected HNPCC conducted?", 
                "Immunohistochemistry staining for the 4 MMR proteins<div>PCR testing for microsatellite instability</div><div><br /></div><div>95% concordance between the two, both are acceptable.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LR)S4K-[dI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In which patients is tumour testing for HNPCC-like features conducted?", 
                "Colorectal cancer diagnosed prior to age 50", 
                ""
            ], 
            "flags": 0, 
            "guid": "dH5CI>6+t)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with HNPCC is diagnosed with colorectal cancer. What type of surgery should be considered?", 
                "Depends on patient factors<div>Segmental colectomy carries high risk (16 - 19%) 10 year risk of a second cancer</div><div>Risk much lower with extended resection (subtotal colectomy or total colectomy) but poorer functional outcomes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xiRw^::btS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the sensitivity and specificity of the Amsterdamn criteria for the diagnosis of&nbsp;Lynch syndrome (hereditary nonpolyposis colorectal cancer)?", 
                "Sensitivity 22%<div>Specificity 98%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rdlA2n6reL", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the lifetime risk of colorectal cancer in males and females with HNPCC?", 
                "Male - 70 - 80%<div>Female - 40 - 50%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rpmbK+6eTd", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the lifetime risk of endometrial cancer in HNPCC?", 
                "40-50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "QuWJZ<q]gR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What risk reduction strategies are recommended in HNPCC that are directed at non-colonic manifestations (3)?", 
                "Strongly consider hysterectomy after childbearing years or at age 40<div>Consider oophorectomy at same time</div><div>Consider 2nd yearly gastroscopy from age 30 if family history of gastric cancer or ethnicity at risk (chinese, korean, japanese, chilean)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ji/U^Ldq{o", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which familial colorectal cancer syndrome carries the highest relative risk of colorectal cancer?", 
                "Familial adenomatous polyposis", 
                ""
            ], 
            "flags": 0, 
            "guid": "gtdXSqU/.9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 bacteria that, when in identified on blood cultures, suggest the possibility of a colorectal malignancy", 
                "Strep gallolyticus (formerly bovis)&nbsp;<div>Clostridium septicum sepsis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N4xK.uRrXp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases", 
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What comprises the 'full house pattern' of immune deposits in membranous glomerunonephropathy, and what is its significance?", 
                "IgG, IgM, IgA, C3, and C1q<div>Very specific for secondary membranous glomerunonephropathy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PVM(n;];|:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 featurea that may be seen in membranous glomerulonephritis that strongly suggests SLE as a cause", 
                "<div>Glomerular deposition of IgG, IgM, IgA, C3, and C1q (ie, a \"full house\")</div><div>Concurrent electron-dense subendothelial or prominent mesangial deposits by electron microscopy</div><div>Tubuloreticular structures in the endothelial cells on electron microscopy (picture 2)</div><div>Immune deposits along the tubular basement membranes and in the small blood vessels</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Bs8$<<p`ZQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Renal"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 5 inflammatory myopathies", 
                "Dermatomyositis<div>Polymyositis</div><div>Inclusion body myositis</div><div>Autoimmune necrotizing myopathy&nbsp;</div><div>Overlap</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GW7s%#jHGW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the clinical presentation of inclusion body myositis", 
                "Slow/insidious onset of proximal and /distal/ weakness<div>May be symmetric or asymmetric</div><div>Dysphagia in 1/3</div><div>Muscle enzymes normal or mildly elevated, CK generally less than 10 times upper limit of normal</div><div>Early involvement of quadriceps, wrist/finger flexors</div><div><div>Atrophy of quadriceps and forearms</div><div>Frequent falls</div><div>Facial muscle wekaness with sparing of oculomotor muscles</div><div>Patient age &gt; 50</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dQ02q_s<:d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the incidence of myalgia and myopathy with statin therapy?", 
                "2-11%<div>Severe myonecrosis 0.5% and rhabdomyolysis 0.1%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m8=NBq{<D?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What comorbidities or medications increase risk of statin myopathy?", 
                "Chronic renal failure<div>Obstructive liver disease</div><div>Hypothyroid</div><div>Concomittant use of another agent that can cause myopathy (e.g. steroid)</div><div>Use of another medication that interfers with CYP 450 (particularly inhibitors)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D*iID|+s:Y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What statins are recommended in patients who have had previous statin-induced myopathy?", 
                "Pravastatin<div>Fluvastatin</div><div>Rosuvastatin</div><div>Pitavastatin&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gukeq>(wJc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is a diagnosis of statin-induced myopathy usually made?", 
                "<div>Raised CK (most patients)</div>Temporal association for both onset with initiation of statin therapy and resolution with statin withdrawal.&nbsp;<div>No need for muscle biopsy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yqQGQu1cQL", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of statin induced myopathy", 
                "Withdraw the statin<div>Supportive care</div><div>Should self-resolve</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O5aW#&pP&R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 autoantibodies associated with malignancy in dermatomyositis", 
                "Anti-TIF1 gamma<div>Anti-NPX-2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "olY}/n`iOq", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 cancers associated with dermatomyositis and polymyositis", 
                "Adenocarcinomas of the cervix, lung, ovaries, pancreas, bladder, and stomach (70 percent of the cancers)", 
                ""
            ], 
            "flags": 0, 
            "guid": "xigHs]IdF[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of investigation for malignancy should be conducted in a patient with a new diagnosis of dermatomyositis of polymyositis", 
                "Age appropriate screening", 
                ""
            ], 
            "flags": 0, 
            "guid": "F5N58vFh$j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When, in relation to a diagnosis of dermato or polymyositis, is a cancer typically diagnosed?", 
                "Cancer can be diagnosed before, simultaneously with, or after the diagnosis of inflammatory myopathy", 
                ""
            ], 
            "flags": 0, 
            "guid": "n90WFMR/Fb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does malignancy associated with dermato or polymyositis have a better or worse prognosis than a similar cancer in the general population?", 
                "Poorer prognosis", 
                ""
            ], 
            "flags": 0, 
            "guid": "hu?-}0f&ha", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How much prednisolone is required to induce a steroid induce myopathy?", 
                "Higher than 10mg per day<div>Higher dose = higher liklihood</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xDbB^5f+#g", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is a diagnosis of steroid-induced myopathy usually made?", 
                "Improvement in muscle strength 3-4 weeks after adequate dose reduction", 
                ""
            ], 
            "flags": 0, 
            "guid": "e@EH<>h$G(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 manifestations of Sjogren's syndrome", 
                "Xerosis (23 - 67%)<div>Raynaud's (13 - 30%)</div><div>Arthritis (50%) - usually mild</div><div>Hypergammaglobulinaemia (36 - 62%)</div><div>Positive RF (40%)</div><div>Interstitial nephritis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "eO9QRmG]EP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Sjogren's syndrome patients are at increased risk of what malignancy?", 
                "Lymphoma RR 6.6<div>High risk in primary Sjogren's</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P*3f7iu&=R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common renal manifestation of Sjogren's syndrome", 
                "Chronic tubulointerstitial nephritis", 
                ""
            ], 
            "flags": 0, 
            "guid": "o1bPPNjDzN", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Sjogren's syndrome is associated with what type of renal tubular acidosis?", 
                "Distal (type 1)", 
                ""
            ], 
            "flags": 0, 
            "guid": "f(nr%wJGh^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 agent that &nbsp;can be used for steroid-sparing in patients in GCA", 
                "Tocilizumab (soon)", 
                ""
            ], 
            "flags": 0, 
            "guid": "vLB)u7mv2]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Rheumatology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the surgical management of early breast cancer", 
                "<div>Wide local excision + radiotherapy (equivalent outcomes to mastectomy)</div><div>Axillary clearance if sentinel lymph node positive</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sB?;%?(cNz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with early breast cancer require mastectomy instead of breast conserving surgery? (6)", 
                "Multicentric disease<div>Large tumour size in relation to breast</div><div>Diffuse malignant-appearing calcifications on imaging</div><div>History of chest RT</div><div>Pregnancy</div><div>Persistenty positive margins at resection</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lT;DY4f!H]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of early breast cancer in broad terms", 
                "Surgery (most important)<div>+/- adjuvant endocrine therapy</div><div>+/- adjuvant chemotherapy</div><div>+/- adjuvant HER2 directed therapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Mr%@}*]qN#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the adjuvant treatment of triple negative early breast cancer", 
                "Give chemotherapy if tumour size &gt;0.5cm<div>No role for endocrine or HER2 directed therapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EqpunX9CkR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the adjuvant therapy of hormone receptor positive early breast cancer", 
                "Endocrine therapy for all patients<div>Consider chemotherapy if:</div><div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>• High grade tumour</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>• Large tumour size (&gt;2cm)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>• Pathologically involved nodes</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>• High 21-gene recurrence score (score &gt;25)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qp~1`l)G6y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the adjuvant treatment of HER2 receptor positive early breast cancer", 
                "<div>Chemotherapy + HER2 directed therapy (trastuzumab)</div><div>Followed by maintenance trastuzumab to complete 1 year of treatment</div><div>+ endocrine treatment if also hormone receptor positive</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gxm`vEaHqv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with early breast cancer who undergo mastectomy will also require radiotherapy?", 
                "<div>Cancer involving deep margins</div><div>Pathologically involved nodes</div><div><br /></div><div>RT is usually not required</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bu;|P``&.R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the role of neoadjuvant chemotherapy in early breast cancer", 
                "May be used to try to downstage patients who would otherwise require mastectomy to make them eligible for breast conserving surgery", 
                ""
            ], 
            "flags": 0, 
            "guid": "tANoceS=10", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 4 types of breast cancer (according to pattern of receptor positivity)", 
                "Basal-like<div>HER2+</div><div>Luminal B-like</div><div>Luminal A-like</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K3jg7`vVYF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the characteristics of basal-like breast cancer?", 
                "Triple negative<div>High proliferation rate and poor prognosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C{]4FXZn%=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the characteristics of luminal B-like breast cancer?", 
                "ER or PR positive (less so than luminal A)<div>HER2 negative</div><div>High proliferation rate</div><div><br /></div><div>Both endocrine and chemotherapy play important role</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dyg.0)CcU(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the characteristics of luminal A-like breast cancer?", 
                "Strongly PR and ER positive<div>HER2 negative</div><div>Low proliferation rate</div><div><br /></div><div>Endocrine therapy plays important role</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I?s#BgKm^b", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the significance of 21 gene expression assays in early breast cancer", 
                "Used in ER positive, HER2 negative, node negative disease<div>Predict the benefit of chemotherapy</div><div>Low and intermediate scores (0-10 and 11 -25) have NO benefit of chemotherapy + endocrine treatment vs endocrine therapy alone, as shown in recent NEJM trial</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ySq]x#L3A|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define early breast cancer", 
                "<div>Stage I, IIA, and subset of IIB (T2N1) are considered early breast cancer</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M&7<p87nI2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define locally advanced breast cancer", 
                "A subset of &nbsp;stage IIB (T3N0), and stage IIIA to IIIC", 
                ""
            ], 
            "flags": 0, 
            "guid": "bKOatc$8N:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of breast cancer patients are metastatic at diagnosis?", 
                "5%", 
                ""
            ], 
            "flags": 0, 
            "guid": "c>Gt{HkfZ?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What chemotherapy is used in early breast cancer?", 
                "Anthracycline (doxorubicin or epirubicin) +/- cyclophosphamide<div>followed by</div><div>Taxane (docetaxel or paclitaxel)</div><div><br /></div><div>Typical regime: doxorubicin/cyclophosphamide q3weekly x 4 cycles, then paclitaxel weekly x12 cycles</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oI(b&aM_/)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 adverse effects of anthracyclines", 
                "Nausea<div>Alopecia</div><div>Bone marrow suppression</div><div>Cardiotoxicity (late, rare, dose-dependent)</div><div>Secondary leukaemia (late, rare)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "IBZ0)v:E:9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the cardiotoxicity seen with anthracycline chemotherapy (5)", 
                "<div>Dose dependent</div><div>Incidence of 6% (symptomatic) and 18% (asymptomatic) after 9 years</div><div>Reduction in left ventricular ejection fraction (LVEF), cardiomyopathy, or symptomatic CHF</div><div>May be acute (immediate after a single dose), early onset chronic progressive, or late onset chronic progressive</div><div>Usually not reversible</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jIkz|2}!ht", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 adverse effects of taxane chemotherapy", 
                "<div>Short term:</div>Allergy<div>Myalgia</div><div>Fluid retention</div><div>Nail changes</div><div>Bone marrow suppression</div><div><br /></div><div>Medium to long term:</div><div>Peripheral neuropathy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rIs[>6fWB^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of trastuzumab", 
                "Monoclonal antibody against HER2 receptor", 
                ""
            ], 
            "flags": 0, 
            "guid": "m&bAGd0]IJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 adverse effects of trastuzumab", 
                "Allergy<div>Diarrhoea</div><div>Fatigue</div><div>Cardiotoxicity</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Cs2xDm3;&`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the cardiotoxicity seen with HER2-directed agents therapy such as trastuzumab", 
                "Asymptomatic decrease in LVEF 11.2%<div>Symptomatic heart failure 2.5% (with chemo) or 0.4%</div><div>Usually reversible with cessation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "OB7R#:`KDW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the monitoring regime for HER2 agent cardiotoxicity", 
                "Echo at baseline and every 3 months", 
                ""
            ], 
            "flags": 0, 
            "guid": "D46gLUf,On", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients are ineligible for HER2 directed therapy due to unacceptable risk of cardiotoxicity?", 
                "LVEF &lt;45% and/or symptomatic heart failure<div><br /></div><div>Can consider treating at lower EF in life-threatening metastatic disease in consultation with a cardiologist</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uv];g^tfmC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7c80e20563554169bc5d5374388e47ec-ao-1", 
                "When should HER2 directed therapy be withheld in patients with asymptomatic decreases in LVEF?", 
                "<img src=\"tmp3tqrgq.png\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-1-A.svg\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "m]X6LoD$XG", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7c80e20563554169bc5d5374388e47ec-ao-2", 
                "When should HER2 directed therapy be withheld in patients with asymptomatic decreases in LVEF?", 
                "<img src=\"tmp3tqrgq.png\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-2-A.svg\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "dBLOqi;Ej7", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7c80e20563554169bc5d5374388e47ec-ao-3", 
                "When should HER2 directed therapy be withheld in patients with asymptomatic decreases in LVEF?", 
                "<img src=\"tmp3tqrgq.png\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-3-A.svg\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Dq/I.eu:b", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7c80e20563554169bc5d5374388e47ec-ao-4", 
                "When should HER2 directed therapy be withheld in patients with asymptomatic decreases in LVEF?", 
                "<img src=\"tmp3tqrgq.png\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-4-A.svg\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "HYv}w6L|J.", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7c80e20563554169bc5d5374388e47ec-ao-5", 
                "When should HER2 directed therapy be withheld in patients with asymptomatic decreases in LVEF?", 
                "<img src=\"tmp3tqrgq.png\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-5-A.svg\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Gm&/_(*%Ln", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7c80e20563554169bc5d5374388e47ec-ao-6", 
                "When should HER2 directed therapy be withheld in patients with asymptomatic decreases in LVEF?", 
                "<img src=\"tmp3tqrgq.png\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-6-A.svg\" />", 
                "<img src=\"7c80e20563554169bc5d5374388e47ec-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "xXkK.UWC^", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When may HER2 directed therapy be resumed in breast cancer patients in whom it had previously been withheld for an asymptomatic decrease in LVEF?", 
                "The LVEF returns &gt; 50% or to &lt; 10 percentage points from baseline", 
                ""
            ], 
            "flags": 0, 
            "guid": "L;Y1IL02if", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should HER2 therapy for breast cancer be permanently discontinued due to cardiotoxicity?", 
                "<div>Persistent LVEF decline is observed, or</div><div>Symptomatic cardiac dysfunction occurs.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ntjOJYC~t4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why does cardiotoxicity occur with HER2 directed therapy?", 
                "There are HER2 receptors on the cardiac muscle<div>Mechanism of injury not clearly understood, but &nbsp;may be due to increased oxidative stress and inhibiting antiapoptotic mechanisms</div><div>Does not cause structural damage, hence is reversible</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DcH65V`w[!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of anthracycline-induced cardiotoxicity?", 
                "Direct injury to cardiac myocytes through increased free radicals and oxidative stress<div>Mostly irreversible</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zTzPx_Jfgl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 risk factors for HER2 directed therapy cardiotoxicity", 
                "<div>Previous or concurrent anthracycline use</div><div>Prior treatment with high dose cyclophosphamide</div><div>Radiotherapy to the chest area</div><div>Age &gt; 60</div><div>HTN</div><div>Coronary artery disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u`H!>X9eyR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism by which HER2 contributes to development of a breast malignancy", 
                "Human epidermal growth factor receptor 2 (HER2) is an oncogene, part of the epidermal growth factor receptor (EGFR) family<div>Codes for a transmembrane glycoprotein receptor with intracellular tyrosine kinase activity</div><div>Activation of signalling promotes proliferation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PrQ*),+*Qy", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of trastuzumab?", 
                "Binds to extracellular portion HER2, resulting in<div>- blocking downstream HER2 signalling pathways</div><div>- flagging the tumour cell for destruction by the immune system via antibody dependent cellular cytotoxicity (killing of an antibody-flagged cell by effector cells such as NK cells)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yprkt+YkF)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Addition of HER2 directed therapy in HER2 positive breast cancer results in what degree of improvement in overall survival?", 
                "Overal survival RR 0.74 (26% improvement)", 
                ""
            ], 
            "flags": 0, 
            "guid": "LPFIi3cbXG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of aromatase inhibitors?", 
                "Suppress plasma estrogen levels by inhibiting or inactivating aromatase, the enzyme responsible for the peripheral conversion of androgens to estrogens", 
                ""
            ], 
            "flags": 0, 
            "guid": "y{vo);1a)l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of tamoxifen?", 
                "Selective estrogen receptor modulator (SERM)&nbsp;<div>Inhibits the growth of breast cancer cells by competitive antagonism of the estrogen receptor (ER).</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P?+T&[!%}i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the endocrine therapy that should be given to a high risk, premenopausal, &nbsp;hormone receptor positive, nonmetastatic breast cancer patient", 
                "Ovarian suppression plus exemestane", 
                ""
            ], 
            "flags": 0, 
            "guid": "BRNqgZ9rY&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the endocrine therapy that should be given to a low risk, premenopausal, &nbsp;hormone receptor positive, nonmetastatic breast cancer patient", 
                "Tamoxifen", 
                ""
            ], 
            "flags": 0, 
            "guid": "Fkda<Gy18h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can aromatase inhibitors be used in women with intact ovarian function?", 
                "No, unless ovarian suppression is also administered", 
                ""
            ], 
            "flags": 0, 
            "guid": "q{XoNFg+Xh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the endocrine therapy that should be given to a postmenopausal, &nbsp;hormone receptor positive, nonmetastatic breast cancer patient", 
                "Aromatase inhibitor - better outcomes than tamoxfen<div>If patients cannot tolerate AI, can switch to tamoxifen</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CiTo<A?A0z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long should endocrine therapy be continued in patients with hormone-receptor positive, non-metastatic breast cancer?", 
                "5 years is standard for low risk women (consider extending depending on tolerance, patient wishes)<div>10 years in high risk women</div><div><div><div><br /></div><div>ATLAS study showed 29% breast mortality benefit by extending to 10 years</div><div>MA17 study showed 24% breast mortality benefit by extending to 10 years</div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F3Lw7YOn}`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How would you councel a woman on tamoxifen regarding pregnancy?", 
                "Avoid pregnancy while on tamoxifen and for 2 months after stopping<div>Tamoxifen is associated with congenital abnormalities</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u};afe`vc2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 side effects of aromatase inhibitors", 
                "Joint pain and stiffness (20 -70%)<div>Sexual dysfunction<br /><div>Hot flushes</div></div><div>Osteoporosis</div><div>Cardiovascular disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vfqhyy3b5h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 side effects of tamoxifen", 
                "<div>Thrombosis</div><div>Endometrial cancer</div><div>Hot flushes</div><div>Vaginal discharge</div><div>Fatty liver disease</div><div>Sexual dysfunction</div><div><br /></div><div>Improves bone mineral density and lowers LDL cholesterol</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L>~XW<`>Or", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which has the greatest disease-free survival benefit in early hormone postive breast cancer:<div>tamoxifen alone</div><div>ovarian suppression + tamoxifen</div><div>ovarian suppression + exemestane</div>", 
                "Ovarian suppresion + exemestane has best disease-free survival (recent NEJM article by Aussie first author), 6% better than tamoxifen<div>However increased side effect profile associated with making someone postmenopausal</div><div>UpToDate recommends this regime in high-risk women and tamoxifen alone in low-risk women</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i-$cVv?F-E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What treatment should be initiated in a patient with first presentation metastatic hormone receptor positive, HER2 negative breast cancer without rapidly progressive disease or extensive visceral metastases?", 
                "<div>Endocrine therapy</div><div><br /></div><div>Use:</div>Ribociclib plus aromatase inhibitor (plus ovarian suppression if premenopausal)", 
                ""
            ], 
            "flags": 0, 
            "guid": "P5JC:Pol6J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of ribociclib?", 
                "Cyclin-dependent kinase (CDK) 4/6 inhibitor<div>Arrest cell cycle at G1 to S</div><div><br /></div><div>Used in metastatic hormone receptor positive breast cancer</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j=oV>!$>nJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why do women with hormone receptor positive metastatic breast cancer eventually progress on hormone treatment?", 
                "Endocrine resistance<div>Mechanism is poorly understood</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H*C4r{t>t1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with hormone receptor positive, HER2 negative metastatic breast cancer should be considered for 1st line chemotherapy?", 
                "Rapidly progressive disease, or&nbsp;<div>Extensive visceral metastases</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G{}tWv0:y0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What 2nd line treatment would you consider for a patient with hormone receptor positive, HER2 negative metastatic breast cancer?", 
                "Aromatase inhibitor plus exemestane", 
                ""
            ], 
            "flags": 0, 
            "guid": "ivCktq%xa5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 1st line therapy for HER2 positive metastatic breast cancer?", 
                "Trastuzumab + pertuzumab + taxane chemotherapy", 
                ""
            ], 
            "flags": 0, 
            "guid": "G}~t<!Z^KU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 2nd line treatment for metastatic HER2 postive breast cancer?", 
                "TDM1 (ado-trastuzumab emtansine)", 
                ""
            ], 
            "flags": 0, 
            "guid": "FIkugPDC*,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the empirical therapy for febrile neutropenia?", 
                "Piperacillin/tazobactam, or<div>Cefepime, or</div><div>Ceftazidime</div><div><br /></div><div>If immediate hypersensitivity to penicillin, seek expert advice per eTG (or ciprofloxacin plus vancomycin per college lecture)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r;@9DDG*x^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define febrile neutropenia", 
                "Fever &gt; 38<div>Neutrophils &lt; 1.0</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DNpLd+)T{P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 mechanisms by which hypercalcaemia in malignancy may occur", 
                "<div>Tumor secretion of parathyroid hormone-related protein (PTHrP) - most common (80%)</div><div>Osteolytic metastases with local release of cytokines (see 'Osteolytic metastases' above)</div><div>Tumor production of 1,25-dihydroxyvitamin D</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ws}vj_>A.S", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which cancers (5) typically cause hypercalcaemia of malignancy due to tumour secretion of parathyroid hormone-related peptide?", 
                "Squamous cell carcinoma (lung, head/neck)<div>Renal</div><div>Bladder</div><div>Breast</div><div>Ovarian</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h*#GMF$W6]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism by which tumour secretion of&nbsp;parathyroid hormone-related protein (PTHrP) results in malignant hypercalcaemia?", 
                "Increased bone resorption&nbsp;<div>Distal renal tubular calcium reabsorption</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GRu&Bp=mdE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "416edf9b137c49ecb0752d56325dc86e-ao-1", 
                "", 
                "<img src=\"tmptwk7dg.png\" />", 
                "<img src=\"416edf9b137c49ecb0752d56325dc86e-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"416edf9b137c49ecb0752d56325dc86e-ao-1-A.svg\" />", 
                "<img src=\"416edf9b137c49ecb0752d56325dc86e-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "jPHB(c75@6", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f3efa4d2ad314d118abd95a70e76c66c-ao-1", 
                "", 
                "<img src=\"tmpsmqx_t.png\" />", 
                "<img src=\"f3efa4d2ad314d118abd95a70e76c66c-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f3efa4d2ad314d118abd95a70e76c66c-ao-1-A.svg\" />", 
                "<img src=\"f3efa4d2ad314d118abd95a70e76c66c-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "cF*Veb~cJ<", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f3efa4d2ad314d118abd95a70e76c66c-ao-2", 
                "", 
                "<img src=\"tmpsmqx_t.png\" />", 
                "<img src=\"f3efa4d2ad314d118abd95a70e76c66c-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f3efa4d2ad314d118abd95a70e76c66c-ao-2-A.svg\" />", 
                "<img src=\"f3efa4d2ad314d118abd95a70e76c66c-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "coIRB5O%QC", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f3efa4d2ad314d118abd95a70e76c66c-ao-3", 
                "", 
                "<img src=\"tmpsmqx_t.png\" />", 
                "<img src=\"f3efa4d2ad314d118abd95a70e76c66c-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f3efa4d2ad314d118abd95a70e76c66c-ao-3-A.svg\" />", 
                "<img src=\"f3efa4d2ad314d118abd95a70e76c66c-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "N&aZ|QQ~l#", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f189765dde4e44018698a3425c30ac77-ao-1", 
                "", 
                "<img src=\"tmpzmqz_c.png\" />", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-1-A.svg\" />", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "EWeKL4u,mC", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f189765dde4e44018698a3425c30ac77-ao-2", 
                "", 
                "<img src=\"tmpzmqz_c.png\" />", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-2-A.svg\" />", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "tn@f?vSiZi", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f189765dde4e44018698a3425c30ac77-ao-3", 
                "", 
                "<img src=\"tmpzmqz_c.png\" />", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-3-A.svg\" />", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "IgiOB![?,j", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f189765dde4e44018698a3425c30ac77-ao-4", 
                "", 
                "<img src=\"tmpzmqz_c.png\" />", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-4-A.svg\" />", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "r3PaD4.LVw", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f189765dde4e44018698a3425c30ac77-ao-5", 
                "", 
                "<img src=\"tmpzmqz_c.png\" />", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-5-A.svg\" />", 
                "<img src=\"f189765dde4e44018698a3425c30ac77-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "igcMT5YHHL", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of malignant hypercalcaemia &gt; 3.0", 
                "IVT, and<div><img src=\"paste-88626650152961.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "o]luud^je~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When would bisphosphonates be indicated in a patient with malignant hypercalcaemia?", 
                "Corrected calcium &gt; 3.0, or<div>Symptomatic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g)n3!*+0$p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with metastatic disease presents with back pain and normal neurology. You suspect cord compression. Describe your investigation and immediate management.", 
                "MRI immediately<div>Dexamethasone 8mg stat then 4mg QID while awaiting result</div><div>Early referral to neurosurgery with result if surgical candidate</div><div>RT if not surgical candidate or neurosurg decline</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rtu+v+j4+m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "After what period of time following initiation of a GnRH agonist do testosterone levels begin to fall?", 
                "1 week", 
                ""
            ], 
            "flags": 0, 
            "guid": "IbpI%ojmRM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "After what period of time following initiation of a GnRH agonist do testosterone levels fall to castate levels?", 
                "3-4 weeks", 
                ""
            ], 
            "flags": 0, 
            "guid": "jE6.6t:-:k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the level of testosterone below which a patient is considered 'castate'?", 
                "&lt;1.7nmol/L", 
                ""
            ], 
            "flags": 0, 
            "guid": "xobYE!HcD4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe familial paraganglioma syndrome (5)", 
                "Autosomal dominant<div>Mutations in SDH subunit genes<br /><div>Head, neck, upper thorax paragangliomas typically parasympathetic and nonsecretory (5% secretory)</div><div>Abdominal paragangliomas typically sympathetic and secrete catecholamines</div><div>Get pheochromocytomas (which are paragangliomas of the adrenal medulla)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i5l{!,_A=E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What symptoms might a patient with familial paraganglioma syndrome present with? (6)", 
                "Intermittent symptoms<div>Palpitations, headache, chest pain, pallor, sweating, hypertension</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c*)wDZlluU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Neurofibromatosis type 1 is caused by mutations in what gene", 
                "NF1", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ke.hii9U9v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Neurofibromatosis type 1 follows what pattern of inheritance?", 
                "Autosomal dominant", 
                ""
            ], 
            "flags": 0, 
            "guid": "vAS%mrA>SY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the penetrance and expression of mutations in NF1 gene", 
                "NF1 gene mutation results in neurofibromatosis type 1<div>Complete penetrance with highly variable expression</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N%ZoX{DP|L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the diagnostic critiera for neurofibromatosis type 1? (7)", 
                "<div>At least two of the following:</div><div>Six or more café-au-lait macules</div><div>Two or more neurofibromas of any type or one plexiform neurofibroma</div><div>Freckling in the axillary or inguinal regions</div><div>Optic glioma</div><div>Two or more iris hamartoma (Lisch nodules)</div><div>Distinctive bony lesion, such as sphenoid dysplasia, or medullary narrowing and cortical thickening of the long bone cortex with or without pseudoarthrosis</div><div>A first-degree relative with NF1</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P?lIU|uptk", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of neurofibromatosis type 1 patients have a de novo mutation in the associated gene (NF1)?", 
                "50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "O[k[Ap~w$M", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common type of neurofibromatosis", 
                "Neurofibromatosis type 1", 
                ""
            ], 
            "flags": 0, 
            "guid": "b[r!UYlP0j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Neurofibromatosis arises due to mutations in what gene?", 
                "NF2", 
                ""
            ], 
            "flags": 0, 
            "guid": "xZ}YemN?/6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What pattern of inheritance does neurofibromatosis type 2 follow?", 
                "Autosomal dominant", 
                ""
            ], 
            "flags": 0, 
            "guid": "LGTs(/kM-j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of neurofibromatosis cases are due to de novo mutation in the relevent gene (NF2)?", 
                "50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "GUHo}):d|&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name clinical manifestations of neurofibromatosis type 2", 
                "Bilateral vestibular schwannoma<div>Intracranial meningioma</div><div>Schwannomas of other cranial nerves</div><div>Spinal tumours</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z,.ACT@<yz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the diagnostic criteria for neurofibromatosis type 2?", 
                "<div>Any of the below:</div><div>1. Bilateral vestibular schwannomas before age 70 years</div><div>2. Unilateral vestibular schwannoma before age 70 years AND first-degree relative with NF2</div><div>3. Any two of: Meningioma, non-vestibular schwannoma, neurofibroma, glioma, cerebral calcification, cataract;&nbsp;</div><div>AND&nbsp;First-degree relative with NF2&nbsp;</div><div>OR&nbsp;Unilateral vestibular schwannoma AND negative LZTR1 testing*&nbsp;</div><div>4. Multiple meningiomas AND&nbsp;Unilateral vestibular schwannoma&nbsp;</div><div>OR&nbsp;Any two of the following: Non-vestibular schwannoma, neurofibroma, glioma, cerebral calcification, cataract&nbsp;</div><div>5. Constitutional or mosaic pathogenic NF2 gene mutation from the blood or by the identification of an identical mutation from two separate tumors in the same individual</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lN@@#g&e?|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is Von Hippel Lindau Disease? (6)", 
                "Autosomal dominant syndrome with:<div><br /><div>Haemangioblastomas (60 -84%) - retina, cerebellum, spinal cord</div><div>Clear cell renal cell carcinoma</div><div>Pheochromocytoma</div><div>Endolymphatic sac tumours of the middle ear</div><div>Pancreatic tumours</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Qu)P/:w$;D", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with Von Hippel Lindau disease goes blind. What has most likely occured?", 
                "Retinal capillary hemangioblastoma<div>Exudation from the tumour causing retinal oedema or tractional effect can result in blindness</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GJIxa1fx{K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient presents with pheochromocytoma. SDHB immunohistochemistry is abnormal. What is the diagnosis?", 
                "Familial pheochromocytoma/paraganglioma syndrome", 
                ""
            ], 
            "flags": 0, 
            "guid": "xF?g</0TI=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient presents with pheochromocytoma and retinal haemangioblastoma. SDHB immunohistochemistry is normal. What is the diagnosis?", 
                "Von Hippel Lindau Disease", 
                ""
            ], 
            "flags": 0, 
            "guid": "fB^?<{uuQd", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A 34 year old patient is found to have multiple polyps and has a strong family history of bowel cancer. Is he more likely to have a mutation in:<div>APC, or</div><div>MLH1</div>", 
                "APC (familial adenomatous polyposis)<div>MLH1 is associated with hereditary nonpolyposis colorectal cancer, should not have polyps</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zdsML2lROt", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a 'founder mutation'?", 
                "A specific mutation that is observed with high frequency in a population<div>Arises due to</div><div>- genetic bottleneck (large number of population die)</div><div>- selective mating (due to geographical isolation, religious/cultural constraints)</div><div>e.g. BRCA mutations in Iceland and Ashkenazi Jews</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p&_)tgzlg6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a 'recurrent mutation'?", 
                "A specific mutation that is common in a population not due to the founder effect, but due to occuring in lots of different people as an independent event<div>Commonly in genes with repeditive sequences as this increases mutation rate</div><div>e.g. cystic fibrosis CFTR delta 508 mutation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ing0xNxv<Y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a missense mutation?", 
                "A point mutation in which a single base change results in a codon that codes for a different amino acid compared to the original", 
                ""
            ], 
            "flags": 0, 
            "guid": "b/n;JuR%kK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a codon?", 
                "Sequence of three nucleotides (bases) that codes for a single protein", 
                ""
            ], 
            "flags": 0, 
            "guid": "gg]RoLBc7[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are introns and exons?", 
                "Exons are coding areas of DNA - i.e. they code for a protein<div>Introns are the areas of DNA between the exons, they are removed by RNA splicing fore the mature RNA molecule is generated</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nLR9W70FC>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How many pairs of chromosomes do we normally have?", 
                "23", 
                ""
            ], 
            "flags": 0, 
            "guid": "G4!D}6*A`,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How many chromosomes do we normally have?", 
                "46", 
                ""
            ], 
            "flags": 0, 
            "guid": "i[ja|(yB,T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a nonsense mutation?", 
                "A single point mutation that results in change of codon to a STOP codon (as opposed to a codon that codes for a protein)", 
                ""
            ], 
            "flags": 0, 
            "guid": "m*_8Fq?#0|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a frameshift mutation?", 
                "An insertion or deletion of one or more nucleotides that shifts the 'reading frame' of a gene<div>Genes are read in sets of three - three bases make one codon</div><div>if a number that is not a multiple of three is added or subtracted, the subsequent bases will be read in different groups of three, altering which amino acid is produced for each</div><div>Can result in an early STOP codon and much shorter protein</div><div>Tend to produce singificantly abnormal protein (more so than non-frameshift mutations)</div><div><br /></div><div>e.g.</div><div><img src=\"paste-36528696852481.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l^X:%N@ooB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is signal to noise ratio, and how is it calculated?", 
                "<div>Signal to noise ratio is used to determine the liklihood that detection of a given mutation is of significance</div><div>Noise is the frequency of the genetic mutation in the population</div><div>Signal is the mutation in cases</div>The signal-to-noise ratio is calculated by dividing the yield in cases by the background rate of variants of uncertain significance (VUS) in controls.<div><br /></div><div>e.g. long QT signal to noise ratio is 19:1 (for 19 true cases there will be 1 false positive)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y-,,W|u}R(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What signal to noise ratio is suggested as a cutoff for use of a genetic test?", 
                "10% or 10:1", 
                ""
            ], 
            "flags": 0, 
            "guid": "dK02o)Fn&/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What positive predictive value is suggested in the college lecture as a cutoff for use of a genetic test?", 
                "40% (can't find another reference!)", 
                ""
            ], 
            "flags": 0, 
            "guid": "I=Of{-m0>/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 cardiac diseases that may be genetic", 
                "Hypertrophic cardiomyopathy<div>Brugada syndrome</div><div>Long QT syndrome</div><div>Dilated cardiomyopathy</div><div>Arrhythmogenic right ventricular cardiomyopathy</div><div>Catecholaminergic polymorphic ventricular tachycardia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bq-r/K5^z~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How are genetic sequence varients classified, in terms of their liklihood of being pathogenic?", 
                "<img src=\"paste-40402757353473.jpg\" />", 
                "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075918/<div>Mentioned in college lecture</div>"
            ], 
            "flags": 0, 
            "guid": "uIByNX_9l?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Heritable cardiac arrythmias may occur due to abnormalities in what four classes of proteins?", 
                "Ion channels - primary electrical disease<div>Cell to cell junction proteins (desmosomes) - ARVC and ARVD</div><div>Contractile sarcomere proteins - hypertrophic cardiomyopathy</div><div>Cytoskletal proteins - dilated cardiomyopathy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D*5q0~[*:y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Heritable primary electrical diseases (channelopathies) such as long QT,&nbsp;catecholaminergic polymorphic ventricular tachycardia [CPVT], and Brugada syndrome arise due to abnormalities in what class of protein?", 
                "Ion channels", 
                ""
            ], 
            "flags": 0, 
            "guid": "L~wlmrqS.-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 channelopathies (primary electrical disorders)", 
                "Long QT<div>Wolff Parkinson White</div><div>Catecholaminergic polymorphic ventricular tachycardia</div><div>Brugada syndrome</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s>wmA5C`(w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Hypertrophic cardiomyopathy arises due to abnormalities in what class of proteins?</div>", 
                "Contractile sarcomere proteins&nbsp;", 
                ""
            ], 
            "flags": 0, 
            "guid": "Gx|1[jszC<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Dilated cardiomyopathy arises due to abnormality in what class of protein?", 
                "Cytoskletal proteins (saith the college lecture)<div>Uptodate says 30% due to sarcomere genes, 70% others</div><div>Very polygenic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pAPg{[oIkT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common genetic cardiovascular disease?", 
                "Hypertrophic cardiomyopathy", 
                ""
            ], 
            "flags": 0, 
            "guid": "yhi3B5cjE=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Congenital long QT is divided into types. Name the 3 most common types.", 
                "Long QT type 1 (30 - 35%)&nbsp;<div>LQT2 (25 - 40%)&nbsp;</div><div>LQT3 (5-10%)</div><div>Remaining other 10 types &lt;5%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "(+4}KcX>&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Congenital long QT type 1 arises due to what mutation", 
                "KVLQT1 on chromosome 11, codes for the slowly acting component of the outward-rectifying potassium current (IK), which prolongs ventricular action potentials", 
                ""
            ], 
            "flags": 0, 
            "guid": "DX:It<9f_P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the clinical significance of the different types of congenital long QT?", 
                "Different T wave morphology<div>Different triggers</div><div>Different treatment</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q1o1_5<E64", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the common triggers for episodes of torsade de pointes in congenital long QT type 1?", 
                "Swimming<div>Exertion</div>", 
                "College lecture"
            ], 
            "flags": 0, 
            "guid": "ewG]HqD5B|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the common triggers for episodes of torsade de pointes in congenital long QT type 2?", 
                "Postpartum period<div>Auditory triggers (phone, doorbell)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J`<9**_.,9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a common trigger for torsade de pointes in congenital long QT type 3?", 
                "Sleep", 
                ""
            ], 
            "flags": 0, 
            "guid": "HovAc>jb`/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Congenital long QT 2 arises due to which mutations?", 
                "<div>A variety of mutations in a potassium channel gene (KCNH2) on chromosome 7</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "0##+P@a(k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Congenital long QT type 3 arises due to mutations in what gene?", 
                "Sodium channel gene (SCN5A) located on chromosome 3&nbsp;", 
                ""
            ], 
            "flags": 0, 
            "guid": "NbsjnGE5XA", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the responsiveness of congenital long QT types 1, 2, and 3 to beta blockers", 
                "Type 1 - very responsive (81% respond, only 4% sudden cardiac death)<div>Type 2 - moderately responsive (59% respond 4% SCD)</div><div>Type 3 - not very responsive (50% respond 17% SCD)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H.b+DB!%4+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 drug that is highly likely to be effective in type 3 congenital long QT syndrome", 
                "Mexiletine<div>Has little to no effect in types 1 and 2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E8Iij8&yuU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients should be tested for long QT mutations? (3)", 
                "Patients with long QT phenotype<div>Family members of the above</div><div>Asymptomatic patient with QTc &gt; 480 (children) or &gt;500 (adult) with no other cause</div><div><br /></div><div>Consider if asymptomatic &gt;460 children and &gt;480 adults</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MoN+ZV>q{|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the yield of genetic testing for congenital long QT syndrome in patients with acquired &nbsp;long QT?", 
                "30%", 
                ""
            ], 
            "flags": 0, 
            "guid": "u4*sjax&Ar", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 risk factors for syncope or sudden cardiac death in congenital long QT syndrome", 
                "biggest risk: QTc &gt; 500 (per college lecture)<div><br /></div><div>Other risk factors (per UpToDate)</div><div>Congenital deafness</div><div>History of syncope</div><div>History of ventricular arrythmia</div><div>Family history of sudden cardiac death</div><div>Female</div><div>QTc &gt; 600msec</div><div>Noncompliance</div>", 
                "College lecture"
            ], 
            "flags": 0, 
            "guid": "w%=fr1K-Dq", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is Brugada syndrome?", 
                "Autosomal dominant disorder with variable expression<div>Characterised by abnormal ECG findings and increased risk of ventricular tachyarrythmias and sudden cardiac death</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MV~~VDwft8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the characteristic ECG findings of Brugada syndrome?", 
                "Pseudo right bundle branch block<div>Persistent ST segment elevation in V1 and V2</div><div><img src=\"paste-48056389074945.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rWU.7PQZH,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the difference between Brugada pattern and Brugada syndrome", 
                "Brugada pattern is the presence of the characteristic Brugada findings on ECG<div>Brugada syndrome is presence of the pattern +&nbsp;&nbsp;sudden cardiac death or a sustained ventricular tachyarrhythmia, or who have one or more of the other associated clinical criteria (long list of factors including family history, other arrythmias, other ECG findings)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DkBAT=eCK6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are Brugada type 1 and 2?", 
                "<div>Two different ECG patterns seen in Brugada syndrome and Brugada patern</div><div><br /></div><div>Type 1: elevated ST segment (≥2 mm) descends with an upward convexity to an inverted T wave (\"coved type\" Brugada pattern)</div><div><br /></div><div>Type 2 Brugada: ST segment has a \"saddle back\" ST-T wave configuration, in which the elevated ST segment descends toward the baseline, then rises again to an upright or biphasic T wave</div><div><br /></div><div><img src=\"paste-48567490183169.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c&>8W&ufBD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What medictation may be given to unmask Brugada syndrome in a drug challenge?", 
                "Sodium channel blocker, such as flecainide, ajmaline, or procainamide", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q;Ez%)J;{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which Brugada ECG pattern type is considered diagnostic in symptomatic patients?", 
                "Type 1<div><br /></div><div>Type 2 patients may need to undergo a drug challenge to unmask the type 1 pattern</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j>Sch:glxZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Are spontaneous or drug induced Brugada syndrome patients at higher risk of serious complications?", 
                "Spontaneous", 
                ""
            ], 
            "flags": 0, 
            "guid": "gnocp$`,}g", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common gene mutation in Brugada syndrome?", 
                "SCN5A (15 - 30%)<div>Gene encoding the alpha subunit of the cardiac sodium channel</div><div>Incomplete penetrance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vgEkDAR@Sp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is genetic testing helpful in the diagnosis of Brugada syndrome?", 
                "No<div>Diagnosis is clinical, only 15-30% have the most common genetic mutation (SCN5A)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DW/.YqE8(*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 2 genes implicated in catecholaminergic polymorphic ventricular tachycardia", 
                "Cardiac ryanodine receptor gene (autosomal dominant ) - more common<div>Calsequestrin 2 gene (autosomal recessive)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uz#:C^Mkf<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how mutation in cardiac ryanodine receptor gene and calsequestrin 2 gene can cause ventricular arrythmias in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT)", 
                "Induce diastolic calcium release from sarcoplasmic reticulum<div>Results in intracellular calcium overload, delayed afterdeolarizations and triggered activity, which can induce VT and VF</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ijey5B@xgf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the diagnostic test for catecholaminergic polymorphic ventricular tachycardia", 
                "Exercise stress test", 
                ""
            ], 
            "flags": 0, 
            "guid": "EX}L=q:)5`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What findings would you expect on exercise stress testing in a patient with catecholaminergic polymorphic ventricular tachycardia", 
                "<div>Increasingly frequent ventricular premature beats with increasing exercise</div><div>Nonsustained and sustained VT may occur</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pz$/kVIkp[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the acute management of catecholaminergic polymorphic ventricular tachycardia", 
                "Cardioversion or defibrillaiton if haemodynamically unstable or pulseless<div>Propranolol to acutely suppress recurrent polymorphic VT</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q;xj0=xZ!d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the long term management of catecholaminergic polymorphic ventricular tachycardia (5)", 
                "Avoid competitive sports/strenuous exercise<div>Beta blockers (long acting nonselective)<br /><div>ICD if history of sudden cardiac arrest, or syncope due to sustained VT or VF despite beta blockers</div></div><div>Add flecanide and/or verapamil if ICD and beta blocker insufficient</div><div>Sympathetic denervation if ongoing symptoms despite max tolerated medical therapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g$AzmeAyzn", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A child is diagnosed with catecholaminergic polymorphic ventricular tachycardia based on genetic testing. They are asymptomatic. Is any therapy indicated?", 
                "Yes - commence beta blockers<div>Less evidence in adults - consider commencing anyway</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y(iQd-Zy7h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 2 most common mutations identified in patients with hypertrophic cardiomyopathy", 
                "MYBPC3<div>MYH7</div>", 
                "College lecture"
            ], 
            "flags": 0, 
            "guid": "Ks;w0|j_.F", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Hypertrophic cardiomyopathy follows what pattern of inheritance?", 
                "Autosomal dominant", 
                ""
            ], 
            "flags": 0, 
            "guid": "j=-1F2vxs}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can arythmogenic right ventricular cardiomyopathy affect both ventricles?", 
                "Yes - does so in around 70-76%", 
                ""
            ], 
            "flags": 0, 
            "guid": "jY&CWx[KU/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of arrythmogenic right ventricular cardiomyopathy cases are genetic?", 
                "30%", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ip9!%Z{h>^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common gene mutation in patients with arrythmogenic right ventricular cardiomyopathy?", 
                "Plakophilin-2<div>Codes for desmosomal protein</div><div>Autosomal dominant</div><div><br /></div><div>There are multiple others.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y1l++a_ce0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Arrythmogenic right ventricular cardiomyopathy follows what pattern of inheritance?", 
                "Most common autosomal dominant<div>Less commonly autosomal recessive</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pg<9`K%uY8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients with out of hospital cardiac arrest with no structural heart disease will have a channelopathy?", 
                "25 - 30%", 
                "College lecture"
            ], 
            "flags": 0, 
            "guid": "hB0P-&01oT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion cases 0f dilated cardiomyopathy are familial?", 
                "20 - 35%", 
                ""
            ], 
            "flags": 0, 
            "guid": "c&T)-~/HGQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common inheritance pattern of dilated cardiomyopathy?", 
                "Autosomal dominant<div><br /></div><div>All inheritance patterns have been identified (lots of different genes identified)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HVI1/89[h8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define typical chest pain (3) and how it is interpreted in terms of diagnosi", 
                "Substernal chest discomfort with characteristic quality and duration<div>Provoked by exertion or emotional stress</div><div>Relieved by rest or nitroglycerin</div><div><br /></div><div>3 is angina</div><div>2 is atypical chest pain</div><div>0 - 1 is nonanginal chest pain</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LO*BYaB#Bi", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 types of stress testing", 
                "Stress ECG<div>Stress echo</div><div>Stress radionuclide myocardial perfusion imaging</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LYymeKR[5]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When might a stress ECG be the most appropriate type of stress test? (4)", 
                "Stable patient<div>At least intermediate pretest probability of CAD</div><div>Able to exercise</div><div>Interpretable ECG</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lzw!rI,t*u", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When would you chose an execise stress test vs a pharmacological one?", 
                "If they can exercise, this is preferred", 
                ""
            ], 
            "flags": 0, 
            "guid": "xDR^es>rH.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why is exercise stress test preferred over pharmacological?", 
                "Exercise stress test assesses exercise capacity as well", 
                ""
            ], 
            "flags": 0, 
            "guid": "bvH[WDR%~,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 ECG changes that make a patient unsuitable for stress ECG testing", 
                "Bundle branch block<div>Paced</div><div>WPW</div><div>ST depression</div><div>Digoxin changes</div><div>LVH</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j^3Qrn)[j<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What stress test is preferred in patients with bundle branch block or pacemaker?", 
                "Myocardial perfusion scan (nuc med)", 
                ""
            ], 
            "flags": 0, 
            "guid": "e<%(0X[[I6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with elevated BMI, is echo or MPI preferred?", 
                "MPI", 
                ""
            ], 
            "flags": 0, 
            "guid": "C+a8^^2g8X", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients might you prefer stress echo over MPI?", 
                "Patients who need to avoid radiation - young females, cancer", 
                ""
            ], 
            "flags": 0, 
            "guid": "I(EekuWIk*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is stress ECG appropriate to exclude CAD?", 
                "Low probability chest pain<div>No baseline ECG changes</div><div>Good exercise capacity</div><div><br /></div><div>Sensitivity is very low (45 - 50%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JN4<uW+_dW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which test modality has the best ability to predict future cardiovascular events in patients with stable chest pain and intermediate pretest probability?", 
                "CTCA (short term)<div>Same as functional testing in long term</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ie3*WEW3pe", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the warranty effect of CTCA", 
                "A negative CTCA means only a 0.2% risk of cardiac event over next 5 years", 
                ""
            ], 
            "flags": 0, 
            "guid": "O|~:1<.9t[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is first line therapy for angina?", 
                "Beta blockers", 
                ""
            ], 
            "flags": 0, 
            "guid": "QG<*.UhhVf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do calcium channel blockers improve angina?", 
                "Coronary and peripheral vasodilatation<div>Reduce contractility</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r]w[kDm%BU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do nitrates improve angina?", 
                "Reduce preload (biggest effect)<div>Reducing afterload<div>Coronary vasodilation (though this does not work in severe calcified stenosis as they cannot dilate)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O+$.4bpUz!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does nicorandil improve angina?", 
                "Potassium channel activator<div>Veno and arterial dilator</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H5tt.g:x0F", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 4th line mangaement of angina?", 
                "Nicorandil", 
                ""
            ], 
            "flags": 0, 
            "guid": "zHzI0`f}3U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the role of ivabradine in angina management", 
                "<div>Used if resistant angina AND heart failure</div>Sinus node inhibitor (does not affect AV node)<div>Negative chronotrope</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Z,-W@y9R=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of perhexiline", 
                "Inhibits fatty acid oxidation<div>Used for angina</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D3;J_)r<=5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 toxicities of perhexiline", 
                "Hepatotoxicity<div>Neurotoxicity</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j-Pb1d1NfI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 prevention interventions for patients with stable coronary artery disease", 
                "Aspirin<div>Statin - plaque stabilisation and reducing lipids</div><div>Risk factor modification</div><div>Stress reduction (physical and psychological)</div><div>Exercise</div><div>Annual influenza vaccine (reduces MACE!)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h0dZMy95j$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is coronary angiogram indicated? (5)", 
                "Sudden cardiac arrest survivor<div>Life threatening ventricular arrythmia</div><div>Symptoms/signs of heart failure</div><div>Noninvasive testing indicates high liklihood of severe disease</div><div>Reduced LV systolic function and moderate risk on noninvasive testing</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vbS+f{6S6.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with left main CAD, is PCI or CABG indicated?", 
                "If low risk SYNTAX score (&lt;22), can do either<div>Otherwise CABG is preferred</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f=sg99qTlv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In proximal LAD stenosis, is PCI or CABG preferred?", 
                "Either (grade 1A)", 
                ""
            ], 
            "flags": 0, 
            "guid": "qLkg|{WE].", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define type 1 myocardial infarction", 
                "Plaque rupture leads to thrombus formation and occlusion of a coronary artery leading to myocardial infarction", 
                ""
            ], 
            "flags": 0, 
            "guid": "JLL#I1=j9-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define type 2 myocardial infarction", 
                "Imbalance in myocardial oxygen supply and demand leading to myocardial necrosis", 
                ""
            ], 
            "flags": 0, 
            "guid": "rhvH*Mf&h8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a type 4 MI?", 
                "PCI related MI<div><br /></div><div>Significant biomarker increase</div><div>- 5x ULN (normal baseline)</div><div>&nbsp;- rise &gt;20% ??</div><div>PLUS new evidence of ischaemia</div><div>- ischaemic ECG changes</div><div>- new Q waves</div><div>- imaging evidence of new infarct</div><div>- angiographic finding of new graft/native vessel occlusion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ijF^?XF*l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a type 5 MI?", 
                "<div>CABG related MI</div><div><br /></div>Significant biomarker elevation<div><div>PLUS new evidence of ischaemia</div><div>- new Q waves</div><div>- imaging evidence of new infarct</div><div>- angiographic findings of flow limiting complication</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c{~7gJ]BT5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is prasugrel the appropriate antiplatelet?", 
                "ACS<div>Undergone PCI</div><div>??3rd factor (look up TRITON-TIMI 38)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BR9/E=},UC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long prior to surgery should the P2Y12 inhibitors be stopped?", 
                "<div>Prasugrel 7 days</div><div>Clopidogrel 5 days</div><div>Ticagrelor 5 days</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jP1X,HgW,:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with NSTEMI prior to PCI, what DAPT should be given?", 
                "Aspirin and ticagrelor, unless ticagrelor is contraindicated<div>Prasugrel is second preference</div><div>Clopidogrel is 3rd preference<br /><div><br /></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J3`?>_BEIZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can prasugrel be given in patients in whom coronary anatomy is not known, e.g. prior to PCI?", 
                "No<div>Contraindicated if anatomy unknown</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EVI&h0IBiu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with STEMI who require thrombolysis and transfer to PCI centre, what is the recommended timeframe within which they should receive the thrombolysis?", 
                "10 minutes", 
                ""
            ], 
            "flags": 0, 
            "guid": "Kx<|kKGO4w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the recommended door to ballon time for STEMI patients who present to a PCI centre?", 
                "60 minutes", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pew(A~]MtR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the recommended door to ballon time for STEMI patients who present to a non-PCI centre?", 
                "90 minutes", 
                ""
            ], 
            "flags": 0, 
            "guid": "oQA:<2q/St", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient who underwent thrombolysis and transfer to a PCI centre arrives. What needs to occur on arrival?", 
                "Assess if meet reperfusion criteria<div>If not -&gt; rescue PCI</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ygb-D3qz^W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What timeframe should PCI be available within for transfer for primary PCI in STEMI patients who present to non PCI centres?", 
                "120minutes", 
                ""
            ], 
            "flags": 0, 
            "guid": "it0.t|A:z=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient is successfully thrombolised with resolution of symptoms and ST changes. When should angiography occur?", 
                "Within 24 hours", 
                ""
            ], 
            "flags": 0, 
            "guid": "k_*nX[7Yfe", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which access is preferred, radial or femoral?", 
                "Radial, if performed by an experienced operator (class 1A)<div>Reduces bleeding and mortality</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "QQ0$hf&u]e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is routine thromboaspiration recommended in STEMI?", 
                "No<div>Higher risk of strokes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l@8WU9jKde", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Should intra-aortic balloon pumps be routinely used in STEMI with cardiogenic shock?", 
                "No<div>Can be considered in patients with shock due to mechanical complication (e.g. ruptured papillary muscle, as bridge to surger)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A;h[>;=_$!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In STEMI patients with multiple lesions and cardiogenic shock, should all lesions be routinely PCI'd in the index procedure or only the culpril lesion?", 
                "Only the culprit lesion<div>All cause mortality and need for renal replacement therapy is higher if multivessel PCI</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "FmlA/-]s~H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with STEMI without cardiogenic shock, should only the culpril lesion by PCI'd or should they all be done (complete revascularisation)", 
                "Complete revacularisation is preferred<div>If not at index procedure, recommended prior to dicharge</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Dz`:NW_&?7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does PCI in FFR positive lesions (&lt;0.80) in stable angina improve outcomes?", 
                "<div>Yes</div>Reduction in death, nonfatal MRI, and urgent revascularisation<div>(FAME trial)</div><div><br /></div><div>No benefit if FFR is not used (COURAGE trial)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M/M7aYTpLZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is there a benefit to early ICD insertion post MI in patients with EF &lt; 35%?", 
                "No<div>Death in these patients is usually due to heart failure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "o36+hbq/ZQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is ICD recommended post MI in patients with heart failure?", 
                "ICD can be inserted if:<div>LVEF &lt; 35% at least 40 days post MI and 90 days post revascularisation<div>NHYA class II-III despite OMT</div><div>Survival estimated &gt;1 year</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qO<y6,qM+A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do LifeVests reduce sudden cardiac death post MI?", 
                "No<div>Did not reduce SCD</div><div>Did reduce overall mortality ?why</div><div>Should not be used routinely</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b;Qv<{B)2n", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What was the ODYSSEY trial?", 
                "<div>Alirocumab (PCSK9 inhibitor) vs OMT in ACS patients with inadequate lipid control despite high dose statin (LDL &gt;1.8)</div><div>Decreased LDL by further 50%</div><div>Reduced MACE, MI, stroke, and all cause mortality</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wX@DSD$-]+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients post ACS may benefit from a PCSK9 inhibitor", 
                "Patients with LDL &gt; 1.8 despite statin<div>Reduced MACE, MI, stroke, and all cause mortality</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p~s_C/5:0e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a SYNTAX score?", 
                "Measurement of coronary artery complexity<div>(add more detail)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AbrV(#e9EX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In left main coronary artery disease and low to intermediate syntax score, does CABG or PCI have better outcomes?", 
                "PCI and CABG have equivalent 3 year outcomes<div>PCI has fewer adverse events and lower mortality within 30 days</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z?moO|`o2E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe when revascularisation should be conducted, based on anatomic findings", 
                "Left main disease with stenosis &gt;50%<div>Proximal LAD stenosis &gt;50%</div><div>Two ro three vessel diseaase with stneosis &gt;50% with LV function impaired (LVEF &lt;35%)</div><div>Large are aof ischaemia detected by functional testin (&gt;10% LV) or abnormal invasive FFR</div><div>Single remaining patent coronary artery with stenosis &gt;50%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uD?K$H<iXp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with triple vessel CAD and diabetes, is PCI or CABG preferred?", 
                "CABG", 
                ""
            ], 
            "flags": 0, 
            "guid": "C08p^F($=f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In triple vessel CAD without diabetes, is PCI or CABG preferred?", 
                "if low &lt;22 syntax score, either<div>if intermediate or high, CABG</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ih2SVPvOiy", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 clinical features that make CABG preferable to PCI", 
                "Diabetes<div>Reduced LVED &lt; 35%</div><div>Contraindiction to DAPT</div><div>Recurrent diffuse in stent thrombosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y%12^@N`]_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 causes of wide QRS tachycardia", 
                "VT<div>Pre-excitation tachycardia (antidromic AVRT, any SVT with preexitation)</div><div>Any SVT with bundle branch or aberrancy</div><div>Any SVT with broad QRS due to metabolic factors (e.g. hyperK, sodium channel blocker)</div><div>Pacemaker mediated rhythm (atrial tracking, pacemaker mediated tachycardia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O{ig$*1GY[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 complication of if flecanide is given to a patient with AF?", 
                "Can convert AF to atrial flutter with 1:1 conduction<br /><div>Always give with AV nodal blocker to prevent</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JhLBOO5VU/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most effective anti-arrythmic in paroxysmal AF?", 
                "Amiodarone", 
                ""
            ], 
            "flags": 0, 
            "guid": "mpBJ5E|Se.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the immediate management of a haemodynamically unstable patient with a malignant rhythm?", 
                "Cardioversion<div><br /></div><div>MORE DETAIL</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H50mWL`L*d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the effect of weight loss in AF", 
                "Reduces symptoms", 
                ""
            ], 
            "flags": 0, 
            "guid": "V&k,8-[I!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of strokes are due to AF?", 
                "20-30%", 
                ""
            ], 
            "flags": 0, 
            "guid": "m1EV]#1Uy,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 complications of AF", 
                "Death<div>Stroke</div><div>Hospitalisaiton</div><div>LV dysfunction</div><div>Cognitive impairment</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N]g0K}R/{5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 methods of rate control in AF", 
                "Beta blockers<div>Rate limiting calcium channel blocker</div><div>Digoxin&nbsp;</div><div>AV node ablation and pacemaker - last resort, usually in elderly</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c.JW!IPh~q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is strict rate control (&lt;80) superior to lenient control (&lt;110) in AF?", 
                "No, both are fine", 
                ""
            ], 
            "flags": 0, 
            "guid": "h].%m)M.jl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where are clots traditionally thought to form in patients with AF?", 
                "Left atrial appendage", 
                ""
            ], 
            "flags": 0, 
            "guid": "Gh]CKSgQN#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the CHADSVASC scores for which anticoagulation is indicated in AF patients", 
                "0 - no anticoagulation<div>1 - consider OAC</div><div>&gt;2 - OAC indicated</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j(5@k~`v=1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is warfarin required for AF, rather than NOAC?", 
                "Prosthetic heart valve<div>Rheumatic mitral stenosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "QNVFW*nlX0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the OAC of choice in AF patients with poor renal function?", 
                "Apixaban", 
                ""
            ], 
            "flags": 0, 
            "guid": "PQE]`rv%4L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with AF and significant contraindication to anticoagulation, what can be done to prevent strokes?", 
                "Left atrial appendage occluder", 
                ""
            ], 
            "flags": 0, 
            "guid": "IH,~}sU-J}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 ways in which AF causes heart failure", 
                "Rapid heart rate<div>Loss of atrial transport</div><div>Irregularity of heart rate</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uywMz)I<Kf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 agents which may be used for rhythm control in AF in patients with no or minimal structural heart disease", 
                "Dronedarone<div>Flecanide</div><div>Propafenone</div><div>Sotalol</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M)@Nq/(aU@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 agents which may be used for rhythm control in AF in patients with coronary artery disease, siginificant valvular diseas, abnormal LVEF", 
                "Dronedarone<div>Sotalol</div><div>Amiodarone</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "flVV(Np*pK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 agent which may be used for rhythm control in AF in patients with heart failure", 
                "Amiodarone", 
                ""
            ], 
            "flags": 0, 
            "guid": "HiDU>h9&Rx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Compared to medical management, does catheter ablation improve outcomes in patients with AF and symptomatic heart failure &nbsp;(NYHA II - IV)?", 
                "CASTLE-AF trial<div>38% redution in all cause death or hospitalisation for heart failure in ablation group</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K{yapK4v>r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with cryptogenic stroke, was is the yield for detecting AF with implantable loop recorders?", 
                "25%", 
                ""
            ], 
            "flags": 0, 
            "guid": "uOPmPGzCEZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the main indication for pulmonary vein isolation in patients with AF?", 
                "To improve symptom control in patietns with poor symptom control despite multiple agents", 
                ""
            ], 
            "flags": 0, 
            "guid": "NCeVnM.NzD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the acute management of SVT to restore sinus rhythm", 
                "Valsalva<div>if does not work<br /><div>Adenosine</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ohELb+Sbh1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "WPW is associated with what structural cardiac abnormality?", 
                "Ebstein's abnormality", 
                ""
            ], 
            "flags": 0, 
            "guid": "J-wHlL.onK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the highest risk feature for ???horrible unstable rhythm/death in WPW?", 
                "Short refractory period", 
                ""
            ], 
            "flags": 0, 
            "guid": "MV,=Em3Eso", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How can WPW patients be stratified into low and high risk of ???horrible unstable rhythm", 
                "Loss of preexcitation at faster sinus rates on holter or exercise testing -&gt; low risk<div>Can be follwed up without invastive testing</div><div>If preexitation persists at maximal heart rate, need invasive testing</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e2Kz>^<X5I", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 causes of low voltage ECG", 
                "<div>Tamponade/pericardial effusion</div><div>Cardiac amyloid</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pMGq87<m>)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which types of long QT subtypes can have autosomal recessive inheritance?", 
                "LQT1 and 5", 
                ""
            ], 
            "flags": 0, 
            "guid": "zOPAPrr7:t", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What factor makes a patient highest risk for sudden cardiac death in congenital long QT?", 
                "Unexplained syncope", 
                ""
            ], 
            "flags": 0, 
            "guid": "FE.UcLtrTp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do asymptomatic type 1 brugada syndrome patients require a defibrillator?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "MNg++G.bM]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 ECG findings in ARVC", 
                "<div>Epsilon wave</div><div>QRS in V1 &gt; 110msec</div><div>Incomplete or complete RBBB</div><div>T wave inversion V1-3</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lq~CMZ%*oQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a normal blood pressure", 
                "12 - 129 systolic<div>80 - 84 diastolic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NeF^9BMzCc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is high normal blood pressure", 
                "130 - 139 systolic<div>85 - 89 diastolic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N^TElMsK1j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How should hypertension be diagnosed", 
                "Repeat office BP measurement, or<div>Out of office BP measurement with ABPM and/or HBPM</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l4![]NFXKu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Should patients with grade 1 hypertension be treated?", 
                "Yes<div>Patients with grade 1 hypertension at low to moderate risk without evidence of end organ damage should be treated if ongoing hypertension after lifestype intervention</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PjK;R1]?u]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the BP target in patients aged over 65?", 
                "130 - 139 systolic", 
                ""
            ], 
            "flags": 0, 
            "guid": "QgdFBte?;M", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What should the diastolic blood pressure target be in hypertensive patients?", 
                "&lt;80 in all patients", 
                ""
            ], 
            "flags": 0, 
            "guid": "Bb3;re+onC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the best drug for resistant hypertension?", 
                "Spironolactone", 
                ""
            ], 
            "flags": 0, 
            "guid": "io.&4=~?M{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When antihypertensive therapy is initiated, what should be used?", 
                "A two drug combination, preferably as a single pill (ESC guidelines)", 
                ""
            ], 
            "flags": 0, 
            "guid": "ziOMq[#}}@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 factors that suggest secondary hypertension<div><br /></div>", 
                "Young onset of grade 2 or 3 HTN (age &lt; 40), or sudden development and rapid worxening if older<div>History of renal/urinary tract idsease</div><div>Recreational drug use</div><div>Repeativie episodes of sweating, headache, anxiety, palpitations (pheo)</div><div>History of sleep apnoea</div><div>History of or current pregnancy</div><div>Symptoms of thyroid or parathyroidism</div><div>history of spontaneous or diuretic provoked hypokalaemia (hyperaldosteronism)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q.j8TAs$QJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 tests that should be done to screen in new hypertension", 
                "ECG<div>Urine alb:cr ratio</div><div>Cr/eGFR</div><div>Fundoscopy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vxG>[1el0K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the recommending treatment of hypertension in diabetes (4)", 
                "When BP &gt;140/90<div>Target 130<br /><div>Not less than 120&nbsp;</div></div><div>Start with a RAS blocker and a CCB or thiazide/thiazide like diuretic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "df`6v(gRl;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is grade 1 hypertension?", 
                "BP 140 - 159/90 - 99", 
                ""
            ], 
            "flags": 0, 
            "guid": "d;vwuaWFDk", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should patients with hight normal BP be commenced on treatment", 
                "If very high risk", 
                ""
            ], 
            "flags": 0, 
            "guid": "sBf5HTnj$z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 lifestype modifications that can be undertaken in hypertensive patients", 
                "Salt restriction (&lt;5g/day)<div>Moderate your alchohol intake</div><div>Increase fruit and veg (Mediterranean diet)</div><div>Weight loss</div><div>Physical activity (endurance training)</div><div>Smoking cessation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cu]IB0%lLi", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 1st line treatment for hypertension?", 
                "ACEi + ARB or CCB or diuretic", 
                ""
            ], 
            "flags": 0, 
            "guid": "lAi^zK0JP|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 2nd line treatment of hypertension", 
                "ACE or ARB + CCB + diuretic", 
                ""
            ], 
            "flags": 0, 
            "guid": "J{tg0hJrCf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 3rd line treatment of HTN", 
                "As spironolactone 25 - 50mg daily<div>(or other diuretic or alpha blocker or beta blocker)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wNXIOH,$:9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 1st line treatment for HTN in patients with CKD?", 
                "ACE or ARB + CCB&nbsp;<div>or&nbsp;</div><div>ACE or ARB + diuretic (or loop diuretic)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zrje)7]HBj", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Patients with CKD commenced on antihypertensives typically have a small rise in creatinine. How much of a rise should prompt further scrutiny?", 
                "30% rise", 
                ""
            ], 
            "flags": 0, 
            "guid": "q)zhR,rb!K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 things that should be done with a patient with resistant hypertension", 
                "Ambulatory monitor to confirm diagnosis<div>Exclude secondary cause</div><div>Optimise usual medications</div><div>Reinforce lifestyle</div><div>Add low dose spironolactone</div><div>Trial bisoprolol or doxazosin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c$q!CWAE:w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define pulmonary hypertension", 
                "Pulmonary artery mean pressure &gt;25<div><br /></div><div>(typical pressure is &lt;18)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B`/Yj[2*~7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "High pulmonary artery wedge pressure (&gt;15) is indicative of what cause of pulmonary hypertension?", 
                "Left heart disease", 
                ""
            ], 
            "flags": 0, 
            "guid": "L&U5(+Zj}]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Pulmonary artery wedge pressure higher than what value is indicative of left heart disease as a cause of pulmonary hypertension?", 
                "15mmHg", 
                ""
            ], 
            "flags": 0, 
            "guid": "l]Wo.-e4ct", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is cardiac output measured in right heart cath?", 
                "Thermodilution method (better)<div>Fick method</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q1h;E,ku8*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 factors that would make cardiac output measurement inaccurate using the thermodilution method during a right heart cath", 
                "Tricuspid regurgitation<div>Shunt</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jrVz9w~TDR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Above what mixed venous oxygen saturation should one assume a shunt is present?", 
                "&gt;75%", 
                ""
            ], 
            "flags": 0, 
            "guid": "i)sv8nJUT.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is pulmonary vascular resistance calculated?", 
                "Transpulmonary gradient divided by cardiac output", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ocs3@3L)tx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is Cpa?", 
                "Cpa describes how many mL of stroke volume are needed to elevate PA pressure my 1mmHg<div>A measure of pulmonary artery compliance</div><div><br /></div><div>Cpa = (SV)/(sPAP - dPAP)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dqo+/#4!Q=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 9 investigations to discover the cause of pulmonary hypertension in a patient with new disease", 
                "ECG<div>CXR</div><div>HRCT for pulmonary disease</div><div>abdo ultrasound for portal pulmonary HTN</div><div>ABG</div><div>RFT</div><div>VQ (not CTPA)</div><div>Echo</div><div>Consider sleep study</div><div>RCH +/- vasoreactivity</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pu@5@H0s$V", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 classes of drug that can be used to treat pulmonary hypertension", 
                "<div>Calcium channel blockers</div>Endothelin receptor antagnoists<div>Phosphodiesterase type 5 inhibitors</div><div>Guanylate cyclase stimulators</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yH[^RPVAbD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do you determine if a patient with pulmonary hypertension will respond to calcium channel blockers?", 
                "Vasoreactivity test on right heart cath (only 10% will respond)", 
                ""
            ], 
            "flags": 0, 
            "guid": "dMc/V.3hcr", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which modality is best for testing for chronic pulmonary emboli in a patient with pulmonary hypertension?", 
                "VQ", 
                ""
            ], 
            "flags": 0, 
            "guid": "tpYo,o*I`d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is TPG and why does it matter?", 
                "Transpulmonary pressure gradient<div>Difference between mean pulmonary arterial pressure and left atrial pressure (usually PCWP used as a surrogate)</div><div><br /></div><div>Used the detection of intrinsic pulmonary vascular disease in patients with type 2 pulmonary hypertension</div><div>i.e. if TPG &gt; 12, this implies that not only d they have pulmonary HTN due to left heart disease, but they also have intrinsic lung disease. If transplanted, would need heart/lung transplant.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EI*.}:-bEp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 causes of secondary dyslipidaemia", 
                "Dietary<div>OCP/HRT</div><div>Hypothyroid</div><div>Nephrotic syndrome</div><div>Chronic liver diease</div><div>Primary biliary cirrhosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c<@vf--B-k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 causes of elevated triglycerides", 
                "Dietary (carbohydrates)<div>Drugs - thiazides, isoretinoin, steroids, HAART, OCP/HRT</div><div>ETOH</div><div>Diabetes</div><div>Hypothyroid</div><div>Pregnancy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ptl$4vX`5|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 factors that lower HDL", 
                "Diet (high saturated fat)<div>Obesity</div><div>Sedentary</div><div>Smoking</div><div>Diabetes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lp/wN^BzkJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the pattern of inheritance in familial hypercholesterolaemia?", 
                "Autosomal dominant", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ep6N5Nko=O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 genetic causes of hyperlipidaemia", 
                "<div>Familial hypercholesterolaemia&nbsp;</div>Familial genetic ApoB100<div>Polygenic hypercholesterolaemia</div><div>Familial combined hyperlipidaemia</div><div>Hyperapobeta lipoproteinaemia</div><div>Type III hyperlipidaemia</div><div>Familial endogenous and familial mixed hypertriglyceridaemia</div><div>Familial&nbsp;chylomicronemia</div><div><br /></div><div>Need to add the mutation for each</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MB1-CaT]MU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the cutoffs for diagnosing dyslipidaemia?", 
                "Total cholesterol &gt; 6.2<div>LDL &gt; 4.14</div><div>Triglicerides &gt; 2.3</div><div>HDL &lt; 1.03</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kRRTfa;(#a", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 lifestyle modifications recommended for dyslipidaemia", 
                "Diet<div>Exercise</div><div>Weight loss</div><div>Smoking cessation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I!]f+#%F:#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is PCSK9?", 
                "Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an enzyme produced in the liver.&nbsp;<div>Binds to the low density lipoprotein receptor on the surface of hepatocytes, leading to its degradation and higher plasma LDL-cholesterol (LDL-C) levels</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mI}:t|rwZB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Above what level is therapy for isolated hypertriglyceridaemia indicated?", 
                "&gt;2.3", 
                ""
            ], 
            "flags": 0, 
            "guid": "zdR&|d1|8m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient has a trigliceride level &gt;11.2. What should be commenced?", 
                "Fibrate<div><br /></div><div>Statins are first line for lower levels, but above this level use fibrates to prevent pancreatitis</div><div>Can add statin as an adjunct</div><div><br /></div><div>(need to confirm)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l+d&)AhDxC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the 3 layers of the pericardium?", 
                "Fibrous(outer)<div>Parietal</div><div>((pericardial cavity in between))</div><div>Visceral (inner)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Hhf=5L0e`a", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common cause of pericarditis?", 
                "Viral or idiopathic (83%)", 
                ""
            ], 
            "flags": 0, 
            "guid": "CC:9v$&Gi5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 2nd most common cause of pericarditis?", 
                "Viral with confirmed serology", 
                ""
            ], 
            "flags": 0, 
            "guid": "r/.PD-Y)3O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 5 most common viral causes of pericarditis", 
                "Coxsackie virus<div>EBV</div><div>CMV</div><div>Parvo</div><div>Influenza or parainfluenza</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oE9Wp?Q2P;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percent of pericarditis is due to connective tissue disease?", 
                "7%", 
                ""
            ], 
            "flags": 0, 
            "guid": "vO@Ibbj:Mp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most specific ECG sign of pericarditis?", 
                "PR segment elevation in aVR (need to confirm)", 
                ""
            ], 
            "flags": 0, 
            "guid": "hYwZ[a=Fa-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is electrical alternans?", 
                "ECG finding in tamponade<div>The heart swings from side to side within the huge fluid cushion of the effusion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L4A_3B~8A_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the medical management of pericarditis?", 
                "Colchicine for 3 months<div><br /></div><div>And either</div><div><br /></div><div>Aspirin 750 - 1000mg o8hrly for 1-2 weeks then decrease dose every 1-2 weeks to stop</div><div>Ibuprofen 600mg 8 hourly for 1-2 weeks, then decrease dose every 1-2 weeks to stop</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tGJy?yI+ON", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 2nd line medical management of pericarditis?", 
                "Steroids<div>- increases recurrence risk</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LO9<_ez$VT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 echo features of tamponade", 
                "Pericardial effusion<div>Diastolic collapse of RV</div><div>IVC dilatation and loss of respiratory variations</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dVPjMn_=r-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is pulsus paradoxus?", 
                "Abnormally large decrease in stroke volume, systolic blood pressure and pulse wave amplitude during inspiration.&nbsp;<div>The normal fall in pressure is less than 10 mmHg</div><div><br /></div><div>Seen in tamponade, constrictive pericarditis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hl=Lixc:uB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In constrictive pericarditis, is total or partial pericardiectomy associated with better survival?", 
                "Total", 
                ""
            ], 
            "flags": 0, 
            "guid": "zH]zLG(gjw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Are ACE inhibitors routinely recommended for patients with stable angina?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "z[xtV3AJHq", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Pulmonary hypertension due to what cause has the best prognosis, compared to other patients with pulmonary hypertension?", 
                "Congenital heart diease", 
                ""
            ], 
            "flags": 0, 
            "guid": "vPFcEHDx*M", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 factor, if seen in patients with AF, is an indication for anticoagluation regardless of the CHADSVASC score", 
                "Mitral stenosis", 
                ""
            ], 
            "flags": 0, 
            "guid": "x8h(FSAt^L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What agent should be used to anticoagulate valvular AF?", 
                "Warfarin<div><br /></div><div>(need to check)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r*C6rA?RL(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient undergoes CABG for stable angina. What antiplatelet therapy is indicated?", 
                "Aspirin alone", 
                ""
            ], 
            "flags": 0, 
            "guid": "tjRGgx:Wwu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient undergoes CABG for ACS. What antiplatelet therapy is indicated?", 
                "12 months aspirin + clopidogrel", 
                ""
            ], 
            "flags": 0, 
            "guid": "f-ly_g2@Pp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the therapy of choice for post-AMI pericarditis?", 
                "Aspirin<br /><div><br /></div><div>NSAIDs are relatively contraindicated peri-ACS</div><div>Risk of myocardial rupture</div><div>(need to look up why not colchicine - lecturer says no :( )</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E}^;5376&P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Pericarditis is typically treated with cochicine + either NSAIDs or aspirin. What is an additional role of the colchicine beyond treating the acute episode?", 
                "Reduce recurrence risk", 
                ""
            ], 
            "flags": 0, 
            "guid": "f:nt&W_Z0s", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of athersclerotic plaque is most vulnerable to rupture", 
                "Thin cap fibro-atheroma", 
                ""
            ], 
            "flags": 0, 
            "guid": "ILO#`8lJQI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does the doppler effect tell us direction of bloodflow?", 
                "Produces ultrasound waves<div>If red cells are moving towards the probe, the ultrasound waves return at a higher frequency</div><div>If they are moving away, they bounce back at a lower frequency (the doppler effect)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MeSU;:ie%@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "b567c1cf56b1497aad235bcca8a7d41b-aa-1", 
                "Which direction would you expect the doppler ultrasound effect to be for flow towards the probe, and away from the probe?", 
                "<img src=\"tmp3qsrby.png\" />", 
                "<img src=\"b567c1cf56b1497aad235bcca8a7d41b-aa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"b567c1cf56b1497aad235bcca8a7d41b-aa-1-A.svg\" />", 
                "<img src=\"b567c1cf56b1497aad235bcca8a7d41b-aa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "jXl/4#o;2R", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "b567c1cf56b1497aad235bcca8a7d41b-aa-2", 
                "Which direction would you expect the doppler ultrasound effect to be for flow towards the probe, and away from the probe?", 
                "<img src=\"tmp3qsrby.png\" />", 
                "<img src=\"b567c1cf56b1497aad235bcca8a7d41b-aa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"b567c1cf56b1497aad235bcca8a7d41b-aa-2-A.svg\" />", 
                "<img src=\"b567c1cf56b1497aad235bcca8a7d41b-aa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "hO]:I/;0kh", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the Bernoulli equation, and how is it used?", 
                "<div><div>Change in pressure = four times the velocity squared</div>delta p = 4v<sup>2&nbsp;</sup></div><div><sup><br /></sup></div><div>Used to estmate pressure</div><div>e.g. PA pressure can be calculated using velocity of tricuspid regurgitation</div><div>This is how pulmonary hypertension is detected on echo</div><div>RV pressure = 4(TR velocity)<sup>2 </sup>+ RA pressure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B1q]WMUwL&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the relationship between systolic RV pressure and PA pressure?", 
                "They are equal if no obstruction between RV and PA", 
                ""
            ], 
            "flags": 0, 
            "guid": "o>EEL:wVnI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the relationship between diastolic RV pressure and PA pressure?", 
                "PA diastolic pressure is higher (the pulmonary valve closes)", 
                ""
            ], 
            "flags": 0, 
            "guid": "cQb3_i^Xc0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient has a peak TR velocity of 4m/s and a right atrial pressure of 5mmHg. What is the pulmonary artery peak systolic pressure, assuming no obstruction between the RV and PA?", 
                "<img src=\"paste-84146999263233.jpg\" /><div>= 70mmHg</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ta&xTIugh7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 causes of mitral stenosis", 
                "Rheumatic heart disease (most common worldwide)<div>Mitral annular calcification (most common in Melbourne)</div><div>Radiation</div><div>Congenital (uncommon)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D*uNs<ZOAZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a normal mitral valve area?", 
                "4 - 6cm<sup>2</sup>", 
                ""
            ], 
            "flags": 0, 
            "guid": "t-<M`CW1<Z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define mild mitral stenosis by valve area", 
                "1.5 - 4cm<sup>2</sup>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c[yGG&f8pl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define moderate mitral stenosis by valve area", 
                "1 - 1.5cm<sup>2</sup>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xD@a/j:e#U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define severe mitral stenosis by valve area", 
                "&lt;1cm<sup>2</sup>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F8|?k3B34f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "At what valve area do symptoms of mitral stenosis begin to appear at rest?", 
                "&lt;1.5cm<sup>2</sup>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gCSqK}2@Y]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 factors used to grade the severity of mitral stenosis", 
                "Valve area<div>Pressure gradient</div><div>Presence of sequelae (e.g. pulmonary hypertension, LA dilation)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ozN>EpaJss", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a normal gradient across the mitral valve?", 
                "0mmHg", 
                ""
            ], 
            "flags": 0, 
            "guid": "gW^Qq(UrS+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What gradient across the mitral valve is considered mild disease?", 
                "&lt;5mmHg", 
                ""
            ], 
            "flags": 0, 
            "guid": "c8w8:J4ha3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What gradient across the mitral valve is considered moderate disease?", 
                "5-10mmHg", 
                ""
            ], 
            "flags": 0, 
            "guid": "8[ny|?*3[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What gradient across the mitral valve is considered severe disease?", 
                "&gt;10mmHg", 
                ""
            ], 
            "flags": 0, 
            "guid": "C)ks@mGcYg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why are patients with mitral stenosis wont to develop pulmonary oedema with tachyarrythmias or exercise?", 
                "Severity of gradient across the valve increases with faster heart rate&nbsp;<div>There is less filling time in diastole, gradient must increase to maintain flow</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kI=J5`~rDF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the preferred beta blocker in pregnancy?", 
                "Metoprolol", 
                ""
            ], 
            "flags": 0, 
            "guid": "j6U(ALyZAO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the indications for balloon valvuloplasty in symptomatic mitral stenosis?", 
                "Moderate or severe MS<div>Can also consider in valve &gt; 1.5cm<sup>2</sup> if pulmonary hypertension on exercise or gradient &gt; 15 on exercise<br /><div>Suitable valve (pliable, non calcified, minimal subvalvar fusion)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P7}.`~QdZF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the indications for balloon valvuloplasty in asymptomatic mitral stenosis patients?", 
                "New AF<div>Pulmonary hyptertension (pulmonary artery systolic pressure &gt; 50mmHg at rest&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "QDteX/k?CO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is balloon valvuloplasty contraindicated in mitral stenosis?", 
                "More than mild mitral regurgitation<div>LA thrombus</div><div>Heavy calcification of both commisures</div><div>Predominant subvalvular involvement</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z%eZ[Z&yok", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the benefits of mitral balloon valvuloplasty?", 
                "May avoid or delay surgery<div>Doubles orifice area</div><div>50% gradient reduction</div><div>80% of patients get long term relief of symptoms</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Kt})7-Yy{9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 complications of mitral valve balloon valvuloplasty", 
                "Severe MR 2 - 10%<div>Cardiac tamponade</div><div>ASD</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dDX|@#|w4G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients who undergo balloon valvuloplasty for mitral stenosis have restenosis at 7 years?", 
                "40%", 
                ""
            ], 
            "flags": 0, 
            "guid": "v$8ks3{#4]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of symptomatic mitral stenosis in pregnancy (4)", 
                "Bed rest<div>Diuretics</div><div>Beta blockers</div><div>May require balloon valvuloplasty if above fails</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sdHg~i.D>H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Until what gestation is it preferable to wait before undergoing a contrast-requiring cardiac procedure such as balloon valvuloplasty?", 
                "22 - 26 weeks<div>Lower foetal radiation risk after this</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b58>xa$sEl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which is the preferred invasive management of symptomatic mitral stenosis in pregnancy - balloon valvuloplasty or surgical commissurotomy?", 
                "Balloon valvuloplasty<div>Mortality 5% vs 38%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DQFU_gaEsO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "By how much is maternal blood volume increased in pregnancy?", 
                "40 - 50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "D=[zE5F.mv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "By how much is maternal cardiac output increased in pregnancy?", 
                "30 - 50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "sIKf/oGZpY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In active labour, cardiac output increases over and above the increase seen in pregnancy. How much is this increase?", 
                "A further 50% (due to increase in stroke volume)", 
                ""
            ], 
            "flags": 0, 
            "guid": "O>_.@y05Oy", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is mitral valve surgery for symptomatic primary mitral regurgitation indicated?", 
                "Severe MR, and:<div><br /><div>Symptomatic and LVEF &gt; 30% (grade I recommend)</div><div>Symptomatic and LVEF &lt; 30% (grade IIb recommend)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xGM51-.5n<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is surgical mitral valve repair indicated for asymtomatic patients with mitral stenosis?", 
                "<div><div>Severe MR, and:</div><div><br /></div><div>LVEF 30 - 60% or LVESD &gt;40mm (grade I recommend)</div></div><div>New onset AF or pulmonary hypertension (grade IIa)</div><div>Asymptomatic and not meeting the above criteria but high (&gt;95%) chance of success and low risk of death (&lt;1%) (grade IIa)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y$+&akjWag", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is surgical mitral valve repair indicated for secondary mitral regurgitation?", 
                "Failure to adequately improve with treatment of the cause<div>Severe symptomatic MR with persistent NYHA III - IV symptoms</div><div>(still only grade IIb recommendation)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "eU/vn8:[4h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why may the ejection fraction be higher than normal in severe mitral regurgitation?", 
                "Heart is ejecting into low pressure left atrium (low afterload)<div>Increased preload causes higher stroke volume (via Frank Starling law)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y9r-ST8S|H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the Frank Starling mechanism", 
                "Increasing the ventricular end diastolic pressure (preload) increases the strength of the subsequent ventricular contraction", 
                ""
            ], 
            "flags": 0, 
            "guid": "El#J8x}z3%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how the Frank Starling curve shifts in exercise", 
                "Up and to the left (increased stroke volume for a given preload)<div><br /></div><div><img src=\"paste-102860171771905.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yU#`_tgX/.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how the Frank Starling curve shifts in heart failure", 
                "Down and to the right<div>Despite increasing preload (end diastoic pressure), contractility does not increase by the usual amount</div><div><br /></div><div><img src=\"paste-102958956019713.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JAK9T0e6.T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how a left ventricular infarction that does not involve the mitral valve annulus or papillary muscles directly can result in mitral regurgitation (2)", 
                "<div>Distortion of the normal wall anatomy drags the fixation point of the papillary muscles/chordae tindineae to a more extreme angle, causing tethering and inability of the valve to close</div><div>Impaired LV contractility can reduce closing forces</div><img src=\"paste-105621835743233.jpg\" />", 
                ""
            ], 
            "flags": 0, 
            "guid": "GF>1|F!Q9~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How may mitral or tricuspid regurgitation arise from chronic AF?", 
                "Chronic AF leads to LA and RA dilataion<div>Causes dilation of the valve annuli and therefore regurgitation (tricuspid typically worse)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gGB1F]w1:`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the preferred method of mitral valve repair - surgical repair or mitral valve replacement?", 
                "Surgical repair", 
                ""
            ], 
            "flags": 0, 
            "guid": "[vNLQG38N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients considered too unwell for surgical mitral valve repair for mitral regurgitation, what may be done instead?", 
                "Percutaneous mitral valve replacement<div>MitraClip</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e%e8hOW>H_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the management of acute severe aortic regurgitation?", 
                "Urgent valve replacement<div><br /></div><div>Do not use balloon pump</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "v`A%j26{9Q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is aortic valve replacement indicated for symptomatic severe chronic aortic regurgitation?", 
                "All patients<br /><div><br /></div><div><img src=\"paste-114804475822081.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "IKeGCG(b#T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is aortic valve replacement indicated for asymptomatic severe chronic aortic regurgitation?", 
                "LVEF &lt; 50% (I)<div>Other cardiac surgery required (I)</div><div>LVEF &gt;50% and LVESD &gt;50mm (IIa)</div><div>LVEF &gt;50% and LVEDD &gt; 65mm and low surgical risk (IIb)</div><div>BP drop with exercise</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N@H`3*?K``", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is aortic valve replacement indicated for progressive chronic aortic regurgitation?", 
                "Patients who need other cardiac surgery anyway (IIb)", 
                ""
            ], 
            "flags": 0, 
            "guid": "PxWrwg&~YA", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common valve disease?", 
                "Aortic stenosis", 
                ""
            ], 
            "flags": 0, 
            "guid": "O;qeKgr%gi", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<img src=\"paste-118803090374657.jpg\" />", 
                "<div>We are looking at LV outflow tract so must relate to aortic valve.</div>Doppler shows flow away from the probe in systole with a jet velocity of 4 - 5 m/s (very high) - aortic stenosis<div>Then there is flow back towards the probe in diastole - aortic regurgitation</div><div>Answer = C</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k<*K9bpL;=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how aortic pseudostenosis may occur", 
                "Mild to moderate aortic stenosis present<div>Then situation causing poor flow arises (low cardiac output, low pressure gradient)</div><div>Unable to generate enough pressure to open the valve fully, so valve area appears severely reduced instead of mild/moderate</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Al?]0W~oCR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient has reduced ejection fraction, low flow, and a low pressure gradient across their aortic valve. The valve area indicates severe AS (&lt;1.0cm2). How can it be determined if this is true severe AS?", 
                "Low flow states may cause aortic valve area to look smaller (not enough pressure to open it fully, making disease look more severe)<div>It may also mask severe AS by masking pressure gradient (not enough pressure to generate gradient)</div><div>Correct the ejection fraction via&nbsp;dobutamine stress echo and see if meet criteria for severe AS</div><div>- valve area improves with only tiny increase in gradient - not true severe AS</div><div>- valve area stays the same and gradient increases &gt; 40mmHg - true severe AS</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MaY-)(]M`3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient has severe AS (valve area &lt;1) with low flow, low gradient (&lt;40mmHg), and reduced EF. It is not correctable with dobutamine stress test (no flow reserve).&nbsp;<div>How may it be determined if this is true severe AS requiring valve replacement?</div>", 
                "<div>This is 'paradoxical' low flow state with normal EF</div><div>Calcium score - significant valve calcification favours true severe AS</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l$<>v,uob+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient presents with apparent severe AS (valve area &lt;1), low flow, low gradient (&lt;40mmHg) and preserved EF. Do they have true severe AS? Why does this occur?", 
                "These patients have 'paradoxical' low flow low gradient<div>e.g. may have severe LV hypertrophy with restricted filling causes reduced flow but normal EF</div><div>Consider intervention if symptomatic and comprehensive evaluation suggests significant valve obstruction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x9wXW2)ei?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In severe AS as defined by mean gradient &gt;40 and AVA &lt; 1, when is valve replacement indicated?", 
                "Symptoms, or<div>LVEF &lt; 50%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pMB;z8o-]v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the workup of a patient with aortic stenosis with valve area &lt;1 and mean gradient &lt;40mmHg", 
                "Rule out measurement error<div>Rule out small body size</div><div>Assess ejection fraction and flow</div><div>- if low EF, perform dobutamine stress echo to correct low flow state. If gradient &gt;40mmHg severe AS confirmed</div><div>- If low EF that is not correctable, perform calcium score</div><div>- If normal EF and low flow, consider replacement after 'careful confirmation of severe AS'</div><div>- if normal EF and normal flow, pseudosevere AS</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wh+Pe?AGdA", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the preferred aortic valve replacement method in patients with no contraindications to either procedure?", 
                "SAVR in low surgical risk patients and no other risk factors", 
                ""
            ], 
            "flags": 0, 
            "guid": "zq*wa{*^~B", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 factors that would suggest TAVI is more appropriate than SAVR for AS", 
                "Porcelain aorta<div>Frailty</div><div>High surgical risk</div><div>Chest RT</div><div>Age &gt; 75</div><div>Previous cardiac surgery</div><div>Coronary bypass grafts at risk when sternotomy performed</div><div>Severe chest deformation or scloliosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w23G!2FE.K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 10 factors that would suggest SAVR is more appropriate than TAVI for AS", 
                "Low surgical risk<div>Age &lt;75</div><div>Endocarditis</div><div>Unfavourable access for TAVI</div><div>Short distance between coronary ostia and aortic valve annulus</div><div>Size of aorta out of range</div><div>Unfavourable aortic root morphology</div><div>Bicuspid valve</div><div>Thrombi in aorta or LV</div><div>Need for other cardiac surgery (CAGS, mitral valve disease, etc)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Li%-mN#{Zb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients should not undergo valve replacement despite severe symptomatic AS?", 
                "<div>Expected survival &lt;1yr</div><div>Severe co-morbidities/advanced age unlikely to have improvement in survival or QoL with intervention</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "t;3:=^S0fE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 complications of surgical aortic valve replacement", 
                "<div>Bleeding</div><div>AKI</div><div>New onset AF</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BRDq|2K6)N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 complications of TAVI", 
                "<div>Pacemaker implantation</div><div>Paravalvular regurgitation</div><div>Vascular complications</div><div>TAVI thrombosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w+;E!V9|bo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 5 year mortality in heart failure?", 
                "50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "f7L+B4UY+]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 3 most common causes of HFrEF", 
                "IHD and prior AMI (cause of 2 in 3 cases)<div>Hypertension (present in 2 in 3 cases)</div><div>Non ischaemic idiopathic DCM (5 - 10%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J^o{CItu,:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 5 most common factors precipitating admission to hospital with heart failure in HFrEF", 
                "Pneumonia (15.3%)<div>ACS (14.7%)</div><div>Arrythmia (12.5%)</div><div>Hypertension (10.7%)</div><div>Nonadherance (8.9%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tza{(=(``Q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the commonest cause of right heart failure?", 
                "Left heart failure", 
                ""
            ], 
            "flags": 0, 
            "guid": "zgy{yl_4Qs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What heart failure medication will make BNP an unreliable measure of heart failure?", 
                "ARNI", 
                ""
            ], 
            "flags": 0, 
            "guid": "Mi/$!hkxfh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a normal ejection fraction?", 
                "55 - 70%", 
                ""
            ], 
            "flags": 0, 
            "guid": "wIu7SMg!hx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Above what level is BNP considered raised?", 
                "&gt;35", 
                ""
            ], 
            "flags": 0, 
            "guid": "OU}aO;dKBM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the cause of dyspnoea and pulmonary oedema in left heart failure?", 
                "Elevated LA pressure", 
                ""
            ], 
            "flags": 0, 
            "guid": "xi5li3.:Ri", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the cause of elevated JVP, liver congestion, and peripheral oedema in right heart failure?", 
                "Elevated RA pressure", 
                ""
            ], 
            "flags": 0, 
            "guid": "CqR0-:ySW]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "BNP is good for ruling in or ruling out heart failure?", 
                "Rule out (highly sensitive)", 
                ""
            ], 
            "flags": 0, 
            "guid": "E~:m]2n&l0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "BNP is not accurate in patients on ARNI. What test should be used instead?", 
                "NT-proBNP", 
                ""
            ], 
            "flags": 0, 
            "guid": "F68U%|1I57", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 agents which reduce symptoms, mortality, hospitalisation, and reverse remodelling in HFrEF", 
                "<div>Beta blocker</div><div>Mineralocorticoid receptor antagonist</div><div>ACE inhibitor</div><div>ARNI</div><div><br /></div><div>(In order from most to least mortality benefit)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nRlA)jH#K*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-1", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-1-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "INH2yoDc-X", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-2", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-2-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "B|Va0zGE)3", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-3", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-3-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "xFT?)N#l]>", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-4", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-4-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "t{XRskUGE=", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-5", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-5-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "bkEs99CC7~", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-6", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-6-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "FnXLR.0)gA", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-7", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-7-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "k@oO/DfI%X", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-8", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-8-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "d26C:~77$4", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-9", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-9-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "h}=v]A)j/g", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-10", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-10-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ltChl>11/i", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-11", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-11-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "lXi:L5elgG", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-12", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-12-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-12-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "p8N(~XMj,6", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-13", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-13-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-13-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Kk%EE4)x}u", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "969e48d26b5f4730b6935dd6701f4d7b-oa-14", 
                "", 
                "<img src=\"tmpl9skhi.png\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-14-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-14-A.svg\" />", 
                "<img src=\"969e48d26b5f4730b6935dd6701f4d7b-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "r6]zJCD5l3", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 nonpharmacological interventions for HFrEF", 
                "2L fluid restriction<div>Daily weight - if increase in 1kg per day for 2 consecutive days, seek medical advice</div><div>2g salt per day max</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B1vUtq$V2R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of diuretics in management of HFrEF", 
                "Symptom management only (other than MRA)<div>Should be minimised when stable</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uhv-IpwG,,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-1", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-1-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "H[obgEZx:$", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-2", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-2-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "h26gpcNc$p", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-3", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-3-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "EnB7J3P,Z`", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-4", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-4-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "s+?IrXhi8]", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-5", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-5-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "IuRI!^!{@%", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-6", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-6-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "J~*f5cdti*", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-7", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-7-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "z3M>WP&3!J", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-8", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-8-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kU~zo:0ONS", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-9", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-9-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "E`6_S5Jz/i", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-10", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-10-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "nKQn>U0$VP", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-11", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-11-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ddpw2}%$So", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-12", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-12-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-12-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "A-dA(p?bNA", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-13", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-13-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-13-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "v5Q^${RS-h", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-14", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-14-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-14-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "PZy=x5awlq", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-15", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-15-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-15-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "j||6Qwq+qo", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-16", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-16-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-16-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "K]-6[[eu8u", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3efad90d456742cb90056c92b0c13663-oa-17", 
                "", 
                "<img src=\"tmpftfert.png\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-17-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-17-A.svg\" />", 
                "<img src=\"3efad90d456742cb90056c92b0c13663-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "zdVl2}*DV<", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Above which heart rate can Ivabradine be prescribed for HFrEF?", 
                "HR &gt; 77", 
                ""
            ], 
            "flags": 0, 
            "guid": "m%3W~i527D", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of sacubitril/valsartan?", 
                "Angiotensin receptor-neprilysin inhibitor (ARNI)", 
                ""
            ], 
            "flags": 0, 
            "guid": "gDYIk!*_#9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of angiotensin receptor-neprilysin inhibitors (ARNI)", 
                "<div>Naturetic peptides like BNP promote natriuresis and vasodilation</div>Neprilysin degrades natriuretic (and other vasoactive) peptides - neprilysin inhibitors block this<div>However neprilysin also breaks down angiotensin II, so inhibition leads to more angiotensin II and RAAS activation</div><div>Therefore ARB must be given concurrently - this combination is ARNI</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fK<a0}i/9H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The PARADIGM-HF trial compared ARNIs to enalapril in HFrEF. What was the outcome?", 
                "Improved CV death, hospitalisation, all cause mortality, less ED visits, less hospitalisation, less ICU admissions", 
                ""
            ], 
            "flags": 0, 
            "guid": "fLZ<1ndqk{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is cardiac resynchronisation indicated (4)", 
                "NYHA III - IV on optimal medical therapy<div>Dilated LV &gt; 55mm with LVEF &lt;35%<br /><div>LBBB and&nbsp;QRS &gt;130</div><div>Sinus rhythm</div></div><div><br /></div><div>Must fulfil all criteria.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uqc`3=-8{^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In which asymptomatic heart failure patients are ICDs recommended?", 
                "Asymptomatic LV systolic dysfynction of ischaemic origin with LVEF &lt;30% who are at least 40 days post infarction<div>Asymptomatic non-ischaemic dilated cardiomyopathy (LVEF &lt;30%) who receive OMT</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ms0FzGeO6b", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In which heart failure patients are ICDs recommended as secondary prevention?", 
                "Survivors of ventricular arrythmia with haemodynamic instability who are expected to survive &gt;1 year with good functional status", 
                ""
            ], 
            "flags": 0, 
            "guid": "f=IJUS?|?R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In which symptomatic heart failure patients are ICDs recommended as primary prevention? (4)", 
                "NYHA II - III<div>LVEF &lt;35% despite 3 months OMT</div><div>Survival &gt;1 year expected</div><div>Cause of heart failure is either ischaemia or dialated cardiomyopathy</div><div><br /></div><div>Must fulfil all the above.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M/{lRdEE#X", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 conditions that can cause HFpEF", 
                "Hypertension<div>Aging</div><div>Coronary artery disease</div><div>Diabetes</div><div>Sleep disordered breathing</div><div>Obesity</div><div>Kidney disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x<b@>,c<Hc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name two functional abnormalities seen on echo in HFpEF", 
                "E/e' &gt; 13<div>e' average &lt; 9</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wy<S_-Hkip", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the gold standard test for HFpEF?", 
                "<div>Right heart catheter with stress testing (e.g. exercise)</div><div>See Increase in systemic blood pressure, pulmonary artery pressure, pulmonary artery mean pressure, PCW pressure, cardic output with exercise</div><div><br /></div><div>e.g. BP 156-92 -&gt; 196-93</div><div>PA 32/14 -&gt; 66/34</div><div>PA mean 21 - &gt; 47</div><div>PCW 10 -&gt; 34</div><div>CO 4.9 -&gt; 8.8</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qK}XV`.v9U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with HFrEF, do the doses of the mortality-modifying medications matter?", 
                "Yes<div>Improved outcomes in achieve recommended doses</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Fnx}]wVY)n", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the target dose of metoprolol in HFrEF?", 
                "200mg daily", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ljy0r1X>qx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the target dose of carvedilol in HFrEF?", 
                "25mg BD", 
                ""
            ], 
            "flags": 0, 
            "guid": "NnMBC#cex?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the target dose of bisoprol in HFrEF?", 
                "10mg daily", 
                ""
            ], 
            "flags": 0, 
            "guid": "NqJO/t,v6d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the target dose of nebivolol in HFrEF?", 
                "10mg daily", 
                ""
            ], 
            "flags": 0, 
            "guid": "EXDLOI`jV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the target dose of ramipril in HFrEF?", 
                "10mg daily", 
                ""
            ], 
            "flags": 0, 
            "guid": "iP?W_{H1g&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the target dose of Candesartan in HFrEF?", 
                "32mg daily", 
                ""
            ], 
            "flags": 0, 
            "guid": "e4j[_>TC.!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the target dose of spironolactone in HFrEF?", 
                "50mg daily", 
                ""
            ], 
            "flags": 0, 
            "guid": "euM;WK9LwT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the target dose of sacubitril/valsartan in HFrEF?", 
                "97/103mg BD", 
                ""
            ], 
            "flags": 0, 
            "guid": "F_6KnIi4uw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the starting dose of sacubitril/valsartan in HFrEF?", 
                "49/51mg BD", 
                ""
            ], 
            "flags": 0, 
            "guid": "M`K!RlpW}6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 oral antiglycaemic agent with a mortality benefit in T2DM and heart failure", 
                "Empagliflozin<div><br /></div><div>Lower rate of CV death</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s=#<!v?OdV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the indications for iron infusion in HFrEF?", 
                "Symptomatic HFrEF, and<div>Iron deficiency:&nbsp;Ferritin &lt;100, or 100 - 299 and transferrin sat &lt;20%<div><br /></div><div>Improves symptoms, exercise capacity, and QoL</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bMJ[3nq&)4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which type of iron infusion must be used in patients with HFrEF?", 
                "Iron carboxymaltose", 
                ""
            ], 
            "flags": 0, 
            "guid": "C~*9S;$N^/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 benefits to iron infusion in patients with HFrEF who meet the appropriate criteria", 
                "Reduces symptoms<div>Improves exercise capacity</div><div>Improves QoL</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w+sN{|j=M:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with HFrEF should be considered for a ventricular assist device? (6)", 
                "&gt;2 months of severe symptoms despite OMT and device therapy, AND one or more of:<div>- LVEF &lt; 25%</div><div>- &gt;3 hospitalisations in previous 12 months without obvious precipitant</div><div>- Dependence on IV ionotropes</div><div>- Progressive end organ dysfunction due to reduced perfusion</div><div>- Deteriorating right ventricular function</div><div><br /></div><div>These patients are on a pathway to transplant</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GJ}2=-VDjK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the percent progression per year from NYHA III to IV heart failure?", 
                "9%", 
                ""
            ], 
            "flags": 0, 
            "guid": "yCU3MUk}-u", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 clinical factors which may indicate disease progression in heart failure", 
                "Persistent hypotension &lt;90<div>Persistent NYHA III or IV symptoms</div><div>2 or more hospitalisations in 12 months</div><div>Recurrent ICD shocks (&gt;2)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l5S`W4w|?}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 medication factors which may indicate disease progression in heart failure", 
                "Requirement of downtitration of ACE/ARB, beta blocker<div>Increasing diuretic requirements</div><div>Prior or ongoing ionotrope requirements</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tDt9SwuGRd", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What findings would you expect on cardiac MRI in ischaemic cardiomyopathy?", 
                "White coloured myocardium at the location of the infarct indicated fibrosis/scar (myocardium should be black)<div>\\</div><div><img src=\"paste-224858717814785.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Hr@rq9%TIP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What MRI findings might one see in idiopathic dilated cardiomyopathy", 
                "Midwall fibrosis (looks like a white line)<div>Indicates poorer prognosis</div><div><br /></div><div><img src=\"paste-225545912582145.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GTlNPh)Wl%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What cardiac MRI findings might be seen in cardiac sarcoidosis?", 
                "Patchy non-coronary distribution scar (appears as white discoloration of the normally black myocardium)<div><br /></div><div><img src=\"paste-226220222447617.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L7Yi&W{KtE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What may be seen on cardiac MRI in amyloid cardiomyopathy?", 
                "Ring of enhancement<br /><img src=\"paste-226245992251393.jpg\" />", 
                ""
            ], 
            "flags": 0, 
            "guid": "E#s/KmVn<~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with HCM should have an ICD? (3)", 
                "<div>Survivor of&nbsp;cardiac arrest due to VT or VF, or</div><div>Sustained&nbsp;VT causing syncope or&nbsp;haemodynamic compromise, and&nbsp;</div><div>Have a life expectancy of &gt;1 year (grade Ib)</div><div><br /></div><div>Patients with a 5 year risk of sudden death &gt;6% using the HCM Risk-SCD formula (IIa), or 4 - 6% if patient wishes (IIb)</div><div><br /></div><div>Can be considered where risk &lt;4% if significant other prognostic factors (IIb)</div><div><br /></div><div><br /></div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s]UchonejP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When was the first heart transplant?", 
                "1967 in South Africa", 
                ""
            ], 
            "flags": 0, 
            "guid": "s}AxP1/~AB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is an orthotopic heart transplant", 
                "The patient's own heart is removed and replaced with the donor heart", 
                ""
            ], 
            "flags": 0, 
            "guid": "p8n+[43Ab)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 indications for heart transplant", 
                "Severe symptomatic heart failure (class IV) with<div>- despite maximal OMT, or</div><div>- on mechanical cardiac support, or</div><div>- cardiogenic shock<br /><div>Frequent discharges from an AICD</div><div>Intractable angina (rare as an indication)</div><div><br /></div><div>Low EF alone is NOT an indication</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q|Pco?3%y2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 contraindications to heart transplant", 
                "Active malignancy<div>Uncontrolled infection</div><div>Complicated diabetes</div><div>Morbid obesity &gt; 30</div><div>Lifestyle factors that result in poor outcomes</div><div>Substance abuse</div><div>Irreversible damage of other organ systems</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N/TQj9Wp0F", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common cause of early mortality post heart transplant?", 
                "Rejection (30%)", 
                ""
            ], 
            "flags": 0, 
            "guid": "vt}/Tapt:X", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the gold standard for diagnosing organ rejection in heart transplant?", 
                "Biopsy", 
                ""
            ], 
            "flags": 0, 
            "guid": "BE9bBUm}Yl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 causes of late mortality in heart transplant", 
                "Coronary allograft vasculopathy<div>Malignancy</div><div>Graft failure</div><div>Acute rejection</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h+O2>d-wW~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 features of coronary allograft vasculopathy", 
                "Transplant coronary artery disease is<div>distal, diffuse, concentric, non-calcified</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w)kp7:f#x/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the average survival post heart transplant", 
                "50% survive 14 years<div>1/3 survive&gt; 20 years<br /><div>vs. 2 years without transplant</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uB-L%0W#?A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What does PCSK9 stand for?", 
                "Proprotein convertase subtilisin/kexin type 9", 
                ""
            ], 
            "flags": 0, 
            "guid": "c%#(a;$#m8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the approximate RV pressure?", 
                "About 25% of systemic pressure", 
                ""
            ], 
            "flags": 0, 
            "guid": "dkw48@fp$f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Should the RV and RA diastolic pressure be the same?", 
                "Yes, in the absence of tricuspid pathology", 
                ""
            ], 
            "flags": 0, 
            "guid": "!8sS1F[/3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "'Cannon' a waves on a right atrial trace indicates...", 
                "Constrictive endocarditis", 
                ""
            ], 
            "flags": 0, 
            "guid": "A8|lgh:O2%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 causes of elevated LV end disatoic pressure", 
                "Hypervolaemia<div>CHF or LVH with diastolic dysfunction</div><div>Tamponade</div><div>Constriction</div><div>Mitral regurg</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PJ1lLDelH=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "LV end diastolic pressure is equivalent to what left atrial pressure (in the absence of valvular disease)?", 
                "LA diastolic pressure", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pkb}g,2A>=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the 3 most common causes of aortic stenosis in patients age &lt; 70?", 
                "Bicuspid (50%)<div>Postinflammatory (25%)<br /><div>Degenerative (18%)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ry]odwQu7?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the 3 most common causes of aortic stenosis age &gt; 70?", 
                "Degenerative (48%)<div>Bicispid (27%)</div><div>Postinflammatory (23%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A,&HsMn<m+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 2 year survival rate with severe symptomatic aortic stenosis?", 
                "50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "raM*1*~&Fr", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is Heyde's sign?", 
                "GI bleeding in AS", 
                ""
            ], 
            "flags": 0, 
            "guid": "Qk^|T{Y)eS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 signs of aortic stenosis", 
                "<div>Murmur</div><div>- Late peaking and longer duration = worse</div>Reduced carotid upstroke<div>Soft S2</div><div>Reversed split S2</div><div>S4 (severe)</div><div>Normal location of apex beat</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xY)${${L9]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What may be seen on exercise stress test in patients with AS that would indicate severe disease?", 
                "Fall in blood pressure with exercise", 
                ""
            ], 
            "flags": 0, 
            "guid": "O=;/Tm6v`W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 sign on echo that can indicate severe AS is more likely in patients with low flow states and valve gradient &lt; 40mmHg", 
                "Dimensionless index &lt;0.25", 
                ""
            ], 
            "flags": 0, 
            "guid": "M8:f~EaJy<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which symptom is most indicative of severe AS?", 
                "Dyspnoea (as inidicates heart failure)<div><br /></div><div>Heart failure &gt; syncope</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e;94TUnW)*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with AF and AS, is S4 a reliable sign of severe disease?", 
                "No<div>Presence of AF makes S4 unreliable</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z%I?N-D.pn", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Above what calcium score of the aortic valve is severe AS likely", 
                "&gt;2000 (different cutoffs in different trials but &gt;2000 definitely high enough)", 
                ""
            ], 
            "flags": 0, 
            "guid": "EtRBVQ=<VO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with hyperdynamic state (e.g. hyperthyoid), what is the most reliable measurement of severe AS?", 
                "Valve area<div><br /></div><div>Gradient is unreliable in hyperdynamic state</div><div>Valve area is independent of hyperdynamic state</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "o=,HEcI~#;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is surgical risk in patients being considered for SAVR identified?", 
                "STS score", 
                ""
            ], 
            "flags": 0, 
            "guid": "F)Jmo.=h<J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 drawbacks of choice of mechanical AVR", 
                "Lifelong anticoagulation<div>Embolic risk</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ra_~haHoDf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 drawback of tissue AVR", 
                "Limited durability", 
                ""
            ], 
            "flags": 0, 
            "guid": "H+QzN}4DEI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 good things about AVR using the Ross proceudre", 
                "No anticoagulation<div>Durable</div><div><br /></div><div>(putting the pulmonary valve in the aortic position then replacing the pulmonary valve)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MZiU*w+|?.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 complications of TAVI", 
                "Pacemaker<div>Annulus rupture</div><div>Coronary artery occlusion</div><div><br /></div><div>need to check this</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jTl`R)L[J{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A young person requires an aortic valve replacement. Anticoagulation is contraindicated. What method might you use?", 
                "Ross procedure<div><br /></div><div>Young patients usually get the more durable option of mechanical valve but this requires anticoagulation</div><div>No need for anticoag with Ross procedure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C4y!^U3l?*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 murmurs that change with Valsalva", 
                "LVOTO murmur augments with reduced preload (Valsalva makes it louder)<div>Mitral valve prolapse murmur - gets longer</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F?D(lJN}_5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of HCM", 
                "Beta blockers<div>Calcium channel blockers (verapamil/diltiazem)</div><div>Septal reduction therapy if ongoing symptoms-</div><div>- Alcohol septal ablation or surgery</div><div><br /></div><div>Add more detail</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "caOXU/5p?<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 signs of severity in AR", 
                "Duration of diastolic murmur<div>Wide pulse pressure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rM?=#HFvEF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why may patients with AR have systolic murmur?", 
                "Flow murmur over the pulmonary valve??<div><br /></div><div>from cardiology course</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O;dl/d3P2J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 indications for intervention in severe AR", 
                "Symptoms&nbsp;<div>LVEF &lt; 50%<div>LV dilatation</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nj0h&T-tn8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Rheumatic fever most common valvular lesion", 
                "Mitral stenosis", 
                ""
            ], 
            "flags": 0, 
            "guid": "F,e8q`X5F5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why can patients with mitral stenosis get a hoarse voice?", 
                "Huge LA compresses recurrent laryngeal nerve", 
                ""
            ], 
            "flags": 0, 
            "guid": "#ln(-MzN~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 medical therapies that can be used to stabilise severe mitral stenosis", 
                "Beta blocker<div>Diuretic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BA`?8^nM4|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is PVR calculated?", 
                "PVR = mPA - mPCWP / Qp<div><br /></div><div>Look this up</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "szp*0UM3]*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is there a mortality benefit to surgical intervention in functional mitral regurgitation?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "A=/oZpP^=X", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 primary causes of TR", 
                "Ebstein<div>Congenital</div><div>Rheumatic</div><div>Endocarditis</div><div>Carcinoid</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F(FV,nLC9_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 signs of TR", 
                "Systolic murmur increases with inspiration<div>V wave in JVP</div><div>Pulsative hepatomegaly</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M9LMw`b%6z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 causes of constrictive pericarditis", 
                "TB pericarditits<div>Recurrent pericarditis</div><div>Mediastinal RT</div><div>Uraemia</div><div>CTD</div><div><br /></div><div>From cardiology course</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Jq!$.BnBD-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What would you expect e' to be in constrictive pericarditis vs restrictive cardiomyopathy?", 
                "e' low in restriction<div>if &gt;8, more consistent with constriction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zYT/p!W@lq", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f55677a94fa48afbff2cf92bbd9c646-oa-1", 
                "", 
                "<img src=\"tmppcwibf.png\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-1-A.svg\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "cUx_p6@J0b", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f55677a94fa48afbff2cf92bbd9c646-oa-2", 
                "", 
                "<img src=\"tmppcwibf.png\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-2-A.svg\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "IX{WhI%}j{", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f55677a94fa48afbff2cf92bbd9c646-oa-3", 
                "", 
                "<img src=\"tmppcwibf.png\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-3-A.svg\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "JGAr}`UUy9", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f55677a94fa48afbff2cf92bbd9c646-oa-4", 
                "", 
                "<img src=\"tmppcwibf.png\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-4-A.svg\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "pVegc=>C?-", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f55677a94fa48afbff2cf92bbd9c646-oa-5", 
                "", 
                "<img src=\"tmppcwibf.png\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-5-A.svg\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "``*^aj}jc", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f55677a94fa48afbff2cf92bbd9c646-oa-6", 
                "", 
                "<img src=\"tmppcwibf.png\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-6-A.svg\" />", 
                "<img src=\"2f55677a94fa48afbff2cf92bbd9c646-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "g$kmeKOhqh", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Elevated RV systolic pressure indicates what pathology in the absence of pulmonary valve abnormality?", 
                "Pulmonary hypertension", 
                ""
            ], 
            "flags": 0, 
            "guid": "Hr|lf&R7,B", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Oxygen has a mortality benefit in which group of pulmonary HTN patients?", 
                "Group 3", 
                ""
            ], 
            "flags": 0, 
            "guid": "iD8*a|lbi&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "'advanced therapy' for pulmonary hypertention is contraindicated in which group", 
                "group 2", 
                ""
            ], 
            "flags": 0, 
            "guid": "fsb2$xQc%i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 symptoms of ASD", 
                "SOB<div>Fatigue</div><div>Atrial arrythmias</div><div>Paradoxical emboli</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bj7J0e*n-t", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 signs of ASD", 
                "Fixed split S2<div>Soft ejection systolic murmur (flow murmur across pulmonary valve from increased R heart flow)</div><div>Signs of pulmonary HTN if severe</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LYgHirNEO*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the procedure of choice to close an ASD", 
                "Device procedure", 
                ""
            ], 
            "flags": 0, 
            "guid": "EYm[bN:k>A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 complications of ASD device closure", 
                "Embolisation<div>Aortic erosion (present with tamponade)</div><div><br /></div><div>Both very rare</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kX-lQ]XR*G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "After what age in children is risk of longterm pulmonary hypertension increased if VSD is not closed prior?", 
                "2 years", 
                ""
            ], 
            "flags": 0, 
            "guid": "xdr2I%!5G&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 clincal features seen in PDA", 
                "Heart failure<div>Eisenmenger syndrome</div><div>Continuous murmur (always flow from aorta to PA)</div><div>Secondary erythrocytosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wRpF`2<AXM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What murmur would you expect to hear in a PDA?", 
                "Continuous murmur<div>Flow is always moving from aorta to PA</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r;tRV2@qK}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should phlebotomy be performed in Eisenmenger syndrome?", 
                "Symptomatic<div>Pre surgery if Hct &gt; 0.65</div><div>Ensure iron replete</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j@{u`EEHd`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 signs of aortic coarctation", 
                "Hypertension in upper limb<div>Reduced femoral pulses</div><div>Radial femoral delay</div><div>Arm-leg BP gradient</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "OwuIoK:%:[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the treatment of choice for aortic coarctation?", 
                "Percutaneous stenting, or<div>Surgery</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ox>J5|A)QU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients with treated aortic coarctation have residual hypertension?", 
                "30%<div>Need to beware recurrence and aneurysm formation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oaW6;~-C.P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is Ebstein's anomaly (5)", 
                "Failure of delamination of septal leaflet of tricuspid valve<div>Results in apical displacement of the tricuspid valve &gt;8mm</div><div>Usually associated ASD or PFO (80%)</div><div>20% have accessory pathway (tachyarrythmia)</div><div>Cyanosis with normal PA pressure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AZdkGqk{^H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the most common complication in adulthood post surgical repair of tetralogy of fallot", 
                "Pulmonary regurgitation - can result in RV failure", 
                ""
            ], 
            "flags": 0, 
            "guid": "RdWZjcDPZu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the indication for pulmonary valve repair in patients with pulmonary regurg post tetralogy of fallot repair?", 
                "RV enlargement", 
                ""
            ], 
            "flags": 0, 
            "guid": "Jf$1LxD9Se", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 risk factors for sudden cardiac death in patients with a history of repaired tetralogy of fallot", 
                "LVEDP &gt; 12<div>NSVT</div><div>QRS &gt; 180</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jbun,r5&W/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What was the historical procedure performed to fix transposition of the great arteries?", 
                "Atrial switch<div>Results in the right ventricle acting as the systemic ventricle - eventually results in heart failure and pulmonary hypertension</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zL;Pk1$O?[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the common proceudre performed to fix transposition of the great arteries?", 
                "Arterial switch<div>Requires re-implantation of the coronary arteries</div><div>Makes the pulmonary valve act as the aortic valve, this can fail with time</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "woYlSbjeq7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of Eisenmenger syndrome (6)", 
                "<div>Avoid intravascular depletion, altitude, pregnancy, vasodilators</div><div>Endocarditis prophylaxis</div><div>Bubble filters on IVC lines</div><div>Phlebotomy if symptomatic</div><div>Ensure iron replete (risk of iron deficiency) (they need their high hb)</div><div>Pulmonary vasodilator therapy (Bosentan, sildenafil)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n/3MM$gxl/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 symptoms of aortic coarctation", 
                "<div>Exercise intolerance</div><div>Claudication</div><div>Angina</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fk.Jkb#{dv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 complications of aortic coarctation", 
                "<div>Heart failure</div><div>Dissection</div><div>Stroke</div><div>Accelerated atherosclerosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Oi_<tRu7=U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 things associated with aortic coarctation", 
                "<div>Bicuspid aortic valve</div><div>Other congenital heart diseases (VSD, PDA, Shone syndrome, HLHS)</div><div>Berry aneurysms (10%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wJSaO#7!v?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the prognosis in aortic coarctation without intervention", 
                "75% mortality by 46", 
                ""
            ], 
            "flags": 0, 
            "guid": "z@[U,cs7Vr", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Endocarditis is most likely to affect valves on the left or right side of the heart?", 
                "Left", 
                ""
            ], 
            "flags": 0, 
            "guid": "hvH?weWP`t", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 class I indications for urgent surgery in left sided endocarditis", 
                "Heart failure<div>Locally uncontrolled infection eg abscess</div><div>Infetion due to fungi or multiresistant organism</div><div>Persistent vegetation &gt;10mm after one or more embolic episodes despite appropriate antis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yq<jBmn&xw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name all the interventions with a mortality benefit in HFpEF, excluding transplant", 
                "There are none", 
                ""
            ], 
            "flags": 0, 
            "guid": "E2eG/ZZnk}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is switch from an ACE to ARNI recommended?", 
                "HFrEF<div>Max tolerated or taget dose of ACE/ARB and BB with or without an MRA</div><div><br /></div><div>A washout period of at least 36hrs required due to risk of angioedema</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lAYcUO;bC7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Exercise/rehab has what improvements in HFrEF", 
                "Reduced hospitalisation<div>Improved quality of life</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e&O&k#^,h+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 common side effect of sacubitril/valsartan", 
                "Hypotension (more than ACE alone)", 
                ""
            ], 
            "flags": 0, 
            "guid": "xqQVxuckWF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does cardiac resynchronisation improve symptoms or mortality in appropriate patients with HFrEF?", 
                "Both", 
                ""
            ], 
            "flags": 0, 
            "guid": "l4Vgpa==?s", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients in HFrEF and NYHA class IV symptoms should not get an ICD?", 
                "ICD not recommended in NYHA IV failure with severe symptoms refractory to OMT unless a candidate for CRT, ventricular assist, or transplant", 
                ""
            ], 
            "flags": 0, 
            "guid": "qL*_(dFN~?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 markers of severity use in MR and AR", 
                "Regurgitant fraction &gt; 50%<div>Regurgitant volume &gt; 60ml</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g^.WtCv!X>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 classifications of cardiomyopathy by morphology", 
                "Dialated<div>Hypertrophic</div><div>Restrictive</div><div>ARVC</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "QAiNDR[Aef", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "An asymptomatic patient has signs of LV hypertrophy on ECG. Deep Q waves (more in the lateral leads than the inferior leads). What is the diagnosis?&nbsp;Septal thickness &gt;1.5cm on echo. What is the diagnosis?", 
                "HCM", 
                ""
            ], 
            "flags": 0, 
            "guid": "vFijNlRtPm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the ECG findings in HCM", 
                "Q waves (lateral &gt; inferior)<div>LFH with strain</div><div>Anteroseptal TWI and ST depression (apical HCM)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CK<K4th.SJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 varients of HCM", 
                "Basal septum<div>Reverse septum</div><div>Neutral septum (concentric)</div><div>Apical varient</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k^JC`1{bXH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "how often should gene positive patients be screened for HCM if well?", 
                "<div>If &lt; 11 years: nothing</div><div>12 - 20: screen every 1 - 1.5 years</div><div>21 - 40: every 2-3 years</div><div>40+ every 4 - 5 years</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uH^Kb]B&X^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common genetic cardiovascular disorder", 
                "HCM", 
                ""
            ], 
            "flags": 0, 
            "guid": "HY)F8*SkGR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is it most common to begin expressing HCM in patients who are gene positve", 
                "Around puberty", 
                ""
            ], 
            "flags": 0, 
            "guid": "l5uJDju|u}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common mutation in HCM", 
                "MYBPC3 (50%)", 
                ""
            ], 
            "flags": 0, 
            "guid": "so+F%rJxG]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the odds of finding a gene mutation in a patient with HCM?", 
                "70 - 80% if family member positive<div>40-50% if no positive family member</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hx3{2m#4Po", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Cardiac MRI with gadolinium is contraindicated below what eGFR?", 
                "eGFR &lt;30", 
                ""
            ], 
            "flags": 0, 
            "guid": "tffUw!f.VB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "what is the prevalence of amyloidosis in HFpEF", 
                "13%", 
                ""
            ], 
            "flags": 0, 
            "guid": "FE=2#:HIj-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is Anderson Fabry disease (8)", 
                "<div>X linked recessive glycolipid storage disease</div><div>Defect in GLA gene (encodes lysosomal enzyme alpha-galactosidase A)</div><div>Causes 4% of HCM, typically late onset</div><div>Other manifestations e.g. cryptogenic stroke, peripheral neuropathy, CKD, stop sweating</div><div>Suspect if LVH and short PR interval or AV block</div><div>Diagnosis: alpha-gal A leukocyte activity (screening) then genetic testing</div><div>Can biopsy involved organ</div><div>Treat with enzyme replacement</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hxlL82CfCY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do you calculate HR on ECG", 
                "Multiply number of QRS complexes by 6 (ECG is a 10 second span)", 
                ""
            ], 
            "flags": 0, 
            "guid": "M&lL.maS6Y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with AF require anticoagulation regardless of CHADSVASC score? (2)", 
                "<div>Cardiac amyloidosis</div><div>- Very high risk of thromboembolism in cardiac amyloidosis<div>- 40% have thrombus on autopsy</div></div><div>Mitral stenosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PE6TYBv(x;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Should patients with cardiac amyloidosis have an ICD?", 
                "Consider in patients with light chain or hereditary transthyretin associated cardiac amyloidosis and ventricular arrythmia causing haemodynamic instability with survival &gt;1 year (grade IIa class C)", 
                ""
            ], 
            "flags": 0, 
            "guid": "iRNkVx_Y^N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is amyloidosis", 
                "Extracellular tissue deposition of fibrils<div>Fibrils are insoluble polymers made of stacked sheets (beta pleated sheets) of protein subunits</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qw/r12D2]_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the two most common types of amyloidosis", 
                "Light chain<div>Transthyretin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ng6i/zkDS3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the 3 possible outcomes of plasma cell clone proliferation with excessive light chain production", 
                "Harmless excretion in urine (MCUS)<div>Myeloma</div><div>AL amyloidosis - light chains deposited as beta pleated sheets in tissues</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tjnZk)Gu3y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where is transthyretin producted?", 
                "The liver", 
                ""
            ], 
            "flags": 0, 
            "guid": "qc|s##Fh[#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the two main subtypes of ATTR amyloidosis", 
                "Wild type ATTR<div>Mutant ATTR (congenital)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "FOALl/r6~p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mean survival after diagnosis of ATTR amyloidosis", 
                "4 years", 
                ""
            ], 
            "flags": 0, 
            "guid": "wdLmey@j<z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the treatment of AL amyloidosis", 
                "Chemotherapy<div>Stem cell transplant</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PVO%(2|vhR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the management of ATTR amyloidosis", 
                "Supportive care - very poor prognosis", 
                ""
            ], 
            "flags": 0, 
            "guid": "xy]<N:)qZH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 findings seen in athlete's heart", 
                "Atrial tachyarrythmias (AF)<div>LA dilatation</div><div>Some degree of LVH</div><div>Some have late gadolinium enhancement (10%)</div><div>LV dilatation (best discriminatory from HCM where this does not occur)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s^F`5jDJtD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is septal reduction with surgery or ETOH indicated in HCM?", 
                "Symptoms with exercise, and<div>Significant inducible LVOT gradient</div><div>After failing medical therapy</div><div><br /></div><div>Only improves symptoms not mortality</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KHFQ}&#VE{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient presents with signs, symptoms, and ECG consistent with takotsubo. Troponin is raiased. What is the next step?", 
                "Angiogram to exclude coronary artery stenosis (always)", 
                ""
            ], 
            "flags": 0, 
            "guid": "PI=.dIUo0W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is family history of sudden cardiac death a risk factor in patients with ARVC?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "bH{ggKR$s3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ARVC pattern of inheritance", 
                "Autosomal dominant<div>Variable penetrance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ilmK(w*cl`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the 5 risk factors for sudden cardiac death in ARVC?", 
                "Sustained VT<div>History of arrest</div><div><br /></div><div>Unexplained syncope</div><div>Nonsustained VT on holter...</div><div>1 more (check slides from cardiology course) (it isn't family history)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J!e10)RZgP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Risk factors for sudden cardiac death in HCM (6)", 
                "<div>Previous sudden cardiac arrest</div><div>Family history of SCD</div>Septal thickness &gt; 30mm<div>Abnormal haemodynamic response to exercise (ventricular tachyarrythmia, BP drop)</div><div>&gt; 15% fibrosis on cardiac MRI</div><div>Apical aneurysm</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LmNJ-jm@%,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e19ed494e6a347f6b02e0e386e0c73f0-oa-1", 
                "", 
                "<img src=\"tmp5lxwog.png\" />", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-1-A.svg\" />", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "h[Yp7Nx(:v", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e19ed494e6a347f6b02e0e386e0c73f0-oa-2", 
                "", 
                "<img src=\"tmp5lxwog.png\" />", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-2-A.svg\" />", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "J3TdRA$.za", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e19ed494e6a347f6b02e0e386e0c73f0-oa-3", 
                "", 
                "<img src=\"tmp5lxwog.png\" />", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-3-A.svg\" />", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "u`##woTPYz", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e19ed494e6a347f6b02e0e386e0c73f0-oa-4", 
                "", 
                "<img src=\"tmp5lxwog.png\" />", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-4-A.svg\" />", 
                "<img src=\"e19ed494e6a347f6b02e0e386e0c73f0-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "G$SV@j-~c.", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long does a cardiac myosite action potential last", 
                "200-400msec<div>about 100 times longer than a normal action potential</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Mq&WoeC1$<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe pacemaker potential", 
                "Unique feature of conducting system myocytes<div>Slow influx of sodium (slow depolarisation)</div><div>When reaches threshold, depolarisation is due to rapid influx of calcium (different to normal myocytes, where it is sodium!)</div><div>Rapid outfux of K cases repolarisation</div><div><br /></div><div><img src=\"paste-25718264168449.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vqFMv]f^nu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which class of antiarrythmic drugs has the greatest effect on conduction velocity", 
                "Class Ic has greatest effect on conduction velocity", 
                ""
            ], 
            "flags": 0, 
            "guid": "d<4<V~Li=k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What difference in the JVP might you see between constrictive pericarditis and tamponade?", 
                "Flat Y descent in tamponade as the atria are trying to eject blood into the RV but the RV is under pressure, so it is not able to fill well<div>Constrictive has rapid Y descent</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mqBvQ/2|vL", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 signs on right heart cath that are hallmarks of constriction", 
                "Rapid Y descent<div>Raised and equalised end diastolic pressures<br /><div>Square root sign (rapid fall in diastolic pressyre, then rapid rise and then plateau due to the 'fixed box')</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KZ/t6v#U,3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most cardioselective bb?", 
                "Nebivolol", 
                ""
            ], 
            "flags": 0, 
            "guid": "lF*xj~Y4^,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the 4 cardioselective beta blockers", 
                "Atenolol<div>Bisoprolol</div><div>Metoprolol</div><div>Nebivolol (most)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "?@9zN3D5:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do you switch from ACE to ARNI?", 
                "Stop ACE 36hrs prior to starting ARNI", 
                ""
            ], 
            "flags": 0, 
            "guid": "eRVh){TH}_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 side effects of ticagrelor", 
                "Unexplained paroxysms of dyspnoea (short, last seconds)<div>Asymptomatic ventricular pases</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pup#H*`;>x", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 contraindications to prasugrel", 
                "Age &gt; 75<div>Weight &lt; 60kg</div><div>History of stroke/TIA</div><div>Not known coronary anatomy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s57Y;(o8)s", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long does it take for platelets to recover function from a P2Y12 inhibtor?", 
                "5 days (new platelets that are not blockaded)", 
                ""
            ], 
            "flags": 0, 
            "guid": "dg1S`[ksk+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does dabigatran work", 
                "Factor IIa (thrombin) inhibitor", 
                ""
            ], 
            "flags": 0, 
            "guid": "O#nz>6I$r}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is non-valvular AF?", 
                "Moderate or severe mitral stenosis<div>Any prosthetic mitral valve</div><div><br /></div><div>These patients are NOT suitable for NOACs</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lAj;D&QwKD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients are not suitable for NOAC anticoagulation for AF?", 
                "Moderate or severe mitral stenosis<div>Any prosthetic mitral valve</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mcPQK^YMWx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do you reverse dabigatran?", 
                "Idaricizumab", 
                ""
            ], 
            "flags": 0, 
            "guid": "Hfkj({qQ1t", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 indications for bridging anticoagulation prior to a procedure", 
                "<div>Mechanical heart valves</div>- Mitral valve prosthesis (any)<div>- Cage ball or tilting single disc aortic valve</div><div>- Stroke/TIA &lt;6 months</div><div>AF</div><div>- CHADSVASC 5 or higher</div><div>- Stroke/TIA &lt;3 months ago</div><div>- Rheumatic valvular heart disease</div><div>VTE</div><div>- high risk thrombophilia</div><div>- VTE &lt; 3 months ago</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z;EH}5>|KO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do most patients on therapeutic anticoagulation require bridging prior to a procedure?", 
                "No, only if very high risk", 
                ""
            ], 
            "flags": 0, 
            "guid": "vIS8]/X*uH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients without CAD at high risk of developing CAD, how helpful is the mediterranean diet?", 
                "1/3 reduction in risk of development of CAD", 
                ""
            ], 
            "flags": 0, 
            "guid": "h1b8cCqfdE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Above what age does being female get you a point on the CHADSVASC score?", 
                "age &gt; 65<div>otherwise do not get a point</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f.4}.^]P[@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does giving adrenaline during CPR help to improve outcomes?", 
                "Increases aortic diastolic pressure -&gt; increased coronary perfusion and cerebral perfusion", 
                ""
            ], 
            "flags": 0, 
            "guid": "sf,FRN{+G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the P2Y12 inhibitor of choice prior to thrombolysis + transfer for STEMI?", 
                "Clopidogrel", 
                ""
            ], 
            "flags": 0, 
            "guid": "emm}09rX6C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most important intervention in ACS with cardiogenic shock?", 
                "Early revascularisation", 
                ""
            ], 
            "flags": 0, 
            "guid": "h?oUxvvmUZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mortality of cardiogenic shock in ACS?", 
                "44%", 
                ""
            ], 
            "flags": 0, 
            "guid": "mfIKNMlpqi", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do men or women have worse mortality after STEMI?", 
                "Women, irrespective of age and revascularisation method<div>In age &lt; 60, OR 1.88</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Hwc(=)<&w|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Are women equally represented (proportional to disease prevalence) compared to men in cardiovascular disease trials?", 
                "No, very underrepresented (except pulmonary HTN)<div>Suggests selection bias in many trials</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GS~Z,cKcy$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In what conditions is prophylaxis required to prevent endocarditis?", 
                "<img src=\"paste-42404212113409.jpg\" />", 
                ""
            ], 
            "flags": 0, 
            "guid": "uI>uDf8n*w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What dental procedures is endocarditis prophylaxis always required for in patients with appropriately high risk cardiac conditions? (4)", 
                "<img src=\"paste-42601780609025.jpg\" />", 
                ""
            ], 
            "flags": 0, 
            "guid": "x()9F^h#u~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which anti-inflammatory raises BP the most?", 
                "Ibuprofen (by around 4mmHg)<div><br /></div><div>Celecoxib is best (no change)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KQTH*V3Lx]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common symptom associated with HFpEF", 
                "Exertional dyspnoea", 
                ""
            ], 
            "flags": 0, 
            "guid": "hV/:m3|bLD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does eplerenone cause gynaecomastia?", 
                "No<div>Spironolactone does</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oqOT@_LGJ_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "SOBOE in heart failure is due to &nbsp;(3)", 
                "endothelial dysfynction in peripheral vessels<div>skeletal muscle atrophy</div><div>inability to increase stroke volume</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sl&f;q~f<C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Anticoagulation is recommended for 2 - 4 weeks after cardioversion for AF. Why?", 
                "Atrial stunning", 
                ""
            ], 
            "flags": 0, 
            "guid": "Kn$EF5j@7q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long is anticoagulation required for after cardioversion for AF?", 
                "2 - 4 weeks (atrial stunning)", 
                ""
            ], 
            "flags": 0, 
            "guid": "qchg0J<A<c", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is tachyphylaxis?", 
                "Tolerance, occurs with nitrates", 
                ""
            ], 
            "flags": 0, 
            "guid": "G3j.YVGeLO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is tachyphylaxis avoided in nitrates?", 
                "Ensure nitrate-free period for 8 - 12 hours per day", 
                ""
            ], 
            "flags": 0, 
            "guid": "x_1c6l(EgA", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is Alirocumab?", 
                "PCSK9 inhibitor", 
                ""
            ], 
            "flags": 0, 
            "guid": "z9jWbI7#UG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Infective endocarditis is infection if which layer of the heart?", 
                "Endothelial layer", 
                ""
            ], 
            "flags": 0, 
            "guid": "I+Mk4[vyUs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which has higher infective endocarditis risk, mechanical or bioprosthetic valve replacement?", 
                "Equivalent", 
                ""
            ], 
            "flags": 0, 
            "guid": "J{Zhm]YOu4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the risk per year of infective endocartitis in non-native valves?", 
                "1-4% in first year<div>1% per year after that</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vM*[Gh|F*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 factors that increase risk of endocarditis", 
                "Rheumatic fever with valve damage<div>Degenerative valve disease</div><div>Previous endocarditis</div><div>Prosthetic valves</div><div>Unrepaired cyanotic congenital heart disease</div><div>Congenital heart disease - AS, bicuspid AV, PDA, coarctation, VSD, tetralogy</div><div>Intracardiac devices</div><div>IVDU</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j]98BEHy$<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Patients with intracardiac devices are predisposed to endocarditis. On which side of the heart does this typically occur?", 
                "Right side", 
                ""
            ], 
            "flags": 0, 
            "guid": "pKeFg?RR&d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 sources of bacteraemia that are associated with endocarditis", 
                "Dental work<div>Bowel flora from underlying bowel disease</div><div>Skin flora from IV lines or skin procedures</div><div>IVDU</div><div>Intravascular devices</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JCpoq^V*$d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 ways in which endocarditis may present", 
                "Acute illness over hours to days with fever, hypotension, emboli, heart failure (more common with aggressive organisms like staph aureus)<div>Subacute presentation over weeks to months with fever, night sweats, weight loss, subacute heart failure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B`cdehsSun", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "IVDU patient presents with fever and symptoms consistent with pneumonia. What differential needs to be considered?", 
                "Infective endocarditis<div>Septic emboli to the lungs can masquerade as pneumonia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sZEQX!$?fO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 signs of endocarditis", 
                "Osler's node<div>Conjunctival haemorrhage</div><div>Splinter haemorrhage (more proximal = more likely to be significant)</div><div>Janeway lesions</div><div>New murmur</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lJ1f;S`^7i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 bacteria that, when present as a bacteraemia, indicate a high liklihood of endocarditis", 
                "Srep mutans (ratio of IE to non IE 14:1)<div>Strep gallolyticus (6:1)</div><div>Strep sanguis (3:1)</div><div>Strep mitis (2:1)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rW!7d@!wx/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the two most common organisms in endocarditis", 
                "<div>Staph aureus (31%)</div>Strep viridans (17%)", 
                ""
            ], 
            "flags": 0, 
            "guid": "E(pMjnK.E6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 organisms that, when present in endocarditis, rapidly destroy the valve", 
                "Staph aureus<div>Candida</div><div>Pseudomonas</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N6hp21]/}O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 bacteria that are likely to cause a subacute presentation of endocarditis", 
                "Strep viridans<div>Strep mutans</div><div>Strep gallolyticus</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fVS^#-QmPh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Coagulase negative staph is found in what percentage of endocarditis?", 
                "11%", 
                ""
            ], 
            "flags": 0, 
            "guid": "roSJmay(,@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the HACEK organisms?", 
                "Aggregatibacter paraphrophilus<div>Aggregatibacter actinomycetemcomitans</div><div>Cardiobacterium hominis</div><div>Eikenella corrodens</div><div>Kingella kingae</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z%#0pI#1?]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the characteristics of the HACEK group of organisms (5)", 
                "<div>Gram negative</div><div>Oral origin</div>Resistant to penicillin<div>Sensitive 3rd generation cephalosporins (ceftriaxone)</div><div>Cause 2% of endocarditis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M&L/Bnz>I>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of endocarditis is culture negative", 
                "7%", 
                ""
            ], 
            "flags": 0, 
            "guid": "zTHY|^Nv7R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 causes of culture negative endocarditis", 
                "Streptococci with preceding antibiotic therapy<div>Bartonella</div><div>Q fever</div><div>Psittacosis</div><div>Legionella</div><div>Tropheryma whipplei</div><div>Brucellosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K?4uFUQ(ur", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient has culture negative endocarditis. Serology for which organisms should be performed seeking the cause? (5)", 
                "Bartonella<div>Q fever</div><div>Tropheryma whipplei</div><div>Psittacosis</div><div>Brucella</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dn>qg0)|R^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Early endocarditis post prosthetic valve surgery is most likely due to what organisms", 
                "<div>Staph aureus</div>Coagulase negative staph<div>Corynebacterium species</div><div>Propionibacterium acnes<br /><div><br /></div></div><div>The latter 3 tend to be subacute while staph aureus is acute</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q?gnzs2$]f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Late infection of prosthetic valve (endocarditis) tends to be due to what organisms? (2)", 
                "Same as native valve endocarditis:<div>Staph aureus</div><div>Strep viridans</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lN$a,+]Z;v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of patients with right sided endocarditis will have pneumonia/septic pulmonary emboli?", 
                "75%", 
                ""
            ], 
            "flags": 0, 
            "guid": "ekNkt]9YzG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which side is more commonly involved in endocarditis in IVDU?", 
                "Left side 57%<div>Right side 40%</div><div>Both sides 16%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pUj?N!AA0*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "An IVDU patient presents with endocarditis. TTE shows right sided endocarditis. Is a TOE necessary?", 
                "Yes<div>TOE is generally necessary to obtain good views of the left side<br /><div>Need to exclude bilateral involvement and need for surgery</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q!!VD~0uu.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient presents with stroke. They are febrile. What must be considered to be the cause until proven otherwise?", 
                "Infective endocarditis", 
                ""
            ], 
            "flags": 0, 
            "guid": "x0KQ.Iy8:(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How many sets of blood cultures should be sent in a patient with suspected endocarditis prior to starting antibiotics?", 
                "3 sets", 
                ""
            ], 
            "flags": 0, 
            "guid": "j5)eAd9xof", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "86fcf23a5df443fe915a0c8d3b527216-ao-1", 
                "What is the sensitivity and specificity of the following investigations in infective endocarditis?", 
                "<img src=\"tmptcmooy.png\" />", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-1-A.svg\" />", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "j@c3s?!Obd", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "86fcf23a5df443fe915a0c8d3b527216-ao-2", 
                "What is the sensitivity and specificity of the following investigations in infective endocarditis?", 
                "<img src=\"tmptcmooy.png\" />", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-2-A.svg\" />", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "EowSw3.l<*", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "86fcf23a5df443fe915a0c8d3b527216-ao-3", 
                "What is the sensitivity and specificity of the following investigations in infective endocarditis?", 
                "<img src=\"tmptcmooy.png\" />", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-3-A.svg\" />", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "HrHlx9>/`q", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "86fcf23a5df443fe915a0c8d3b527216-ao-4", 
                "What is the sensitivity and specificity of the following investigations in infective endocarditis?", 
                "<img src=\"tmptcmooy.png\" />", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-4-A.svg\" />", 
                "<img src=\"86fcf23a5df443fe915a0c8d3b527216-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "N2O~l$Ywdu", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can a negative TTE exclude endocarditis?", 
                "No, sensitivity is not high enough (50% prosthetic valve, 70% native valve)", 
                ""
            ], 
            "flags": 0, 
            "guid": "Gfo@0`AygO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the major criteria according to the Duke criteria for endocarditis? (5)", 
                "Microbiologic<div>- Typical bugs in two bottles, or</div><div>- Persistently positive blood cultures, or</div><div>- Positive serology for C. burnetti (q fever)</div><div><br /></div><div>Endocardial involvement</div><div>- Oscillating mass, abscess, new partial dehiscence of prosthetic valve, or</div><div>- New valvular regurgitation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KjPD~]@.CT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the modified Duke criteria for diagnosis of infective endocarditis", 
                "Vegetation or intracardiac abscess demonstrating active endocarditis on histology, OR<div>Microorganism demonstrated by culture or histology of a vegetation or intracardiac abscess, OR</div><div>Meeting&nbsp;2 major,&nbsp;1 major and 3 minor, or all 5 minor criteria</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e/BJ$A%v7d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the 'typical' organismis in infective endocarditis according to the Duke criteria? (5)", 
                "Staph aureus<div>Viridans strep</div><div>Strep gallolyticus</div><div>HACEK organism</div><div>Community acquired enterococci</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wW)kR+@~`&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the minor criteria for endocarditis according to modified Duke criteria?", 
                "<div>Intravenous drug use or presence of a predisposing heart condition</div><div>Fever</div><div>Vascular phenomena: Major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, or Janeway lesions</div><div>Immunologic phenomena: Glomerulonephritis, Osler nodes, Roth spots, or rheumatoid factor</div><div>Microbiologic evidence: Positive blood cultures that do not meet major criteria OR serologic evidence of active infection with organism consistent with IE</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yv_7H+!K9#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 complications of infective endocarditis", 
                "Heart failure from valvular dysfunction (acute or subacute)<div>Embolisation</div><div>Periannular extension of infection</div><div>Splenic abscess</div><div>Mycotic aneurysm</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M8ahk2O-(U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 risk factors for embolisation in infective endocarditis", 
                "Vegetation &gt; 1cm<div>Anterior mitral valve vegetation</div><div>Staph aureus cause</div><div>First week of antibiotic treatment</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wFB`]>|X^=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which respiratory tract procedures require endocarditis prophylaxis in patients who meet criteria? (3)", 
                "Invasive ear/nose/throat or respiratory tract procedure to treat an established infection (eg drainage of abscess)<div>Tonsillectomy or adenoidectomy</div><div><br /></div><div>In procedures where routine prophylaxis is used, these patients should receive the same routine regimen as other patients</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "it+A:`w$S6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which gastrointestinal and genitourinary tract procedures require endocarditis prophylaxis in patients who meet criteria? (2)", 
                "Suspected or confirmed genitourinary tract or intra-abdominal infection (regardless of whether a procedure is involved)<div>Genitourinary or gastrointestinal tract procedure where surgical antibiotic prophylaxis is routinely indicated</div><div><br /></div><div>In both instances, choose an agent that covers enterococci</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x|`LkZD2ah", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the standard antibiotic prophylaxis to prevent endocarditis in at-risk patients undergoing at-risk dental procedures?", 
                "Amoxicillin 2g PO, or<div>Amoxy/ampicillin 2g IV/IM</div><div><br /></div><div>Give 1 hour pre procedure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bU`F&}0P!*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the standard antibiotic prophylaxis to prevent endocarditis in at-risk patients undergoing at-risk dental procedures, who have non-immediate hypersensitivity to penicillin?", 
                "Cephalexin 2g PO (1 hour prior), or<div>Cephazolin 2g IV (15-30min prior), or</div><div>Cephazolin 2g IM (30min prior)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qhq]GjHFy]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the standard antibiotic prophylaxis to prevent endocarditis in at-risk patients undergoing at-risk dental procedures who have immediate hypersensitivity to penicillin?", 
                "Clindamycin 600mg PO/IV (1 hour prior)", 
                ""
            ], 
            "flags": 0, 
            "guid": "i]l3NkN5GM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What antibiotic prophylaxis may be used in at-risk patients undergoing at-risk genitourinary or gastrointestinal procedures, or with GU/GI infection?", 
                "Use the recommended surgical prophylaxis or treatment<div>If this does not include enterococci cover, add:</div><div><br /></div><div>amoxy/ampicillin 2g IV or IM</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JI7s,X5UW9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What antibiotic prophylaxis may be used in at-risk patients undergoing at-risk genitourinary or gastrointestinal procedures, or with GU/GI infection, who are hypersensitive to penicillin?", 
                "Use the recommended surgical prophylaxis or treatment<div>If this does not include enterococci cover, add:</div><div><br /></div><div>vancomycin, or</div><div>teicoplanin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q0tc6jegbM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the empiric treatment of native valve endocaritis?", 
                "<div>gentamicin IV, once daily</div><div>PLUS</div><div>benzylpenicillin 1.8 g IV, 4-hourly</div><div>PLUS</div><div>flucloxacillin 2 g IV, 4-hourly</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L<&om|BgRI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with native valve endocarditis who require empiric therapy and MRSA is suspected, what should be used?", 
                "<div>gentamicin IV, once daily; see Appendix 2.2 for dosage and principles of use</div><div>PLUS</div><div>Vancomycin IV</div><div>PLUS</div><div>flucloxacillin 2 g (child: 50 mg/kg up to 2 g) IV, 4-hourly.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n+4Bxh5h$q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the empiric treatment of native valve endocaritis in patients with nonimmediate penicillin hypersensitivity?", 
                "<div>gentamicin IV, once daily</div><div>PLUS</div><div>vancomycin IV</div><div>PLUS EITHER</div><div>cefalotin 2 g IV, 4-hourly</div><div>OR</div><div>cephazolin 2 g IV, 8-hourly.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s=(DruAv>K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the empiric treatment of native valve endocaritis in patients with immediate penicillin hypersensitivity?", 
                "<div>gentamicin IV</div><div>PLUS</div><div>vancomycin IV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E$$x)=LpAM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the empiric treatment of prosthetic valve endocaritis?", 
                "<div>gentamicin IV, once daily</div><div>PLUS</div><div>flucloxacillin 2 g IV, 4-hourly</div><div>PLUS</div><div>vancomycin IV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dARLPu%8k8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the empiric treatment of prosthetic valve endocaritis and nonimmediate penicillin hypersensitivity?", 
                "<div>Gentamicin IV, once daily</div><div>PLUS</div><div>vancomycin IV</div><div>AND EITHER</div><div><div>cefalotin 2 g IV, 4-hourly</div><div>OR</div><div>cephazolin 2 g IV, 8-hourly.&nbsp;</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uIFZO+jeJ=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the empiric treatment of prosthetic valve endocaritis and immediate penicillin hypersensitivity?", 
                "<div>gentamicin IV, once daily;</div><div>PLUS</div><div>vancomycin IV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B4zoTn/$xH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the targeted antibiotic management of endocarditis due to viridans strep", 
                "Benzylpenicillin<div>AND</div><div>Gentamicin</div><div>For 2 - 4 weeks</div><div><br /></div><div>Can also use benzylpenicillin alone or ceftriaxone in uncomplicated disease with low MIC</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ml(eQB||?-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What extra caution must be taken in treating patients with viridans strep?", 
                "Can be resistant to penicillin (20%)<div>Need to check the minimum inhibitory concentration (MIC)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x8|nqZ)=E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the targeted management of enterococcal IE", 
                "Gentamicin&nbsp;<div>AND</div><div>Benzylpenicillin&nbsp;</div><div>OR&nbsp;</div><div>Amoxy/ampicillin</div><div><br /></div><div>For 4 - 6 weeks</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f%(2cCn+uX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the targeted therapy for staphylococcus endocarditis", 
                "Flucloxacillin 2g IV 4 hourly for 4 - 6 weeks", 
                ""
            ], 
            "flags": 0, 
            "guid": "OQzT!/eQ0<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with staph aureus endocarditis may be eligible for a shortened course of flucoxacillin (2 weeks)? (7)", 
                "<div>No prosthetic valve</div><div>Right sided lesion</div><div>No metastatic infection</div><div>No complications</div><div>Vegetation smaller than 20 mm</div><div>Clinical and microbiological response within 72 to 96 hours of starting therapy</div><div>No severe immunosuppression</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g&/rO)WHG^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the targeted antibiotic therapy for MRSA endocaritis", 
                "Vancomycin 4- 6 weeks", 
                ""
            ], 
            "flags": 0, 
            "guid": "e}CV[xxY,d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the targeted antibiotic therapy for patients with HACEK group endocarditis&nbsp;", 
                "Ceftriaxone 2g IV daily, or<div>Cefotaxime 2g IV 8hrly</div><div><br /></div><div>For 4 - 6 weeks</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I84sTZiz/E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the antibiotic therapy for culture negative endocarditis?", 
                "Ceftriaxone or benzylpenicillin for 3-4 weeks, AND<div>Gentamicin for 2 weeks</div><div><br /></div><div>To cover bartonell, streptococci, HACEK</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F/hF<@|+Nl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the directed therapy for Q fever endocarditis", 
                "Doxycycline, AND<div>Plaquenil, AND</div><div>Rifampicin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G,Rh}XSkRX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the directed therapy for bartonella endocarditis", 
                "Aminoglycoside, plus<div>Ceftriaxone</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ng112!{7Z{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 indications for surgery in native valve endocarditis", 
                "Heart failure<div>AR or MR with raised LVED or LA pressure or moderate/severe pulmonary hypertension</div><div>Fungal or other highly resistant organism</div><div>Heart block, annular/aortic abscess, fistula, mitral leaflet perforation in AV endocarditis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kE!A`jWQP*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define pyrexia of unknown origin", 
                "Fever &gt; 2 - 3 weeks<div>No diagnosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y$*P,d^VAm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 3 most common causes of pyrexia of unknown origin, in broad categories", 
                "Infection<div>Connective tissue disease</div><div>Malignancy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qV,9y3pR+|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 infective causes of pyrexia of unknown origin", 
                "Subacute bacterial endocarditis<div>TB</div><div>Intra-abdominal abscess</div><div>HIV opportunistic infection e.g. cryptococcus, MAC</div><div>Other: EBV, CMV, brucella, Q wever, psittacosis, malaria</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "o5*#]J@n^P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 connective tissue and immunologic diseases that make cause pyrexia of unknown origin", 
                "Polymyalgia rheumatica<div>Giant cell arteritis</div><div>Vasculitis</div><div>Adult onset Still's disease</div><div>SLE</div><div>Thyroiditis</div><div>Granulomatous disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nhjP3iDc>a", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 malignancies that are associated with pyrexia of unknown origin", 
                "Lymphoma<div>Renal cell carcinoma</div><div>Hepatoma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dH2|El(XY/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 causes of a transudate pleural effusion", 
                "Heart failure<div>Cirrhosis</div><div>Nephrotic syndrome</div><div>SVC obstruction</div><div>Peritoneal dialysis</div><div>Glomerulonephritis</div><div>Hypoalbuminaemia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e/=#:H,F.f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 10 broad causes of an exudative pleural effusion", 
                "Neoplastic<div>Drug induced</div><div>Infectious</div><div>PE</div><div>Chylothorax</div><div>Gastrointestinal</div><div>Haemothorax</div><div>Cardiac</div><div>Obstetric</div><div>Rheumatologic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NUQdq{C(Nn", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are Light's criteria?", 
                "<div>Used to diagnose pleural effusion as exudate or transudate</div><div><br /></div>Pleural fluid protein:serum protein ratio &gt; 0.5, OR<div>Pleural fluid LDH:serum LDH ratio &gt; 0.6, OR</div><div>Pleural fluid LDH &gt; 2/3 upper limit of normal serum LDH</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xZ_YD3wSJ|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of pleural effusions will be incorrectly identified as exudate using Light's criteria?", 
                "8 - 25%", 
                ""
            ], 
            "flags": 0, 
            "guid": "J8eQ|j8j2e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with a suspected transudative pleural effusion meets Light's criteria for exudative effusion. What other factors can be looked at to support a diagnosis of transudate? (3)", 
                "Serum:pleural protein gradient &gt; 31g/L<div>Serum: pleural albumin gradient &gt; 12g/L<br /><div>Pleural fluid total protein concentration &lt; 30g/L</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g@*`qM]t+p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 1 year mortality of patients with CCF and a transudative pleural effusion?", 
                "50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "LOF8=OUG36", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 1 year mortality for patients with renal failure with associated transudative pleural effusion?", 
                "46%", 
                ""
            ], 
            "flags": 0, 
            "guid": "y&F1bI^L&E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 1 year mortality for hepatic failure and associated transudative pleural effusion?", 
                "25%", 
                ""
            ], 
            "flags": 0, 
            "guid": "scDa%uJPxb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of transudates are due to cardiac failure?", 
                "80%", 
                ""
            ], 
            "flags": 0, 
            "guid": "N+>T9&6TyT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient presents with a new pleural effusion. Cardiac failure is suspected as a cause. Name 1 test that may be performed on the pleural fluid to support this diagnosis", 
                "NT-proBNP (correlates well with serum)<div>Reduces missclassification by Light's criteria (common with diuretic use)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LIB@(32Q@v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 pleural fluid factors that would support the diagnosis of a parapneumonic effusion", 
                "Neutrophilic exudative effusion<div>CRP in pleural fluid &gt; 45, even better if &gt;100</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D|Vjt^`lE<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 test that may be performed on pleural fluid to support the diagnosis of pleural TB", 
                "Adenosine deaminase<div><br /></div><div>(pleural fluid microscopy yield &lt; 30%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PQD6MV,?77", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the sensitivity of bronchial washings for pleural TB?", 
                "7%", 
                ""
            ], 
            "flags": 0, 
            "guid": "xWw`3;N2Tf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 tests that may be performed to diagnose pleural TB", 
                "Pleural fluid&nbsp;ADA and lymphocyte:neutrophil ratio &gt; 0.75 (sensitivity 89%)<div>Pleural biopsy (Abram's needle) with culture and AFB (sensitivity 79%) - not used in developed countries</div><div>Both of the above: sensitivity 94%</div><div><br /></div><div>Thoracoscopy with histology and AFB stain (sensitivity 100%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ltge^UlIeZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is pleural fluid culture a good method to diagnose pleural TB in patients with a pleural effusion?", 
                "No<div>Sensitivity only 7% (100% specific)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qnR1jqugf^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 biomarkers seen in pleural fluid or serum in mesothelioma", 
                "<div>Mesothelin</div><div>Fibulin 3</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A-GiY2ZbE^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 types of mesothelioma", 
                "Epitheliod&nbsp;<div>Sarcomatoid (more aggressive)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D{aAYfEIIb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52781e8155c04b6c82ee099b758e50c8-ao-1", 
                "", 
                "<img src=\"tmpcmpnvo.png\" />", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-1-A.svg\" />", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "u#bK%5k@xT", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52781e8155c04b6c82ee099b758e50c8-ao-2", 
                "", 
                "<img src=\"tmpcmpnvo.png\" />", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-2-A.svg\" />", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Hb=kue(@>?", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52781e8155c04b6c82ee099b758e50c8-ao-3", 
                "", 
                "<img src=\"tmpcmpnvo.png\" />", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-3-A.svg\" />", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "n7,0nC2e+]", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52781e8155c04b6c82ee099b758e50c8-ao-4", 
                "", 
                "<img src=\"tmpcmpnvo.png\" />", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-4-A.svg\" />", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "tHS,L8f/JQ", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "52781e8155c04b6c82ee099b758e50c8-ao-5", 
                "", 
                "<img src=\"tmpcmpnvo.png\" />", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-5-A.svg\" />", 
                "<img src=\"52781e8155c04b6c82ee099b758e50c8-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "m=/SCBWXyY", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "bbf40be7fba14a59b224ab47ee07a4b5-ao-1", 
                "", 
                "<img src=\"tmpvftffn.png\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-1-A.svg\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "iXcz1X/>{P", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "bbf40be7fba14a59b224ab47ee07a4b5-ao-2", 
                "", 
                "<img src=\"tmpvftffn.png\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-2-A.svg\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "LB:.@~Bx>)", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "bbf40be7fba14a59b224ab47ee07a4b5-ao-3", 
                "", 
                "<img src=\"tmpvftffn.png\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-3-A.svg\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "uw7:OmX>@j", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "bbf40be7fba14a59b224ab47ee07a4b5-ao-4", 
                "", 
                "<img src=\"tmpvftffn.png\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-4-A.svg\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "vrH|lj=L0z", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "bbf40be7fba14a59b224ab47ee07a4b5-ao-5", 
                "", 
                "<img src=\"tmpvftffn.png\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-5-A.svg\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "t=[t!DQ|[s", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "bbf40be7fba14a59b224ab47ee07a4b5-ao-6", 
                "", 
                "<img src=\"tmpvftffn.png\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-6-A.svg\" />", 
                "<img src=\"bbf40be7fba14a59b224ab47ee07a4b5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "H$fV1XewtL", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What does a pH &lt; 7.2 in pleural fluid in patients with parapneumonic effusion indicate?", 
                "Need for pleural drainage", 
                ""
            ], 
            "flags": 0, 
            "guid": "jzQjTP!tE,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 indictions for pleural drainage in parapneumonic effusion based on fluid biochemistry", 
                "pH &lt; 7.2<div>Glucose &lt; 2.2</div><div><br /></div><div>These are markers for 'complicated' effusions</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ghYB,t)T9l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which is the better test for complex paraneumonic effusion, pH or glucose?", 
                "Glucose<div><br /></div><div>Delay to processing increases pH (may rise to a falsely reassuring level)</div><div>Glucose is stable</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n~i;bNgcN:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of infective pleural effusion will have no organism identified?", 
                "26%", 
                ""
            ], 
            "flags": 0, 
            "guid": "Olvwzr^FLq", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "what is the causative pathogen in q fever?", 
                "Coxiella burnetii", 
                ""
            ], 
            "flags": 0, 
            "guid": "h]6$6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do atypical organisms cause pleural space infection?", 
                "No.<div>Cover for atypicals is not required.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "^TjLWhQ=H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 medications that, in addition to antibiotics, can improve outcomes in pleural infection in patients in whom standard therapy has failed and are not candidates for thoracic surgery", 
                "DNase<div>tPA</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gc)vx`Y<dK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with pleural infection require an ICC? (4)", 
                "Macroscopically purulent, or<div>Gram stain/culture positive, or</div><div>pH &lt; 7.2, or</div><div>pH &gt; 7.2 and failed trial of antibiotics (increasing size or nonresolving sepsis)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tkl0L1!W;m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient presents with suspected pleural infection. Describe your management. (5)", 
                "Pleural fluid tap for biochem and culture (plain and blood culture bottle)<div>Broad spectrum antibiotics (without atypical cover)</div><div>Insert ICC if:</div><div>- Macroscopically purulent, or<div>- Gram stain/culture positive, or</div><div>- pH &lt; 7.2, or</div><div>- pH &gt; 7.2 and failed trial of antibiotics (increasing size or nonresolving sepsis)</div></div><div>If ongoing sepsis or large residual collection, refer for surgical drainage and VATS</div><div>If not candidate for OT, tPA and DNase</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "co<8I<CK2!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 management options for malignant pleural effusion", 
                "VATS<div>Repeat thoracentesis</div><div>Slurry pleurodesis (talc)</div><div>Indwelling pleural catheter</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l!JIOo%~XA", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does VATS compare to indwelling pleural catheter for malignant pleural effusion management? (3)", 
                "No difference in dyspnoea, chest pain, quality of life<div>Shorter length of stay</div><div>Increased complications (infection)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z`:9Sf@3$4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In what percentage of patients with an active malignancy and a pleural effusion will the effusion be due to the malignancy?", 
                "50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "w{J(HCylns", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role for pleural biopsy in patients with suspected pleural infection?", 
                "Increases yield when done in addition to pleural fluid culture (from 20% to 45%)<div>Can be done under ultrasound at time of pleural fluid sampling</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G6z829ckgG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "At what rate do patients progress from compensated to decompensated liver cirrhosis?", 
                "5-7% per year", 
                ""
            ], 
            "flags": 0, 
            "guid": "Bf^CAsYeM@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the median survival of compensated liver cirrhosis?", 
                "12 years", 
                ""
            ], 
            "flags": 0, 
            "guid": "f^kH?O-x+4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the median survival of decompensated liver cirrhosis?", 
                "2 years", 
                ""
            ], 
            "flags": 0, 
            "guid": "ycXGn.B1@B", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how cirrhosis leads to complications such as ascites, hyponatraemia, and hepatorenal syndrome. (6)", 
                "Cirrhosis -&gt;<div>Intrahepatic resistance (due to fibrosis of the sinusoids) -&gt;</div><div>Portal (sinusoidal) hypertension -&gt;</div><div>Increased splanchnic/systemic vasodilation (which leads to high cardiac output and high output cardiac failure) -&gt;</div><div>Greatly reduced effective arterial blood flow -&gt;</div><div>RAAS activation (sodium/water retention, renal vasoconstriction)</div><div><br /></div><div>Water retention causes hyponatraemia</div><div>Sodium retention causes refractory ascites</div><div>Renal vasocontriction causes reduced renal blood flow and hepatorenal syndrome (can also be due to high output cardiac failure)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "FCrmfe=2;f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e166cc3270146619840bd9235d3d698-ao-1", 
                "Management of complications of liver cirrhosis", 
                "<img src=\"tmpsavpu1.png\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-1-A.svg\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "J:JWJ{}jQS", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e166cc3270146619840bd9235d3d698-ao-2", 
                "Management of complications of liver cirrhosis", 
                "<img src=\"tmpsavpu1.png\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-2-A.svg\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "n(v0LJ4HS?", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e166cc3270146619840bd9235d3d698-ao-3", 
                "Management of complications of liver cirrhosis", 
                "<img src=\"tmpsavpu1.png\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-3-A.svg\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "BV1AFi!yto", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e166cc3270146619840bd9235d3d698-ao-4", 
                "Management of complications of liver cirrhosis", 
                "<img src=\"tmpsavpu1.png\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-4-A.svg\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "KXSe<a9xrT", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e166cc3270146619840bd9235d3d698-ao-5", 
                "Management of complications of liver cirrhosis", 
                "<img src=\"tmpsavpu1.png\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-5-A.svg\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "b[(c50Y7Vo", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e166cc3270146619840bd9235d3d698-ao-6", 
                "Management of complications of liver cirrhosis", 
                "<img src=\"tmpsavpu1.png\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-6-A.svg\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "G9IV[K,FnM", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e166cc3270146619840bd9235d3d698-ao-7", 
                "Management of complications of liver cirrhosis", 
                "<img src=\"tmpsavpu1.png\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-7-A.svg\" />", 
                "<img src=\"2e166cc3270146619840bd9235d3d698-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "q$2TX0S+o3", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients with compensated cirrhosis develop ascites each year?", 
                "5-10%", 
                ""
            ], 
            "flags": 0, 
            "guid": "uH,u7S*rKD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 5 year survival of patients with compensated liver cirrhosis who develop ascites?", 
                "30%<div>Should prompt referral for transplant assessment if a candidate.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A:|y+dc*JM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how cirrhosis leads to ascites", 
                "Effective hypovolaemia due to splanchnic arterial vasodilation<div>RAAS activation with sodium retention leads to positive fluid balnce</div><div>Extracellular fluid volume expansion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hM8?r2P;jm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What serum-ascites albumin gradient is indicative of portal hypertension as the cause of ascites?", 
                "&gt;11g/L", 
                ""
            ], 
            "flags": 0, 
            "guid": "t4[KOg}Z`E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What acitic fluid protein level increases risk of spontaneous bacterial peritonitis in patients with cirrhosis?", 
                "&lt;15g/L", 
                ""
            ], 
            "flags": 0, 
            "guid": "r,RllztoGg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the management of ascites in patients with cirrhosis?", 
                "Sodium restriction<div>Diuretics (spironolactone up to 400mg/day, better than frusemide as RAAS activation is the mechanism)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H}Y^Cv~378", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is refractory ascites in liver cirrhosis?", 
                "Ascites that does not respond to diuretics or recurrs quickly after large volume paracentesis (i.e.not prevented from recollecting by diuretics)<div>Diuretic should be stopped (to avoid renal side effects); paracentesis is mainstay</div><div>Poor prognosis (6 months median survival)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k3c!{g1etK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the required albumin replacement in paracentesis for liver cirrhosis", 
                "1 bottle 20% conc albumin per 2L drained", 
                ""
            ], 
            "flags": 0, 
            "guid": "B]3Vu)W;0}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the prevalence of spontaneous bacterial peritonitis in liver cirrhosis patients with ascites?", 
                "1.5 - 3.5% outpatients<div>10% inpatients</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kni$zOFZ&U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 criteria for diagnosis of spontaneous bacterial peritonitis on ascitic tap", 
                "<div>Leukocytes &gt; 500/mm<sup>3</sup></div>Neutrophils &gt; 250/mm<sup>3</sup>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Hfqn(}dR`0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of liver cirrhosis patients with spontaneous bacterial peritonitis will be culture negative?", 
                "60%", 
                ""
            ], 
            "flags": 0, 
            "guid": "CicktSo!7w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the empiric management of spontaneous bacterial peritonitis (2)", 
                "Ceftriaxone 2g &nbsp;IV daily<div>AND</div><div>Albumin 20% 100ml IV twice daily for 3 days</div><div><br /></div><div>Antiobiotic treatment duration 5 - 7 days</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mClMalaoC-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with liver cirrhosis require spontaneous bacterial peritonitis prophylaxis?", 
                "History of GI bleed (primary prevention)<div>History of spontaneous bacterial peritonitis (secondary prevention)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F5B?OQwRia", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the antibiotic prophylaxis for spontaneous bacterial peritonitis in appropriate patients with cirrhosis", 
                "If indicated due to GI bleed:<div>- norfloxacin 400mg BD for 2 days</div><div>If indicated as secondary prevention (following an episode of SBP):</div><div>- trimethoprim/sulfamethoxazole 160/800mg daily</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g>vm_0gcO$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 1 year survial of patients with liver cirrhosis who develop spontaneous bacterial peritonitis?", 
                "30-50%<div>Should be referred for transplant if appropriate</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "v]bDTOz[S>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 1 year recurrence rate of spontaneous bacterial peritonitis in liver cirrhosis patients?", 
                "70%<div>Can be reduced to 20% with antibiotic prophylaxis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zaVTb`mXE-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of liver cirrhosis patients develop varices each year?", 
                "7% per year", 
                ""
            ], 
            "flags": 0, 
            "guid": "n>P_a*vfeY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients with cirrhosis will develop varices?", 
                "75%", 
                ""
            ], 
            "flags": 0, 
            "guid": "k~`:a2.ow/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the risk of variceal haemorrhage per year in liver cirrhosis patients with oesophageal varices?", 
                "5-15% per year<div>Depends on size/appearance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q]z2t2aO-j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 factors that increase risk of variceal bleeding", 
                "<div>Size (?most important)</div><div>Higher Child class</div><div>Presence of red wale marks</div><div>Ongoing ETOH</div><div>HVPG &gt; 12</div><div>Previous bleed</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C!bn}Dg=9V", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 2 year rebleeding risk in oesophageal varices without secondary prophylaxis?", 
                "60 - 70%", 
                ""
            ], 
            "flags": 0, 
            "guid": "hIsZMU8~!7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How often should patients with liver cirrhosis be sceened for oesophageal varices?", 
                "<div>Scope at diagnosis</div><div>If small varices, screen yearly</div><div>If none, every 2 years</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "QZVfaDt*,L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is hepatic venous pressure gradient?", 
                "Hepatic venous pressure gradient = wedged hepatic venous pressure - free hepatic venous pressure<div>Used to quantify degree of portal hypertension that is due to sinusoidal resistance to blood flow</div><div>(The wedged pressure approximates sinusoidal pressure)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f9Gd2?RkY2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the normal values and interpretation of hepatic venous pressure gradient", 
                "<div>Normal 1 - 5</div><div>Portal hypertension present if &gt;6</div><div>Clinically significant portal hypertension &gt;10</div><div>At risk of ascites and varices &gt; 12</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LMF1Ou(25w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the primary prophylaxis against haemorrhage in oesphageal varices", 
                "Nonselective beta blocker (propranolol), or<div>Endoscopic band ligation</div><div><br /></div><div>Equally effective in high risk varices</div><div><br /></div><div>Band ligation is preferred due to less side effects</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x,?h+ERNsh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 types of oesphageal varices that are considered high bleeding risk", 
                "Medium or large size<div>Small size but child pugh C</div><div>Any size with red wale markings</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MwXnfKW|SJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism by which nonselective beta blockers reduce risk of variceal bleeding in portal hypertension", 
                "Reduce cardiac output and thereby reduce splachnic bloodflow<div>Allow unopposed alpha 1 adrenergic receptor activity which results in splanchnic vasoconstriction -&gt; less blood flow into portal vein -&gt; lower portal pressure<br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m=9HP`aw/$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Should advanced cirrhosis patients be on nonselective beta blockers to prevent bleeding from oesphageal varicies?", 
                "No, may be detrimental<div><br /></div><div>Advanced cirrhosis patients are reliant on tachycardia to maintain perfusion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F?Jw0{7fcs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the secondary prophlaxis against bleeding oesophageal varices in liver cirrhosis", 
                "Nonselective beta blocker (propranolol), AND<div>Endoscopic band ligation</div><div><br /></div><div>Note beta blockers should not be used in advanced disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s4eu*7llEH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of acute bleeding oesophageal varices (7)", 
                "Nonaggressive resuscitation<div>Octreotide OR terlipressin for 5 days</div><div>Endoscopy with banding within 12 hours</div><div>- If fails or not possible, consider balloon tamponade</div><div>Consider emergency TIPS if ongoing bleeding</div><div>Ceftriaxone, then step down to norfloxacin (minimum 2 days, up to 7 days treatment)</div><div>PPI has minimal evidence but is usually given</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oa3<?MH@kj", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of hepatic encephalopathy (3)", 
                "<div>Seek and reverse cause or trigger&nbsp;</div><div>If no clear cause, give empiric antibiotics covering SBP (ceftriaxone or cefotaxime)</div>Lactulose 30ml every 1-2hrs until laxative effect, then reduce to TDS - QID", 
                ""
            ], 
            "flags": 0, 
            "guid": "oV@B!scUSG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 causes or triggers of hepatic encephalopathy in cirrhotic patients", 
                "Renal impairment<div>GI bleeding</div><div>Infection/SBP</div><div>Electrolyte disturbance</div><div>Constipation</div><div>Noncompliance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "FQw|ikciZ;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the therapy used to prevent recurrent hepatic encephalopathy", 
                "Lactulose 30ml TDS or QID<div>If repeated episodes despite this, add:</div><div>Rifaximin 550mg BD</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sLX{w^||]v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of hepatorenal syndrome that does not improve with correction of precipitating factors (2)", 
                "Terlipressin, and<div>Albumin</div><div><br /></div><div>Can consider dialysis as a bridge to transplant if a candidate</div><div>Can consider emergency TIPS but poor outcomes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dD+/Py>`:h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the diagnostic criteria for hepatorenal syndrome acute kidney injury (HRS-AKI, formerly known as HRS type 1) (5)", 
                "More than 2 fold increase from baseline creatitine<div>Does not improve with diuretic withdrawal and volume expansion with albumin</div><div>No shock</div><div>No recent nephrotoxic drugs</div><div>No parenchymal renal disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Qve,udpf%+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the pathogenesis of hepatorenal syndrome (6)", 
                "<div>Portal hypertension --&gt;</div>Splanchic arterial vasodilatation (due to increased production of vasodilators, mainly nitric oxide) --&gt;<div>Decreased effective circulatory volume, rise in cardiac output, fall in&nbsp;systemic vascular resistance --&gt;<div>RAAS activation --&gt;</div><div>Renal vasoconstriction --&gt;</div><div>Renal hypoperfusion and hepatorenal syndrome</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Li*?4vO7dB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the expected urinalysis findings in a patient with hepatorenal syndrome (4)", 
                "Benign urine sediment<div>No or minimal proteinuria</div><div>Very low sodium</div><div>Oliguria</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g54,1Uv!3p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe type 1 and type 2 hepatorenal syndrome", 
                "Type 1: The more serious type; at least a twofold increase in serum creatinine (reflecting a 50 percent reduction in creatinine clearance) to a level greater than 221 micromol/L in &lt; 2 weeks<div>Type 2: more insidious onset than type 1. Characterised by treatment-resistant ascites.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N:5X5`kY;U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of hepatorenal syndrome (5)", 
                "Progressive rise in serum creatinine<div>Oliguria</div><div>Normal urine sediment</div><div>No or minimal proteinuria</div><div>Very low urinary sodium</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q[2Y;ATi8n", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the typical patient who may develop hepatorenal syndrome (4)", 
                "Advanced liver disease with high Child Pugh score<div>Ascites</div><div>Low MAP</div><div>Dilutional hyponatraemia (median 127)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n6CFnP;WE*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of terlipressin in the treatment of hepatorenal syndrome? (4)", 
                "Terlipressin is a long acting vasopressin<div>Causes vasoconstriction by activation of vasopressin receptor (V1)</div><div>This is expressed on vascular smooth muscle cells in the splanchic bed</div><div>Thus reverses splanchnic vasodilation</div><div><br /></div><div>Should be given as a continuous infusion. Can be continued indefinitely as a bridge to transplant.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lhi<8i.Zy<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the only definitive therapy for hepatorenal syndrome?", 
                "Liver transplant", 
                ""
            ], 
            "flags": 0, 
            "guid": "O]4s_GUVBl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the 5 year survival post liver transplant?", 
                "80%&nbsp;", 
                ""
            ], 
            "flags": 0, 
            "guid": "KE@gYV&<YD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 indications for liver transplant", 
                "Chronic liver disease with MELD &gt; 15<div>Small HCC that fulfil certain criteria</div><div>Acute liver disease unlikely to spontaneously recover (e.g. paracetamol-induced)</div><div><br /></div><div>There are a long list of additional indicators that relate to severe complications of chronic liver disease with poor prognosis (e.g. diuretic resistant ascites, recurrent encephalopathy, recurrent SBP etc.)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s$B[5_Hp:|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the Model for End-stage Liver Disease (MELD) score and how is it calculated?", 
                "Cirrhosis severity score that predicts 3 month survival, using:<div>Bilirubin</div><div>Creatinine</div><div>INR<br /><div><img src=\"paste-75896367087617.jpg\" /></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fIte*z~;:]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name exclusion criteria for liver transplant (8)", 
                "Malignancy (except HCC meeting certain criteria)<div>Acitve infection (other than hep B, C, or HIV)</div><div>Severe CAD</div><div>Severe cerebrovascular disease</div><div>Severe metabolic syndrome</div><div>ETOH liver disease with low liklihood of abstinance</div><div>Smoking</div><div>Inadequate social support</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sdA[rk?e%~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What criteria are used to assess patients with acute liver failure for transplant?", 
                "King's College criteria<div>- Paracetamol induced</div><div>- Nonparacetamol induced</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "eTFyT]D,l$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the King's College criteria for liver transplant in paracetamol induced acute liver failure", 
                "<div>pH &lt; 7.3, or&nbsp;</div><div><br /></div><div>all three of:&nbsp;</div><div>INR &gt; 6.5</div><div>creatinine&gt; 300</div><div>grade III-IV encephalopathy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P%=[F+QO]/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the King's College criteria for liver transplant in nonparacetamol induced acute liver failure?", 
                "<div>INR &gt; 6.5, or&nbsp;</div><div><br /></div><div>three out of five of:&nbsp;</div><div>age &lt;11 or &gt;40</div><div>bilirubin &gt;300</div><div>jaundice to coma time &gt; 7 days</div><div>INR &gt; 3.5</div><div>drug toxicity</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Gs@I=>7fwy", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the usual initial immunosuppressive regimen post liver transplant (3)", 
                "Steroid<div>Mycophenolate</div><div>Tacrolimus or cyclosporin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z7iS3Voln{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of calcineurin inhibitors to bring about immunosuppression (2)", 
                "<div>Without calcineurin, the nuclear factor of activated T cells (NFAT) does not translocate to the nucleus, and interleukin (IL)-2 production (along with a number of other genes) is shut down</div><div>Results in markedly diminished T-cell response to class I and class II antigens, and a significant reduction in the rejection cascade</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "iha!Qt439?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of tacrolimus?", 
                "A macrolide antibiotic with immunosuppresive action<br />Binds to FK-binding proteins, which then competitively binds to and inhibits calcineurin<div>This inhibits the translocation of a family of transcription factors (NF-AT), leading to reduced transcriptional activation of cytokine genes for</div><div>- interleukin (IL)-2</div><div>- (TNF)-alpha</div><div>- IL-3</div><div>- IL-4</div><div>- CD40L</div><div>- granulocyte-macrophage colony-stimulating factor</div><div>- interferon-gamma</div><div>Ultimately, proliferation of T lymphocytes is reduced.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "QgzXbdCMx-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 short term complications post liver transplant", 
                "Graft failure<div>Infection</div><div>Biliary stricture</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q,E`rdS>7p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Post liver transplantation, what infection prophylaxis is required? (4)", 
                "PCP (bactrim)<div>CMV (valganciclovir)</div><div>HSV prophylaxis (aciclovir or valaciclovir) if HSV-1 or -2 IgG positive, or recurrent oral or genital HSV</div><div>Other fungal infections if high risk</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L<GYb3i}h/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 long term complications post liver transplant", 
                "<div>Infections</div><div>Malignancy (skin most common, also get lymphoproliferative)</div><div>HTN</div><div>Diabetes, obesity, and dyslipidaemia</div><div>Renal disease</div><div>Metabolic bone disease</div><div><div>Recurrent disease</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MGc7Ed(.:$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 features of cellular rejection in liver transplantation (3)", 
                "<div>A mixed inflammatory infiltrate in the portal triad</div><div>Destructive or nondestructive nonsuppurative cholangitis involving interlobular bile duct epithelium</div><div>Endotheliitis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "COkifGu!.Y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology", 
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of acute rejection post liver transplantation", 
                "Elevated ALT, AST, and ALP &nbsp;7 - 10 days post transplant (though the college lecturer says it shold be a cholestatic picture with normal ALT)<div>Followed by jaundice, fever</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j#@1iA0$1k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of acute cellular rejection post liver transplant", 
                "High dose steroids (pulse methylprednisolone)<div>Increase background immunosuppression</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Cc{vueq?DX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients will experience acute rejection post liver transplant?", 
                "15 - 25%<br />", 
                ""
            ], 
            "flags": 0, 
            "guid": "k}3=wT.gbg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe chronic rejection post liver transplant", 
                "Rare (3%), months to years after transplant<div>Presents with cholesttic picture, 'vanishing bile duct' syndrome on biopsy</div><div>Manage by increasing immunosuppression</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MU(Ar[V/[P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the Milan criteria for liver transplant in HCC patients?", 
                "Single lesion &lt; 5cm, or<div>up to 3 lesions all &lt; 3cm</div><div>No evidence of vascular invasion, regional nodal, or distant mets</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r;u?k{nl8V", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Gastroenterology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 complications of sleep apnoea", 
                "<div>Motor vehicle accidents</div><div>Cardiovascular disease (CAD, stroke, HTN, pulmonary hypertension)</div><div>T2DM</div><div>Nonalcoholic fatty liver disease</div><div>Perioperative complications</div><div>All cause mortality 2-3x increase</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g.O_@}_9vd", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 risk factors for sleep apnoea", 
                "Obesity<div>Male</div><div>Craniofacial abnormalities</div><div>Pregnancy</div><div>Heart failure</div><div>Chronic lung disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jF3M].m;9B", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the clinical presentation of sleep apnoea (5)", 
                "Snoring<div>Excessive daytime sleepiness</div><div>Witnessed apnoeas</div><div>MVA</div><div>Poor work performance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u*+l;51^g5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 findings that may be present on physical examination in sleep apnoea", 
                "High BMI<div>High neck circumference &gt;40cm</div><div>Nasal obstruction</div><div>Hypertension</div><div>Crowded oropharynx (high Malampatti score)</div><div>Large tonsils (if these are the cause)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zN@p|Ztbua", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the STOP-BANG score?", 
                "<div>Snoring</div><div>Tiredness</div><div>Observed apnoeas</div><div>blood Pressure</div><div>BMI</div><div>Age</div><div>Neck circumference</div><div>Gender (male)</div><div><br /></div><div>Screening tool for sleep apnoea</div><div>&gt;3 is good sensitivity but poor specificity</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E6eI{&,73-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<img src=\"paste-90426241449985.jpg\" /><div>Descibe the above sleep study trace (hypnogram)</div>", 
                "Shows apnoea<div>Thoracic and abdominal trace shows respiratory effort, however there is no flow</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q0^AHf`e7d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<img src=\"paste-90537910599681.jpg\" /><div>Red: O2 sats</div><div>Blue: Airflow</div><div>Green: thoracic and abdominal movements</div><div><br /></div><div>What does this hypnogram show?&nbsp;</div>", 
                "Hypopnoea<div>There is a reduction but not total cessation in airflow</div><div>Thoracic and abdominal traces show respiratory effort</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B1{q*(-MU>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<img src=\"paste-90619514978305.jpg\" /><div>What does this hypnogram show?</div>", 
                "Central sleep apnoea<div>Cessation of airflow with NO respiratory effort (flatline thoracic and abdominal trace)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hI}yiK&FuP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 causes of central apnoeas", 
                "CCF<div>Drugs (e.g. opioids)</div><div>Central (stroke, tumour)</div><div>Idiopathic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q00^>oHMN6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of Adaptive Servo Ventilation (ASV) in the treatment of sleep apnoea and HFpEF?", 
                "<div>Recent trial in heart failure had to be stopped prematurely due to higher mortality in ASV group</div><div><br /></div><div>ASV should not be used in HFrEF</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "OJJrtSkTq5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of central sleep apnoea", 
                "Treat underlying cause (e.g. CCF)<div>Trial of CPAP (caution as higher pressures &gt;10cm can worsen disease)</div><div>Consider ASV, but not in HFrEF as increases mortality (recent trial)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s00T[F/Yu^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is sleep apnoea diagnosed?", 
                "Sleep study with elevated RDI or AHI (both measures of number of events including hypopnoeas, apnoeas, others)", 
                ""
            ], 
            "flags": 0, 
            "guid": "lz&GRoE=n0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for mild, moderate, and severe sleep apnoea by AHI", 
                "AHI &lt; 5 normal<div>5 - 15 mild</div><div>15 - 30 moderate</div><div>&gt;30 severe</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M0A#AKxtpE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What measurement on sleep study has the strongest correlation with cardiovascualr outcomes?", 
                "Oxygen desaturation index 4% (ODI4%)<div>Is a measure of the number of times O2 sats fall by 4% from baseline per hour of sleep</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gi4T=AlY(<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the diagnostic criteria for OSA?", 
                "AHI &gt;5 and one symptom, or<div>AHI &gt; 15</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ap%z!Rug[&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of OSA", 
                "Weight loss, lifestyle modification (very low energy diet) +/- bariatric intervention<div>Nasal treatments (nasal dilating strips or intranasal steroids)</div><div>Surgery</div><div>Position treatments (vibrate when lie supine)</div><div>Mandibular advancement splint</div><div>CPAP (Australian invention!)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lR~UeUIbmz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients should trial CPAP for sleep apnoea?", 
                "Epworth sleepiness core &gt;10/24 with moderate to severe disease<div>Severe disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DOJoZ*Of(r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of sleep apnoea patients fail to tolerate CPAP long term?", 
                "20-50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "n7~/#TQlc.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the benfits of CPAP in OSA?", 
                "Improve cognitive function, sytolic/diastolic blood pressure, quality of life, depression, sleepiness", 
                ""
            ], 
            "flags": 0, 
            "guid": "zk)MC8E:i[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the impact of CPAP use on cardiovascular outcomes?", 
                "<div>Do not improve cardiovascular mortality in RCTs, some data in observational trials show does improve.</div><div>NO improvement in cardiovascular event rates in patients with cardiovascular disease (SAVE trial: NEJM 2016, Australian study)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "frwbBR&%8_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does CPAP work?", 
                "Pneumatically 'splints' the upper airway open<div>Provides constant pressure</div><div>Does not ventilate the patient; they need to breath</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nh1Hia$`Zb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the two types of CPAP?", 
                "Fixed pressure - deliver one constant pressure<div>Automatic - detects reduction in flow and matches the delivered pressure to patient's need. Good to use for a trial to determine patient's 'ideal'pressure. 50% more expensive than fixed pressure.</div><div><br /></div><div>Both equally good at fixing AHI</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c)1(CNpH=U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does BiPAP work?", 
                "Gives background expiratory positive airway pressure (EPAP) (also called CPAP) to open up airway<div>Then on top of this gives inspiratory positive airway pressure (IPAP) which breathes for the patient</div><div>Then IPAP switches off and the natural chest recoil causes breath out, against the constant background pressure</div><div><br /></div><div><img src=\"paste-94704028876801.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "IL^qio/qT#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Should vented or nonvented masks be used with CPAP and BiPAP?", 
                "BiPAP masks may be vented or nonvented<div>CPAP must ALWAYS have a vented mask or they will just rebreath their own CO2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pNonFp>t]X", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe 3 modes a BiPAP can be set to", 
                "Spontaneous mode (S) - patient trying to breath, BiPAP detects and gives a breath to help<div>Timed mode (T) - breath given every certain (programmed) number of seconds (would use in patients making no respiratory effort at all)</div><div>ST mode - BiPAP will give a breath if patient tries to breath, and if no effort detected after a certain time period, will give a breath (most are set this way)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b-n-rmi8lb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are type 1 and type 2 respiratory failure?", 
                "Type 1: hypoxia with normal CO2<div>Type 2: hypoxia with elevated CO2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rdm4|EbA.&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 broad causes of type 2 respiratory failure", 
                "Increased dead space<div>- anything in the alveoli e.g. infection, fluid</div><div>Reduced minute ventilation</div><div>- normal lungs but reduced respiratory effort e.g. sedation, respiratory muscle weakness</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EPa^AL.X*E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is A-a gradient calculated?", 
                "PAO2 - PaO2<div><br /></div><div>Where</div><div>PAO2 = amount of oxygen in the alveoli</div><div>PaO2 = arterial concentration of oxygen on arterial blood gas</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mc,7_+jn<4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is PAO2 calculated?", 
                "<div>PAO2 is the alveolar oxygen tension</div><div><img src=\"paste-95764885798913.jpg\" /></div><div><br /></div><div>where&nbsp;</div><div>FiO2 is the fraction of inspired oxygen (0.21 at room air)</div><div>Patm is the atmospheric pressure (760 mmHg at sea level)&nbsp;</div><div>PH2O is the partial pressure of water (47 mmHg at 37ºC)</div><div>PaCO2 is the arterial carbon dioxide tension</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qll#}R>U;2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a normal A-a gradient?", 
                "For a young nonsmoker breathing room air, 5-10mmHg<div>Increases normally with age</div><div>Can use normal &lt; &nbsp;[age in years/4] + 4</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sl`.LqnsG7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What does a high A-a gradient indicate in a hypoxic patient?", 
                "Cause of hypoxia likely due to oxygen transfer/gas exchange problems (e.g.&nbsp;alveolar membrane diseases, interstitial diseases, or ventilation/perfusion (V/Q) mismatch.)", 
                ""
            ], 
            "flags": 0, 
            "guid": "E+al6(Xx80", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What does a normal A-a gradient indicate in a hypoxic patient?", 
                "Hypoxia likely due to hypoventilation e.g. respiratory muscle weakness, sedation", 
                ""
            ], 
            "flags": 0, 
            "guid": "kBV9d={LIS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What O2 sats should clinicians aim for in type 2 respiratory failure?", 
                "88 - 92%<div>Higher can cause worsening respiratory failure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PAhw&s,(R6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 contraindications to BiPAP", 
                "Severely impaired conscious state<div>Patient cannot protect upper airway</div><div>Upper airway burns/trauma/surgery</div><div>Haemodynamic instability</div><div>Unable to cope with BiPAP</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yb1-bzdC_e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define chronic respiratory failure", 
                "Awake with PaCO2 &gt; 45 with normal pH", 
                ""
            ], 
            "flags": 0, 
            "guid": "fjV|caF~]?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define nocturnal hypoventilation", 
                "CO210mmHg higher asleep than awake", 
                ""
            ], 
            "flags": 0, 
            "guid": "Qj]9>^UM<+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with restless legs syndrome, what is the most common deficiency?", 
                "Iron", 
                ""
            ], 
            "flags": 0, 
            "guid": "dF4A~h=|&G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is iron deficiency thought to play a role in restless legs syndrome?", 
                "<div>Iron is a cofactor for dopamine</div><div>Deficiency of dopamine transport are thought to be involved in pathogenesis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nugX+?{aah", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which neurological disorder is most likley to present with REM sleep disorder as the presenting complaint?", 
                "Parkinson's disease", 
                ""
            ], 
            "flags": 0, 
            "guid": "OTI$o7t$r{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory", 
                "Sleep"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the test of choice for narcolepsy?", 
                "Mean sleep latency test<div>4 naps over 24 hours</div><div>Sleep latency &lt; 8 mins and two or more sleep onset rapid eye movement periods (SOREMs) is considered diagnostic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x_ih-)8tfv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory", 
                "Sleep"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a maintenance of wakefulness test?", 
                "Patient sits in recumbent position and tries to stay awake<div>Used to assess response to therapy for sleepiness</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M}Uv0c>)_B", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory", 
                "Sleep"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 changes to sleep that occur with normal aging", 
                "Less REM sleep<div>Reduced sleep efficiency</div><div>Increased wake time after sleep onset (WASO)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n-wF|[SJ.$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory", 
                "Sleep"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the cause of daytime sleepiness in sleep apnoea?", 
                "Recurrent nighttime arousals", 
                ""
            ], 
            "flags": 0, 
            "guid": "iSj<;?#O)A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory", 
                "Sleep"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7744f708601047169ef739ac6d185723-ao-1", 
                "Name the causes of left and right shift of the oxygen haemoglobin dissociation curve", 
                "<img src=\"tmpffuqhp.png\" />", 
                "<img src=\"7744f708601047169ef739ac6d185723-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7744f708601047169ef739ac6d185723-ao-1-A.svg\" />", 
                "<img src=\"7744f708601047169ef739ac6d185723-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "C2?g[P-:VM", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory", 
                "Sleep"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7744f708601047169ef739ac6d185723-ao-2", 
                "Name the causes of left and right shift of the oxygen haemoglobin dissociation curve", 
                "<img src=\"tmpffuqhp.png\" />", 
                "<img src=\"7744f708601047169ef739ac6d185723-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7744f708601047169ef739ac6d185723-ao-2-A.svg\" />", 
                "<img src=\"7744f708601047169ef739ac6d185723-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "FLA0^$.@Kr", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory", 
                "Sleep"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the cause of shifting the oxygen-haemoglobin dissociation curve to the right?", 
                "Reduced oxygen-haemoglobin affinity<div><img src=\"paste-104187316666369.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ntw]aDBjc/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory", 
                "Sleep"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the cause of shifting the oxygen-haemoglobin dissociation curve to the left?", 
                "Increased oxygen-haemoglobin affinity<div><img src=\"paste-104191611633665.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qDC_*Kf[q|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory", 
                "Sleep"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of breathing pattern in seen in HFrEF patients with sleep disordered breathing?", 
                "Central sleep apnoea with Cheyne-Stokes respiration", 
                ""
            ], 
            "flags": 0, 
            "guid": "J*,/nz;kB?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory", 
                "Sleep"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the hallmark of obstruction on spirometry?", 
                "Reduced FEV1/FVC ratio, &lt; 0.7 (also known as forced expiratory ratio, FER)", 
                ""
            ], 
            "flags": 0, 
            "guid": "Keh2NW%e?K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fd6504b24b0a4b67b23364682e33d2d0-ao-1", 
                "What are the causes of the abnormalities in these flow volume loops?", 
                "<img src=\"tmpzhc2ks.png\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-1-A.svg\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "MZ*LLQ3Wy)", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fd6504b24b0a4b67b23364682e33d2d0-ao-2", 
                "What are the causes of the abnormalities in these flow volume loops?", 
                "<img src=\"tmpzhc2ks.png\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-2-A.svg\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "e%S=sJ$+O#", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fd6504b24b0a4b67b23364682e33d2d0-ao-3", 
                "What are the causes of the abnormalities in these flow volume loops?", 
                "<img src=\"tmpzhc2ks.png\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-3-A.svg\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q~HGWp,IXf", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fd6504b24b0a4b67b23364682e33d2d0-ao-4", 
                "What are the causes of the abnormalities in these flow volume loops?", 
                "<img src=\"tmpzhc2ks.png\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-4-A.svg\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "o%1[UVwS=k", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fd6504b24b0a4b67b23364682e33d2d0-ao-5", 
                "What are the causes of the abnormalities in these flow volume loops?", 
                "<img src=\"tmpzhc2ks.png\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-5-A.svg\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "c(}}QrT$?(", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fd6504b24b0a4b67b23364682e33d2d0-ao-6", 
                "What are the causes of the abnormalities in these flow volume loops?", 
                "<img src=\"tmpzhc2ks.png\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-6-A.svg\" />", 
                "<img src=\"fd6504b24b0a4b67b23364682e33d2d0-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "G3hE;=~^`8", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "da2f6aba7da7441d944fc99508e0d38f-ao-1", 
                "What is causing the abnormalities in these flow volume loops?", 
                "<img src=\"tmpf56ngg.png\" />", 
                "<img src=\"da2f6aba7da7441d944fc99508e0d38f-ao-1-Q.svg\" /><div><br /></div><div><br /></div>", 
                "", 
                "", 
                "Variable intrathoracic obstruction - reduction in peak achieved expiration", 
                "", 
                "", 
                "<img src=\"da2f6aba7da7441d944fc99508e0d38f-ao-1-A.svg\" />", 
                "<img src=\"da2f6aba7da7441d944fc99508e0d38f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Ghbm1!Dlxz", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "da2f6aba7da7441d944fc99508e0d38f-ao-2", 
                "What is causing the abnormalities in these flow volume loops?", 
                "<img src=\"tmpf56ngg.png\" />", 
                "<img src=\"da2f6aba7da7441d944fc99508e0d38f-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"da2f6aba7da7441d944fc99508e0d38f-ao-2-A.svg\" />", 
                "<img src=\"da2f6aba7da7441d944fc99508e0d38f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Dz&AM.)C+W", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 causes of airflow obstruction", 
                "Bronchospasm<div>Airway inflammation</div><div>Mucuous hypersecretion</div><div>Dynamic airway collapse (loss of airway traction/recoil ability due to architecture change, e.g. emphysema)</div><div>External compression</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fK(f=})Amx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How much response is required with bronchodilator for it to qualify as bronchodilator-responsive obstruction?", 
                "Improvement in FEV1 and/or FVC of &gt;12% and &gt;200ml<div>Improvement of &gt;20% suggestive of asthma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f6ZzQ_]jgX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "4623716c49b34a94bc45e7c85e3078f3-ao-1", 
                "This spirometry shows what pattern?", 
                "<img src=\"tmpz08912.png\" />", 
                "<img src=\"4623716c49b34a94bc45e7c85e3078f3-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"4623716c49b34a94bc45e7c85e3078f3-ao-1-A.svg\" />", 
                "<img src=\"4623716c49b34a94bc45e7c85e3078f3-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "B9PH|2Mg]4", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21a562a5036b48af849ce3c068e827a6-ao-1", 
                "This spirometry shows what pattern?", 
                "<img src=\"tmpz08912.png\" />", 
                "<img src=\"21a562a5036b48af849ce3c068e827a6-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21a562a5036b48af849ce3c068e827a6-ao-1-A.svg\" />", 
                "<img src=\"21a562a5036b48af849ce3c068e827a6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "nwXaO:^8F~", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "5842a16355004d39af51ed18e1b30126-ao-3", 
                "", 
                "<img src=\"tmpbdwfrq.png\" />", 
                "<img src=\"5842a16355004d39af51ed18e1b30126-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"5842a16355004d39af51ed18e1b30126-ao-3-A.svg\" />", 
                "<img src=\"5842a16355004d39af51ed18e1b30126-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "d_eAoIO&-{", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "5842a16355004d39af51ed18e1b30126-ao-4", 
                "", 
                "<img src=\"tmpbdwfrq.png\" />", 
                "<img src=\"5842a16355004d39af51ed18e1b30126-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"5842a16355004d39af51ed18e1b30126-ao-4-A.svg\" />", 
                "<img src=\"5842a16355004d39af51ed18e1b30126-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "E8CI||5A><", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ad96db1f3c094851a73354db2488a812-ao-1", 
                "", 
                "<img src=\"tmphgkv4v.png\" />", 
                "<img src=\"ad96db1f3c094851a73354db2488a812-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"ad96db1f3c094851a73354db2488a812-ao-1-A.svg\" />", 
                "<img src=\"ad96db1f3c094851a73354db2488a812-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "z{+Ya[Sn&;", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ad96db1f3c094851a73354db2488a812-ao-2", 
                "", 
                "<img src=\"tmphgkv4v.png\" />", 
                "<img src=\"ad96db1f3c094851a73354db2488a812-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"ad96db1f3c094851a73354db2488a812-ao-2-A.svg\" />", 
                "<img src=\"ad96db1f3c094851a73354db2488a812-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ywqhAxRXfH", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ad96db1f3c094851a73354db2488a812-ao-3", 
                "", 
                "<img src=\"tmphgkv4v.png\" />", 
                "<img src=\"ad96db1f3c094851a73354db2488a812-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"ad96db1f3c094851a73354db2488a812-ao-3-A.svg\" />", 
                "<img src=\"ad96db1f3c094851a73354db2488a812-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "PEwU9+mN$.", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "949eee3a93554fa5acd8acb1cdfdeb4d-ao-1", 
                "", 
                "<img src=\"tmppgl8oz.png\" />", 
                "<img src=\"949eee3a93554fa5acd8acb1cdfdeb4d-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"949eee3a93554fa5acd8acb1cdfdeb4d-ao-1-A.svg\" />", 
                "<img src=\"949eee3a93554fa5acd8acb1cdfdeb4d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "k.M-P.Twl8", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "949eee3a93554fa5acd8acb1cdfdeb4d-ao-2", 
                "", 
                "<img src=\"tmppgl8oz.png\" />", 
                "<img src=\"949eee3a93554fa5acd8acb1cdfdeb4d-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"949eee3a93554fa5acd8acb1cdfdeb4d-ao-2-A.svg\" />", 
                "<img src=\"949eee3a93554fa5acd8acb1cdfdeb4d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "lcLUzlx{}a", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "949eee3a93554fa5acd8acb1cdfdeb4d-ao-3", 
                "", 
                "<img src=\"tmppgl8oz.png\" />", 
                "<img src=\"949eee3a93554fa5acd8acb1cdfdeb4d-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"949eee3a93554fa5acd8acb1cdfdeb4d-ao-3-A.svg\" />", 
                "<img src=\"949eee3a93554fa5acd8acb1cdfdeb4d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "p+oHXOrMnh", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ee0fa0f7a85046288699624d42bc3854-ao-1", 
                "", 
                "<img src=\"tmp73mfto.png\" />", 
                "<img src=\"ee0fa0f7a85046288699624d42bc3854-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"ee0fa0f7a85046288699624d42bc3854-ao-1-A.svg\" />", 
                "<img src=\"ee0fa0f7a85046288699624d42bc3854-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "k|D%,8=/ng", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ee0fa0f7a85046288699624d42bc3854-ao-2", 
                "", 
                "<img src=\"tmp73mfto.png\" />", 
                "<img src=\"ee0fa0f7a85046288699624d42bc3854-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"ee0fa0f7a85046288699624d42bc3854-ao-2-A.svg\" />", 
                "<img src=\"ee0fa0f7a85046288699624d42bc3854-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "htF]P=AQ<s", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ee0fa0f7a85046288699624d42bc3854-ao-3", 
                "", 
                "<img src=\"tmp73mfto.png\" />", 
                "<img src=\"ee0fa0f7a85046288699624d42bc3854-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"ee0fa0f7a85046288699624d42bc3854-ao-3-A.svg\" />", 
                "<img src=\"ee0fa0f7a85046288699624d42bc3854-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "M[H(?!}?tJ", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 causes of variable extrathoracic upper airway obstruction", 
                "vocal fold paralysis<div>extrathoracic tracheomalacia</div><div>polychondritis</div><div>mobile tumors</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gt}p2/+hEH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 causes of variable intrathoracic airway obstruction", 
                "tracheomalacia<div>polychondritis</div><div>tumors of the lower trachea or main bronchus</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JS4b$3).3*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 causes of fixed upper airway obstruction", 
                "postintubation stenosis<div>goiter</div><div>endotracheal neoplasms</div><div>tracheal stenosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L.?ND,ISLM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What might be seen on spirometry in restrictive lung disease?", 
                "Reduced FVC<div><br /></div><div>Need to measure lung volumes to confirm</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pv5jup}ojQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 methods used to measure lung volumes", 
                "Body plethysmography<div>Multi-breath dilution technique</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K@,;uBdp=#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "eb3e9520847748738c28835188fd95e4-ao-1", 
                "Describe these lung volumes", 
                "<img src=\"tmpdun3wp.png\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-1-A.svg\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "v]Do&zOx*5", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "eb3e9520847748738c28835188fd95e4-ao-2", 
                "Describe these lung volumes", 
                "<img src=\"tmpdun3wp.png\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-2-A.svg\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "iVkB=D.,K,", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "eb3e9520847748738c28835188fd95e4-ao-3", 
                "Describe these lung volumes", 
                "<img src=\"tmpdun3wp.png\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-3-A.svg\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "tDBTZiQPN>", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "eb3e9520847748738c28835188fd95e4-ao-4", 
                "Describe these lung volumes", 
                "<img src=\"tmpdun3wp.png\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-4-A.svg\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "HbKl5E5u.,", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "eb3e9520847748738c28835188fd95e4-ao-5", 
                "Describe these lung volumes", 
                "<img src=\"tmpdun3wp.png\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-5-A.svg\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "QC(&)mT>^m", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "eb3e9520847748738c28835188fd95e4-ao-6", 
                "Describe these lung volumes", 
                "<img src=\"tmpdun3wp.png\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-6-A.svg\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "NWz|S3zQ%)", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "eb3e9520847748738c28835188fd95e4-ao-7", 
                "Describe these lung volumes", 
                "<img src=\"tmpdun3wp.png\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-7-A.svg\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "l1%}P2!b9M", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "eb3e9520847748738c28835188fd95e4-ao-8", 
                "Describe these lung volumes", 
                "<img src=\"tmpdun3wp.png\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-8-A.svg\" />", 
                "<img src=\"eb3e9520847748738c28835188fd95e4-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "paCrz)*tK+", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 lung volumes that cannot be measured during spirometry", 
                "Total lung capacity<div>Residual volume</div><div>Functional residual capacity</div><div><br /></div><div>The residual volumes require lung volume measurement to be calculated.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "iHzgAGo4PD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What lung volume abnormality would indicate restrictive lung disese?", 
                "Low total lung capacity (TLC)", 
                ""
            ], 
            "flags": 0, 
            "guid": "Jf[vZ9IW<.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What lung volume abnormality is seen in hyperinflation?", 
                "High total lung capacity (TLC)", 
                ""
            ], 
            "flags": 0, 
            "guid": "gVN[^n+iy{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What measurement on lung volume indicates gas trapping?", 
                "High residual volume/total lung capacity ratio (RV/TLC)", 
                ""
            ], 
            "flags": 0, 
            "guid": "KR?rC{FAq}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 broad causes of restrictive lung disease as detected by reduced total lung capacity (TLC)", 
                "Reduced lung compliance (stiff lungs, e.g. ILD)<div>Stiff chest wall (e.g. kyphoscoliosis)</div><div>Neuromuscular disorders</div><div>Lung resection</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "iIgfYNDXLg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the changes in lung volumes with normal aging? (2)", 
                "Increase in residual volume<div>Increase in functional residual capacity</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GhY=ngnG7R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is gas transfer/diffusing capacity (TLCO) measured?", 
                "Breath in a known quanity of CO up to total lung capacity and hold for 10 seconds<div>When breath out, can measure the concentration that is left and use to calculate how much has been transferred</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y}vf9U4*`&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is TLCO?", 
                "<div>The amount of CO that can access available haemoglobin</div>Measurement of diffusing capacity, i.e. the ability to conduct gas exchange", 
                ""
            ], 
            "flags": 0, 
            "guid": "q|i]GO(-jm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What parameters are measured in gas exchange? (3)", 
                "TLCO - diffusing capacity (can be corrected for Hb if anaemia)<div>VA - alveolar volume</div><div>KCO (TLCO/VA): transfer coefficient, the gas exchange per unit of lung volume.&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wj:OTR6nnv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 factors that reduce TLCO", 
                "Problems with the blood-gas barrier (diffusion)<div>- thickening of the membrane (e.g. ILD, pulmonary oedema)</div><div>- reduction in surface area (emphysema)</div><div>Capillary blood problems (rate of combination)</div><div>- anaemia</div><div>- change in capillary blood colume</div><div>Reduced lung volume</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f+y!#=z}Mo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why might a patient with asthma have a reduced FVC that corrects with bronchodilator?", 
                "Gas trapping<div>Not true restriction.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pw$KWg;K^^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of KCO in interpretation of lung volumes?", 
                "<div>KCO - ratio of TLCO to alvolar volume (VA)</div><div>Increased in:</div><div>- pneumonectomy (discrete&nbsp;loss of alveolar volume and only small impairment in DLCO)</div><div>- incomplete lung expansion, e.g. kyphoscoliosis, neuromuscualar disorders (reduced VA more than reduced DLCO)</div><div>Low in</div><div>- emphysema</div><div>- interstitial lung disease (reduced DLCO, reduced VA)</div><div>- pulmonary vascular disease (reduced DLCO, normal VA)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r^ys;=6^#N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>What abnormality is shown?</div><img src=\"paste-227143640416257.jpg\" />", 
                "<div>Normal spirometry</div><div>No response to bronchodilator</div><div>Reduced TLCO with reduced KCO indicates diffusion defect - patient has scleroderma lung disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x,=H7N{g[}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What abnormality is shown?<div><img src=\"paste-227229539762177.jpg\" /></div>", 
                "Airflow obstruction with &gt;20% reversibility<div>This is typical of asthma</div><div>Note reduced FVC prior to bronchodilator - due to gas trapping, not true restrictive lung disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u}-}N<%:t.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Describe the defect below</div><img src=\"paste-237172389052417.jpg\" />", 
                "Flow volume shows fixed upper airway obstruction<div>Patient has tracheal stenosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p;)GE(j)dM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>What is the pathology below?</div><img src=\"paste-237430087090177.jpg\" />", 
                "Variable extrathoracic obstruction (flattened insiratory curve)<div>The notch in expiration is normal<br /><div>Patient had vocal cord paralysis on bronchoscopy</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fk%|e-s~f<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Describe the defect below.</div><img src=\"paste-239770844266497.jpg\" />", 
                "Restriction on spirometry (reduced FEV1 and FVC with normal ratio)<div>TLCO within normal limits despite reduced alveolar volume</div><div>Recued maximal inspiratory and expiratory pressures confirm respiratory muscle weakness (patient has motor neuron disease)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G&Zm)A$=1^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Describe the defect below</div><img src=\"paste-239942642958337.jpg\" />", 
                "Severe obstructive defect with decreased FVC<div>Reduced TLCO with reduced alveolar volume</div><div>Raised TLC and FRC indicate hyperinflation</div><div>RV/TLC raised confirms gas trapping as cause of reduced FVC</div><div><br /></div><div>Patient has severe COPD.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g;k+_Z,.=I", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In healthy controls, maximal cardiorespiratory function is limited by which - cardiac or respiratory function?", 
                "Cardiac function is the limitation.<div>There should be ventilatory reserve.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ba=js0Us&[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What parameters are given on cardipulmonary exercise test? (4)", 
                "Wmax: workload<div>VEmax: mean ventilation at end of exercise (maximum ventilation)</div><div>HRmax: maximum expected heart rate</div><div>VO2max: oxygen consumption</div><div><br /></div><div>Should have some ventilatory reserve at the end of exercise</div><div><img src=\"paste-240715737071617.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tk[{-0t*k+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What result on cardiopulmonary exercise testing might indicate the lungs as a cause of exercise limitation, as opposed to the heart?", 
                "Go above maximum expected ventilation (VEmax high, or go above the dashed line on graph), indicating no respiratory reserve<div>Reduced workload achieved</div><div>Oxygen desaturation with increased exercise<br /><div><br /></div><div><img src=\"paste-240818816286721.jpg\" /></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hKKty:covQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Describe the results of this cardiopulmonary exercise test</div><img src=\"paste-241076514324481.jpg\" />", 
                "No respiratory reserve (exceeded VEmax, left hand graph dots go above the dashed line)<div>Poor workload (41% predicted)<br /><div>Desaturation with exercise</div><div><br /></div><div>Limitation due to respiratory dysfunction</div><div><br /></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jB}=0-5#Di", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<img src=\"paste-241299852623873.jpg\" /><div>Describe the abnormality on this cardiopulmonary exercise test</div>", 
                "Tachycardia at start of study<div>Did not exceed VEmax (respiratory reserve is present)</div><div>Poor workload achieved (43%)</div><div>Baseline tachycardia and exceed HRmax</div><div><br /></div><div>Exercise limitation due to cardiac dysfunction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w2f~MG0OYw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the second most common cancer in Australia", 
                "Colorectal", 
                ""
            ], 
            "flags": 0, 
            "guid": "yh&IllqwSu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the median age of diagnosis of colorectal cancer?", 
                "69", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ex$RY*z{U)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Right sided and transverse colorectal cancers arise from the midgut or the hindcut?", 
                "Midgut", 
                ""
            ], 
            "flags": 0, 
            "guid": "nqNV.m<z36", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Left sided colorectal cancers arise from the midgut or the hindcut?", 
                "Hindgut", 
                ""
            ], 
            "flags": 0, 
            "guid": "Gf?SRV7NfC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "BRAF mutation is more common in left or right sided colorectal tumours?", 
                "Right side", 
                ""
            ], 
            "flags": 0, 
            "guid": "FbfF}6u`sa", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 non-lifestyle related risk factors for colorectal cancer", 
                "Personal history of CRC&nbsp;<div>History of large adenomatous polyl &gt;1cm</div><div>Family history</div><div>Ulcerative colitis</div><div>Chron's disease</div><div>Abdominal radiation</div><div>Diabetes</div><div><div>ADT</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JfNHnO>:lM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 lifestyle-related risk factors for colorectal cancer", 
                "<div><div>Obesity</div><div>Sedentary</div></div><div>Western diet (high processed meat)</div><div>ETOH</div><div>Smoking</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "iqko:%[oo,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of patients with a family history of colorectal cancer will have a detectable heritable mutation?", 
                "10%", 
                ""
            ], 
            "flags": 0, 
            "guid": "dOB%YTN>hL", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of colorectal cancer patients will have a family history?", 
                "25%", 
                ""
            ], 
            "flags": 0, 
            "guid": "t(C%>O?}#`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which MMR gene is most commonly affected in HNPCC?", 
                "MSH2 41%<div><br /></div><div>MLH1 37%</div><div>MSH6 13%</div><div>PMS2 9%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rKI2tTUM`F", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Colorectal cancers in HNPCC most commonly occur where?", 
                "Right side", 
                ""
            ], 
            "flags": 0, 
            "guid": "v8#&^yf~<h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients with HNPCC will have synchonous or metachronous cancers?", 
                "10%", 
                ""
            ], 
            "flags": 0, 
            "guid": "Lg3^9<_Qp>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Endometrial cancer in HNPCC is most associated with mutations in which MMR gene?", 
                "MSH6", 
                ""
            ], 
            "flags": 0, 
            "guid": "w[We#_QA5S", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "BRAF mutant colorectal cancers are usually MSI-high or MSI-low?", 
                "MSI-high", 
                ""
            ], 
            "flags": 0, 
            "guid": "s1p>8~0mS[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is attenuated FAP?", 
                "Less severe variant of FAP with fewer adenomas (&lt;100) with older age of cancer diagnosis (in 50s)", 
                ""
            ], 
            "flags": 0, 
            "guid": "gYZDKj>0(p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should screening colonoscopies be commenced in patients with FAP?", 
                "Age 10-12 with flexi-sig or colonoscopy<div>Continue until colectomy, usually in late teens or early twenties depending on number and size of adenomas</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M2P#HO`BDf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should surveillance colonoscopies commence in patients with AFAP?", 
                "Age 25", 
                ""
            ], 
            "flags": 0, 
            "guid": "O,ts9nR_Mv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Australia's bowel cancer screening program has improved colorectal cancer mortality by how much?", 
                "20-30%", 
                ""
            ], 
            "flags": 0, 
            "guid": "zL2q5~5$L^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the participation rate in FOBT testing?", 
                "40%", 
                ""
            ], 
            "flags": 0, 
            "guid": "d1qdEiTPfF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What number of patients with positive screening FOBT will have colorectal cancer?", 
                "1 in 32", 
                ""
            ], 
            "flags": 0, 
            "guid": "csW:4mU0eu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients should be considered for screening colonoscopies for colorectal cancer? (3)", 
                "Personal history of CRC<div>Hereditary CRC syndrome</div><div>Strong family history</div><div>- two first degree relatives, or one age &lt; 50: recommend colonoscopy every 5 years from age 50 or 10 years younger than age of first CRC in family</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Nq`Q(Q~e&b", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is aspirin thought to function in its role as primary prophylaxis against colorectal cancer? (3)", 
                "Inhibition of COX2 (70% of CRC express COX2)<div>Antiplatelet effect thought to decreases rate of metastasis</div><div>Direct modulation of ocogene induced expression of transcription factors</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E~Sfe}B{,m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of asprin on colorectal cancer risk?", 
                "Reduced incidence (HR 0.76) and mortality (HR 0.65)<div>Benefit is delayed - onset of effect after around 5 years</div><div>Patients with colorectal cancer with a history of aspirin use have a better prognosis if PIK3CA mutant</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e]ww,Aya<+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of aspirin in HNPCC carriers?", 
                "Reduces risk of colorectal cancer (59% risk reduction)<div>Reduces risk of all HNPCC-associated cancers (HR 0.45)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hfDn;<g,Bk", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of stage II CRC are cured with surgery alone?", 
                "80%", 
                ""
            ], 
            "flags": 0, 
            "guid": "zdoFY}|Jz3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of stage II (T3 - T4, N0) colorectal cancer", 
                "Surgery (80% cure)<div>adjuvant chemo with single agent 5FU or capecitabine has limited benefit (up to +4%), only recommended if high risk:</div><div>- T4 tumour</div><div>- Perforation/obstruction</div><div>- LVI/PNI</div><div>- Poorly differentiated</div><div>- Inadequate node sampling (&lt;12)</div><div><br /></div><div>Do NOT use if MMR deficient - trend towards harm</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NCEI:`^$*M", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define stage II colorectal cancer", 
                "T3N0 or T4N0", 
                ""
            ], 
            "flags": 0, 
            "guid": "dEc4I}5GYq", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define stage I colorectal cancer", 
                "T1N0<div>T2N0</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M%5@XfHF+G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of stage I (T1-2, N0) colorectal cancer", 
                "Surgery alone<div>No role for chemotherapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tXygi4G?Hs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the chemotherapy of choice in stage II colorectal cancer, if required?", 
                "Single agent adjuvant capecitabine or 5FU<div>+4% cure rate in addition to surgery</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p`%2_6Kn86", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define stage III colorectal cancer", 
                "Any T<div>N1 or N2</div><div>M0</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q:/jacULz4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the standard management of stage III colorectal cancer?", 
                "<div>Surgery</div>Adjuvant FOLFOX for 6 months<div>- there is an argument for 3 months of therapy if low risk (e.g. only 1 positive lymph node) to avoid toxicity<br /><div>HR 0.8 of disease free survival with addition of chemo</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l$AjD#&MPD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with rectal cancer who are considered fit for surgery appropriate for neoadjuvant chemotherapy?", 
                "T3 or T4 tumour<div>Low rectal cancer not amenable to local excusion</div><div>Tumour invades or in close proximity to mesorectum</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p4#mO9Brs$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with rectal cancer who received neoadjuvant chemo will also receive adjuvant chemo?", 
                "Adjuvant chemo considered if patients are found on histopath to have responded to neoadjuvant chemo", 
                ""
            ], 
            "flags": 0, 
            "guid": "Fgh!7QLnh7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the surveillnace post curative-intent treatment for early stage colon cancer", 
                "<div>Frist 2 years: 3 monthly clinical review, plus&nbsp;CEA and CT every 6 months</div><div>Yaer 3 - 5: 6 monthly clinical review and CEA, plus annual CT</div><div>Colonoscopy 1 year post, then every 2nd year</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DFQa6icR)Q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with metastatic colorecal cancer should receive intensive therapy?", 
                "Potentially resectable mets (to achieve cure)<div>Nonresectable with high tumour burden and tumour-related symptoms (to improve QoL)</div><div><br /></div><div>Patients with low volume or indolent disease can be managed more conservatively</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KriLe_G@tc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does RAS or RAF status influence the appropriateness of bevacizumab for metastatic colorectal cancer?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "bA.=0qFA{R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does primary tumour location (right or left) influence the appropriateness of bevacizumab for metastatic colorectal cancer?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "b:O:}!&2L;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 EGFR inhibitors", 
                "Cetuximab<div>Panitumumab</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q^eGA!+$>#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why can EGFR inhibitors not be used in RAS mutant tumours?", 
                "<div>the EGFR pathway leads to cell proliferation, survival, invasion and metastasis</div><div>Blocking the EGFR receptor switches off this pathway</div><div>However if RAS mutant, there are mutations further down the pathway in KRAS or NRAS which result in the pathway being permanently activated, regardless of EGFR signalling</div><div>Hence blocking EGFR signas in these patients is ineffective</div><img src=\"paste-297748607795201.jpg\" />", 
                ""
            ], 
            "flags": 0, 
            "guid": "kI[$MfpIXX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 toxicities of cetuximab", 
                "Rash (most common)<div>- More severe rash indicates likely response to therapy</div><div>GI (nausea, vomiting, diarrhoea)</div><div>Fever</div><div>Infusion reaction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c!B<e{Xw4R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the preventive therapy for cetixumab rash", 
                "Moisturiser<div>Sunscreen</div><div>Hydrocortisone 1% daily</div><div>Doxycycline BD</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BLmb.yeeMI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Addition of cetuximab to FOLFIRI (standard chemotherapy) in metastatic KRAS wild type colorectal cancer is associated with what benefit?", 
                "8% improvement in overall survival, progression free survival, response rate", 
                ""
            ], 
            "flags": 0, 
            "guid": "jh-8i8O#Qt", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the significance of BRAF mutation in terms of response to EGFR inhibitors in colorectal cancer", 
                "Poor response<div>EGFR inhibitors should NOT be used</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H8FMx`UpqT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with metastatic colorectal cancer, left sided tumour, and RAS wild type, should bevacizumab or cetuximab be used in addition to standard chemo?", 
                "Cetuximab<div><br /></div><div>Must be RAS wild type and metastatic to be a candidate for cetuximab</div><div>In left sided lesions, cetuximab is suprior to bevacizumab</div><div>In right sided lesions, bevacizumab may be superior (though either can be used)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oA/|^;(EEd", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Phase II trials have shown a benefit of which immunotherapy in metastatic MMR deficient cancers?", 
                "Anti-PDL1 (pemprolizumab)", 
                ""
            ], 
            "flags": 0, 
            "guid": "Mzngr8]4jF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which metastatic colorectal cancers may benefit from immunotherapy with anti-PDL1 (pembrolizumab) according to early (phase II) trials?", 
                "MMR deficient tumours<div>Thought to be due to high mutation load</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w2#cD(435!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a577b6793bf04096a6769bb0dba3284b-ao-1", 
                "", 
                "<img src=\"tmpxb_icv.png\" />", 
                "<img src=\"a577b6793bf04096a6769bb0dba3284b-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a577b6793bf04096a6769bb0dba3284b-ao-1-A.svg\" />", 
                "<img src=\"a577b6793bf04096a6769bb0dba3284b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "L~4qEl+g+i", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a577b6793bf04096a6769bb0dba3284b-ao-2", 
                "", 
                "<img src=\"tmpxb_icv.png\" />", 
                "<img src=\"a577b6793bf04096a6769bb0dba3284b-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a577b6793bf04096a6769bb0dba3284b-ao-2-A.svg\" />", 
                "<img src=\"a577b6793bf04096a6769bb0dba3284b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Jdlc5TE!e,", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the normal range of E/e'", 
                "&lt;10 is normal", 
                ""
            ], 
            "flags": 0, 
            "guid": "dQF@-fevRA", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the leading cause of death in stable moderate to severe COPD patients with no comorbidities?", 
                "Cardiovascular disease", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ec[$[,?GA,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where is the 'choke point' of the airway tree (the area of highest airflow resistance) in healthy lungs?<div>A) Conducting zone (large diameter airways with cartiledge)</div><div>B) Respiratory zone (tiny airways without cartiledge)</div>", 
                "Conducting zone<div>Highest resistance around generation 5 airways (of total 23)</div><div><img src=\"paste-5153960755201.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GWi,>jo[Yp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which part of the lung has the highest total cross-sectional surface area?", 
                "Repiratory zone, distal to the terminal bronchioles<div><br /></div><div><img src=\"paste-5196910428161.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "o)4:meziJ]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Draw the expected flow volume loop pre and post bronchodilator in a patient with asthma.", 
                "<img src=\"paste-5308579577857.jpg\" />", 
                ""
            ], 
            "flags": 0, 
            "guid": "CYEW,U[yLa", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 broad categories of disorder that can cause abnormal spirometry", 
                "Airway<div>Lung parenchymal</div><div>Chest wall/pleural</div><div>Neuromuscular</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K:qt!kl0:M", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 causes at the of narrowed airway lumen<div><img src=\"paste-5785320947713.jpg\" /></div>", 
                "Mucus/cells/other material plugging lumen<div>Thickened of airway wall</div><div>Shotening of smooth muscle around the lumen (bronchospasm)</div><div>Collapse of airway wall into the lumen (lung parenchymal disease)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G;+V`cW20P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the test of choice for occupational asthma?", 
                "Serial peak flow measurements<div>Will vary from day to day, worse on exposure days</div><div><br /></div><div><img src=\"paste-7258494730241.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tz$%+i?fIq", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is considered a positive result on an airway hyperresponsiveness test, and how is severity graded?", 
                "FEV1 decrease &gt;20% from baseline<div>Severity expressed as PD20 (dose required to provoke 20% reduction from baseline FEV1)</div><div>The lower the PD20, the more hyperresponsive - indicates a lower dose provokes significant response<br /><div><div><br /></div><div><img src=\"paste-7425998454785.jpg\" /></div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pUYg;,B%}r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 types of airway hyperresponsive testing and how they work", 
                "Indirect: active mast cells to release histamine and other bronchoconstrictors<div>Direct: directly constrict airway muscle via smooth muscle receptors</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vDBBTyM;&W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 agents used in direct airway hyperresponsiveness testing", 
                "<div>methacholine</div><div>histamine</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nRB7Wp:3b>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 agents used in indirect airway hyperresponsiveness testing", 
                "mannitol<div>hypertonic saline</div><div>exercise</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w@,he*Z^8_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What do the direct and indirect airway hyperreactivity test methods test for?", 
                "Indirect: indicates inflammatory component of airway hyperresponsiveness<div>Direct: indicates persistent airway remodelling (how thick and juicy the airway smooth muscle is)</div><div><br /></div><div>Patients may be positive for one without the other</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Po^gc[L*0.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which region of the airways is most sensitive to bronchoconstriction?", 
                "The more proximal airways (the 'conducting zone', up to generation 16) due to more smooth muscle", 
                ""
            ], 
            "flags": 0, 
            "guid": "QKl=t(B{qC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define asthma", 
                "Symptoms, plus<div>Airflow obstruction that is</div><div>- reversible, OR</div><div>- variable, OR</div><div>- inducible</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wcn$vuZnvm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a40f62570e4455db93b0f94a01effe6-ao-1", 
                "Describe the stepwise management of asthma", 
                "<img src=\"tmpxnfucu.png\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-1-A.svg\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "AqXZMxin;:", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a40f62570e4455db93b0f94a01effe6-ao-2", 
                "Describe the stepwise management of asthma", 
                "<img src=\"tmpxnfucu.png\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-2-A.svg\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "I%E1/0EuVp", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a40f62570e4455db93b0f94a01effe6-ao-3", 
                "Describe the stepwise management of asthma", 
                "<img src=\"tmpxnfucu.png\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-3-A.svg\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "p};4|$u-5C", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a40f62570e4455db93b0f94a01effe6-ao-4", 
                "Describe the stepwise management of asthma", 
                "<img src=\"tmpxnfucu.png\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-4-A.svg\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "s8?EEDmB]=", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a40f62570e4455db93b0f94a01effe6-ao-5", 
                "Describe the stepwise management of asthma", 
                "<img src=\"tmpxnfucu.png\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-5-A.svg\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "cU?7?qG>TN", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a40f62570e4455db93b0f94a01effe6-ao-6", 
                "Describe the stepwise management of asthma", 
                "<img src=\"tmpxnfucu.png\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-6-A.svg\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "mdF]KEH1:N", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a40f62570e4455db93b0f94a01effe6-ao-7", 
                "Describe the stepwise management of asthma", 
                "<img src=\"tmpxnfucu.png\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-7-A.svg\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "p5KKp:nRXe", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a40f62570e4455db93b0f94a01effe6-ao-8", 
                "Describe the stepwise management of asthma", 
                "<img src=\"tmpxnfucu.png\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-8-A.svg\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "bK#$,f2wWg", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a40f62570e4455db93b0f94a01effe6-ao-9", 
                "Describe the stepwise management of asthma", 
                "<img src=\"tmpxnfucu.png\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-9-A.svg\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "z!$]~%B`ib", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a40f62570e4455db93b0f94a01effe6-ao-10", 
                "Describe the stepwise management of asthma", 
                "<img src=\"tmpxnfucu.png\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-10-A.svg\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "eUzYKMMV41", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a40f62570e4455db93b0f94a01effe6-ao-11", 
                "Describe the stepwise management of asthma", 
                "<img src=\"tmpxnfucu.png\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-11-A.svg\" />", 
                "<img src=\"9a40f62570e4455db93b0f94a01effe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "u`Neq?}7iB", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 medication that can decrease the frequency of asthma exacerbations", 
                "Inhaled corticosteroids<div><br /></div><div>LABA and SABA control symptoms, do not decrease exacerbations</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lnxGbYi&*A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define COPD (3)", 
                "Disease characterised by:<div>- presistent respiratory symptoms and airflow limitation</div><div>due to</div><div>- airway and/or alveolar abnormalities</div><div>usually caused by</div><div>- significant exposure to noxious particles or gases</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qHMR2*/e{!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "cbb33d0be0b44b4c975bf5a8a97a6c52-ao-1", 
                "Name 3 mechanisms by which irreversible airflow obstruction arises in COPD", 
                "<img src=\"tmpbkq8c9.png\" />", 
                "<img src=\"cbb33d0be0b44b4c975bf5a8a97a6c52-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"cbb33d0be0b44b4c975bf5a8a97a6c52-ao-1-A.svg\" />", 
                "<img src=\"cbb33d0be0b44b4c975bf5a8a97a6c52-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "qi;%]S$0Ys", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "cbb33d0be0b44b4c975bf5a8a97a6c52-ao-2", 
                "Name 3 mechanisms by which irreversible airflow obstruction arises in COPD", 
                "<img src=\"tmpbkq8c9.png\" />", 
                "<img src=\"cbb33d0be0b44b4c975bf5a8a97a6c52-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"cbb33d0be0b44b4c975bf5a8a97a6c52-ao-2-A.svg\" />", 
                "<img src=\"cbb33d0be0b44b4c975bf5a8a97a6c52-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "hP3:6Hk:b5", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "cbb33d0be0b44b4c975bf5a8a97a6c52-ao-3", 
                "Name 3 mechanisms by which irreversible airflow obstruction arises in COPD", 
                "<img src=\"tmpbkq8c9.png\" />", 
                "<img src=\"cbb33d0be0b44b4c975bf5a8a97a6c52-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"cbb33d0be0b44b4c975bf5a8a97a6c52-ao-3-A.svg\" />", 
                "<img src=\"cbb33d0be0b44b4c975bf5a8a97a6c52-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "E[pLZ%JW_W", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients who quit smoking, does FEV1 improve or return to normal?", 
                "Rate of decline returns to normal, however any loses are not recovered/never catch up to where they could have been if a nonsmoker<div><br /></div><div><img src=\"paste-20963735371777.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AkJ?`9n_j-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the GOLD system classification of COPD airflow obstruction severity", 
                "<div>Used to assess severity of airflow obstruction</div><div><br /></div>GOLD 1: &gt;80% predicted<div>GOLD 2: 50 - 79</div><div>GOLD 3: 30 - 49</div><div>GOLD 4: &lt;30</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "!}nr1-HK=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "57cb4863ccf945d598ce5f4518bda8c5-ao-1", 
                "Describe the GOLD classification of COPD by symptoms and risk of exacerbations (ABCD assessment tool)", 
                "<img src=\"tmpgqvkgb.png\" />", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-1-A.svg\" />", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "D9F3F.KJ:,", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "57cb4863ccf945d598ce5f4518bda8c5-ao-2", 
                "Describe the GOLD classification of COPD by symptoms and risk of exacerbations (ABCD assessment tool)", 
                "<img src=\"tmpgqvkgb.png\" />", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-2-A.svg\" />", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "pr_meW{:-I", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "57cb4863ccf945d598ce5f4518bda8c5-ao-3", 
                "Describe the GOLD classification of COPD by symptoms and risk of exacerbations (ABCD assessment tool)", 
                "<img src=\"tmpgqvkgb.png\" />", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-3-A.svg\" />", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "fbnj[+Bieh", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "57cb4863ccf945d598ce5f4518bda8c5-ao-4", 
                "Describe the GOLD classification of COPD by symptoms and risk of exacerbations (ABCD assessment tool)", 
                "<img src=\"tmpgqvkgb.png\" />", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-4-A.svg\" />", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "MThU0,H(n,", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "57cb4863ccf945d598ce5f4518bda8c5-ao-5", 
                "Describe the GOLD classification of COPD by symptoms and risk of exacerbations (ABCD assessment tool)", 
                "<img src=\"tmpgqvkgb.png\" />", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-5-A.svg\" />", 
                "<img src=\"57cb4863ccf945d598ce5f4518bda8c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kq9I|2dv*8", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a47d52de5124cc2bacee1e11193bd5f-ao-1", 
                "Describe the GOLD classification of COPD by symptoms and risk of exacerbations (ABCD assessment tool)", 
                "<img src=\"tmpgqvkgb.png\" />", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-1-A.svg\" />", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "fP=/i5uS8]", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a47d52de5124cc2bacee1e11193bd5f-ao-2", 
                "Describe the GOLD classification of COPD by symptoms and risk of exacerbations (ABCD assessment tool)", 
                "<img src=\"tmpgqvkgb.png\" />", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-2-A.svg\" />", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Ceq6AN|W.>", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a47d52de5124cc2bacee1e11193bd5f-ao-3", 
                "Describe the GOLD classification of COPD by symptoms and risk of exacerbations (ABCD assessment tool)", 
                "<img src=\"tmpgqvkgb.png\" />", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-3-A.svg\" />", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "jp<C^`#g{3", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a47d52de5124cc2bacee1e11193bd5f-ao-4", 
                "Describe the GOLD classification of COPD by symptoms and risk of exacerbations (ABCD assessment tool)", 
                "<img src=\"tmpgqvkgb.png\" />", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-4-A.svg\" />", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "b=d/!vI|nG", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9a47d52de5124cc2bacee1e11193bd5f-ao-5", 
                "Describe the GOLD classification of COPD by symptoms and risk of exacerbations (ABCD assessment tool)", 
                "<img src=\"tmpgqvkgb.png\" />", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-5-A.svg\" />", 
                "<img src=\"9a47d52de5124cc2bacee1e11193bd5f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "I;YNbeM0.~", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "476f0a43f1fc4b98a92ee0702a838030-ao-1", 
                "Describe COPD treatment by GOLD grade", 
                "<img src=\"tmpnx3dnv.png\" />", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-1-A.svg\" />", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "c;b<9M@>6f", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "476f0a43f1fc4b98a92ee0702a838030-ao-2", 
                "Describe COPD treatment by GOLD grade", 
                "<img src=\"tmpnx3dnv.png\" />", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-2-A.svg\" />", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "v<5lE.R,1F", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "476f0a43f1fc4b98a92ee0702a838030-ao-3", 
                "Describe COPD treatment by GOLD grade", 
                "<img src=\"tmpnx3dnv.png\" />", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-3-A.svg\" />", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Kf8n2-ScO#", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "476f0a43f1fc4b98a92ee0702a838030-ao-4", 
                "Describe COPD treatment by GOLD grade", 
                "<img src=\"tmpnx3dnv.png\" />", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-4-A.svg\" />", 
                "<img src=\"476f0a43f1fc4b98a92ee0702a838030-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "O))Y:F}!FX", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What intervention has the greatest impact on disease progression in COPD?", 
                "Smoking cessation", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ns^ByNWc*x", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with exacerbation of COPD, what intervention is most likely to prevent hospital admission?", 
                "Oral steroids", 
                ""
            ], 
            "flags": 0, 
            "guid": "dyC;fWX>cI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of exacerbation of COPD (6)", 
                "Increase dose/frequency of bronchodilators: salbutamol plus either ipratropium or terbutaline<div>Systemic corticosteroid (reduce severity, shorten recovery)</div><div>Antibiotics if evidence of infection</div><div>Other (e.g. theophylline)</div><div>Oxygen if hypoxic</div><div>Ventilatory support if type 2 respiratory failure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Wg6+u3`%E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the BODE index?", 
                "Composite score of dyspnoea, BMI, 6 minute walk test, and FEV1 in COPD<div>Predictor of mortality, better than FEV1 alone</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": ".&dG1,fm^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What does the RACP believe is the best predictor of mortality in COPD?", 
                "Hospitalisation for acute exacerbation (2008 paper 2)<div><br /></div><div>Uptodate disagrees but does not offer a no1 alternative</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K~W8(hucRd", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 prognostic markers for mortality and disease progression in COPD", 
                "FEV1<div>Airway responsiveness</div><div>Smoking</div><div>Low BMI &lt;21</div><div>HIV</div><div>Decreased exercise capacity</div><div>Elevated CRP &gt;3</div><div>BODE index</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "QL7bC;<v03", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which of the following is most effective in improving disease outcomesin asthma?<div>1) Action plain</div><div>2) Peak flow monitoring</div><div>3) Regular medical follow up</div><div>4) Asthma education</div>", 
                "3) regular follow up", 
                ""
            ], 
            "flags": 0, 
            "guid": "K6d+iKB^Rb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the clinical manifestations of eosinophillic asthma (5)", 
                "Persistent eosinophilia despite maximal optimal inhaled steroids<div>Less likely to have atopy/allergy</div><div>More likely to have severe sinus disease/nasal polyps</div><div>May also have aspirin exacerbated respiratory disease (AERD)<br /><div>Prone to recurrent exacerbations of asthma</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e;0$P]mwu*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What agent, in addition to standard therapy, may be of use in eosinophillic asthma?", 
                "Anti-IL-5 monoclonal antibody (mepolizumab)", 
                ""
            ], 
            "flags": 0, 
            "guid": "e77]JPZj66", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 severe asthma phenotypes", 
                "Childhood onset allergic asthma (onset age &lt; 12)<div>Adult onset atopic asthma</div><div>Adult onset nonatopic asthma</div><div>Hypereosinophilic asthma</div><div>Aspirin exacerbated respiratory disease</div><div>Asthmatic granulomatosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "OHB0Wdcn56", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define severe asthma", 
                "<div>Treatment with guidelines suggested medications for GINA steps 4-5 asthma (high dose inhaled glucocorticoid and long-acting beta agonist [LABA] or leukotriene modifier/theophylline) for the previous year, OR</div><div>Treatment with systemic glucocorticoid for ≥50% of the year</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M3du9PL9KC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define uncontrolled asthma (4)", 
                "<div>At least one of:</div><div>- Poor symptom control</div><div>&nbsp;- Frequent severe exacerbations: two or more bursts of systemic glucocorticoids (more than three days each) in the previous year</div><div>- History of serious exacerbation: at least one hospitalization, intensive care unit stay, or mechanical ventilation in the previous year</div><div>- Airflow limitation: after appropriate bronchodilator withhold FEV1 &lt;80% predicted</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yEVd02+l:V", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A minimum of how many anterior ribs should be seen in an inspiratory chest xray, if there has been adequate inspiratory effort?", 
                "6", 
                ""
            ], 
            "flags": 0, 
            "guid": "y[ezW,6N>A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which is conventionally used, AP or &nbsp;PA projection for chest xrays?", 
                "PA (beams from posterior to anterior)", 
                ""
            ], 
            "flags": 0, 
            "guid": "qB0~6:kWx%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect on the apparent size of the heart when AP, as opposed to PA, projection is used when taking a chest xray?", 
                "AP projection can make the heart appear larger", 
                ""
            ], 
            "flags": 0, 
            "guid": "B?CJc{%IJX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe hounsefield units, with examples", 
                "Units used to describe density of a structure on CT<div>Water: 0</div><div>Air: -1000</div><div>Fat: -100</div><div>Brain, blood, muscle, liver: 30 - 60</div><div>Bone: 700 - 1000</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s6I3BTq_bx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define a pulmonary nodule", 
                "Focal pulmonary opacity size &lt; 3cm (larger is a mass)", 
                ""
            ], 
            "flags": 0, 
            "guid": "ua|dWQ0!`,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-1", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-1-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "p9GqC65~x6", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-2", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-2-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "m200c(3xFT", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-3", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-3-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "k)g&p{pd>(", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-4", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-4-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "A0~X%1>DvD", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-5", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-5-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "xPe4RJ#$IH", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-6", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-6-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Il92=8Nl!x", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-7", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-7-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "vmwg+u<fpA", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-8", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-8-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Dh9Bq8PI<:", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-9", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-9-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "xgK`/tzq|1", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-10", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-10-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "m+0zJLWpJ`", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-11", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-11-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "QyA}HGFd:E", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-12", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-12-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-12-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "uHO},IF&<C", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-13", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-13-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-13-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "n|LIukwe@L", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "538a2fdd2a6a417e885e0d1b10853a49-ao-14", 
                "Fleischner Society 2017 Guidelines for Management of Incidentally Detected Pulmonary Nodules in Adults", 
                "<img src=\"tmpwthhra.png\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-14-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-14-A.svg\" />", 
                "<img src=\"538a2fdd2a6a417e885e0d1b10853a49-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "b6ws5!yKl$", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 'tree in bud' finding on CT chest?", 
                "<div>CT appearance of multiple areas of centrilobular nodules with a linear branching pattern.</div><div>Can be seen in:</div>Bronchiolar luminal impaction with mucus, pus, or blood<div>Bronchiolitis with thickening of bronchiolar walls</div><div>Bronchiectasis with mucus plugging</div><div><br /></div><div><img src=\"paste-20779051778049.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ea7;.NcUfp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 'crazy paving' on chest CT?", 
                "Nonspecific HRCT appearance of ground glass opacity with superimposed interlobular septal thickening and itralobular reticular thickening<div><img src=\"paste-20929375633409.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K;6|OGLmEC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 causes of 'crazy paving' on HRCT chest", 
                "ARDS<div>Interstitial pneumonia</div><div>Pulmonary alveolar proteinosis</div><div>Pulmonary haemorrhage</div><div>Pulmonary infection</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M@||<[.B>W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology", 
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 causes of increased uptake on FDG PET scan", 
                "Cancer<div>Granulomatous disease</div><div>Abscess</div><div>Post-surgical</div><div>Inflammation</div><div>Foreign body reaction</div><div>Excessive bowel uptake with metformin therapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x#/Y6x#>Ui", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 sites that have physiological high uptake of FDG on PET scan", 
                "Brain<div>Skeletal muscle after use</div><div>Myocardium</div><div>Intestinal wall</div><div>Genitourinary tract</div><div>Brown fat</div><div>Thymus</div><div>Bone marrow</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m8#v((};WB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Air bronchograms indicate what pathology on chest xray?", 
                "Alveolar consolidation - something other than air fills the alveoli (pus, water, blood, cell, protein)<div><br /></div><div><img src=\"paste-23300197580801.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "twM1i?$(Gp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 signs on chest xray of pulmonary interstitial oedema", 
                "Upper lobe diversion<div>Interstitial markings</div><div>- Peribronchial cuffing</div><div>- Kerly B lines</div><div>- Fluid in fissure</div><div>Alveolar opacity</div><div>Pleural effusion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MFn0_#Bprn", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the appearance of Kerly B lines on chest xray", 
                "<div>These are thin lines 1-2 cm in length in the periphery of the lung(s). They are perpendicular to the pleural surface and extend out to it. They represent thickened subpleural interlobular septa and are usually seen at the lung bases.&nbsp;</div><div>Seen in pulmonary oedema, usually when PCWP &gt; 20 - 25</div><div><br /></div><img src=\"f933f4c7e73d09aede91c52d5a476c2d.jpg\" /><div><img src=\"Chest_radiograph_of_a_lung_with_Kerley_B_lines_-_annotated.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Evcm=l^-1+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is peribronchial cuffing?", 
                "<div>Seen in pulmonary oedema.</div><img src=\"paste-25941602467841.jpg\" /><div><img src=\"paste-26014616911873.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "upkD31k~O@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with mitral valve regurgitation and left ventricular failure, which part of the lung is the pumonary oedema most likely to affect?", 
                "Right upper lobe", 
                ""
            ], 
            "flags": 0, 
            "guid": "M)C$aTd)U]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the radiographic findings of tension pneumothorax", 
                "Usual signs of pneumothorax<div>PLUS</div><div>Mediastinal shift</div><div>Increased rib distance</div><div>Flattening of hemidiaphragm</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q,KT7(y>*]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 signs of bronciectasis on cest CT`", 
                "<div>Bronchi larger than adjacent pulmonary artery (should be 1:1)</div>Lack of tapering of bronchi<div>Bronchi seen within 1cm of costal pleura</div><div>Bronci abutting mediastinal pleura</div><div>Bronchial wall thickening</div><div>Signet ring sign</div><div><br /></div><div><img src=\"paste-26676041875457 (1).jpg\" /></div><div><img src=\"paste-26688926777345.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EXq3-&,m}>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a secondary pulmonary lobule (5)?", 
                "Smallest anatomic unit of pulmonary structure<div>1-2cm size</div><div>Contains 5 - 15 acini, which contain alveoli</div><div>Supplied by terminal bronchiole at the centre with parallel centrilobular artery</div><div>Pulmonary veins and lymphatics run in along the periphery within the interlobular septa</div><div><img src=\"paste-26938034880513.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "OVz9qSl*Qh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Describe these findings</div><img src=\"paste-27346056773633.jpg\" />", 
                "Septal thickening (black arrows)<div>Pleural effusion (star)</div><div><br /></div><div>This patient has pulmonary oedema. Septal thickening is from fluid in the septa.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c9M!V7#3z:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3aeee34ace0044d09a0ab2b02a98d121-ao-1", 
                "What is this finding on CT chest called?", 
                "<img src=\"tmphzsimf.png\" />", 
                "<img src=\"3aeee34ace0044d09a0ab2b02a98d121-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3aeee34ace0044d09a0ab2b02a98d121-ao-1-A.svg\" />", 
                "<img src=\"3aeee34ace0044d09a0ab2b02a98d121-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q_5%-SxxE}", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7380b5e4bfb04ae3aa341425dca3c2ae-ao-1", 
                "What is this finding called?", 
                "<img src=\"tmpuqgpds.png\" />", 
                "<img src=\"7380b5e4bfb04ae3aa341425dca3c2ae-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7380b5e4bfb04ae3aa341425dca3c2ae-ao-1-A.svg\" />", 
                "<img src=\"7380b5e4bfb04ae3aa341425dca3c2ae-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ck7|MnjDz~", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "79ea9babed5846b48cbd210dce585292-ao-1", 
                "", 
                "<img src=\"tmplargxl.png\" />", 
                "<img src=\"79ea9babed5846b48cbd210dce585292-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"79ea9babed5846b48cbd210dce585292-ao-1-A.svg\" />", 
                "<img src=\"79ea9babed5846b48cbd210dce585292-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "FfajaJYHPr", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "79ea9babed5846b48cbd210dce585292-ao-2", 
                "", 
                "<img src=\"tmplargxl.png\" />", 
                "<img src=\"79ea9babed5846b48cbd210dce585292-ao-2-Q.svg\" />", 
                "This patient has idiopathic pulmonary fibrosis with usual interstital pneumonia pattern", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"79ea9babed5846b48cbd210dce585292-ao-2-A.svg\" />", 
                "<img src=\"79ea9babed5846b48cbd210dce585292-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "KnKuDn[h17", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "79ea9babed5846b48cbd210dce585292-ao-3", 
                "", 
                "<img src=\"tmplargxl.png\" />", 
                "<img src=\"79ea9babed5846b48cbd210dce585292-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"79ea9babed5846b48cbd210dce585292-ao-3-A.svg\" />", 
                "<img src=\"79ea9babed5846b48cbd210dce585292-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kj|INRbaY&", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is usual interstitial pneumonia (UIP)?", 
                "A histological pattern seen on HRCT<div><div>May be due to</div><div>- idiopathic pulmonary fibrosis</div><div>- asbestosis</div><div>- connective tissue related pulmonary fibrosis</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KG/tA_/9Q6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9d75589dbb3049cab84de554edf0ee42-ao-1", 
                "", 
                "<img src=\"tmpnqvtuo.png\" />", 
                "<img src=\"9d75589dbb3049cab84de554edf0ee42-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9d75589dbb3049cab84de554edf0ee42-ao-1-A.svg\" />", 
                "<img src=\"9d75589dbb3049cab84de554edf0ee42-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ne:KwFX?vB", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9d75589dbb3049cab84de554edf0ee42-ao-2", 
                "", 
                "<img src=\"tmpnqvtuo.png\" />", 
                "<img src=\"9d75589dbb3049cab84de554edf0ee42-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9d75589dbb3049cab84de554edf0ee42-ao-2-A.svg\" />", 
                "<img src=\"9d75589dbb3049cab84de554edf0ee42-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "e=Vj>t|`-x", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the histopathological findings of usual interstital pneumonia (UIP)?", 
                "Fibroblastic foci (hallmark)<div><div><div>Heterogeneity - normal lung adjacent to abnormal</div></div></div><div><img src=\"paste-41158671597569.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "OEmP=.*3TL", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is nonspecific interstitial pneumonia? (5)", 
                "A pattern seen on CT and histopathology:&nbsp;<div>- reticulation</div><div>- ground glass opacities</div><div>- traction bronchiectasis<div>Associated with connective tissue diease pulmonary fibrosis</div><div>Better prognosis than usual interstitial pneumonia</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xS-^20Rk:%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What pattern is shown below?<div><img src=\"paste-42021960024065.jpg\" /></div>", 
                "Nonspecific interstitial pneumonia (NSIP)", 
                ""
            ], 
            "flags": 0, 
            "guid": "l*oarkx/gj", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c7156e55d7ad42bf9cd9efeb16e773d5-ao-1", 
                "This patient has nonspecific interstitial pneumonia. Identify the changes below.", 
                "<img src=\"tmpix5qim.png\" />", 
                "<img src=\"c7156e55d7ad42bf9cd9efeb16e773d5-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c7156e55d7ad42bf9cd9efeb16e773d5-ao-1-A.svg\" />", 
                "<img src=\"c7156e55d7ad42bf9cd9efeb16e773d5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q)z%Sqc=>K", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c7156e55d7ad42bf9cd9efeb16e773d5-ao-2", 
                "This patient has nonspecific interstitial pneumonia. Identify the changes below.", 
                "<img src=\"tmpix5qim.png\" />", 
                "<img src=\"c7156e55d7ad42bf9cd9efeb16e773d5-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c7156e55d7ad42bf9cd9efeb16e773d5-ao-2-A.svg\" />", 
                "<img src=\"c7156e55d7ad42bf9cd9efeb16e773d5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "g<5)i[-}[+", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "c7156e55d7ad42bf9cd9efeb16e773d5-ao-3", 
                "This patient has nonspecific interstitial pneumonia. Identify the changes below.", 
                "<img src=\"tmpix5qim.png\" />", 
                "<img src=\"c7156e55d7ad42bf9cd9efeb16e773d5-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"c7156e55d7ad42bf9cd9efeb16e773d5-ao-3-A.svg\" />", 
                "<img src=\"c7156e55d7ad42bf9cd9efeb16e773d5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "L&{K#5/buz", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the best predictor of mortality in patients with interstitial lung disease?", 
                "FVC<div><br /></div><div>DLCO is also used as a secondary endpoint</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E`QYi6d7$w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is the 6 minute walk test a good way to monitor disease progression in interstitial lung disease?", 
                "No, it is not used", 
                ""
            ], 
            "flags": 0, 
            "guid": "VqE{BS9=W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Radiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient being investigated for suspected interstitial lung disease undergoes bronchial lavage. CD4/CD8 ratio &gt;4 is identified (normal range 0.9 - 2.5). Other inflammatory cell counts are normal. What is the likely diagnosis?", 
                "Sarcoidosis<div><br /></div><div>CD4/CD8 &gt; 4 is highly specific for sarcoidosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I+6ujuUkV%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient being investigated for suspected interstitial lung disease undergoes bronchial lavage. The lymphocyte differential count is &gt;50%. What is the likely diagnosis? (2)", 
                "Hypersensitivity pneumonitis, or<div>Cellular nonspecific interstital pneumonia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q3?`-D/7}o", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient being investigated for suspected interstitial lung disease undergoes bronchial lavage. Eosinophilic differential count is &gt;25%. What is the likely diagnosis?", 
                "<div>Acute or chronic eosinophilic pneumonia.</div><div><br /></div>This finding is virtually diagnostic.", 
                ""
            ], 
            "flags": 0, 
            "guid": "G6fq89|-HC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient being investigated for suspected interstitial lung disease undergoes bronchial lavage. They are found to have &gt;1% mast cells, &gt;50% lymphocytes, and &gt;3% neutrophils. What is the likely diagnosis?", 
                "Acute hypersensitivity pneumonitis", 
                ""
            ], 
            "flags": 0, 
            "guid": "LGT>/3uyAh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient being investigated for suspected interstitial lung disease undergoes bronchial lavage. Lymphocyte differential count is &gt;25% (normal 10 - 15%). What is the differential diagnosis? (6)", 
                "Granulomatous disease (sarcoid, hypersensitivity pneumonitis)<div>Cellular nonspecific interstitial pneumonia</div><div>Drug reaction</div><div>Lymphoid interstitla pneumonia</div><div>Cryptogenic organising pneumonia</div><div>Lymphoma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y|nU}n$Ve-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient has a classic UIP pattern on their CT chest. Is lung biopsy required to confirm the diagnosis?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "N@B9g,SVm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the preferred method of lung biopsy in patients who require diagnostic evaluation for interstitial lung disease?", 
                "VATS", 
                ""
            ], 
            "flags": 0, 
            "guid": "tCS$6VWZ0(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which group of patients with idiopathic pulmonary fibrosis has the better prognosis - usual interstital pneumonia (UIP) or nonspecific interstitial pneumonia (NSIP)", 
                "NSIP is much better<div>Both have a poor prognosis</div><div><br /></div><div><img src=\"paste-52072183496705.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "v7Bi2d{i+d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the proposed pathogenesis of idiopathic pulmonary fibrosis", 
                "<div>IPF is perpetuated by aberrant wound healing, not chronic inflammation</div><img src=\"paste-52145197940737.jpg\" />", 
                ""
            ], 
            "flags": 0, 
            "guid": "u;lD9b{#nT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of idiopathic pulmonary fibrosis (7)", 
                "<div>Pirfenidone or nintendanib (if meet criteria)</div><div>Treat GORD</div>Oxygen if hypoxic<div>Pulmonary rehab</div><div>Manage comorbidities</div><div>Conser list for lung transplantation</div><div>Consider refer to clinical trials</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I:!A8qRrfk", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is azathioprine, prednisolone, and n-acetylcystine triple therapy indicated for idiopathic pulmonary fibrosis?", 
                "No - greater mortality, more hospitalisations (PANTHER trial - discontinued early) than placebo", 
                ""
            ], 
            "flags": 0, 
            "guid": "q!IKJV~~r4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of pirfenidone? (3)", 
                "<div>Has antifibrotic, anti-inflammatory, and antioxidant effect</div><div>Regulates activity of TGF B1 and TNF alpha</div><div>Inhibits fibroblast proliferation and collagen synthesis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "o-(Np]?;#x", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the ASCEND trial for pirfenidone in idiopathic pulmonary fibrosis", 
                "Slower decline in FVC and 6min walk test<div>Improved progression free survival</div><div>No reduction in dyspnoea or death</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "iNAOH|510K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 side effects of pirfenidone", 
                "Photosensitivity +++ (the kits come with sunscreen, full sun protection is required)<div>Nausea</div><div>Rash</div><div>Diarrhoea</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G<oqy4kC,p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of nintedanib?", 
                "Intracellular inhibitor targeting multiple tyrosine kinases", 
                ""
            ], 
            "flags": 0, 
            "guid": "k!)IZk:jZ`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the INPULSIS trial findings for nintedanib in idiopathic pulmonary fibrosis", 
                "Slowed FVC decline<div>No change in quality of life, time to first exacerbation, mortality</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O-I:SXm-`z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 side effects of nintedanib", 
                "<div>Diarrhoea (60%), can be severe and treatment-limiting</div><div>GI upset</div><div>Nausea</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CNXP]dSwN5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do&nbsp;pirfenidone and nintedanib reverse disease in patients with idiopathic pulmonary fibrosis?", 
                "No - they only slow progression (FVC decline)<div>No regain of lost function</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d#&5@T*Ro?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 7 criteria for accessing pirfenidone or nintedanib for idiopathic pulmonary fibrosis", 
                "HRCT consistent with IPF in last 12 months<div>FEV1/FVC &gt; 0.7 (not obstructed)</div><div>FVC &gt; 50% (not too severe)</div><div>DLCO &gt; 30%</div><div>Multidisciplinatry diagnosis (MDT)</div><div>Not due to other known causes (e.g. connective tissue, environmental exposure)</div><div>Treated by a respiratory physician</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wHS$A(UE:0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is there a benefit for 'advanced therapy' targetting pulmonary hypertension in patients with idiopathic pulmonary fibrosis?", 
                "No, strong recommendation to NOT use", 
                ""
            ], 
            "flags": 0, 
            "guid": "WZi:ur^0P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9c0771cd971c48a299fcc0625e70d317-ao-1", 
                "", 
                "<img src=\"tmpzppauq.png\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-1-A.svg\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "B=;w>eQa8w", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9c0771cd971c48a299fcc0625e70d317-ao-2", 
                "", 
                "<img src=\"tmpzppauq.png\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-2-A.svg\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "o(yb(E9U^b", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9c0771cd971c48a299fcc0625e70d317-ao-3", 
                "", 
                "<img src=\"tmpzppauq.png\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-3-A.svg\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "K,d=`J4!ty", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9c0771cd971c48a299fcc0625e70d317-ao-4", 
                "", 
                "<img src=\"tmpzppauq.png\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-4-A.svg\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kda+8kXWV^", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9c0771cd971c48a299fcc0625e70d317-ao-5", 
                "", 
                "<img src=\"tmpzppauq.png\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-5-A.svg\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "DB3Q$GL^9j", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9c0771cd971c48a299fcc0625e70d317-ao-6", 
                "", 
                "<img src=\"tmpzppauq.png\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-6-A.svg\" />", 
                "<img src=\"9c0771cd971c48a299fcc0625e70d317-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "w}x-1$%UQt", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What pattern of involvement do scleroderma patients with interstitial lung disease typically have?", 
                "Nonspecific interstitial pneumonia (NSIP)", 
                ""
            ], 
            "flags": 0, 
            "guid": "G2Y2m!ZVl%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What pattern of involvement do rheumatoid arthritis patients with interstitial lung disease typically have?", 
                "UIP", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q6<1GxNZyJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which group has the better prognosis, connective tissue associated interstital lung disease or idiopathic pulmonary fibrosis?", 
                "CTD-associated disease does better<div><img src=\"paste-67976447393793.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KnIfl$nf>n", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients with apparent idiopathic interstitial lung disease have an underlying connective tissue disease?", 
                "15%", 
                ""
            ], 
            "flags": 0, 
            "guid": "CoAl@%vz_}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which pattern of interstitial lung disease is hypothesied to always be due to an underlying connective tissue disorder?", 
                "NSIP", 
                ""
            ], 
            "flags": 0, 
            "guid": "fD<c>vJ;H4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is interstitial pneumonia with autoimmune features (IPAF)?", 
                "Clinical subset of interstital lung disease with features of connective tissue disease that do not meet criteria for any given autoimmune disease", 
                ""
            ], 
            "flags": 0, 
            "guid": "D+1KO@R,7R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the management of patients with connective tissue interstitial lung disease (CT-ILD) (3)", 
                "Steroids<div>Immunosuppression (e.g. cyclophosphamide, azathioprine, methotrexate, mycophenolate, rituximab)</div><div>Manage reflux</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dr/l-c.$/~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why is it important to distinguish between idiopathic pulmonary fibrosis (IPF) and connective tissue associated interstital lung disease (CT-ILD)?", 
                "Management is very different<div>IPF is managed with antifibrotics (pirfenidone, nintedanib), steroids/immunosupression not used</div><div>CT-ILD is managed with steroids and immunosuppression</div><div><br /></div><div>IPF also has a poorer prognosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LCkx]j+m!I", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the problem with using spirometry to monitor patients with co-existing emphysema and interstitial lung disease (e.g. IPF)?", 
                "Emphysema increases lung volumes, ILD decreases<div>Can get normal spirometry as the two processes equal out</div><div><br /></div><div>In this case, use DLCO to monitor, as DLCO is reduced by both</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f0JBV$MQ9_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the diagnostic workup of suspected interstital lung disease (6)", 
                "HRCT - check pattern of involvement<div>Screen for autoimmune disease</div><div>Screen for co-existant emphysema and pulmonary hypertension<br /><div>Serial lung function, check FVC and DLCO trends</div><div>+/- Bronchioalveolar lavage</div><div>+/- Biopsy</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KQv,y;Fo%:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe these findings and give a diagnosis<div><img src=\"paste-70446053588993.jpg\" /></div>", 
                "Nonspecific interstital pneumonia (NSIP) pattern<div>- ground glass</div><div>- traction bronchiectasis</div><div>- no honeycombing</div><div><br /></div><div>Patient was diagnosed with connective tissue related interstital lung disease (CT-ILD)</div><div>Later diagnosed with scleroderma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PD9p9(lQC(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with connective tissue interstital lung disease (CT-ILD) has good improvement in their FVC with immunosuppression. However their DLCO continues to decline. What might explain this?", 
                "Concurrent pulmonary hypertension<div>Can consider treating with advanced therapy (therapy directed at pulmonary hypertension)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m%9]{2E6vr", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with idiopathic pulmonary fibrosis does not respond to initial therapy with pirfenidone. Is there a role for switching to nintedinib?", 
                "Yes<div><br /></div><div>Can switch from pirfendone to nintedanib, or vice versa</div><div>Cannot use both together</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E2/H~F[@Qc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 relative contraindications to bronchoscopy", 
                "Respiratory insufficiency<div>Platelet &lt; 50</div><div>INR &gt; 1.5</div><div>Antiplatelet/anticoagulation (need to be withheld prior)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hIM(Hd1slO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common complication of standard bronchoscopy?", 
                "Transient fever/chills (25 - 50%)<div>Occurs due to cytokine release</div><div>Self limiting</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Eqi$8MbLmo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which lymph node 'stations' are accessible for biopsy via linear endobronchial ultrasound (linear EBUS)?", 
                "Upper zone<div>Subcarinal</div><div>Hilar and interlobar</div><div><br /></div><div><img src=\"paste-77133317668865.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lJTlyq.la0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which is the preferred procedure for sampling mediastinal masses, such as lymph nodes?", 
                "Linear EBUS<div>Superior to surgical approaches</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bgAy;/S+?*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 methods that may be used to biopsy a peripheral lung lesion", 
                "Radial EBUS, or<div>Transthoracic needle aspiration/biopsy, or</div><div>Surgical resection biopsy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q*-ePRrt2c", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is radial EBUS?", 
                "An ultrasound probe is inserted through a bronchoscope<div>Gives 360 degree view of surrounding tissue</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qjV8]4wtB#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the 3 most common cancers worldwide, excluding nonmelanoma skin cancer?", 
                "1. Lung<div>2. Breast</div><div>3. Colorectal</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d:1E]ro[;(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "NSCLC and SCLC account for what percentage of lung cancer cases, respectively?", 
                "NSCLC 85%<div>SCLC 15%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "4]U!P|8N2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 mutations which may be identified in patients with lung adenocarcinom", 
                "EGFR (15%)<div>ALK (5%)</div><div>KRAS (30%)</div><div><br /></div><div>EGFR and ALK have targeted therapies available and are routinely tested</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vD->VvMjtl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 mutations which may be identified in patients with squamous cell carcinoma of the lung", 
                "PIK3CA amplification (25%)<div>FGFR1 (20%)</div><div>PIK3CA mutation (15%)</div><div>PTEN (10%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I(u5KI!XYo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What proportion of NSCLC are adenocarcinoma, squamout cell carcinoma, or other?", 
                "Adenocarcinoma 50%<div>Squamous 30%</div><div>Other 20% (e.g. large cell)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q7T#5!~3-Q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 4 most common sites of lung cancer metastasis", 
                "Brain<div>Liver</div><div>Adrenals&nbsp;</div><div>Bone</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xP6jh(D*35", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common neurologic paraneoplastic manifestation of lung cancer?", 
                "Lambert-Eaton syndrome", 
                ""
            ], 
            "flags": 0, 
            "guid": "x[IQ_e`_MN", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 paraneoplastic manifestations of lung cancer", 
                "<div>Skeletal</div><div>- Clubbing</div><div>- Hypertrophic osteoarthropathy</div><div>Endocrine</div><div>- Hypercalcaemia</div><div>- SIADH</div><div>- Cushings</div><div>Neurologic</div><div>- Lambert-Eating</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fj-Y<Cw>IY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 methods that may be used to biopsy peribronchial, peritracheal, or mediastinal lesions", 
                "Linear EBUS<div>Bronchoscopy with transbronchial needle aspiration (blind)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "*e1CTyo=f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 method used to biopsy central lung lesions", 
                "Flexible bronchoscopy", 
                ""
            ], 
            "flags": 0, 
            "guid": "N2UR]a.Eh5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the method of choice for mediastinal staging in patients with lung cancer?", 
                "&nbsp;endobronchial ultrasound-guided transbronchial needle aspiration (EBUS TNBA)", 
                ""
            ], 
            "flags": 0, 
            "guid": "zHPi*dtnT/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Respiratory"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is a population of naive B cells with different surface receptors (to match to different antigens) generated from common lymphoid progenitor cells (CLP)?", 
                "Antigen receptor (VDJ) rearrangement: randomly generated receptor through random gene segment recombination&nbsp;<div>This results in a unique immunoglobulin displayed on its surface</div><div>It can then wait for a matching antigen, and undergo clonal expansion if it does</div><div><br /></div><div>Note it can randomly generate an immunoglobulin against self (occurs in 60 - 80% prior to selection)</div><div>Negative selection reduces this population</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d5oYfmCE!>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Maturing T cells undergo what process as they mature in the thymus?", 
                "Positive selection on bases of strength of binding to self HLA<div>- removal of strongly binding (anti-self)</div><div>- removal of no-binding useless T cells</div><div>- keep the weakly binding T cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Iq^#-3[1;f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does the thymus avoid producing anti-self T cells?", 
                "AIRE<div>Expression molecule in the thymus that regulates self-expression</div><div>Allows the thymus to present a variety of 'self' molecules (e.g. a bit of thyroglobulin, a bit of insulin, etc) to insure anti-self T cells against these are deleted</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l67LL_(u*)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is it determined what kind of T helper cell population will be created during a given immune response?", 
                "The predominant cytokine present at the time<div>e.g. if IL-4 is around, they become Th2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l/koy1,@34", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Immune responses against blood borne pathogens mostly occurs in which organ", 
                "the spleen", 
                ""
            ], 
            "flags": 0, 
            "guid": "hloO)@}-$Q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Different immunoglobulins (IgG, A, M, etc) have what differences?", 
                "A different heavy chain (e.g. IgG all have the same heavy chain)", 
                ""
            ], 
            "flags": 0, 
            "guid": "ln&%|ewIc@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the structure of an immunoglobulin", 
                "Heavy chain (constant)<div>Hinge region</div><div>Light chain (end of the light chain is variable antigen binding site)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z#,|TT>Wy.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "On an immunoglobulin IgG, how many hypervariable regions are there?", 
                "12", 
                ""
            ], 
            "flags": 0, 
            "guid": "H9i:q;XV9g", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of the hypervariable region of immunoglobulin?", 
                "antigen binding", 
                ""
            ], 
            "flags": 0, 
            "guid": "x2oQ8>=q3}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the roles of the Fc and Fab regions of an immunoglobulin?", 
                "Fc = effector region (heavy chain)<div>Fab = antigen binding (light chain)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j_0#iC<X1N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the difference between avidity and affinity in immunoglobulins", 
                "<div>Avidity = overall interaction between antibody and target</div><div>Affinity = interaction between one antibody binding site and its target</div><div><br /></div><div>E.g. IgM has lots of binding sites that are weak. It has high avidity but low affinity.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "7[!V<tmzQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of IgG?", 
                "Predominates in serum<div>Main antibody of specific immune response</div><div>- slower but more durable response to infection</div><div>- important defence against bacteria, viruses</div><div>- opsonising&nbsp;</div><div>- activates complement</div><div>Crosses placenta and protects neonate</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C:7,t#.QY|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the function of IgM", 
                "Exists in serum and on B cell surface<div>Exists as a pentamer in serum - multivalency (which increases its affinity despite low avidity)</div><div>Extra constant domain in place of hinge of IgG</div><div>Rapid response to infection but short lived</div><div>Good at activating complement and agglutinating bacteria</div><div>Important defence against bacteria, viruses</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h_@Xtc=HXD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What produces IgG in the secondary immune response?", 
                "Memory B cells", 
                ""
            ], 
            "flags": 0, 
            "guid": "Mmd+jB8=LJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of IgA?", 
                "<div>Mucosal surface protection.</div><div>Predominates in secretions (saliva, breast milk, tracheobronchial and genitourinary secretions)<div>Inhibits pathogenic colonoisation of mucosal surfaces/tissues</div><div>Binds to mucsu and traps pathogens</div><div>Inhibits penetration of bacterial toxins</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "t+9r!QpL)l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is IgA transport mediated?", 
                "Polymeric Ig receptor (pIgR)<div>Synthesised by epithelial cells. Sits on luminal surface, binds IgA and transports across epithelium</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e4BqS1M}!,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of IgD?", 
                "Co-expressed on surface of naive B cells with IgM<div>Possible role in mucosal protection - not clear</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EW>t;R?`)6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the role of IgE", 
                "Exists on surface of mast cels and basophils<div>Trace amounts in serum<br /><div>Role in parasitic infections</div><div>Pathogenic role in allergic disease (allergen cross-linking and degranulation)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b@poGNEljc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how antibody activation of B cells works", 
                "Immunoglobulins on B cell surface activate B cells when they (surface Ig (smIg)) are cross linked by antigen<div>B cells then go on (with T cell help) to produce the identicl Ab present on their cell surface</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M,;jem*^Qf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 functions of immunoglobulins", 
                "Activate B cells<div>Neutralisation of toxins, viruses, bacteria</div><div>Activate complement</div><div>Opsonisation</div><div>Ab-depndent cell mediated cytotoxicity</div><div>Activate innate cells (neutrophils, macrophages)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "o)X2)m{IuE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long does maternal IgG last in a newborn after birth, conferring protection?", 
                "6 months", 
                ""
            ], 
            "flags": 0, 
            "guid": "dgqyHp0kzP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define isotype", 
                "Variations in Igs which are present in all members of the species", 
                ""
            ], 
            "flags": 0, 
            "guid": "iJ^EY?xh{_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define idiotype in relation to immunoglobulin", 
                "Structural variation in the antigen binding region of an immunoglobulin", 
                ""
            ], 
            "flags": 0, 
            "guid": "wfzwIRUp/P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a hapten? Given an example", 
                "A small molecule that alone will not elicit an immune response, but will do so when linked to a larger one (called a carrier)<div>e.g. penicillin is a tiny molecule, too small to elicit an immune response on its own, but can do so when bound to albumin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E!YDW[EO1U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is an adjuvant with regards to immune response?", 
                "Substance that enhances the immune reponse, which can turn a toleragen into an immunogen", 
                ""
            ], 
            "flags": 0, 
            "guid": "cY0:`cZoM-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is an epitope (determinant)", 
                "A portion of a macromolecule to which an antibody binds", 
                ""
            ], 
            "flags": 0, 
            "guid": "gM-r%UT~z8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the process of B cell antibody production (4)", 
                "Recognise antigen via immunoglobulin IgM on its surface (SmIg, 'b cell receptor')<div>Break down Ag and re-present to T cells as peptides on surface MHC class II</div><div>T cells provide activation signal ('help')</div><div>B cells differentate to antibody secreting cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vMrKVh:>}_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are KRECS and TRECs?", 
                "<div>Circular DNA segments that are markers of new B cell output (KRECS) and T cell output (TRECs)</div><div>Absence can be used to screen newborns for severe combined immunodeficiency, agammaglobulinaemia prior to clinical manifestations</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nV#HZ=FVXg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What screening do B cells undergo just prior to exiting the bone marrow as naive B cells?", 
                "Tolerance<div>- highly cross linking self Ag -&gt; apoptosed</div><div>- minimally cross linking self-Ag -&gt; angergy (inactivation)</div><div>- receptor editing rearranges other light chain to escape autoreactivity (40 - 50% of developing B cells)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I<5TLg]|9]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of B cell activating factor (BAFF)?", 
                "Promotes survival of naive B cells at late transitional stage<div>- upregulates TLR expression</div><div>- promotes Ig class switching</div><div>Mutations block development -&gt; no B cells</div><div>BAFF levels are increased in autoimmune disease (belimumab for SLE is anti-BAFF,)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xWZ6?cI5fF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What happens to B cells after they exit the bone marrow?", 
                "Naive B cells migrate to spleen, LN, MALT, GALT and await a specific antigen (and T cell help) before differentiating further", 
                ""
            ], 
            "flags": 0, 
            "guid": "KuKl0cS++^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the process of somatic hypermutation of B cells, and how it brings about affinity maturation", 
                "Occurs in germinal centres, after a naive B cell has encountered a matching antigen<div>B cell moves to the germinal centre and multiplies rapidly</div><div>Very high mutation rate, random point mutations introduced by AID into the V regions (hypervariable CDR 'hotspots')</div><div>Done to try to improve affinity (affinity maturation)</div><div>Cells are then tested (at the T cell/B cell border) for increased affinity to the antigen; if higher, they survive, if not, die by apoptosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DoDO~G{ckg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is isotype switching?", 
                "Activated B cells, which are proliferating in a germinal centre after being activated by encountering an antigen, switch isotypes (e.g. from IgM/IgD to IgG, IgA, IgE)<div>They change the constant region of the antibody heavy chain without changing the V regions and thus the specificity to a particular antigen</div><div>Changes the effector function of the antibody produced</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ksdr|8HZ5u", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What two types of cells are generated following B cell maturation and clonal proliferation in a germinal centre?", 
                "Plasma cells (antibody-producing)<div>Memory B cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wB2x({vD!_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of Rituximab?", 
                "Anti-CD20 monoclonal antibody<div>Destroys mature B cells</div><div>Does not target plasma cells or pre-cell precursors</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "v#y5Nf-19C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What do T cells do?", 
                "Recognise antigen as degraded peptide gragments present on the MHC<div>- by T cell receptor (TCR)</div><div><br /></div><div>Two major subsets, CD4 and CD8</div><div><br /></div><div>Major roles</div><div>- cytotoxic (CD8, CTL)</div><div>- helper (CD4)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B=z,<(}?,$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the structure of T cell receptor?", 
                "Two chains, alpha and beta<div>Always membrane bound, never secreted</div><div>V and C regions</div><div>Bind antigens in their variable region</div><div>Associated with signalling chains of CD3 complex</div><div>Role is to recognise peptide presented on MHC</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dZhniS_JN[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the two major classes of T cells?", 
                "CD4 (helper)<div>CD8 (cytotoxic)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k&+#.}=4bg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which MCH do CD4 and CD8 bind to?", 
                "CD4 binds to MHC class II and strengthens that interaction<div>CD8 binds to MHC class I and strengthens that interaction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P*]T3if}dC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe T cell development", 
                "T cell progenitors migrate from marrow to thymus<div><div>Undergo T cell receptor gene rearrangement (to make a wide variety of variable regions to recognise different antigens)</div><div>- Express functional TCR complex and expression of accessory molecules (CD4 or CD8)</div><div>Selection (learning to respond to MHC)</div><div>- 95% fail</div><div>- need to interact with self MHC but not too strongly (anti-self) or too weakly (useless)</div><div>- self reactive T cells may become T regulator cells</div></div><div><br /></div><div>As they mature move from the cortex of the thymus, to the medulla, then exit to the periphery</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h8YF5X>Nsw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do T cells undergo somatic hypermutation, as B cells do?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "c.^|l1aHTs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do T cells become either CD4 or CD8 positive?", 
                "When maturing they are positive for both, as it is not known if their will react better with MHC class I or II<div>If their T cell receptor ends up with an interaction with MHC class I -&gt; keep their CD8, get rid of the other</div><div>If interacts with MHC class II -&gt; keep their CD4, get rid of the other</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KK9=o%x*A`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of IL2 in T cell maturation?", 
                "Required ot generate T regulatory cells<div>- Acts via CD25 (IL-2R alpha)</div><div>- Induces Foxp3<br /><div>Loss leads to out of control action of CD4 and CD8 T cells</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b6=8*dUoXy", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the role of AIRE and FEZF2 in T cell maturation?", 
                "AIRE = autoimmune regulator<div>Exists in the cortical epithelial cells of the thymys<br /><div>Turns on expresiosn of tissue specific Ags at low levels in the thymus</div></div><div>This allows developing T cells to see 'self' from various parts of the body, and be deleted if they react too strongly (deletion of high affinty T cells)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dt8M+rX.{~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe autoimmune polyendocrine syndrome type 1", 
                "Autosomal recessive disorder due to mutated AIRE<div>- failure to express tissue-specific antigens in the thymus (for training T cells)</div><div>- therefore failyre to delete T cells specific for multiple tissue antigens</div><div>autoimmune T cells released into the periphery, causing autoimmunity</div><div>lymphocytic infiltration of multiple tissues and multiple autoantibodies</div><div><br /></div><div>Cardinal manifestations:</div><div>- chronic mucocutanous candidiasis (antibody to cytokines that protect against candida, IL17 and IL22)</div><div>- autoimmune hypoparathyroidism</div><div>- autoimmune addison's disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p]q;@y=gef", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What occurs when T cells leave the thymus?", 
                "Mature T cells (naive and memory) leave and circulate through lymphoid tissue<div>Look for MHC+foreign peptide on APCs</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tja#2T44s&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 types of memory T cell", 
                "Central memory: circulate in lymphoid tissue<div>Effector memory: circulate through other tissue</div><div>Tissue resident memory: do not circulate, reside in tissue</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KE4YIX!C(U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe T cell activation and co-stimulation", 
                "Requires two signals to activate:<div>- signal 1: MCH+peptide</div><div>- signal 2: co-stimulation</div><div><br /></div><div>Absence of co-stimulation results in tolerance (no activation)</div><div>Costimulation mediated by CD80 and CD86 on the APC</div><div>These interact with CD28 (activation) and CTLA4 (delayed deactivation, eventual cause of switch off of response) on the T cell</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jm{F9#6~l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the role of IL2 with regards to T cell function", 
                "<div>IL2 is released from T cells</div><div>Drives resting T cell division (acts on IL2R)</div><div>Induces regulatory T cells (critical for induction and maintenance of Treg cells)</div><div><br /></div><div>Target in renal cell cancer immunotherapy</div><div>Calcineurin inhibitors inhibit IL2 induction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vR)%=U(oTS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe peripheral T cell tolerance (3)", 
                "A lot of tolerance occurs in the thymus (central tolerance via AIRE)<div><br /><div>Peripheral tolerance mediated by</div><div>- Inhibitory molecule engagement (CTLA4, PD-1): inhibitory molecules expressed on T cell surface</div><div>(this is why checkpoint inhibitors like anti-PD1 results in autoimmunity; lifts the lid on the usual suppressive action of these molecules)</div><div>- Angery (MCH and TCR bind but no co-stimulation -&gt; switch off of response or morph to Treg)</div><div>- Clonal ignorance: T cells do not 'see' antigen in priviledged sites (brain, eye, testes) as the T cells don't go there, or if they do are killed</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uVpy,%cO5`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how sympathetic opthalmia works", 
                "T cells usually do not 'see' self antigens in the eye (T cells are ignorant of eye antigens)<div>Penetrating eye injury causes circulation of 'eye' antigens into the lymphatics</div><div>T cells react to eye antigens as non-self</div><div>T cell attack on both eyes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BBgn+o7%j^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 markers of Treg cells", 
                "CD4+<div>Often CD25 pos</div><div>Express foxp3</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rC?zoM[e_O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is IPEX (immune dysfunction, polyendocrinopathy, enterpathy, X-linked)", 
                "Lack of foxP3 means no Treg cells<div>Global overactivity of immune function</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L,lc}5.g9U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 types of Treg cell", 
                "Thymic<div>- induced by moderate interaction with self, AIRE-dependent<br /><div>Peripheral</div><div>- induced by interaction with self of commensals in setting of suppressive cytokines</div><div>Induced (in vitro - therapeutic use)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w_QG^I@KxR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do Treg cells work to suppress the immune repsonse?", 
                "Express CTLA4<div>- CTLA4 pulls off costimulator B7 from APCs (can't costimulate - can't generate T cell response)</div><div>Secrete inhibitory cytokines (Il10, TGF beta) and make dendritic cells secrete them too</div><div>IL2-R alpha binds IL-2 (restricts access to conventrional T cells)</div><div>Kill other cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mJK;t*AO~:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Wha are super antigens? (4)", 
                "Antigens that stimulate a wide range of T cells at once (2-20% of all T cells)<div>Bind outside the MHC:peptide groove</div><div>MAssive cytokine release, T cell proliferation and then apoptosis</div><div>Important in pathogenesis of tocix shock syndrome toxin 1 (TSST-1) and staphylococcal enterotoxins</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oPG(kA`RrS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the three main subsets of helper T cells that differentiate from naive T cells?", 
                "Th1<div>Th2</div><div>Th17</div><div><br /></div><div>Mostly CD4, but some CD8</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NTz&t2SV(h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How are effector T cell subsets (Th1, Th2, Th17 and Treg) classified?", 
                "By the cytokines they make", 
                ""
            ], 
            "flags": 0, 
            "guid": "b:AEFCkcTF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe Th1 cells", 
                "Differentiate in rsponse to Il-12 and IFN-gamma<div>Secrete interferon gamma, TNF, lymphotoxin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h&JC=Z#?~-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the actions of interferon gamma, produced by Th1 cells", 
                "Activate macrophages<div>Antigen uptake</div><div>Antigen processing and expression</div><div>Costimulators</div><div>Cytokine release</div><div>Activate NK cells</div><div>Act on B cells to stimulate antibody formation</div><div>Induce specific Ig isotypes</div><div>Defence against intracellular pathogens</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dd>IImM^MZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What does a deficiency of Th1 pathway components result in?", 
                "Mendelian susceptibilty to myocbacterial disease (MSMD)<div>Susceptibility to: non-TB mycobacteria, TB, invasive salmonellosis, BCG vaccine</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ExDP}<g#dM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What do Th2 cells do?", 
                "Differentiate in response to Il-4<div>Produce IL4, IL5, IL13 (also IL6, IL10)</div><div>Role in atopic response</div><div>- IL4 and IL13 make B cells produce IgE</div><div>- IL3 stimulates eosinophils</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GmrZT,VM0X", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What do Th17 cells do?", 
                "Differentiate in response to IL1, IL6, IL23<div>Secrete IL17</div><div>- stimulate release of chemokines that attract neutrophils</div><div>- definsins and other AMPs</div><div>Secrete IL22</div><div>- stimulate release of definsins and other AMPs</div><div><br /></div><div>Defence against</div><div>- Candida</div><div>- Staphylococcus</div><div><br /></div><div>Th17 deficiency results in increased susceptibilty to candida (Australian discovery)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "OR3?MabAJF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the importance of Th17 cells and psoriasis", 
                "IL17 (produced by Th17) has a critical role<div>- Il17 and Th17 found in lesions, in concert with TNF</div><div>IL17 stimulates keratinocytes</div><div>Blocking IL17 (secukinumab) works very well</div><div><br /></div><div>Further upstream, can block IL23 (Ustekinumab - IL23 causes T cells to differentiate into Th17)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BCX^>dp-7;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are follicular helper T cells?", 
                "Subset of helper T cells<div>Express CXCR5, ICOS</div><div>Secrete IL12</div><div>Migrate to lymphoid follicules</div><div>Help B cells there with</div><div>- class switching</div><div>- affinity maturation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M@ybI%|s>U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the importance of Th2 in the atopy response", 
                "Th2 dominates the atopy response<div>Produces:<br /><div>- IL4: act on naive B cells to create more Th2, B cells to promote IgE switching</div><div>- IL13: act on B cells to promote IgE switching</div><div>- IL 5: act on attracts eosinophils</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c|Z#y%iy-m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the hygine theory for atopy", 
                "Clean environment results in downregulation of Treg cells, resulting in overactivation of Th1 and Th2<div>Th2 is the dominant T cell in the atopy response</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rxAXp}hw~C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 causes of elevated IgE", 
                "Atopic dermatitis<div>ABPA</div><div>Parasitic infection</div><div>Lymphoma, especially Hodgkins</div><div>Wiskott-Aldrich</div><div>Hyper IgE syndrome</div><div>IgE melanoma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tX4FpjuxUN", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the early and late phase allergen responses", 
                "Early: effects caused by vasoacive mediators from mast cells (steroid resistant)<div>Late: Influx of leukocytes, especially eosinophils</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e4RI|yF/=:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of CD8 T cells?", 
                "Cytotoxic T cells<div>Role is to eliminate virally infected cells</div><div>- infected cell displays peptides derived from intracellular viral prtoein on cell surface in MHC class I</div><div>- CD8 T cell recognises viral peptide-MHC complex</div><div>- Kills target</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jF}>E$gqw.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do cytotoxic T cells kill their targets (fatal hit)? (3)", 
                "Perforin-granzyme<div>- insertion of perforin into target cell membrane, causes pore formation -&gt; target cell osmotic swelling and lysis. Proteolytic enzymes passed into target cell.<br /><div>Fas pathway</div><div>- FAsL on T cell surface binds Fas on target cell</div><div>- activation of caspases</div><div>- apoptosis and cleavage of viral genes</div><div>TNF pathway</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D<NR2gu{OF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 clues to the presence of immunodeficiency", 
                "High frequency of infections<div>Infections of unusual severity</div><div>Infections of excessive duration</div><div>Complicated infections (spread to other organs)</div><div>Infections with unusual organisms (fungi, intracellular)</div><div>Family history of immunodeficiency</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "e2eZ6n)^,q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the first test of choice in suspected immunodeficiency", 
                "Immunoglobulin levels", 
                ""
            ], 
            "flags": 0, 
            "guid": "D}F,Q-6IpD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 classificationss of immunodeficiency", 
                "Antibody (most common)<div>T cell</div><div>Complement</div><div>Granulocyte</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G@jE%ck4EP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Lack of antibody response results in...", 
                "Recurrent sinopulmonary and gut infection<div>Infection by polysaccharide-encapsulated pyogenic organisms</div><div>- strep pneumoniae</div><div>- h influenza type b</div><div>- strep pyogenes</div><div>- branhamella catarrhalis</div><div>Infection with</div><div>- stpah aureus</div><div>- giardia</div><div>- campylobacter jejuni</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "&hrFsaSnz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Lack of T cells results in...", 
                "Infection with intracellular organisms (like in AIDS)<div>Fungi</div><div>- mucosal candida</div><div>Viruses</div><div>- CMV, VZV, HSV, protozoa,</div><div>Listeria</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I1GlvN.EF,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Lack of neutrophils/monocytes reulst in...", 
                "High grade bacteria infection<div>- staph aureus</div><div>- gram negatives (e coli, p mirabilis, serratia, pseudominas)</div><div>fungi (invasive aspergillus, systemic candida)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I]nL^<(Q=x", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 10 causes of secondary immunodeficiency", 
                "Haematological malignancies<div>Chemotherapy</div><div>Immunosuppressive drugs</div><div>Radiotherapy</div><div>Malnutrition</div><div>Hypoproteinaemic state (e.g. nephrotic syndrome, liver failure)</div><div>Fe deficiency (-&gt; candida infection)</div><div>Structural (e.g bronchial obstruction, CF)</div><div>Burns</div><div>Skin desquamation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b{[pTU<R.H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 9 investigations in a patient with suspected immunodeficiency", 
                "FBE<div>- +/- neutrophil oxidative metabolism test (screen for chronic granulomatous disease)<br /><div><div>Biochem and LFT</div><div>Fe study</div><div>HIV studies</div></div><div>Immunoglobulin levels (+/- IgG subclasses)</div><div>EPG (exclude paraproteinaemia)</div><div>Response to vaccination</div><div>- if previous vaccination, check antibodies to tetanus, diptheria</div><div>- give a vaccine e.g. pneumovax and check post-vaccination antibody levels</div><div>T cell subsets (% and count)</div></div><div>Completment (screen with CH50)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "erN2~@ASjg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "All T cells express what marker?", 
                "CD3<div>(check this)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mt{%}B@wtC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of T cells express CD4", 
                "70%", 
                ""
            ], 
            "flags": 0, 
            "guid": "KL^f%95xF3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 B cell immunodeficiencies", 
                "Common variable immunodeficiency<div>Bruton's agammaglobulinaemia</div><div>- X linked</div><div>- autosomal recessive</div><div>- other</div><div>IgA deficiency</div><div>IgG subclass deficiency</div><div>Specific Antibody syndrome</div><div>Hyper IgM syndrome</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KezF!/aFMt", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of CVID is familial?", 
                "10%", 
                ""
            ], 
            "flags": 0, 
            "guid": "ph;Tm3%$vn", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common immunodeficiency requiring treatment in adults?", 
                "CVID", 
                ""
            ], 
            "flags": 0, 
            "guid": "dyJ8J@5,So", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the GIT manifestations of CVID", 
                "Chronic or recurrent diarrhoea<div>Malabsoprtion</div><div>- diarrhoea, LOW</div><div>- Sprue-like syndrome with nodular lymphoid hyperplasia of the SI</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nh$ATm#&3z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of CVID patients will have autoimmunity?", 
                "20%", 
                ""
            ], 
            "flags": 0, 
            "guid": "ybqAdcwleI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "NAme 6 autoimmune manifestations of CVID", 
                "Immune cytopenias (ITP, AIHA)<div>Thyroid disease</div><div>Pernicious anaemia</div><div>Polyarthropathy (RA)</div><div>Polymyositis</div><div>Vitiligo</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CV,4b=1T&Q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 neoplasms seen in CVID", 
                "Lymphoma (most common malignancy is NHL)<div>Pseudolymphoma</div><div>Stomach cancer</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A~7XfH[:7`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What must be excluded in patients with likely new CVID? (4)", 
                "Drugs (carbemazepine, sulfasalazine)<div>Myeloma, lymphoma</div><div>Nephrotic syndrome</div><div>GI protein loss</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ogew|lDa@A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 pathology findings in CVID", 
                "Immunoglobulin levels<div>- low IgG, one of both of IGA and IgM also low</div><div>Normal B cell count in most (though may be &lt;1% in some patients)</div><div>EGP: hypogammaglobulinaemia</div><div>Impaired vaccine response</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p=]E([$q`.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of CVID", 
                "<div>Immunoglobulin</div><div>Antiboitics for infection - start early, treat for longer, identify the organism</div>HRCT and lung function every year (looking for bronchiectasis)<div>Avoid live vaccines</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HEdxT8C`cz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 genetic causes of CVID", 
                "PIK3CD (27% of genetic CVID)<div>LRBA (27% of genetic CVID)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qWeYZo{h9C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of CVID patients will have an identifiable genetic mutation?", 
                "Around 30%", 
                ""
            ], 
            "flags": 0, 
            "guid": "zuR4*kxdL}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is X linked agammaglobulinaemia (Bruton's agammaglobulinaemia)?", 
                "Early onset (age 6mo)<div>No B cells</div><div>Mutation in Bruton's TYR kinase causes block of B cell development at pre-B-I stage</div><div>- signalling molecule essential for development: signals successful deployment of surface immunoglobulin, so cannot develop further if this not functional</div><div>Family history in 50%, others are spontaneous mutation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kFBwg&~fbg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 clinical manifestations of X linked agammaglobulinaemia", 
                "<div>Onset at 6 months of age</div>B cell type infections of resp and gastro tract<div>Malabsorption</div><div>Polyarthropathy (RA)</div><div>Cjrpmoc echovirus meningoencephalitis (may be fatal)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n`S)T(:aR^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigation results that would suggest &nbsp;X linked agammaglobulinaemia", 
                "Undetectable IgG<div>B cell count = 0</div><div>No plasma cells or germinal centres on tissue biopsy</div><div>B cell precursors present in marrow</div><div>Btk expression by flow cytometry</div><div>Genetic analysis of Btk gene</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uDxiP%%|4d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe IgA deficiency", 
                "Most do not present, found incidentally<div>- recruitment of oligometrig IgM into secretions to cover for IgA lack</div><div>Mucosal infections (sinopulmonary, giardia)</div><div>Associated with&nbsp;</div><div>- atopy</div><div>- cow's milk allergy</div><div>- autoimmune</div><div>- Coeliac and other&nbsp;GIT disease (nodular lymphoid hyperplasia, inflammatory bowel)</div><div>(can have false negative coeliac disease testing due to IgA deficiency, can't make the antibody)</div><div>- Anaphylaxis if transfuse IgA containing blood products</div><div>Occurs at any age</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hDu?h|25?Q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe IgG subclass deficiency", 
                "Any single or combination of low IgG subclasses (1 - 4)<div>- IgG1 is most prevalent in serum; if this is low, tend to have frank hypogammaglobulinaemia<br /><div>May have no manifestations</div></div><div>May have recurrent sinopulmonary infection</div><div>Normal B cell count</div><div>Can't get IVIG replacement on PBS</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H%&5-BGc!`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe specific antibody deficiency (SAD)", 
                "All Ig levels normal and B cells present<div>Specific antibody to vaccination is impaired</div><div>- pneumova, prevenar, HIB</div><div>Present with recurrent URTI</div><div>Can manage with trial of IVIG or vaccination</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G&BE)zy,H6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe hyper IgM syndrome", 
                "Absent CD40-CD40L signal<div>- failure of B cell isotype switching and memory B cell generation</div><div>- impairment of APC:T cell interaction</div><div>Type I is X linked (other types rare)</div><div>Can only make plasmoblasts and make IgM, cannot make anything except IgM</div><div>Recurrent severe bacterial infections (respiratory++, especially PCP)</div><div>Normal circulating B cells</div><div>Impaired antibody repsonses ot T cell dependent antigens</div><div>Neutropenia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LTas1vst0O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigation findings in hyper IgM sydrome (5)", 
                "Very low IgA, IgG, IgE; normal or raised IgM<div>Normal circulating B cells</div><div>Impaired antibody response to T cell dependent antigens</div><div>Flow cytometry for surface CD40L - absent</div><div>Molecular studies</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m*]/Pe?zV|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 adult T cell deficiencies", 
                "Idiopathic CD4 lymphopenia (ICP)<div>Chronic mucocutaneous candidiasis / APECED</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fRNb9Y:$yO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe idiopathic CD4 T cell lymphopenia", 
                "Low CD4 count, HIV negative<div>T cell type infections</div><div>- oesohpageal candida, MAC infection, disseminated VZV, cryptococcal pneumonia/meningitis</div><div>CD4 count &lt; 300 or 20% of lymphocytes</div><div>Managed with prophylaxis for opportunistic infections</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O}f|1j,(-y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe chronic mucocutaneous candidiasis", 
                "Chronic/recurrent candida<div>Onset in childhood, affects skin, nails, mucosa, oesophagus, pulmonary<br /><div>Often lack Th17 cells</div><div>Genetic (e.g. STAT1 gain of function mutation) or thymoma associated</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A-[:2l(eLY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the pathogenesis of SCID", 
                "<div>Lack of a component essential for T cell function</div>- most common failure of gamma-common chain (cannot develop mature T cells)", 
                ""
            ], 
            "flags": 0, 
            "guid": "NP]V0FRi1C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe chronic granulomatous disease", 
                "Deficiency of 1 or 4 subunits of DADPH oxidase, which is responsible for respiratory burst of neutrophils necessary for killing organisms<div>Usually pediatric onset</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C._-Xt_C_d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the infections seen in chronic granulomatous disease", 
                "<div>Recurrent infection of skin, lungs, other tissues with coag negative bacteria and fungi</div><div>staph infections of skin (especially ears, nose)</div><div><br /></div><div>Purulent dermatitis</div><div>Lymphadenitis, often granulomatosis</div><div>Recurrent bronchopneumonia</div><div>intestinal obstruction</div><div>Chron's like syndrome</div><div>Osteomyelitis</div><div>Aspergillus pneumonia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kDUz1s;=>m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigations for chronic granulomatous disease (3)", 
                "<div>Tests of activated granulocyte ability to gnerate reactive oxygen species for microbicidal action:</div>NBT<div>Chemoluminescence</div><div>Flow cytometry for dihydrorhodamine reduction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "br)ig[-5iV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of chronic granulomatous disease", 
                "Chronic antibiotics<div>Immunisation</div><div>Interferon gamma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p&-GMVy{e%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What activates the complement alternate pathway? (3)", 
                "surfaces of bacteria, viruses, other microbes<div>IgA immune complexes</div><div>C3 nephritic factor (autoantibody against C3bBb)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qqpA]p|y~J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 principle funtions of complement", 
                "Opsonisation<div>Cytolysis</div><div>Activation of inflammatory response (anaphylactoxins C3a, C4a, C5a)</div><div>Immune complex clearing</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sKs[a2]Fo2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the classical pathway components", 
                "C1q, C1r, C1s, C2, C4, C3", 
                ""
            ], 
            "flags": 0, 
            "guid": "y6#9?|;QqL", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the alternate pathway components of the complement cascade", 
                "C3, B, D, Properdin", 
                ""
            ], 
            "flags": 0, 
            "guid": "i_zZW<dp-/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the membrane attack complex components", 
                "C5, C6, C7, C8, C9", 
                ""
            ], 
            "flags": 0, 
            "guid": "D#I!z1g}R}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the alternate pathway in the complement cascade", 
                "C3 spontaneously activated to C3b (constant 'tickover')<div>C3b can bind onto a foreign surface if present (if not, it is degraded)</div><div>Bound C3b activates distal components (factor B), which is then cleaved by factor D to make C3bBb, which binds to PRoperdin, which then makes lots of C3 convert to C3b and coat more of the target</div><div>C3bBb also binds to more C3b -&gt; forms C5 convertase</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AO1SW`##<S", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the classical pathway", 
                "Antibody binds to bacteria<div>This activates C1</div><div>This causes C2 and C4 to convert to C2a and C4a</div><div>C2aC2b forms, which is a C3 convertase - C3 is converted to C3b and coats the bacteria</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p$>LhQ*w~<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are anaphylatoxins", 
                "Act locally and facilitate acute inflammation<div>Can cause anaphylactic shock when in excess</div><div>cause</div><div>- smooth muscle contraction</div><div>- increased vasc permeability</div><div>- expression of adhesion molecules</div><div>- activate mas cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N+pOznpDp_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What stops complement being activated by 'self'?", 
                "<div>Complement control proteins</div>Multiple proteins acting at many levels to stop complement being deposited on 'self'<div>e.g. C1inh supresses the classical and lectin pathway</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hCGyj){8jS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the role of C1 esterase inhibitor", 
                "Serine protease inhibitor<div>Acts to suppress the classical and lectin complement pathways</div><div>Binds to C1r:C1s, causes them to dissociate from C1q, limits time available to activate C4 and C2</div><div>7 fold more C1inh than C1 in serum - hence deficiency means C1 cannot be controlled</div><div>Deficiency results in hereditary angioedema</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y<6PGx<eNF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does the compleemnt system distinguish self from non-self?", 
                "Self expresses complement control proteins (DAF, CR1, MCP, etc)", 
                ""
            ], 
            "flags": 0, 
            "guid": "rS70#(83=r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe hereditary angioedema", 
                "Hemizyous deficiency of C1 esterase inhibitor (defect in 1 gene is enough deficiency to cause problem)<div>Increased classical C' activation</div><div>Activation of contact pathway of coagulation</div><div>Increased bradykinin release is the main driver of the swelling, rather than a complement problem (increased HMW kininogen to bradykinin)</div><div>Binds bradykinin B2 receptor -&gt; oedema</div><div>Autosomal dominant, SERPING1 gene</div><div>- type I and type II</div><div><br /></div><div>Uncontrolled activaiton of C1 results in:</div><div>- Activation and consumption of C4, C2 (not C3) - continuous, not just during attacks</div><div>- Excessive formation of FXIIa and kallikrein: bound (with HMW kininogen) to endothelium -&gt; increases bradykinin -&gt; oedema</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z>Vbba2Ql]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe type 1 hereditary angioedema", 
                "marked reduction in c1-inh level<div>80 - 85% cases</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q_!9W{S#6m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "describe type 2 hereditary angioedema", 
                "dysfunctional C1inh protein<div>c1inh levels normal or increased</div><div>15 - 20% cases</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q<Uw=m|:_i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "describe acquired c1inh deficiency", 
                "type1: b cell lymphoproliferative disorders; consumption of c1inh<div>type 2: associated with autoimmune disease or idiopathic; autoantibody to c1inh</div><div><br /></div><div>C1q levels reduced (normal in hereditary)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oCKYbvqhoZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "describe the diagnosis of hereditary angioedema and acquired angioedema", 
                "C4 reduced, C3 normal<div>C1-INH: reduced in type 1, normal in HAE type II, and acquired type II</div><div>functional C1-inh assay is abnormal in all</div><div>C1q: decreased in acquired forms (consumption)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I@exnJBR4V", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the acute treatment of hereditary angioedema episodes", 
                "Replacement of purified C1-INH protein if life-threatening<div>Bradykinin-2 receptor antagonist (icatibant) - patients can self administer without ED presentation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DZLwy=,B$j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the prevention of hereditary angioedema episodes (5)", 
                "Regular C1-inh infusions if very severe<div>Anabolic steroids e.g. danazol</div><div>Tranexamic acid</div><div>Anti-kallikrein mAb (lanadelumab)</div><div>If acquired, also treat underlying disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MFBQ;FGV_o", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common complement deficiency syndrome", 
                "C2 deficiency", 
                ""
            ], 
            "flags": 0, 
            "guid": "vbTmT+4]#+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "All hereditary complement deficiency syndromes follow what pattern of inheritance", 
                "Autosomal recessive (except properdin - x linked)", 
                ""
            ], 
            "flags": 0, 
            "guid": "y2Ph_F#w!p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Hereditary complement deficiencies early in the cascade cause what type of problem?", 
                "Early complement component deficiencies cause immunocomplex disease: SLE, glomerulonephritis, vasculitis", 
                ""
            ], 
            "flags": 0, 
            "guid": "I>AT1VirAn", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the pathogenesis paroxysmal nocturnal haemoglobinuria", 
                "Somatic mutation in PIG-A on X chromsome - &gt; clonal expansion of haematopoietic stem cell<div><div>Results in deficiency of membrane-bound complement regulatory proteins CD59 and CD55 on red cell surface<div><div>Results in a clone of red cells without complement control protein which become targets for complement - &gt; recurrent episodes of intravascular haemolysis</div></div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oP<GAfr(ki", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is eculizumab", 
                "Monoclonal antibody against C5a<div>Used in paroxysmal nocturnal haemoglobinuria, atypical HUS</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sfhQpl3z[:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where are HLA proteins coded for?", 
                "Chromosome 6 short arm", 
                ""
            ], 
            "flags": 0, 
            "guid": "yEB3_m.}~_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of class I HLA proteins", 
                "Bind peptides derived from degrated intracellular proteins and present them on the cell surface to interact with CD8 T cells' T cell receptor", 
                ""
            ], 
            "flags": 0, 
            "guid": "q-ExaNW<7c", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of class II HLA proteins?", 
                "Present on antigen presenting cells<div>Bind peptides derived from degraded extracellular proteins (all types of forein pathogens) and express them on cell surface, to interact with CD4 T cells' T cell receptor</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "eC!d$<9@C_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the structure of HLA class I molecules", 
                "<div>2 components:</div>Heavy chain with three domains: alpha 1, 2, and 3<div>- Alpha 3 can bind to CD8</div><div>- Peptide binding groove between alpha 1 and 2 (very polymorphic, which determines what peptide can be bound)</div><div>Beta 2 microclobulin</div><div>- coded for on chromosome 15</div><div>- levels reflect cell turnover</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wtTg#9ZQVl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where are HLA class I molecules expressed?", 
                "Most cells<div>Not on red blood cells, some neuronal cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G-VUPEX14G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where are HLA class II molecules expressed?", 
                "Antigen presenting cells (B cells, dendritic cells, macrophages, vascular endothelial cells)", 
                ""
            ], 
            "flags": 0, 
            "guid": "FGo<Zy/7F8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does HLA class I help CD8 cells determine healthy and unhealthy cells?", 
                "Healthy cells present self antigens via HLA I, are ignored<div>Unhealthy/nfected cells present foreign antigens, are targeted</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l;.B-;tY]L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Most variation between HLA molecules occurs where?", 
                "Peptide binding groove", 
                ""
            ], 
            "flags": 0, 
            "guid": "j<<+-x/6Tn", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 antigen presenting cells", 
                "B cells<div>Macrophages</div><div>Dendritic cells</div><div>Vascular endothelial cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gf;3(i5RgO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does variation in HLA alleles protect the population from widespread disease?", 
                "Some variations in HLA will be good at binding a particular pathogen - it will be readily recognised and prompt an immune response<div>Other variations in HLA may not bind so well, so the pathogen prompts less response, and the individual is more severely affected</div><div>This variation means the population is affected differently by the same pathogen, and we are unlikely to be all wiped out by the same pathogen</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dYHi9EbJS%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is HLA typing performed?", 
                "Molecular genetics<div>Gold standard is sequencing based typing (e.g. Sanger sequencing or next generation sequencing)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nXQ@w8ZjG%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does HLA nomenclature work?", 
                "HLA-[gene name]*[allele number]<div>e.g. HLA-DRB1*04:01</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D}vY1b=81N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is linkage disequilibrium?", 
                "When genes or alleles are non-randomly associated<div>i.e. the frequency of association between different genes is higher or lower than would be expected if they were independent and associated randomly</div><div><br /></div><div>e.g. two genes located next to each other on the same chromosome are likely to be inherited together; there is linkage disequilibrium</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "v9OtYe!~5?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How are HLA genes inherited?", 
                "Tend to be inherited together in a block (a haplotype)<div>One haplotype from each parent</div><div>e.g. each parent has two haploptypes (parent 1: A and B, parent 2: C and D)</div><div>Each child will randomly inherit a haplotype from each parent - e. A and C, A and D, B and C, or B and D</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dzZB@Rn+jI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how a patient may become refractory to platelet transfusion", 
                "<div>Platelets express HLA class I</div>Patients may development anti-HLA antibodies - in this case need HLA matched transfusions", 
                ""
            ], 
            "flags": 0, 
            "guid": "o2!W]/}EPU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do HLA DQ2 and DQ8 contribute to the pathogenesis of coeliac disease?", 
                "They can present gluten peptides, activating CD4 T cells", 
                ""
            ], 
            "flags": 0, 
            "guid": "it8::>nocx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 HLA alleles associated with coeliac disease", 
                "HLA DQ2&nbsp;<div>HLA DQ8</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F}>HUAg.j8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What HLA type should not be given abacavir?", 
                "HLA B*:57:01<div>This HLA binds a derivative of abacavir and presents it to T cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F!G0!a7]NL", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What HLA type should not be given carbemazepine?", 
                "HLAB*15:02<div>HLA A *31:01</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cJ|Mwsz!X@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How to T and B cells recognise antigen?", 
                "B cells recognise intact antigen<div>T cells require it to be processed and expressed with MHC (class II for CD4, class I for CD8)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EP/Y8pJj=b", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of antigen presenting cells?", 
                "Process an external antigen then present it via MHC II to CD4 T cells<div>- antigen broken into peptide fractments</div><div>- transported into endoplasmic reticulum</div><div>- MHC II molecules synthesied in ER and bind peptides in groove</div><div>- present on cell surface to CD4 cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EYO[0;Y(l:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of MHC class I?", 
                "Sample cytoplasmic peptides and present on the cell surface<div>Allows continuous monitoring of the intracellular environment</div><div>- if cell is healthy, these will be 'self' peptides</div><div>- if foreign proteins present, this will be recognised by CD8 and cell targeted for killing</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E9Jkl$DChw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how intracellular proteins are expressed on the cell surface via MHC class I", 
                "<div>Cytoplasmic peptides degraded by proteosome</div><div>Free cytoplasmic peptides transported into endoplasmic reticulum by TAP-1 and TAP-2</div><div>Transported peptides associate with and stabilise MHC class I molecules and beta 2 microglobulin</div><div>Complex transported to the cell surface via Golgi apparatus</div><div>If foreign, will be recognised by CD8 and targeted for killing</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JI[gsr30CU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does HSV subvert the MHC class I antigen presenting process?", 
                "TAP inhibitor protein<div>Results in downregulation of MHC class I molecules (the virus avoids being expressed on cell surface to hide from CD8)</div><div>However NK cells recognise the lack of MHC class I anyway and kill it</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nIC*RS`/WK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does adenovirus try to avoid intracellular detection by CD8?", 
                "Prevents surface expression of MHC class I<div>However NK cells recognise the lack of MHC class I anyway and kill it</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n+sN8rCh0z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does CMV try to avoid intracellular detection by CD8 cells via MHC class I?", 
                "Accelerates transport of peptides out of the endoplasmic reticulum, reduces their chances of being bound to MHC class I and expressed on the cell surface", 
                ""
            ], 
            "flags": 0, 
            "guid": "KXO>By/4O&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how MHC class II pathway works", 
                "Antigen is taken up from the extracellular space into the intracellular space (into an endosome)<div>Protease activated in the endosome degrates the antigen peptide into fragments</div><div>Vesicles containing MHC II molecules fuse</div><div>- MHC class II groove is occupied by CLIP protein, which was keeping it from binding to things in the meantime</div><div>- CLIP is removed by HLADM</div><div>Antigen is loaded into MHC II groove and presented on the surface to be recognised by CD4 (signal 1)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MrB3N]b5yh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the function of classic dendritic cells (CDC)", 
                "Antigen presenting cell<div><div>Process the antigen (break it into peptides)</div><div>Present in surface via MHC class II</div><div>Express costimulator molecules</div><div>Migrate to&nbsp;meet immune reactive cells in the lymph nodes, spleen, or MALT</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "v?=S&IB#Es", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the plasmacytoid dendritic cell", 
                "Respond to viral infection<div>- Role is to recognise virus and&nbsp;release a lot of type 1 interferon: induce rapid antiviral state</div><div>Not antigen presenting ells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Dh[A]Jsg`~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 absolute contraindications to skin prick testing", 
                "Antihistamines<div>Tricyclic antidepressants</div><div>Topical steroids (&lt;72hrs)</div><div>Severe eczema</div><div>Dermatography</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bL_AF=Im];", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 relative contraindications to skin prick testing", 
                "<div>Pregnancy</div><div>Persistent or unstable asthma</div><div>Severe anaphylaxis to the allergen</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M}.NJf7`J~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mangaement of atopy", 
                "<div>Allergen avoidance</div>Intranasal corticosteroids<div>Antihistamines (oral or intranasal)</div><div>Desensitisation (immunotherapy)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M^*EsGbV,q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 contraindications to immunotherapy for atopy", 
                "Malignancy<div>Autoimmune</div><div>Beta blockers</div><div>Asthma with FEV1&lt;70% or poor control</div><div>Pregnancy at the start of immunotherapy</div><div>Acute infection</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x61Z`H0K.b", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 types of allergy immunotherapy", 
                "Sublingual<div>Subcutaneous</div><div><br /></div><div>Comparable efficacy</div><div>Sublingual can be used at home (more convenient) but more expensive</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LusO5b8MZ#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is allergy immunotherapy thought to work?", 
                "Downregulation of inflammation via induction of T regulator cells", 
                ""
            ], 
            "flags": 0, 
            "guid": "Fze#/(&P]k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe omalizumab", 
                "Anti-IgE monoclonal antibody<div>Binds free IgE and downregulates high affinty IgE expresiosn on mast cells</div><div>Proven for severe refractory allergy asthma, allergic rhinitis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N&RsNg7rgy", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of food allergy", 
                "Avoidance<div>Action plan +/- epipen</div><div>Treat comorbidities (asthma, cardiovascular)</div><div><br /></div><div>Immunotherapy under trial, not used yet</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kpbwW?ypgQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Are egg, milk, and nut allergies in childhood likley to resolve?", 
                "<div>80% egg and milk resolve by age 5</div><div>Only 20% nut resolves</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k*nku+2*~G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is egg allergy/anaphylaxis a contraindication to influenza vaccine?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "D8Vbc.}}iT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the use of tryptase in anaphylaxis", 
                "Peaks at 60 - 90min, persists up to 5 hours after anaphylaxis<div>May not be elevated with food anaphylaxis</div><div>Persistent elevation = suspicious for mastocytosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O+GIh#S{`p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the diagnosis of venom allergy (e.g. beesting)", 
                "Skin prick testing<div>Specific IgE is less useful, can be done as an adjunct</div><div>Basophil activation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lXL${Ynwel", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When can intradermal skin testing be done?", 
                "<div>Can be done for venom and drug allergy testing</div><div>NEVER for food or airborne allergens (too risky)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M5FB=%,|21", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of venom allergy (e.g. beesting anaphylaxis)", 
                "Desensitisation - reduces risk of repeat anaphylaxis from 60% to &lt;5%<div>Needs to be done urgently</div><div>Typically do for 3-5 years</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s@:9CiOsWY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long should allergy immunotherapy be continued?", 
                "At least 3 years", 
                ""
            ], 
            "flags": 0, 
            "guid": "IQULF>m!#0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do opiates case pruritis?", 
                "Opiates are 'natural mast cell degranulators'", 
                ""
            ], 
            "flags": 0, 
            "guid": "X{oJoeG*~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Are true/type 1 (IgE mediated) drug allergies dose depndent", 
                "No<div>Minute dose of allergen sufficient to case reaction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HncB@T;B4w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 4 types of hypersensitivty to drugs", 
                "Type 1: IgE mediated<div>Type 2: antibody mediated</div><div>Type 3: immunocomplex mediated</div><div>Type 4 (delayed): T cell mediated</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xH;lL<sB(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigation of suspected drug allergy (5)", 
                "<div>IgE mediated:</div>- Skin prick testing&nbsp;<div>- intradernal skin testing (ONLY ever do this for venom or drugs)<div>Non IgE mediated</div><div>- Patch testing</div><div>- Delayed reading of intradermal testing</div><div><br /></div><div>Can do drug provocation test in either (gold standard)</div></div><div><br /></div><div>Generally do skin prick testing then provocation test in patients where you are trying to exclude allergy</div><div><br /></div><div>Specific IgE (less useful)</div><div>Tryptase if suspect anaphylaxis (within 5 hours of episode)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dJ+eY#TwNU", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of drug allergy", 
                "Stop drug, seek alternative<div>Beware cross-reactivity<br /><div>Consider desensitisation</div><div>- lifelong therapy, or</div><div>- recurrent desensitisation</div></div><div>(because tolerance is lost)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c4_73D|f&J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 contraindications to desensitisation for drug allergy", 
                "SJS<div>TEN</div><div>Haemolytic anaemia</div><div>Type II - IV reactions</div><div>Hepatitis</div><div>Interstitla nephritis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qH:2j/JPZf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the cross reactivity rate of penicillin allergy with imipenen/meropenem?", 
                "&lt;2%", 
                ""
            ], 
            "flags": 0, 
            "guid": "nYU<iq,r:?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the cross reactivity of cephalosporins with penicillin in patients with allergy?", 
                "1st gen: 5 - 16%<div>2nd: 4%</div><div>3rd: 1-2%</div><div><br /></div><div>Particularly high crossreactivity between amoxicillin and cephalexin/cefaclor</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PW@bOIESQ5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the diagnosis of radiocontrast medial allergy", 
                "Skin prick testing (high specificity but horrible sensitivity)<div>No serum IgE</div><div>Provocatin too dangerous</div><div>Can do patch testing and diluted delayed intradermal for delayed reaction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b@CaZ,TR(_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of allergy to contrast media", 
                "Use low losmolar contrast or gadolinium<div>Premedication - prednisolone and diphenhydramine</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gkLG;YYB%g", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient is commenced on an ACE inhibitor and presents with tongue swelling. What is going on?", 
                "Angioedema<div>Non-IgE mediated drug reaction, class effect</div><div>ACE inhibits bradykinin degratation, results in increased NO and -&gt; angioedema</div><div>1-2% cross-reactivity with ARB</div><div>Need to avoid ACE for life (cannot desensitise)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ojd#l`f%A^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how aspirin and NSAIDs result in urticaria/asthma/angioedema reactions", 
                "Shunting of arachidonic acid metablism down the leukotrene pathway -&gt; increased production of cysteinyl leukotrienes", 
                ""
            ], 
            "flags": 0, 
            "guid": "J/^kiE#WD>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 non-IgE mediated drug reactions to aspirin/NSAIDs", 
                "AERD<div>NSAID exacerbation urticaria/angioedema</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pB$c5]qrH8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigation of suspected NSAID/aspirin angioedema or urticaria", 
                "Provocation challenge<div>Cannot do skin prick as non-IgE mediated</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "FD8x-kVybX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 requirements that must be met before considering desensitisaiton for drug allergy", 
                "No alternative or the alternative is inferior<div>No history of anaphylaxis to the medication</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qeRRdozW`m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe chronic idiopathic urticaria (5)", 
                "Itchy hives for &gt;6 weeks, recurrent, last &lt;24hrs<div>No known trigger</div><div>Not type 1 allergy</div><div>30% have antithyroid antibodies (but normal thyroid function)</div><div>Other investigations normal</div><div>Theory is that autoantigen binds to IgE on mast cells causing degranulation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cr744k10]:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of chronic idiopathic urticaria (4)", 
                "Nonsedating H1 antihistamines (works in 50%)<div>- no benefit to adding H2</div><div>Omalizumab 300mg subcut every 4 weeks (works in 60-70%)</div><div>Cyclosporin if fail omalizumab, (works in 60 - 70%)</div><div>Short course oral steroids for acute flares</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j4@N2ayV1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define Stevens Johnson syndrome and toxic epideermal necrolysis (TEN", 
                "SJS: &lt;10% body surface<div>TEN: &gt;30%</div><div><br /></div><div>Severe delayed type hypertensitivity (type IV, T cell mediated)</div><div>Mortality 5 - 15%</div><div>Associations with HLA phenotypes in some drugs</div><div>Do not do skin prick testing or intradermal testing. Can test HLA.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uB+SG!;J2f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of SJS/TENS", 
                "<div>Treatment</div><div>- supportive care</div><div>- Consider steroids + IVIG, cycA, TNF inhibitor</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f!}gqMahb,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can SJS/TENS occur weeks after starting a drug?", 
                "Yes, is a delayed type reaction, can occur 4 - 8 weeks after starting", 
                ""
            ], 
            "flags": 0, 
            "guid": "PFrSMJtntI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 drugs associated with SJS/TENs", 
                "Antiinfective sulphonamides<div>Carbamazepine and phenytoin (aromatic antiepileptics)</div><div>NSAIDs</div><div>Allopurinol</div><div>Nevirapine, abacavir</div><div>Herbal remdies</div><div>Checkpoint inhibitors</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mtcUdi9gnZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 risk factors for SJS/TENS", 
                "Age &gt;70<div>Active malignancy</div><div>Autoimmune disease</div><div>AKI</div><div>HIV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C0KC1n3$@K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe Takayasu arteritis", 
                "Chronic inflammatory granulonatous aortitis<div>More common in Asians, South Americans</div><div>Cause unclear, thought to be due to T cells/IL6</div><div>Younger patients</div><div>Gold standard: angiogram (CT or MR), shows beading/stenosis/aneurysms</div><div>Can monitor with PET</div><div>Manage with steroids + steroid sparing agent (e.g. tocilizumab, rituximab)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "opRbkoau)T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of giant cell arteritis", 
                "Steroids<div>Methotrexate as steroid-sparing agent</div><div>Toxilizumab if refractory</div><div>Low dose aspirin if high cardiovascular risk</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hQjf`f?hm~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient has suspected giant cell arteritis. Biopsy is unavoidably delayed. Should steroids be started immediately or post biopsy?", 
                "Immediately to preserve vision<div>Biopsy changes persist for several weeks (at least 2?)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sH>?~Dd-A^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe polyarteritis nodosa", 
                "Systemic necrotising vasculitis of medium sie muscular arteries<div>Inflammation, luminal narrowing, aneurysms, thrombosis</div><div>Associated with hep B in 33% (higher mortality)</div><div>Also associated with hep c, HIV, hair cell leukaemia</div><div>Present with constitutional symptoms, skin, joints, kidneys, hypertension, GIT, nerves, coronary arteries, orchitis</div><div>ANCA negative</div><div>Require biopsy and angiogram</div><div>manage with pred + cyclophosphamide, then maintenance pred + aza</div><div>Antivirals if hep B positive</div><div>80% 5 year survival</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P(vx2v?#6L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Granulomatosis with polyangiits with associated with what renal manifestaiton?", 
                "Rapidly progressive pauci-immune crescentic glomerulonephritis", 
                ""
            ], 
            "flags": 0, 
            "guid": "l;k8rhEEly", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Granulomatosis with polyangiits is typically positive for which antibody?", 
                "ANCA PR3 (80 - 90%)", 
                ""
            ], 
            "flags": 0, 
            "guid": "sp4j:ZEG_m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the other name for Churg-strauss vasculitis?", 
                "Eosinophilic granulomatosis with polyangiits", 
                ""
            ], 
            "flags": 0, 
            "guid": "zrMG_(XH1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define&nbsp;eosinophilic granulomatosis with polyangiits", 
                "Eosinophil rich necrotising granulomatous inflammation of small vessels<div>ACR criteria</div><div>- asthma (adult onset and severe)</div><div>- eosinophilia &gt; 1.5</div><div>- mononeuropathy</div><div>- polyneuropathy</div><div>- pulmonary infiltrates</div><div>- paranasal sinus abn</div><div>- eosinophilic granulomas<br /><div>ANCA pos in 30-40%</div></div><div>Mangae with pred + cyclo if organ threatening, or pred + milder steroid sparing agent if not</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E=0Psk49Wi", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 causes of rapidly progressive GN", 
                "ANCA positive vasculitis (e.g. GPA)<div>GBM disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zU~aLNlQqY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is anti-GBM disease?", 
                "Pathogenic autoantibody against NC alpha 3 chain of type IV collagen<div>Presents with rapidly progressive crescentic GN</div><div>60 - 70% have lung involvement (this is Goodpasture syndrome?)</div><div>Anti-GBM positive in vast majority</div><div>1/3 ANCA positive</div><div>Require renal biopsy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h[+b:H.,#w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Patients with henoch-scholein purpura may have what prodrome?", 
                "URTI infection (beta haemolytic strep)", 
                ""
            ], 
            "flags": 0, 
            "guid": "DcK{>437F-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a good marker of prognosis in HSP?", 
                "Presence of renal impairment (poor prognostic marker)", 
                ""
            ], 
            "flags": 0, 
            "guid": "vcVOgHQs3c", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of Kawasaki disease", 
                "Aspirin<div>IVIG (reduces coronary aneurysms)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kN[gbs1-`E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the criteria for Kawasaki disease", 
                "Bilateral conjunctival injection (80 - 90%)<div>Oropharyngeal mucosal changes (e.g. strawberry tongue, injeted pharynx, fissured lips) 80 - 90%</div><div>Peripheral extemity changes (erythema/oedema or hands or feet, or periungal desquamation) 80%</div><div>Polymorphous rash - primarily truncal, no vesicles &gt;90%</div><div>Cervical lymphadenopathy 50%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ia8poS+XbY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "NAme 3 major toxicities of methotrexate", 
                "Hepatotoxicity<div>Myelosuppression</div><div>Pulmonary fibrosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H}0s3Z)aZ]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 major toxicities of azathioprine", 
                "Hepatoxicity<div>Myelosuppression (check TPMT)</div><div>Skin cancer</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GfNQdg3cd5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 major toxicities of MMF", 
                "GIT<div>Hepatotoxicity</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G6uV.::0+j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 major toxicities of cyclophosphamide", 
                "Amenorrhoea<div>Infertility (cumulative dose and age)</div><div>Teratogenicity</div><div>Bladder toxicity</div><div>Infection</div><div>Myelosuppression</div><div>Malignancy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "emkp{/RQ{8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is hyperacute transplant rejection mediated?", 
                "Antibody mediated<div>Pre-existing anti-ABO or anti-HLA antibodies</div><div>- natural IgM ant-ABO antibodies may exist</div><div>- may form anti-HLA due to pregnancy (paternal HLA), transfusion, previous transplant<br /><div>Occurs within minutes of perfusion of transplanted organ</div></div><div><br /></div><div>Patients are screened for anti-HLA prior to transplant, and are given ABO matched transplant to avoid.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MPUGFn,EPk", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how direct pathway leads to acute organ rejection", 
                "Occurs within days<div><br /><div>Recipient T cells (CD8) are activated by&nbsp;HLA class I on donor tissue cells, which present donor peptide, which appear foreign to the native T cell</div><div>Aggressive and rapid reaction - graft cells killed by cytotoxic T cells</div><div><br /></div><div>Also:</div><div>HLA class II on donor dendritic cells carried with the graft</div><div>- foreign HLA II molecule looks like self HLA + foreign peptide, activates D4</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Gy;Oq1`uEN", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the indirect pathway leading to chronic organ rejection", 
                "Dendritic cells infiltrate the graft, replace any donor antigen presenting cells<div>They process and present graft antigens in HLA II to CD4</div><div>Results in chronic rejction, both T cell and antibody mediated</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pJfVr|QIuE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Most renal transplant loss due to rejction occurs due to hyperacute, acute, or chronic rejection?", 
                "Chronic rejection", 
                ""
            ], 
            "flags": 0, 
            "guid": "CrH_:=A{fa", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 steps taken when a donor and recipient are being evalualted for renal transplant", 
                "HLA typing of donor and recipient<div>No donor-specific anti-HLA antibodies in the recipient (regular screening while on waitlist)</div><div>Negative HLA serological crossmatch (mix donor lymphocytes and recipient serum - positive indicates recipient antibodies to donor HLA, would cause hyperacute rejection)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n42W_eQzod", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is HLA typing done prior to all solid organ transplants?", 
                "Tends to be done for renal transplant, tends not to be done for others<div>This is due to small organ pool, urgeny, limited cold ischaemia time (organ needs to be transplanted urgently)</div><div>Just do HLA crossmatch instead</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w4nmbE%((7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can an ABO-incompatible kidney be transplanted? How?", 
                "Pre-conditioning with rituximab, plasma exchange, and immunosuppressives to remove recipient anti-ABO antibodies<div>Must be living donor</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xHx~GsSxMV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In the first year following solid organ transplant, what is the most common cause of death in patients with a functioning graft?", 
                "Cardiovascular", 
                ""
            ], 
            "flags": 0, 
            "guid": "iCqDGvX[xL", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "After the first year following solid organ transplant, what is the most common cause of death in patients with a functioning graft?", 
                "Cancer", 
                ""
            ], 
            "flags": 0, 
            "guid": "G3vkpMb$6#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What testing is done prior to haematopoietic stem cell transplant?", 
                "HLA typing<div>- closer match = improved graft survival, reduced graft vs host disease. Best to use complete match (all 6 types that are tested)<br /><div>Test for absence of donor specific HLA antibodies</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jP.-+mn!$O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which HLA types are routinely tested prior to transplants where HLA testing is required? (6)", 
                "HLA-A, -B, -C, -DRB1, -DQB1, -DPB1", 
                ""
            ], 
            "flags": 0, 
            "guid": "jeYPv<Lupg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "T cell depletion to try to reduce graft vs host disease prior to haematopoietic cell transplant in leukaemia patients carries what major risk?", 
                "Risk of leukaemic recurrence", 
                ""
            ], 
            "flags": 0, 
            "guid": "ce{?J+Hr#)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the grades of graft vs host disease", 
                "Grade A: rash &lt;25%, no liver or GIT<div>Grade B: 25 - 50% rash, diarrhoea 0.5 - 1.5L/day or bilirubin 34- 104</div><div>Grade C: generalised erythroderma OR bili 104 - 25 OR diarrhoea 1.5 - 2L/day</div><div>Grade D: generalised erythroderma with bullous formation OR bili &gt;256 OR diarroea &gt;2L/day OR pain OR ileus</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "{RUadWvlD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When does aute graft vs host disease occur", 
                "6 - 100 days after transplant", 
                ""
            ], 
            "flags": 0, 
            "guid": "i3##I;D`T-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When does chronic graft vs host disease occur?", 
                "&gt;100 days post transplant", 
                ""
            ], 
            "flags": 0, 
            "guid": "A=8q~l@_qF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common cause of death in the first year following haematopoietic stem cell transplant?", 
                "Infection (52%)", 
                ""
            ], 
            "flags": 0, 
            "guid": "tEIG(?N)Ax", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 ways we can try to prevent graft vs host disease", 
                "<div>Reduced intensity pre-conditioning</div><div>Blockade of inflamamtory cytokines</div>T cell depletion", 
                ""
            ], 
            "flags": 0, 
            "guid": "IQP^3~B6(D", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the chance of a sibling being hapoloidentical (sharing one HLA haplotype)/", 
                "75%", 
                ""
            ], 
            "flags": 0, 
            "guid": "sBL{0|)`-B", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How can mild graft vs host disease be beneficial?", 
                "Graft T cell activity against residual leukaemic cells", 
                ""
            ], 
            "flags": 0, 
            "guid": "F,07GfJZPx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the chances a parent will be a haploidentical HCT donor?", 
                "100%<div><br /><div>Haploidential means sharing one HLA haplotype (50% of a person's HLA genes)</div></div><div>You must inherit one haplotype from each parent</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x9(0f8BQLo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do glucocorticoids bring about immunosuppression? (3)", 
                "Bind to glucocorticoid receptor<div>Alter transcripion and intercept 2nd messengers<br /><div>Inhibit synthesis/release of cytokines, prostaglandins, leukotrienes, plasminogen activator</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "On#Y.?95S+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of azathioprine?", 
                "Metabolised to:<div>- 6-mercaptopurine: inhibit de novo purine biosynthesis&nbsp;</div><div>- thioguanine: inforporated into ribosomes, antiproliferative effect on lymphocytes, inhibit cytotoxic and natural killer T cells, induce apoptosis of T cells via Rac1 gen modulation&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l3P|~:Fdt|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how calcineurin usually works in T cells", 
                "<div>T cell receptor binds to MHC</div><div>This opens calcium channels</div><div>Calcium binds calmodulin, which activates calcineurin, which goes on to signal to the T cell nucleus to produce cytokines particularly IL2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HU}$:Bs^Gn", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does methotrexate work?", 
                "Inhibit dihydrofolate reductase<div>- Reduction of tetrahydrofolate and thymidylate<br /><div>Essential for DNA synthesis</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m1c.r?IX_P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does cyclophosphamide work?", 
                "Alkylating agent<div>- cell cycle inhibitor</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m8=*4eQKr~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is an epitope?", 
                "The part of a protein to which an antibody binds", 
                ""
            ], 
            "flags": 0, 
            "guid": "jb_9ocOpv8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 drawbacks to using monoclonal antibodies", 
                "Immune response blocks efficacy/blocks the antibody<div>Trigger allergy reactions or anaphylaxis (complement mediated)</div><div>Expensive</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u%:mueU.qi", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a biosimilar monoclonal antibody?", 
                "Same target as established mAb (e.g. rituximab) but differnt protein sequence (arise from a different cell line, because original company is not sharing theirs)", 
                ""
            ], 
            "flags": 0, 
            "guid": "cgvH![O#4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "CD20 is expressed by?", 
                "Mature B cells", 
                ""
            ], 
            "flags": 0, 
            "guid": "DujWjbm,ie", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is tumour necrosis factor?", 
                "Transmembrane protein<div>Acts on TNFR-I and II</div><div>Activates endothelium causing leukocyte egress, increases vascualr permeability, fever, mobilisaiton of metabolites, shock</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n]b@WPg!8c", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name two major complications of anti-TNF therapy", 
                "Infections (especially tuberculosis)<div>Drug induced lupus</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j45-!CU-&X", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the action of IL1", 
                "Induces inflammatory response<div>Increase expresison of adhesion molecules -&gt; transmigration of leukocytes to sites of infection</div><div>Fever</div><div>Regulate haematopoiesis</div><div>Stimulate IL6 production</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DHO0R8_NxX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does abatacept (CTLA4-Ig) work?", 
                "Blocking activation of T cells by B7 co-stimulatory molecules", 
                ""
            ], 
            "flags": 0, 
            "guid": "F!G!=vt0Xh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the two signals required for T cell activation", 
                "Signal 1: peptide on MHC binds to T cell receptor<div>Signal 2: CD80 or 86 (on APC) binds to CD28 (on T cell)</div><div>- signal 2 is down-modulated by T cell expresison of CTLA4, which has tronger binding than CD28 and imparts a negative signal</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xI>&f=aTUP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do checkpoint inhibitors work?", 
                "Usually T cells require two signals to be activated (signal 1: MHC + T cell receptor, signal 2: costimulation)<div>Switching off the downregulation of signal 2 results in more T cell activity</div><div>Signal 2 usually downregualted by CTLA4, which is expressed on T cells and binds to B7 on APC</div><div>- anti-CTLA4 like ipilimumab are therefore a T cell stimulator</div><div><br /></div><div>(need to check this)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Nb<zN=)]&i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of mepolizmab?", 
                "Anti-IL5<div>IL-5 is important for eosinophils</div><div>Used in severe refractory eosinophilic asthma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k4T@Lq_B.p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of ustekinumab", 
                "Anti-p40<div>p-40 is expressed on IL12 and IL23, so blocks both</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Or}5BAvANe", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do integrin blockers work?", 
                "Integrin allows leukocytes to get into the tissues<div>Blocking stops them getting in to cause trouble</div><div>e.g. vedolizumab: anti-alpha4beta7 integrin, stops T cells getting into the gut endothelium, used in Chron's and UC</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pr^k.[9LM~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is tofacitinib?", 
                "Jak inhibitor", 
                ""
            ], 
            "flags": 0, 
            "guid": "gXal9]O0pV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe T cell tolerance mechansims", 
                "Central tolerance<div>- deletion of self reactive T cells</div><div>- induction of regualtory T cells<br /><div>Peripheral tolerance</div></div><div>- antigen without costimulatory signals -&gt;anergy (switch off)</div><div>- tolerogenic envirnoment e.g. gut</div><div><br /></div><div>everywhere: clonal ignorance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xwKp2[JE<%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "describe mechanisms of B cell tolerance (3)", 
                "Deletion/anergy<div>Lack of T cell help</div><div>Cloncal ignorance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ApvaEWnU/]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What 4 sites are immune complexes most likely to desposit?", 
                "skin<div>glomeruli</div><div>joints</div><div>gut</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jLT~0a@NS~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common gene implicated in autoimmunity?", 
                "MHC", 
                ""
            ], 
            "flags": 0, 
            "guid": "LcOdtmKG4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 causes of drug induced lupus", 
                "Procainamide<div>Hydralazine</div><div>TNF inhibitors</div><div>Minocycliine/doxycycline</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bTu6t6yE+J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does infection break tolerance?", 
                "Bystander activation of anti-self T cells<div>- dendritic cell was presenting self, which was tolerated</div><div>- dendritic cell then picks up foreign antigen and presents it, acitivating T cells; previously silent T cells that are anti-self become activated<br /><div>Molecular mimicry</div></div><div>- Foreign antigen is similar to self, immune response accidentally targets self</div><div><br /></div><div>e.g. in europe a H1N1 flu vaccine had a nucleoprotein that looked similar to hypocretin receptor 2, ther as a 17-25fold increase in narcolepsy, all patients were HLADQB1*06:02 positive - due to molecular mimicry the patients developed autoimmunity causing narcolepsy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j~,pq~V;jx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 mechanisms of autoimmunity", 
                "Autoantibodies<div>Immune complex formation</div><div>T cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b&G789@[3Y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Immunology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How many new cases of HIV are diagnosed in Australia per year?", 
                "1000", 
                ""
            ], 
            "flags": 0, 
            "guid": "kVgK9u;_J$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the biggest risk factor for contracting HIV in Australia?", 
                "Men who have sex with men (75% new cases)", 
                ""
            ], 
            "flags": 0, 
            "guid": "A_VKKub4/i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3333092d7fa24648b826956283d014e6-ao-1", 
                "Label this graph about HIV", 
                "<img src=\"tmplwciiq.png\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-1-A.svg\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "e@FuJ.PY#k", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3333092d7fa24648b826956283d014e6-ao-2", 
                "Label this graph about HIV", 
                "<img src=\"tmplwciiq.png\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-2-A.svg\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "pOjjU=BB,k", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3333092d7fa24648b826956283d014e6-ao-3", 
                "Label this graph about HIV", 
                "<img src=\"tmplwciiq.png\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-3-A.svg\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "g9EMsM6w5_", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3333092d7fa24648b826956283d014e6-ao-4", 
                "Label this graph about HIV", 
                "<img src=\"tmplwciiq.png\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-4-A.svg\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "t/_cUVwp3{", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3333092d7fa24648b826956283d014e6-ao-5", 
                "Label this graph about HIV", 
                "<img src=\"tmplwciiq.png\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-5-A.svg\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "th*-Re*&([", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "3333092d7fa24648b826956283d014e6-ao-6", 
                "Label this graph about HIV", 
                "<img src=\"tmplwciiq.png\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-6-A.svg\" />", 
                "<img src=\"3333092d7fa24648b826956283d014e6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "s<qXUZ(c*E", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of HIV patients will have a seroconversion illness?", 
                "25 - 50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "t#5~cHRkEG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe HIV seroconversion illness (9)", 
                "Fever<div>Lethargy/malaise<div>Pharyngitis</div><div>Lymphadenopathy</div><div>Arthropathy</div><div>Anorex/weight loss</div><div>Nausea/vomiting</div></div><div>Headache, meningitis</div><div>Maculopapular rash</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D]Ij)GzrN^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In HIV patients who present late with a low CD4 count and opportunistic infections, can ART increase their CD4 count sufficiently to avoid futher opportunistic infecitons?", 
                "Usually no - CD4 count never recovers sufficiently", 
                ""
            ], 
            "flags": 0, 
            "guid": "lCkUrDBO3+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What infections are HIV patients at risk of with a CD4 count of 200 - 500?", 
                "Herpes zoster<div>Pneumococcal pneumonia</div><div>Oral candida</div><div>TB</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "iashsrGFNq", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What infections/conditions are HIV patients at risk of with a CD4 count of 50 - 200? (6)", 
                "PJP<div>CNS toxoplasmosis</div><div>Cryptococcus</div><div>Kaposi's carcoma</div><div>Non-hodgkin's lymphoma</div><div>Primary CNS lymphoma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LQnkb?ug1y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What infections are HIV patients at risk of with a CD4 count of &lt;50? (3)", 
                "Disseminated MAC<div>CMV retinitis</div><div>Cryptosporidiosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cb~4b(x<<c", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the primary prophylaxis for HIV patients with CD4 &lt; 200", 
                "Prophylaxis for PJP and CNS toxoplasmosis.&nbsp;<div>Use:<div>Trimethoprim/sulfamethoxazole DS (800/160mg)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yzX>F]CY%+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the primary prophylaxis for HIV patients with CD4 &lt; 50", 
                "Prophylaxis against MAC<div>Use:</div><div>Azithromycin 1g weekly</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "IHCe5t+jg3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can weight loss improve asthma?", 
                "Yes<div>Obese patients who lose weight achieve better asthma control</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tW00mZZM_C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can weight loss improve atrial fibrillation?", 
                "Yes", 
                ""
            ], 
            "flags": 0, 
            "guid": "O|`_Fi=]Z6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of obesity on testosterone?", 
                "Lower testosterone", 
                ""
            ], 
            "flags": 0, 
            "guid": "I3@cA@m@PS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 cancers where obesity significantly increases risk", 
                "Breast<div>Endometrial</div><div>Bowel</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E1r$SYf&ZV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 genetic causes of obesity", 
                "Reduced production or defective leptin (genes: Ob and ObR)<div>Reduced production or defective melanocyte stimulating hormone (MSH) (genes: POMC and prohormone convertase)</div><div>Both autosomal recessive</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Bk2JYu;M7@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the regulation of appetite by the brain", 
                "Controlled by the arcuate nucleus of the hypothalamus<div>- neuropeptide y nerves: activation = hunger</div><div>- POMC nerves (produce POMC, from which MSH is cleaved): activation = satiety</div><div><br /></div><div>In response to circulating hormones (see other card)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KURCvl{[D{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 hormone produced outside the brain that increases hunger, and where it is produced", 
                "Ghrelin - stomach", 
                ""
            ], 
            "flags": 0, 
            "guid": "NTbd)|*<,l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 hormones produced by the gut that inhibit hunger", 
                "CCK<div>Oxynto-modulin</div><div>GLP-1</div><div>PYY3-36</div><div>Uroguanylin&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O,?DI:7<vK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 hormone produced by fat that inhibits hunger", 
                "Leptin", 
                ""
            ], 
            "flags": 0, 
            "guid": "QS)U>nTFHY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 hormones produced by the pancreas that inhibit hunger", 
                "Amylin<div>Insulin</div><div>Pancreatic polypeptide</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n3_NU)F0r>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which satiety hormone does not vary with meals?", 
                "Leptin", 
                ""
            ], 
            "flags": 0, 
            "guid": "Nt$~iL6A^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which is more likely to succeed, rapid or gradual weight loss?", 
                "Rapid<div>- More likely to achieve target</div><div>- Less likely to drop out</div><div>- No difference in weight regain</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tMu;kUnAaG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of weight loss on leptin, ghrelin, and energy expenditure?", 
                "Leptin (satiety hormone) drops<div>Ghrelin (hunger hormone) increases</div><div>Reduced non-resting energy expenditure</div><div><br /></div><div>These effects are sustained for years</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wN;9gx,m3C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 drugs for obesity", 
                "Phentermine<div>Orlistat - lipase inhibitor, causes steatorrhea if eat fat</div><div>Liraglutide (long-acting GLP1 mimetic)</div><div>Topiramate (antiepileptic, not on PBS for weight loss)</div><div>Exanatide (GLP1 agonist, not on PBS for weight loss)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mz{mJjlF!t", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Other than mechanical, how does sleeve gastrectomy result in weight loss?", 
                "Loss of ghrelin production", 
                ""
            ], 
            "flags": 0, 
            "guid": "CX@%[1mi~5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name two bone turnover markers used in osteoporosis", 
                "P1NP - marker of bone formation, synthesised by osteoblasts<div>C-terminal telopeptide of type 1 collagen (CTX) - marker of bone resorption</div><div><br /></div><div>Will be low in osteoporosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E;GS99B[W#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the PBS criteria to access teriparatide?", 
                "<div>T score -3</div><div>2 or more fractures with minimal trauma</div><div>At least 1 new fracture after 12 months of antiresorptive</div><div>Lifetime maximum 18 months</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pl2qahEN/o", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of teriparatide", 
                "Recombinant form of parathyroid hormone<div>The only agent for osteoporosis that results in bone growth (anabolic)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yDi.uWS;n!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define osteoporosis", 
                "<div>Disease of&nbsp;&nbsp;low bone mass, microarchitectural disruption, and skeletal fragility, resulting in decreased bone strength and an increased risk of fracture.</div><div><br /></div><div>Criteria:</div>BMD 2.5 or more standard deviations below mean (T score &lt; -2.5), OR<div>Fracture with minimal trauma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ow/^:zcLJ2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is peak bone mass attained?", 
                "3rd decade of life", 
                ""
            ], 
            "flags": 0, 
            "guid": "BU{E^48*eG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should T scores, vs Z scores, be used for osteoporosis?", 
                "Z scores are used for pre-menopausal women and men age &lt;50 (sex and aged matched)<div>T scores in postmenopausal and men age &gt; 50 (compared to young/normal reference mean)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "iJMwN?SrBT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 basic investigations that might be done in a patient with new osteoporosis?", 
                "FBE<div>UEC</div><div>LFT</div><div>CMP</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jHc[F:Ff_Y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 hormone/regulatory type investigations that might be done in a patient with new osteoporosis?", 
                "<div>TFT</div><div>Vitamin D</div><div>PTH</div><div>Cortisol excess</div><div>Ostetradio/testosterone/LH/FSH/prolactin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rXohFFOz;m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 more specialised investigations that may be done in selected patients with new osteoporosis", 
                "<div>Iron studies</div><div>Coeliac screen</div><div>SPEP/UPEP</div><div>Iron studies</div><div>Tryptase</div><div>Bone biopsy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s4N$^p:zC3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How can tenofovir affect bone mineral density?", 
                "Tenofovir is an NRTI used for hep B<div>Causes hypophosphataemia</div><div>Can result in hypophosphatemic osteomalacia (can be misdiagnosed as normal osteoporosis)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E}p~XTeexd", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the role of calcium in osteoporosis management", 
                "Aim 1300mg/day, ideally with diet<div>Supplement if cannot achieve the above (daily 500 - 600mg PO)</div><div>There may be increased risk of myocardial infarct with calcium oversupplementation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AbnR]%>dKo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the role of vitamin D in osteoporosis management", 
                "Supplement if low.<div>Aim &gt; 75 (normal range 'adequate' is &gt;50)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kL<x_9l&^@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of high dose vitamin D in the elderly?", 
                "Increases falls in patients age &gt; 70<div><br /></div><div>Trial gave 500,000units once a year to women age &gt;70, found increased risk of falls and fractures</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wA]pg5N&0e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe alendronate", 
                "Bisphosphonate used for osteoporosis<div>Increase BMD by 9% (spine) over 3 years<br /><div>Reduces new fracture risk by 50% vs placebo</div></div><div>Good choice for initial therapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N9)vCqz4bl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe risedronate", 
                "Bisphosphonate used for osteoporosis<div>Increase spine BMD by 4 - 5%</div><div>Reduces risk of future fractures</div><div>Good initial agent of choice</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nisFphV67|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe zoledronic acid", 
                "Bisphosphonate used for osteoporosis - is the 'most potent' bisphosphonate<div>Reduces vertebral fractures by 70%, hip fractures by 41%</div><div>Is given IV so usually risedronate or alendronate are preferred as first line</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hN,=~8giF!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When might zoledronic acid be used, as opposed to an oral bisphosphonate? (4)", 
                "Esophageal disorders<div>Gastrointestinal intolerance</div><div>History of Roux-en-Y gastric bypass</div><div>Inability to follow the dosing requirements of oral bisphosphonates e.g. inability to sit upright for 30 to 60 minutes and/or to swallow a pill</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KE,6mD*3IZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 serious side effects of long term bisphosphonates", 
                "Atypical femoral fracture<div>Osteonecrosis of the jaw</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rQ%>ZlB]!y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How long should bisphosphonates be continued?", 
                "Very little evidence regarding long term safety.<div>High risk women: continue up to 10 years (oral) or 6 years (IV)</div><div>Not high risk womenb: continue 3 - 5 years, then consider 2 - 3 year drug holiday</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s-%}0z+zs]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe atypical femoral fractures seen with bisphosphonate therapy (5)", 
                "Proximal 1/3 of femoral shaft<div>No or minimal trauma</div><div>Complete fracture, often with medial spike, or incomplete fracture only involving lateral cortex</div><div>Often have a prodrome of pain</div><div>Increased risk with longer bisphosphonate exposure, women, Asians, glucocorticoids</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uM1-tke.R;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 risk factor s for osteonecrosis of the jaw on bisphosphonates", 
                "<div>High dose IV bisphosphonates</div><div>Malignancy</div><div>Longer duration</div><div>Glucocorticoids</div><div>ETOH/tobacco</div><div>Age</div><div>Poor dental hygiene</div><div>Dental procedures</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y`ddPo<P1#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the gains seen in osteoporosis with teriparatide therapy", 
                "<div>65% reduction in new vertebral fractures, 53% reduction in nonvertebral fractures</div><div>Increases BMD in lumbar spine by 9% and femoral neck by 3%</div><div>Needs to be followed by an antiresorptive so as not to lose the anabolic gains</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DB<])OF8w#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 side effects of teriparatide", 
                "Dizziness<div>Leg cramps</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E~q?`J$E3)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 contraindications to teriparatide", 
                "Pre-existing malignancy<div>Paget's disease</div><div>Skeletal irradiation</div><div>Renal stones</div><div>Gout</div><div>Unexplained ALP rise</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Vwk:2tm~X", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of denosumab", 
                "Human monoclonal antibody to RANK ligand, an osteoclast differentiating factor<div>RANK ligand interacts with RANK receptor on osteoclasts and osteoclast precursors<br /><div>Results in activation, migration, differentiation, and fusion of hematopoietic cells of the osteoclast lineage to begin the process of bone resorption</div><div>--&gt; blocking inhibits formation, function, and survival of osteoclasts --&gt; decreased bone resorption</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q5ew6wcus<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how denosumab is given", 
                "6 monthly injection subcut", 
                ""
            ], 
            "flags": 0, 
            "guid": "F({2XP{Z>E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name side effects of denosumab (6)", 
                "<div>Musculoskeletal pain (most common)</div><div>Hyperlipidaemia</div><div>Increased risk of fracture with discontinuation (rebound increase in bone turnover) - bisphosphonates should be given</div><div>Hypocalcaemia<div>- more in CKD, malapsorption, hypoparathyroidism</div></div><div><br /></div><div>Osteonecrosis of the jaw is rare</div><div>Atypical femur fractures are rare</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K&1*[sO~a0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "After completing denosumab therapy, what needs to be done for a patient with osteoporosis?", 
                "Risk of rebound increase in bone turnover<div>Need bisphosphonates to prevent - no clear recommendation, perhaps 2 years oral bisphosphonates (per college lecture)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lB}UJO.1:)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of HRT on bone mineral density?", 
                "Improves BMD", 
                ""
            ], 
            "flags": 0, 
            "guid": "coF$T+Ys?o", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Should patients with premature menopause receive HRT?", 
                "Yes, until age of natural menopause<div>Improves BMD, reduce fracture risk, improve symptoms</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q8[cqtr#sv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 conditions for which the Women's Health Initiative study found HRT increased risk", 
                "Cardiovascular disease<div>Stroke&nbsp;</div><div>Breast cancer</div><div>PE</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m,K(lXYC;H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 conditions for which the Women's Health Initiative study found HRT decreased risk", 
                "Fracture/BMD loss<div>Colon cancer</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ndbaSSv[<j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the lifestyle measures recommended for osteoporosis. (5)", 
                "Adequate calcium and vitamin D intake<div>Exercise</div><div>Smoking cessation</div><div>Falls prevention councelling</div><div>Avoid heavy ETOH</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qRTZx.(ucf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients require pharmacotherapy for osteoporosis?", 
                "Patients with established osteoporosis (T score &lt;-2.5 or fragility fracture)<div>High risk postmenopausal women with T score -1 to -2.5</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "eT%,2^T_Sk", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the preferred 1st line therapy for osteoporosis?", 
                "Oral bisphosphonates (alendronate or risedronate)", 
                ""
            ], 
            "flags": 0, 
            "guid": "i#%oX}2l#W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients commenced on pharmacotherapy for osteoporosis, when should DEXA be repeated?", 
                "In 2 years", 
                ""
            ], 
            "flags": 0, 
            "guid": "Oq,0xp*Z{/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should a change of agent be considered in patients on bisphosphonates for osteoporosis?", 
                "Intolerance (allergy, severe bone pain)<div>Decease in BMD &gt; 5%</div><div>Fracture after 1 year on therapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L/pP3OJd<j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the 4 stages of type 1 diabetes", 
                "Stage 1: normal blood sugar, &gt;2 autoantibodies<div>Stage 2: abnormal blood sugar, &gt;2 autoantibodies</div><div>Stage 3: clinical diagnosis, &gt;2 autoantibodis</div><div>Stage 4: longstanding T1DM</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sLb0DJPC7)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Having a relative with type 1 diabetes has what effect on an individual's risk of the disease?", 
                "15 fold increased risk (risk is 1 in 20 instead of 1 in 300)", 
                ""
            ], 
            "flags": 0, 
            "guid": ",h&8Xz!*H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What findings might one expect on pancreas biopsy of a patient with type 1 diabetes?", 
                "Absence of insulin producting islet cells<div>T cell infiltrate</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cRDkuV(pMV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the population risk of type 1 diabetes?", 
                "1 in 300", 
                ""
            ], 
            "flags": 0, 
            "guid": "L/GHrW.tS$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which confers the higher risk of type 1 diabetes, a mother with the disease, or a father with the disease?", 
                "Father<div>Risk is 4.7% if your father has it, 1.7% if your mother has it</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CIJ!;#9Wj1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the risk of type 1 diabetes in identical twins, if one twin develos the diease?", 
                "Other twin has 30 - 40% risk", 
                ""
            ], 
            "flags": 0, 
            "guid": "M.f3l_NA0w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which gene has the strongest association with type 1 diabetes?", 
                "HLA-DQ/DR (mostly DR3 and DR4)<div>Only 3% of type 1 diabetics lack a mutation in DR3 or DR4</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Br>_(,FrzH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Congenital rubella is associated with what endocrine condition?", 
                "Type 1 diabetes in the baby", 
                ""
            ], 
            "flags": 0, 
            "guid": "LNB$E0+@9l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 antigen targetsin type 1 diabetes?", 
                "Glutamic acid decarboxylase<div>Insulin</div><div>IA2</div><div>ZnT8</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AI10mP{B((", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In individuals with 2 or more autoantibodies inplicated in type 1 diabetes, is development of the disease certain?", 
                "Yes<div>All individuals with &gt;2 autoantibodies eventually develop clinical disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HxGAi|Eymo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 types of type 1 diabetes", 
                "Type 1a: type 1 diabetes with detectable autoantibodies<div>Type 2a: type 1 diabetes without detectable autoantibodies</div><div>LADA: latent autoimmune diabetes of adults, have antibodies</div><div>Fulminant diabetes: whole panceas inflammation, severe and rapid development of type 1 diabetes (can occur after checkpoint immunotherapy)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "byZiRX_KkR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe latent autoimmune diabetes in adults (LADA)", 
                "A type of adult onset type 1 diabetes<div>Can clinically resemble type 2</div><div>Can be distinguished by presence of pancreatic autoantibodies</div><div>Do not respond well to oral hypoglycaemics</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vj:!,9+pW!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The Diabetes Control and Complications (DCCT) trial in 1995 showed conventional or intensive BSL control in type 1 diabetes was associated with better outcomes?", 
                "Intensive is better<div>Leads to lower HbA1c, which leads to less complications</div><div><br /></div><div>Even years later when HbA1c became the same across the two groups, outcomes were better in the intensive control group ('metabolic memory')</div><div>Similar findings in trials in type 2 diabetes - period of good control leads to better mortality down the track</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E6dx.+W1q.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the general HbA1c target for type 1 diabetes?", 
                "&lt;7.0", 
                ""
            ], 
            "flags": 0, 
            "guid": "zMx*weXen`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the HbA1c target for type 1 diabetes in pregnancy, or planning a pregnancy?", 
                "&lt; 7.0", 
                ""
            ], 
            "flags": 0, 
            "guid": "g$_[D#EA<q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the HbA1c target for type 1 diabetes in patients with recurrent severe hypoglycaemia, or hypo unawareness?", 
                "HbA1c &lt; 8.0", 
                ""
            ], 
            "flags": 0, 
            "guid": "Atdd4KpI!V", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the retinopathy screening guidelines for diabetic patients?", 
                "At diagnosis<div>Then every 1-2 years</div><div>Early referral to opthalmologist when abnormality detected</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gOL$+<aAgM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the leading cause of new end stage renal disease?", 
                "Diabetes", 
                ""
            ], 
            "flags": 0, 
            "guid": "o]-bV/uLw`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is ther recommended screening for nephropathy in diabetes?", 
                "Annual urinalysis for albuminuria (not dipstick)<div>Annual eGFR</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A:bT0pk$Rz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What steps should be taken in a patient with diabetes in whom microalbuminuria is identified? (4)<br />", 
                "Improve glycemic control, HbA1c &lt;7<div>Improve BP control</div><div>Commence ACE inhibitor or ARB</div><div>Smoking cessation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jRLZ3?}&>6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the patient education in diabetes to prevent foot ulcers (4)", 
                "Daily foot inspection<div>Hygiene</div><div>Well fitting footwear</div><div>Avoid injurious situations and objects</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c[gRm!|pHp", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the requirements for driving (private licence) with insulin-treated diabetes?", 
                "<div>Conditional licence</div><div>Driver notifies DLA</div>2 yearly review for licensing by the treating doctor", 
                ""
            ], 
            "flags": 0, 
            "guid": "o&O@sTPl1[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the requirements for driving (commercial licence) with insulin-treated diabetes?", 
                "Specialist advice about conditional licence<div>Driver notifies DLA</div><div>Annual review for licensing by specialist</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uS`og33JM]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the role of SGLT2 inhibitors in type 1 diabetes?", 
                "Can be used, reduce HbA1c<div>Can cause euglycaemic ketoacidosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NRYcn}7P!Z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 'cures' for type 1 diabetes", 
                "Pancreas transplant (or kidney/pancreas transplant)<div>Islet transplant (only last around 5 years)<br /><div>'Closed loop' insulin pump and sensor</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I[#/z1m>y~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 complication of denosumab in patients with stage 4 or worse renal failure", 
                "Hypocalcaemia", 
                ""
            ], 
            "flags": 0, 
            "guid": "B/7~jV:-@R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of calcium and vitamin D supplementation on fracture risk in the elderly?", 
                "Reduces fracture risk (primary prevention, less so for secondary prevention)", 
                ""
            ], 
            "flags": 0, 
            "guid": "t]7y;^NN){", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of bone is preferentially lost in primary hyperparathyroidism?", 
                "Cortical bone (hip, radius more than spine)", 
                ""
            ], 
            "flags": 0, 
            "guid": "hiBnFF-T^W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is surgery indicated for asymptomatic primary hyperparathyroidism? (5)", 
                "<div>Any of:</div><div><br /></div>Serum calcium &gt; 2.90<div>24hr urine calcium &gt;10mmol/day</div><div>eGFR &lt; 60, nephrolithiasis or nephrocalcionisis</div><div>BMD &lt; -2.5 (T score)</div><div>Age &lt; 50</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i@~r/4j-qk", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why is surgery indicated for certain patients with asymptomatic primary hyperparathyroidism?", 
                "To prevent future fractures<div>Relative risk returns to normal postop</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j:LojdqYPd", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with primary hyperparathyroidism who do not require surgery, what monitoring should be instituted?", 
                "12 monthly calcium, creatinine clearance, eGFR<div>BMD every 12 - 24 months</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n!ab/h`]S=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Vitamin D deficiency has what effect on primary hyperparathyroidism?", 
                "Makes it worse<div>Should supplement to avoid</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "joRRa6|;}<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of persistent or inoperable primary hyperparathyroidism", 
                "<div>Calcimimetics</div>Oestrogen<div>SERMs</div><div>Alendronate</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Lfk?Aob>bf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of surgery is typically performed for primary hyperparathyroidism, and what are its requirements? (3)", 
                "Minimally invasive surgery<div>Need preoperative localisation of a single adenoma on SPECT or neck ultrasound<br /><div>Need to establish &gt;50% fall in intraoperative PTH; if not achived, convert to total neck exposure</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Bunt0<RpXf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A 22 year old presents with polyuria, polydypsia, anorexia, nausea, and weight loss after skiing. They had similar symptoms last summer.<div>Ca = 3.34</div><div>Phosphate normal</div><div>ALP normal</div><div>Urine calcium = 12 (3.7 - 6.2)</div><div>What is the diagnosis, and the likely underlying cause?</div>", 
                "<div>Hypercalcaemia of sarcoidosis.</div><div><br /></div>Key factor is hypercalcaemia aggravated by exposure to sunlight&nbsp;<div><br /><div>HIgh calcitriol arises due to extrarenal calcitriol (1,25 dihydroxyvitamin D, the active metabolite of vitamin D)&nbsp;production from calcidiol (25-hydroxyvitamin D) by activated macrophages in lung and lymph nodes, independent of PTH</div><div>This calcitriol production is resistent to the usual negative feedback<br /><div>Hypercalcaemia arises due to increased intestinal calcium absorption induced by high serum calcitriol&nbsp;</div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HBDJvn;Mbz", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 causes of increased sensitivity to vitamin D (i.e. sunlight-induced hypercalcaemia)", 
                "Granulomatous diseases - the granulomas contain activated monocytes that convert calcidiol to calcitriol, causing more intestinal calcium reabsoroption<div><br /></div><div>Sarcoidosis (most common)</div><div>TB</div><div>Beryllosis</div><div>Silicosis</div><div>Fungal infections</div><div>Foreign body granulomas</div><div>Nonhodgkin's and Hodgkin's lymphoma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f%>QIkHfX%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where is 25 hydroxyvitamin D (calcidiol) primarily converted to 1,25hydydroxyvitamin D (calcitriol), and by what enzyme?", 
                "Proximal tubule<div>by enzyme 1 alpha hydroxylase</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hW)=vq5vW9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 extrarenal sites of conversion of calcidiol to calcitriol (activation of vitamin D)", 
                "Placenta<div>Peripheral monocytes</div><div>Granulomas</div><div><br /></div><div>All these sites produce 1 alpha hydroxylase, which is responsible for the conversion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uHT$fgK6@m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 malignancies that may cause hypercalcaemia by production of PTHrP", 
                "Squamous cell carcinoma (lung, skin, head and neck)<div>Renal cell</div><div>Breast</div><div><br /></div><div>Melanoma</div><div>Genitourinary</div><div>Lymphoma</div><div>Multiple myeloma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vQPU:xI|2m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the hypercalcaemia seen with lithium treatment", 
                "High calcium<div>High PTH</div><div>Occurs in 20% of lithium patients</div><div>Parathyroid adenoma or hyperplasia can occur</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tw)lIRGNB`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe familial benign hypercalcaemia", 
                "<div>Autosomal dominant</div><div>The set point for calcium in the parathyroid glands is upregulated</div><div>This is due to inactivation mutaiton of calcium-sensing receptor (CaSR)</div><div>High calcium</div><div>Low urinary calcium</div>PTH normal or high", 
                ""
            ], 
            "flags": 0, 
            "guid": "I2YShxV):O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe autosomal dominant hypocalcaemia (8)", 
                "<div>Autosomal dominant</div><div>Activating mutation of the calcium sensing receptor in parathyroid and kidney</div><div>Set point for calcium is downregulated</div>Very low calcium<div>Normal or slightly high phosphate</div><div>Low bone turnover (low ALP)</div><div>High urinary calcium</div><div>Suppressed PTH</div><div><br /></div><div>Treat with calcium</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f(MHxEpYXv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 causes of hypomagnesemia", 
                "Chronic ETOH use<div>Malabsorption</div><div>Aminoglycosides</div><div>PTN</div><div>Cisplatin</div><div>PPIs</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tr!l0+M8jb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of hypomagnesemia on calcium?", 
                "Causes functional hypoparathyroidism (hypocalcaemia)<div>Due to peripheral resistance to PTH and reduced PTH release</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sCd~2`.}+U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient on a PPI is noted to have low magnesium. What should be done?", 
                "PPI can cause hypomagnesaemia<div>This can result in functional hypoparathyroidism (hypocalcaemia)</div><div>Check the calcium - if low, cease PPI</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ja#9~;dMgG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe tumour-induced osteomalacia", 
                "Rare paraneoplastic syndrome<div>Hypophosphataemia (renal phosphate wasting)</div><div>Elevated FGF23</div><div>Low to normal 1,25 vitamin D</div><div>Usually due to benign mesenchymal tumours - do PET/CT to localise, treatment is resection</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": ")2U/^8vB`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 broad causes of hypophosphataemia", 
                "Redistrubtion of phosphate into cells<div>Decreased intestinal absorption</div><div>Increased urinary excretion</div><div>Removal by renal replacement therapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F0bji?)z:w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 causes of hypophosphataemia that relate to redistribution of phosphate to the intracellular space", 
                "Stimulation of glycolysis by administration of insulin, glucose, glucagon, adrenaline<div>Acute respiratory alkalosis</div><div>Hungry bone syndrome following parathyroidectomy or thyroidectomy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Iun<-&C}JN", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 causes of hypophosphataemia that relate to decreased intestinal absorption", 
                "Poor intake<div>Chronic diarrhoea</div><div>Prolonged antacid use</div><div>Phosphate binders</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J>K_|4[&qe", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 causes of hypophosphataemia that relate to increased urinary excretion", 
                "hyperparathyroidism<div>vitamin D deficiency</div><div>Fanconi syndrome (generalized impairment in proximal tubular function that causes urinary wasting of phosphate)</div><div>- most commonly caused by multiple myeloma</div><div>osmotic diuresis</div><div>proximally acting diuretics</div><div>acute volume expansion</div><div>intravenous iron administration</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b]?~hLd:fR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe vitamin D metabolism", 
                "<div>Cholecalciferol is synthesised in the skin from 7-dehydrocholesterol in the presence of ultraviolet light</div><div>Hydrocylated to form 25-hydroxyvitamin D (aka calcidiol) by the hepatic enzyme 25-hydroxylase</div><div>Enters circulation bound by vitamin-D binding protein</div><div>Filtered by the glomerulus and reabsorbed by the tubule</div><div>Then either enters the 1-alpha-hydroxylase pathyway to become calcitriol (the active metabolite), or the 24-alpha-hydroxylase pathyway to become 24,25dihydroxyvitamin D (the inactive metabolite)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L?eHILZ)K9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does calcitriol act to increase plasma calcium? (3)", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Increased intestinal absorption</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>-&nbsp;Enhanced apical intestinal calcium absorption by increased expression of transient receptor potential vanilloid 6 (TRPV6) and basolateral efflux via increased expression of PMCA1b</div><div>Bone resorption</div><div>Renal resorption</div><div>- Increased expression of TRPV5 and calbindin-D28k</div><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u:X[m80[;O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the regulation of calcitriol (3)", 
                "<div>Regulated by PTH, serum calcium and phosphate, and FGF-23</div><div><br /></div><div>In response to low calcium, PTH increases activity of 1-alpha-hydroxylase, thereby increasing production of calcitriol</div><div><br /></div><div>Excessive rise in calcium is prevented by rise in calcitriol, as calcitriol has a negative feedback effect on the parathyroid, and directly inhibits 1-alpha-hydroxylase in the kidney</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ng[[/$L9N9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is PTH secreted?", 
                "<div>PTH is secreted in response to low serum calcium.</div><div>Change detected by calcium-sensing receptor (CaSR) on parathyroid cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gAosiLJBfY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does PTH act to increase calcium? (3)", 
                "<div>Increased intestinal absorption</div><div>Bone resorption</div><div>Renal reabsorption</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N:dc}Gk~[h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how PTH promotes serum calcium increase through increased intestinal absorption", 
                "<div>Promotes renal formation of calcitriol (1,25dihydroxylvitamin D), aka active vitamin D, which enhances intestinal calcium and phosphate absorption</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F*}+Cy_TX[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how PTH promotes calcium increase through bone resorption", 
                "<div>Mobilises calcium stores readily available in extracellular fluid</div><div>Activates bone resorption by binding to PTH receptors on osteoblasts, which increase osteoclast activity and number and result in bone resorption.&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HaoZ35hFA3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how PTH results in increased serum calcium through renal reabsorption", 
                "<div>Increases active calcium reabsorption in the distal nephron.&nbsp;</div><div>Activates adenylyl cylclase --&gt; inceases cyclic adenosine monophosphate (AMP) levels --&gt; stimulates protein kinase A --&gt; protein kinase A phosphotylates and activates TRPV5 --&gt; results in increased transceullular calcium transport. Also increases expression of calcium transport proteins TRPV5, calbindin –D28k, NCX1, and PMCA1b.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yo$ua-!>5g", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how PTH is regulated by negative feedback", 
                "<div>Elevations in plasma calcium bind to CaSR on parathyroid glands - &gt; lower PTH via negative feedback</div><div>Increase in calcitriol inhibits production and secretion of PTH.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KfvE?~1C-<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe renal handlihng of calcium", 
                "<div>99% of renally excreted calcium is reabsorbed</div><div>- 70% passively in conjunction with sodium in proximal tubule</div><div>-&nbsp;20% passively in thick ascending loop of Henle via paracellular mechanism mediated by the tight junction protein claudin-16</div><div>- 10-15% actively in distal nephron via transcellular mechanism. Calcium enters tubular cells via transient reeptor protential vanilloid 5 (TRPV5) channel, expressed on the apical membrane of both distal convoluted tubule and connecting tubule cells. Inside the cell the calcium binds to calbindin-D28k protein, which takes it to the basolateral surface. It is then extruted into the circulation via two channels, NCX1 and PMCA1b.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pmNyZ_X@Z@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What compound is required for intestinal calcium absorption?", 
                "Activated vitamin D (calcitriol)", 
                ""
            ], 
            "flags": 0, 
            "guid": "lA<HnY5zHf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how calcium is absorbed in the GI tract (3)", 
                "<div>Active transcellular pathway via transient receptor potential vanilloid 6 &nbsp;(TRPV6) channel on the apical membrane of the duodenum and the proximal jejunum</div><div>Paracellular calcium transport that occurs throughout the length of the intestine</div><div><br /></div><div><div>Calcium combines with anions in the intestinal lumen to form insoluble salts (calcium phosphate, calcium oxalate) that are not absorbed. Thus not all dietary calcium is absorbed.</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wd_)/UO,-{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe hypophosphataemic rickets disease (3)", 
                "<div>A form of hereditary rickets</div>Most commonly caused by X linked dominant mutation in PHEX (phosphate regualting neutral endopeptidase) gense which increases FGF 23 levels<div>Vitamin D resistant</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rhmD/a{`/P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the commonest cause of ricket's disease?", 
                "Nutritional rickets (insufficient vitamin D)", 
                ""
            ], 
            "flags": 0, 
            "guid": "sv9bPi;&v~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 types of ricket's disease", 
                "Nutritional rickets (most common)<div><br /></div><div>Genetic rickets:<br /><div>Vitamin D dependent rickets - genetic defects in vitamin D activation, have alopecia and intact eyelashes</div><div>Vitamin D resistant rickets (hypophosphataemic rickets)</div><div>Vitamin D resistant rickets type 3 - CYP3A4 gain of function mutation, accelerated inactivation of vitamin D</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ykji_nfHK6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 diagnostic tests for diabetes", 
                "Fasting plasma glucose &gt;7, twice<div>Random BSL &gt; 11 and symptoms</div><div>Oral glucose tolerance test (gold standard)</div><div>- use only if fasting glucose 5.5 - 6.9, or random glucose 5.5 - 11, or pregnancy GDM screen</div><div>HbA1c &gt; 6.5</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p-nwsWqQb&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 factors that may make HbA1c unreliable", 
                "Altered erythropoiesis (increased erythropoeisis will decrease HbA1c, reverse also true)<div>Altered haemoglobin</div><div>Glycation</div><div>Erythrocyte desctruction (increased lifespan = increase HbA1c, reverse also true)</div><div>Assays</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i_@vpNVts>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When may HbA1c not be used to diagnose diabetes? (8)", 
                "Children and young people<div>Suspected type 1</div><div>Symptoms less than 2 months</div><div>Patients at high risk who are acutely ill</div><div>Patients on medications that cause rapid glucose rise (steroids, antipsychotics)</div><div>Acute pancreatic damage</div><div>Pregnancy</div><div>Presence of factors that make HbA1c unreliable (see other card)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Foa0=H6g(m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Should pancreatic autoantibodies be routinely tested in new diagnoses of diabetes?", 
                "Yes, including older patients with presumed type 2<div>May have LADA</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hhd}/jenP$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is c peptide used for patients with new diabetes?", 
                "When there is uncertainty about type 1 vs type 2 (i.e. LADA is suspected)<div>Usually ordered together with pancreatic autoantibodies</div><div><br /></div><div>C peptide will be lower in LADA, inducating less endogenous insulin production</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ojCk?-|@90", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is Whipple's triad?", 
                "Hypoglycaemic symptoms<div>Documented low BSL at time of symptoms</div><div>Resolution of symptoms with restoration of normal glucose</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l_:O*?dWeZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is this sign?<div><img src=\"paste-320065257865217.jpg\" /></div>", 
                "Pemberton's sign<div>This patient has a large retrosternal goitre</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b?NN:p9:O?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 investigations in a patient with a goitre", 
                "TFT<div>Thyroid antibodies</div><div>Thyroid ultrasound</div><div>+/- CT (do not give contrast if TSH is low - iodine load!)</div><div>+/- nuclear scan (if hyperthyroid)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ch$!I)sVJe", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of older patients will have a thyroid nodule on ultrasound?", 
                "25%", 
                ""
            ], 
            "flags": 0, 
            "guid": "jYfRyAx*o!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the approach to a thyroid nodule", 
                "<img src=\"paste-326207061098497.jpg\" />", 
                ""
            ], 
            "flags": 0, 
            "guid": "LmE`dOCtzV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigations for hypothyroidism", 
                "TSH, T3, T4<div>Anti-TPO</div><div>Anti-thyroglobulin</div><div><br /></div><div>Ultrasound or nuc med scan usually not required</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k4Z)A%N1Gb", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigations for hyperthyroidism (4)", 
                "<div>TSH, T3, T4</div>TSH receptor antibodies<div>Anti TPO and anti-thyroglobulin antibodies</div><div>Thyroid nuclear scan (not needed if clinical features of Graves)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b~WDY8yZJD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Biotin (vitamin B7) has what effect on thyroid function?", 
                "None, but it interfers with assays<div>May make the patient appear to have Grave's disease (but they don't)<br /><div>Can affect TSH, T4, T3, TSH receptor antibodies</div></div><div>Effect goes away after 3 days</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cq61@^0H0U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigations required after finding an incidental adrenal mass", 
                "Aldosterone-renin ratio (Conn syndrome)<div>24hr urine catecholamines +/- plasma metanephrins (Pheochromocytoma)<br /><div>1mg dexamethasone suppression test (Cushing's)</div></div><div>If all normal, repeat adrenal CT in 6 months and 12 months</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JNi{KACR>~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe Conn's syndrome", 
                "Primary (nonsuppressible) hypersecretion of aldosterone<div>Presents with hypertension and hypokalaemia (salt retaining, potassium wasting)</div><div>May be due to aldosterone producing adenoma, bilateral adrenal hyperplasia, or rarely familial hyperaldosteronism</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qdD_#..`[j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What investigations should be ordered in suspected Conn's syndrome? (6)", 
                "Serum K (low)<div>Aldosterone (normal or high)</div><div>Renin (low)<br /><div>Aldosterone:renin ratio (high)</div></div><div>Aldosterone suppression test (oral sodium load, measure urine aldosterone) - does not suppress</div><div>CT adrenals</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dT(=WdA1+i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should adrenal vein sampling be considered in a patient with Conn's syndrome (primary hyperaldosteronism)?", 
                "CT adrenals is normal<div>Bilateral CT abnormalities</div><div>Unliateral abnormality but age &gt; 35</div><div><br /></div><div>AVS done to confirm unilateral disease, so can pursue surgical management</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k^{i+4Cx^G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 drugs that interfere with testing for primary hyperaldosteronism (Conn syndrome)?", 
                "Minteralocorticoid receptor antagonists (spironolactone)<div>ACE inhibitors</div><div>ARBs</div><div>Direct renin inhibitors</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d/F/KBHq`T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe Addison's disease", 
                "Primary adrenal insufficiency - failure of adrenals to produce cortisol<div>High ACTH, low cortisol</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EVDY_gW.[/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe 2 investigations used in suspected Addison's disease", 
                "<div>ACTH stimulation test: cortisol will not rise with ACTH being given (note secondary and tertiary adrenal insufficency also tend not to respond due to atrophy of adrenals)<br /><div><div>Insulin induced hypoglycaemia test - contraindicated if seizures or cardiovascular disease. Hypoglycaemia is induced and cortisol stress response is recorded.</div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wEA90dF9<K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the causes of Addison's disease", 
                "<div>70-90% autoimmune</div><div>Remainder due to infection, malignancy, adrenal haemorrhage/infarction, or drugs</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Jz0?9jl@X3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the next test that should be ordered in a patient with low testosterone?", 
                "FSH, LH (to distinguish primary vs secondary hypogonadism)", 
                ""
            ], 
            "flags": 0, 
            "guid": "o8/M_X*O6=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of the oral contraceptive pill on LH and FSH", 
                "They will be low", 
                ""
            ], 
            "flags": 0, 
            "guid": "rSp>oJb:}-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the 2 best screening tests for Cushing's?", 
                "24hr urinary free cortisol<div>Overnight 1mg dexamethasone suppression test</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C-!J%Vsm]n", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient presents with high cortisol which does not suppress with low dose dexamethasone. Describe the investigations that should be done next (3)", 
                "<div>Patient may have Cushing's</div><div><br /></div>ACTH<div>- if &lt;1, ACTH independent (adrenal source)</div><div>- if &gt;65, ACTH dependent (pituitary (most common) or ectopic ACTH cause)</div><div>- if 1 - 65, usually ACTH dependent</div><div>Consider high dose dexamethasone suppression test<br /><div>Consider pituitary MRI</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nG/hRm~BD9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How can crush fractures confound DEXA scans?", 
                "BMD may be falsely elevated due to crush fractures making the bone look denser<div>Do plain XR to check for this if discordant spine/hip results</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D%<CPZ$EhN", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What would be the expected effect on bone turnover markers (P1NP, CTx) in patients on antiresorptive therapy for osteoporosis?", 
                "Supressed", 
                ""
            ], 
            "flags": 0, 
            "guid": "wp[~Utio3x", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which is the 'active' thyroid hormone, T3 or T4?", 
                "T3", 
                ""
            ], 
            "flags": 0, 
            "guid": "o7pA8+8d?i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of acute illness on thyroid function?", 
                "Non-thyroidal illness syndrome<div>Result sin low T3</div><div>More severe illness results in low T4 and TSH</div><div>Treatment is not required</div><div>Should exclude pituitary disease if TSH, T3, and T4 all low</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jan#t?sSq6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 T cell mediated autoimmune thyroid diseases", 
                "Hashimoto's<div>Idiopathic hypothyroidism</div><div>Lymphocytic and postpartum thyroiditis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c9/r;*VQ~j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 features of Grave's disease that are relatively specific to the disease (as opposed to the usual signs and symptoms of hyperthyroidism)", 
                "Graves ophthalmopathy<div>Pretibial myxoedema</div><div>Thyroid acropachy (clubbing)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w8TkkA(o0p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the disease course of Graves disease (5)", 
                "Relapsing remitting<div>25% will spontaneously remit</div><div>50% will remit with conservative treatment</div><div>Once in remission, 25% will recur, 25% will become hypothyroid</div><div>Untreated mortality 11 - 50%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "As8{K!~zE:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What antibody is seen in Graves' disease, and how does it cause disease?", 
                "Thyroid-stimulating hormone (TSH, thyrotropin)-receptor antibodies (TRAb)&nbsp;<div>These activate the receptor, thereby stimulating thyroid hormone synthesis and secretion as well as thyroid growth</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j.4^N`b<tu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is chemosis?", 
                "Oedema of the conjunctiva", 
                ""
            ], 
            "flags": 0, 
            "guid": "j6ilLcH-9+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 possible treatments for graves disease", 
                "Antithyroid drugs<div>Radioiodine ablation</div><div>Surgery</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F`Oh3fbS>T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the initial management of Graves' disease in younger patients with small goitres", 
                "<div>Antithyroid drugs are first line for first time presentations</div><div>- Particularly in young patients with small goitre</div><div>After 12-18 months and stable on treatment, wean and cease to see if remission has occured</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ni{tsh8dYt", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the initial management of Graves' disease in patients with large goitres with obstructive symptoms", 
                "Commence antithryoid drugs to achieve euthyroidism<div>Then surgery</div><div>If not fit for surgery, radioactive iodine may be used instead</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wQ|aU1Q+dM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of recurrent or severe Graves' disease", 
                "Antithyroid treatment until euthyroid<div>Then either radioactive iodine or surgery</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Jx$<Wa^,6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of Graves' disease in older patients", 
                "Initial antithryoid therapy<div>Followed by radioiodine</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zEuS|D)zNw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the antithyroid drug of choice in Graves' disease?", 
                "Carbimazole", 
                ""
            ], 
            "flags": 0, 
            "guid": "v]}#w9QePe", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of Graves' disease in pregnancy (5)", 
                "Propylthiouracil before conception and in first trimester<div>Then switch to carbimazole</div><div>If hyperthyroidism is difficult to control after the first trimester, requiring high carbimazole dose, consider surgery</div><div>Be aware high risk of postpartum recurrence</div><div>Block-replace therapy is contraindicated in pregnancy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qn68R|@l3?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the relationship between Graves' eye disease and the use of radioactive iodine", 
                "Radioactive iodine should NOT be used in moderate or severe orbitopathy<div>Can exacerbate eye disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uut0aYs#}`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the symptomatic management of Graves' disease", 
                "Propranolol<div>If beta blockers contraindicated:</div><div>Diltiazem</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gv=F8BwX{u", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the toxicities of carbimazole (4)", 
                "Rash (10%)<div>Foetal abnormalities in 1st trimester</div><div>Agranulocytosis (0.4%) - sudden, acute, and idiosyncratic (no monitoring)</div><div>- Patients should stop drug if coryza or unexplained fever</div><div>Mild neutropenia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J(@x-ZRHIm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe gestational hyperthyroidism (3)", 
                "bHCG is similar to TSH, has TSH activity<div>Causes a mild hyperthyroidism that self-resolves as bHCG drops after the 1st trimester</div><div>Usually no teatment required</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u&^+=B8vBB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigation findings in Graves' disease (2)", 
                "<div>Low TSH, high T3, normal T4</div>Radioiodine scan: diffuse increased uptake", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ogm8<lKX-7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe toxic multinodular goitre (5)", 
                "Result of focal and/or diffuse hyperplasia of thyroid follicular cells whose functional capacity is independent of regulation by TSH<div>Women &gt; men</div><div>Onset age &gt; 50</div><div>Nodular goitre often present for years</div><div>Hyperthyroidism may be after iodine load e.g. contrast</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "IC.N0:!ho*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigation results in toxic multinodular goitre", 
                "<div>T3 &gt; T4</div><div>Thyroid uptake scan: normal or multifocal uptake</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HPvrU%m%PG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of toxic multinodular goitre", 
                "Radioactive iodine is first line<div>Surgery for compressive symptoms, large goitre, or coexisting other indication (e.g. cancer)</div><div>Occasionally long term low dose carbimazole is needed</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y*k1#c>m@!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe hyperthyroidism due to toxic adnoma (4)", 
                "Somatic activating mutation of TSH receptor gene or of signal transduction gene (G protein gene)<div>Female &gt; male</div><div>Onset age 30 - 50</div><div>Slow growing solitary nodule, usually &gt;3cm</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E+gRlZ>I)f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of toxic thyroid adenoma", 
                "Radioactive iodine is first line<div>Remission is rare without definitive treatment.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JE|QEFi2~:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigation results in toxic thyroid adenoma (2)", 
                "T3 &gt; T4<div>Radionuclide scan: focal uptake with suppression of surrounding thyroid uptake</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d;C?qx7+nE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the difference between T3 and T4 hyperthyroidism", 
                "T3 toxicosis: high T3, normal T4. Seen in Graves' and toxic multinodular goitre.<div>T4 toxicosis: high T4, normal T3. Seen in nonthyroidal illnesss that decreases extrathyroidal conversion of T4 to T3, and in amiodarone-induced hyperthyroidism</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Mz(/f#Dr)N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 risk factors for gestational thyrotoxicosis", 
                "Anything that is associated with higher bHCG, such as<div>- twin pregnancy</div><div>- molar pregnancy</div><div>- hyperemesis gravidarum</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ew<N-POGVg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe TSH dependent hyperthyroidism", 
                "High TSH, high T3 and T4<div>Very rare</div><div>Due to TSH secreting pituitary adenoma or partial resistance to feedback from T3/T4</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nu#-JLw,8U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the expected findings in factitious hyperthyroidism (3)", 
                "Low TSH, normal or high T4 and/or T3 (levothyroxine is T4)<div>Low serum thyroglobulin</div><div>24hr radioiodine uptake scan: nearly absent uptake</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pw5?65|%(?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe struma ovarii", 
                "A teratoma of thyroid tissue<div>5% of ovarian teratomas</div><div>A rare differential for women with hyperthyroidism without goitre who have minimal/absent uptake on radioiodine scan (this is usually due to exogenous thyroxine intake or thyroiditis)</div><div>Can be benign or malignant</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D%dw,Y7:/$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how one may differentiate between exogenous thyroid hormone use and struma ovarii", 
                "Both will have low TSH, high T3 and/or T4, no goitre, and low/absent neck radioiodine uptake<div>- exogenous use will have low thyroglobulin</div><div>- struma ovarii will have normal thyroglobulin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C7H6Tq+{D`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigation findings in amiodarone-induced thyrotoxicosis (4)", 
                "Low TSH, disproportionately high T4 compared to T3<div>Thyroglobulin and IL-6 may be elevated in type 2 (but overlap)<br /><div>Radioiodine scan: low uptake</div><div>Ultrasound: normal or increased vascularity in type 1, diminished or absent in type 2</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G|7uF)_t0x", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe type 1 and 2 amiodarone-induced thyrotoxicosis", 
                "<div><div>Type 1: increased thyroid hormone synthesis due to iodine load</div><div>Type 2: destructive thyroiditis</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I9R&E3{Mr2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of amiodarone induced thyrotoxicosis type 1", 
                "<div>Antithyroid drugs (carbimazole)</div><div>Stop amiodarone unless life-threatening indication</div><div><br /></div><div>If normal TSH with high T4, no treatment</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w.g`O`gYES", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of amiodarone induced thyrotoxicosis type 2", 
                "<div>Prednisolone 40 - 50mg daily</div><div>Stop amiodarone unless life-threatening indication</div><div><br /></div><div>If high T4 but normal TSH, no treatment required</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Is/58,oqov", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In many patients with amiodarone induced hyperthyroidism, differentiating between type 1 and 2 can be difficult. Describe the management approach in this group.", 
                "Carbimazole and prednisolone<div>If rapid response (50% T4 fall in 2 weeks), is type 2 - stop carbimazole, continue prednisolone. Otherwise, do the reverse.</div><div>Stop amiodarone unless life-threatening indication</div><div>Surgery if deteriorates despite therapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r6*blbm0NL", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of subclinical hyperthyroidism", 
                "If TSH &lt; 0.1 and persists, treat.<div>- antithyroids if subclinical Graves' and young</div><div>- radioiodine for older patient with multinodular goitre</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wYp0sHwAPn", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does subclinical hyperthyroidism have risk of long-term adverse effects?", 
                "Yes - progression to overt disease, osteoporosis, atrial fibrillation, heart failure.", 
                ""
            ], 
            "flags": 0, 
            "guid": "dli2V]QzQk", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe 6 clinical features of thyroid storm", 
                "Fever<div>Tachycardia/arrythmia (e.g. rapid AF)</div><div>Proximal myopathy and tremor</div><div>Nausea, abdo pain, jaundice</div><div>Dehydration, shock</div><div>Coma/seizure/delirium</div><div>End organ dysfunction - often hepatic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JJMH*yNr$/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 factors which may precipitate thyroid storm", 
                "Infection<div>Trauma</div><div>Surgery (especially thyroid)</div><div>Radioiodine (rare)</div><div>Poor compliance with antithyroid drugs</div><div><br /></div><div>May or may not have a history of thyrotoxicosis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ko6[5|rHnG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of thyroid storm (7)", 
                "<div>HDU or ICU</div><div><br /></div>Propylthiouracil (PO or rectal) to block synthesis, AND<div>Lugol solution to block hormone release</div><div>Consider adding&nbsp;dexamethasone</div><div>Consider adding cholestyramine (to increase T4 clearance)</div><div><br /></div><div>Control tachycardia with:</div><div>propranolol or esmolol</div><div><br /></div><div>Plasmapheresis if desparate</div><div>Plan for thyroidectomy when stable</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bjw_Ho_27;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe subclinical hypothyroidism (4)", 
                "Raised TSH (&lt;10) and normal T3/T4<div>2.6% progress to hypothyroidism per year</div><div>Do not treat if TSH &lt; 10, unless pregnant or planning pregnancy (in which case treat TSH &gt; 4)</div><div>Check antibodies to predict progression</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u7?#6=l|[$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe myxoedema coma (4)", 
                "Severe hypothyroidism leading to slowing of function in multiple organs<div>It is a medical emergency with a high mortality rate (40%)</div><div>Hallmarks: decreased mental status, hypothermia.&nbsp;</div><div>Often with hypotension, bradycardia, hyponatraemia, hypoglycaemia, hypoventilation<br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L`Tp=NchN3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of myxedema coma (3)", 
                "Thyroid hormone (T4/levothyroxine and T3/liothyronine) IV<div>High dose glucocorticoids</div><div>ICU and supportive measures</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pdkdD%--Ao", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe subacute thyroiditis (5)", 
                "Probably a post-viral syndrome, often follows URTI<div><div>Destruction of thyroid follicles and release of stored thyroid hormone</div><div>HLAB35 positive in 75%</div><div>Female: male 5:1</div></div><div>Onset 20 - 60</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s/[tx1?9[d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the clinical presentation of subacute thyroiditis", 
                "Neck pain, radiating up to the jaw<div>Tender diffuse goitre</div><div>Hyperthyroidism for 1-2 months, then hypothyroidism for 4 - 6 months (permanent hypothryoid in 10%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K@jZu=)LlJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigation findings in subacute thyroiditis (3)", 
                "Low TSH &lt; 0.1, raised T3/T4<div>Low uptake on radiodine uptake scan</div><div>High ESR, CRP</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l$J@Ei!}^=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of subacute thyroiditis (4)", 
                "NSAID or aspirin for pain relief<div>Prednisolone 40mg/day if no relief with above, or if severe pain</div><div>Beta blockers if troublesome hyperthyroid symptoms</div><div>Thyroxine replacement in hypothyroid phase if symptomatic</div><div><br /></div><div>No role for antithyroid drugs or radioactive iodine (thyroiditis results in release of preformed hormone)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i-2Cwz<Rts", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe postpartum thyroiditis (3)", 
                "Autoimmune process, destruction of thyroid follicles with release of preformed hormone<div>1 - 6 months after delivery</div><div>More common in type 1 diabetics, patients with positive antithyroid peroxxidase antibodies, and who have had it before</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yq^%W=#Yr~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the clinical findings in postpartum thyroiditis (3)", 
                "Diffuse, small goitre<div>Painless</div><div>Classic pattern: hyperthyroid for 1-2 months, followed by hypothyroid for 4 - 6 months; hypothyroid permanent in 20%</div><div>- may have only hyperthyroid or only hypothyroid phase</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sg*u`A8zL:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigation results in postpartum thyroiditis (4)", 
                "Hyperthyroid pattern if hyperthyroid phase, hypothyroid pattern in hypothyroid phase<div>Radionuclide thyroid scan: near absent uptake</div><div>TPO antibody high tire positive, anti-Tg positive</div><div>Normal ESR</div><div>If biopsy: lymphocytic infiltrate</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uwG!{fy_Zo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of postpartum thyroiditis (2)", 
                "Betablocker if symptomatic of hyperthyroidism (propranolol preferred)<div>Thyroxine in hypothyroid phase if symptomatic, breastfeeding, or trying to conceive</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JHQ0a1A+4~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define Hashimoto's thyroiditis", 
                "Gradual thyroid failure, with or without goitre, due to autoimmune-mediated destruction of the thyroid gland and apoptosis of thyroid epithelial cells", 
                ""
            ], 
            "flags": 0, 
            "guid": "x5]NfMJUoo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the biopsy findings in Hashimoto's thyroiditis", 
                "<div>Lymphocytic infiltration and follicular destruction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q.Il1Zlb?z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 autoantibodies one would expect to be positive in Hashimoto's thyroiditis", 
                "<div>High tire anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J1o|?B2z9n", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the usual clinical course in Hashimoto's thyroiditis", 
                "Gradual loss of thyroid function", 
                ""
            ], 
            "flags": 0, 
            "guid": "q56OZw9V&v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with Hashimoto's thyroiditis, is hypothyroidism typically permanent or transient?", 
                "Permanent", 
                ""
            ], 
            "flags": 0, 
            "guid": "iGV-wLod3R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the pathogenesis of Hashimoto's thyroiditis (6)", 
                "<div>Starting point is not known - may be molecular mimicry or bystander activation</div><div><br /></div><div>Once started:</div>B cells secrete anti-thyroid antibodies<div>T cells react with processed thyroid antigens, then secrete cytokines to activate other immune cells</div><div>- Th2 get involved with antibody production</div><div>- Th1 cytotoxic T cells cause apoptotic destruction of thyroid cells</div><div>- T cells regulate the local immune response</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oe=$W0}`^g", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the concept of molecular mimicry", 
                "Foreign antigen shares similar structure to 'self' substance<div>Anti-foreign response cross-reacts with self</div><div>e.g. rheumatic fever and streptococcal infection, reactive arthritis, narcolepsy after H1N1 fluvax</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A75X5tM:Fv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the concept of bystander activation with regards to immunology", 
                "Anti-self T cells usually tolerised by presentation of self-antigen by immature tolerogenic dendritic cells (that do not express B7 so cannot co-stimulate and produce a response)<div>Infection engages innate immunoreceptors and stimulates B7 expression</div><div>--&gt; activation of self-reactive T cells</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GIwsHu25U_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common cause of hypothyroidism in iodine-sufficient areas?", 
                "Hashimoto's thyroiditis", 
                ""
            ], 
            "flags": 0, 
            "guid": "eGvx%X$sW{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 2 forms of Hashimoto's thyroiditis, and how they differ", 
                "Goitrous<div>Atrophic</div><div><br /></div><div>Different degree of lymphocytic infiltration, fibrosis, and thyroid follicuylar cell hyperplasia</div><div>Same pathophysiology</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m_>_Wjvu5S", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "At what rate do patients with subclinical hypothyroidism and thyroid antibodies progress to overt hypothyroidism?", 
                "5% per year", 
                ""
            ], 
            "flags": 0, 
            "guid": "iY|6Lm{./u", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 risk factors for Hashimoto's thyroiditis", 
                "<div>Female</div><div>Age</div><div>Personal or family history of autoimmune phenomena (e.g. type 1 diabetes)</div><div>High iodine intake</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "t^0{cL`S~^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe Hashimoto encephalopathy (5)", 
                "Thought to be due to autoimmune vasculitis, not due to thyroid disease<div>Heterogenous presentation - fulminant, subacute, or chronic course of declining mental status, with seizures and myoclonus</div><div>Positive anti-TPO, other findings nonspecific</div><div>Manage with trial of corticosteroid</div><div>Majority have good outcome</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B>K<1re2~Y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe painless thyroiditis (6)", 
                "<div>A varient of Hashimoto's thyroiditis</div><div>Autoimmune destructoin of thyroid follicles, release of preformed thyroid hormone</div><div>Female &gt; male</div><div>Age 20 - 50</div><div>Nonpainful, diffuse small goiter</div>Hyperthyroidism 1-2 months, followed by hypothyroid 4- 6 months, then recovery (permanent hypothyroid 20%)", 
                ""
            ], 
            "flags": 0, 
            "guid": "N.J85|+i9?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigation findings in painless thyroiditis (5)", 
                "<div>Hyperthyroid phase, then hypothyroid phase</div><div>Anti-TPO positive high titre</div><div>Normal ESR</div><div>Very low uptake on radioiodine uptake scan</div><div>Reduced flow on doppler ultrasound</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ot78:0`|QR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of painless thyroiditis (2)", 
                "Betablocker if hyperthryoid symptoms<div>Thyroxine if prolonged or symptomatic hypothyroid phase</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LpUHo2Roob", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of clinically apparent thyroid nodules are malignant?", 
                "5 - 15%", 
                ""
            ], 
            "flags": 0, 
            "guid": "htQ4YvCT-R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of 'hot' thyroid nodules are malignant?", 
                "&lt;1%", 
                ""
            ], 
            "flags": 0, 
            "guid": "LT!TNQxLQ>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 types of thyroid cancer", 
                "Papillary (80%)<div>Follicular</div><div>- includes Hurthle cell</div><div>Medullary</div><div>Anaplastic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NU9(q3O()`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 3 types of thyroid follicular epithelial-derived cancers", 
                "<div>Papillary</div>Follicular<div>Anaplastic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s_hC{*-qQJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 features suggestive of malignancy on thyroid nodule ultrasoudn", 
                "<div>TI-RADS score</div><div><br /></div><div>Three points:</div><div>Very hypoechoic</div><div>Taller-than-wide</div><div>Extrathyroid extension</div><div>Punctate echogenic foci</div><div><br /></div><div>Two points:</div><div>Solid (rather than cystic or mixed)</div><div>Lobulated or irregular margins</div><div>Peripheral calcifications</div><div><br /></div><div>&gt;4 points = biopsy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pcZlp|w#w,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how size impacts on the management of thyroid nodule (4)", 
                "&lt;1cm: repeat evaluation in 6 - 12 months<div>- if increase by 30% volume or 10% diameter, biopsy<br /><div>&gt;2cm: FNA (if not cyst or spongioform)</div><div>In between: assess characteristics on ultrasound (TI-RADS score)</div></div><div><br /></div><div>Do not biopsy a hot nodule, regardless of the above.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "o7]K]N@=e]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Differentiated thyroid cancer (papillary and follicular) are associated with what mutations? (4)", 
                "Mutations in the&nbsp;mitogen-activated protein kinase (MAPK) pathway<div>- RET/PTC</div><div>- NTRK1</div><div>- RAS</div><div>- BRAF</div><div><br /></div><div>Present in up to 70% of patients</div><div><br /></div><div><img src=\"paste-405539402022913.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p5N%:Rk_(#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of thyroid cancer (5)", 
                "Total thyroidectomy<div><div>Remnant ablation with radioiodine&nbsp;(I131)&nbsp;</div><div>+/- adjuvant radiotherapy if high risk</div><div>Levothyroxine to replace thyroid hormone and to suppress TSH</div><div>Surveillance with thyroglobulin measurement</div><div>Retreat with radioactive iodine if recurrence</div><div>TKI therapy (serafenib, vandetinib, lenvatinib) or BRAF inhibitors (venurafenib, dabrafenib) are showing promise when radioactive iodine resistant</div><div><br /></div><div>If young and tumour &lt; 4cm and no nodal mets, can consider partial thyroidectomy</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J+ifG`28uC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 poor prognostic factors in papillary thyroid cancer", 
                "Age<div>Larger tumour</div><div>Soft tissue invasion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ngu~SXo:z6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What 2nd agent should be chosen for blood pressure control in patients with diabetes?", 
                "Calcium channel blocker (e.g. amlodipine)<div>Superior to hydrochlorothiazide</div><div><br /></div><div>(the 1st agent will be ACE or ARB)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AJ%cMM,!0j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should patients with diabetes take their antihypertensive(s)?", 
                "At least one of them should be taken in the evening - reduces cardiovascular event rate<div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ij;&|upnT]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 lifestyle measures to reduce lipids in patients with diabetes", 
                "Reduce saturated fat, trans fat, cholesterol intake<div>Increase omega 3, viscous fiber, plant sterols</div><div>Weight loss</div><div>Exercise, break up sedentary time</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EajxS9B:3.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does fenofibrate decrease cardiovascular events in diabetes (in addition to a statin)?", 
                "Not in all patients<div>Does if high triglycerides and low HDL</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pv/DC_~S5j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which diabetic patients should be on a statin for primary prevention of cardiovascular disease?", 
                "All of them, regardless of lipid profile<div><br /><div>Except age &lt;40 and no risk factors</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bZuIq!4npe", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with diabetes who have inadequate lipid control on a statin, what agent can be added to improve outcomes?", 
                "Ezetimibe<div>Reduces risk of cardiovascular events, in addition to statin (primary prevention)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hM/{^pUqk.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is an appropriate blood pressure target in patients with diabetes?", 
                "At least &lt; 130<div>Differing evidence on if &lt; 120 improves outcomes (SPRINT trial in nondiabetes showed improvements, but trial in diabetics did not)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sh7QdHpeXv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does aspirin have a role in primary prevention of cardiovascular disease in diabetes?", 
                "No, not routinely<div><br /></div><div>Can be considered in patients that are high risk (e.g. smoker, microalbuminuria, family history)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O-U5@([=<M", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In diabetic patients with known cardiovascular disease, what medications should be used to prevent events? (4)", 
                "ACE inhibitor<div>Statin</div><div>Aspirin</div><div>If prior myocardial infarction: beta blocker for at least 2 years</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "v6WV*Nu/$P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give 2 examples of GLP1 agonists", 
                "Exenatide<div>Liraglutide</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l+<?nqsVwm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the actions of glucacon-like peptide 1 (GLP1) (5)", 
                "<div>GLP1 is an incretin</div><div>Produced from the proglucagon gene in L-cells of the small intestine and is secreted in response to nutrients</div><div>Binds to GLP-1 receptor in various tissues, including pancreatic beta cells, stimulating glucose-dependent insulin release</div><div>Also slows gastric emptying, inhibits glucacon, reduces food intake</div><div>Degraded by dipeptidyl peptidase-4 (DPP-4)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N|{lr).KsQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the action of&nbsp;dipeptidyl peptidase-4 (DPP-4)", 
                "Enzyme that degrades glucagon-like peptide (GLP1)", 
                ""
            ], 
            "flags": 0, 
            "guid": "N.7*]!yk9+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 DPP4 inhibitors", 
                "Linagliptin<div>Saxagliptin</div><div>Sitagliptin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D``YyF)hfc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of DPP4 inhibitors (4)", 
                "Inhibit DPP4, which breaks down glucagon like peptide 1 (GLP1) and gastric inhibitory polypeptide (GIP)<div>Results increased concentration of these incretins, therefore more insulin release and less glucagon secretion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zP38$)(-hF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do DPP4 inhibitors (gliptins) improve cardiovascular outcomes in type 2 diabetes, in addition to conventional glucose-lowering therapy?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "Lq{<[5T%4@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do SGLT2 inhibitors improve cardiovascular outcomes in type 2 diabetes, in addition to conventional blood glucose control?", 
                "Yes - EMPA-REG study<div>14% lower CV death, nonfatal MI, or nonfatal stroke</div><div>32% lower mortality</div><div>35% less hospitalisaion for heart failure</div><div><br /></div><div>40% reduction in renal complications as well in a similar trial</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bG/WGLSnJ*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do GLP1 agonists improve cardiovascular outcomes in type 2 diabetes, in addition to conventional blood glucose control?", 
                "Yes - LEADER study, SUSTAIN study", 
                ""
            ], 
            "flags": 0, 
            "guid": "BD$QD2(%09", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 glucose-lowering medications that, in addition to standard blood sugar control, improve cardiovascular outcomes in type 2 diabetes", 
                "SGLT2 inhibitors (e.g. empagliflozin) (also improve renal outcomes)<div>GLP1 agonists (e.g. exenatide)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K$~_ifT+0#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the best indicator of chronic kidney disease in diabetes?", 
                "eGFR<div><br /></div><div>Microalbuminuria is highly variable - can have albuminuria without CKD, can have CKD without albuminuria</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n`lYjik{kO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does tight glycaemic control in type 2 diabetes improve renal outcomes?", 
                "<div>Yes, HR 0.54</div>ADVANCE-ON trial", 
                ""
            ], 
            "flags": 0, 
            "guid": "ONbQ+bmRk4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients with type 1 or 2 diabetes should be on ACE or ARB to prevent renal disease/prevent progression of renal disease?", 
                "Patients with hypertension and any degree of albuminuria (including macroalbuminuria)<div>Slows progression of nephropathy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "z!o|C1%2-#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What monitoring for chronic kidney disease is recommended in all diabetics?", 
                "Yearly eGFR/creatinine, urinary albumin excretion, potassium", 
                ""
            ], 
            "flags": 0, 
            "guid": "L(Td9E&m#c", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 9 interventions in diabetes that improve outcomes in terms of primary prevention of complications", 
                "<div>Lifestyle modifications, smoking cessation</div>Intensive BSL control<div>ACE if hypertensive (to prevent CVS disease)</div><div>ACE if hypertension and any degree of albuminuria (to prevent renal disease)</div><div>Statin for all patients (unless age &lt; 40 and no risk factors)</div><div>- Add ezetimibe if inadequate control on statin</div><div>- Add fenofibrate if high triglycerides and low HDL</div><div>SGLT2 inhibitor</div><div>GLP1 agonist</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E|u]]Chdc6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does intensive multifactorial intervention in diabetes (ACE, statin, intensive BSL control, lifestyle, etc) improve outcomes in diabetes?", 
                "Yes, improvement in complications and mortality", 
                ""
            ], 
            "flags": 0, 
            "guid": "K9KTZ!]2~X", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of ACE inhibitors on the afferent and efferent arterioles of the glomerulus?", 
                "Decrease efferent arteriolar tone (it dilates)", 
                ""
            ], 
            "flags": 0, 
            "guid": "wd2Q&z2pc$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>What medication is derived from this guy?</div><img src=\"gila_01.jpg\" />", 
                "This is a Gila monster!<div>Exenatide (GLP1 agonist) is derived from its saliva</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bcq*vK@%}*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 sulfonylureas", 
                "Gliclazide<div>Glimepiride</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JJnvLQ,h#%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of sulfonylureas?", 
                "Increase insulin secretion via the pancreatic sulfonylurea receptor", 
                ""
            ], 
            "flags": 0, 
            "guid": "odrlAi.)hd", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-1", 
                "", 
                "<img src=\"tmpwk03le.png\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-1-A.svg\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "gjdb2cK3w$", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-2", 
                "", 
                "<img src=\"tmpwk03le.png\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-2-A.svg\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Ar6e16.N)E", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-3", 
                "", 
                "<img src=\"tmpwk03le.png\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-3-A.svg\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "F5)~45eQF-", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-4", 
                "", 
                "<img src=\"tmpwk03le.png\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-4-A.svg\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Br}s1]!d;R", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-5", 
                "", 
                "<img src=\"tmpwk03le.png\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-5-A.svg\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "vNX0bF=y)w", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-6", 
                "", 
                "<img src=\"tmpwk03le.png\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-6-A.svg\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "l5+II#5*1U", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-7", 
                "", 
                "<img src=\"tmpwk03le.png\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-7-A.svg\" />", 
                "<img src=\"0ff0fef4c1c44b109e8fbd79b7dc13bd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "IEsth<4Ya,", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give the equation for calculating incidence from carrier frequency for autosomal recessive disorders", 
                "<div>Incidence = 4 x (carrier frequency)<sup>2</sup></div><div><br /></div><div>Example:</div><div>Friedreich ataxia has carrier frequency of 1/100</div><div>100 squared = 10,000</div><div>10,000 x4 = 40,000</div><div>Incidence is 1 in 40,000</div><br /><div><br /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vB_[UycAz_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give the equation for calculating carrier frequency from incidence for autosomal recessive disorders", 
                "<div>Carrier frequency = square root of (Incidence/4)</div><div><br /></div><div>Example</div><div>The incidence of cystic fibrosis = 1 in 2,500 Caucasians</div><div>2500/4 = 625</div><div>Square root of 625 = 25</div><div>Carrier frequency = 1 in 25</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I&ACg]$)os", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the Hardy-Weinberg equation? Give an example on how to use it for cystic fibrosis.", 
                "p²+ 2pq+ q² = 1<div>Where:</div><div>p is the indicence of allele 1</div><div>q is the incidence of allele 2</div><div>2pq is the frequency of the carrier state</div><div><br /></div><div>Example:</div><div><div>Let q be the gene for cystic fibrosis, and p be the normal gene</div><div><br /></div><div>For CF the frequency of qq in northern Europeans = 1 in 2500</div><div><br /></div><div>&nbsp; &nbsp; &nbsp;q2=1/2500</div><div><br /></div><div>&nbsp; &nbsp; &nbsp;q = 1/50</div><div>&nbsp; &nbsp; &nbsp;</div><div>&nbsp; &nbsp; &nbsp;Since the sum of the alleles &nbsp; q + p = 1 , p = 1 - q</div><div><br /></div><div>&nbsp; &nbsp; &nbsp;p= 49/50</div><div><br /></div><div>&nbsp; &nbsp; &nbsp;Carrier frequency = 2pq= 2*(49/50)(1/50) = 98/2500 =.04</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vR&a[U[sO&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Genetics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the action of ADH (4)", 
                "<div>Secreted by the posterior pituitary</div>Results in V2 receptor mediated aquaporin insertion&nbsp;<div>Aquaporin in distal convoluted tubule</div><div>Increased free water reabsorption, concentrated urine, lower serum sodium (due to water reabsoprtion)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pR/ATXov|?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is serum osmolality calculated", 
                "(2 x serum Na) + glucose + urea", 
                ""
            ], 
            "flags": 0, 
            "guid": "A6hhSU@p$/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the osmolar gap", 
                "osmolar gap = osmolality (measured) - osmolality (calculated)<div><br /><div>&gt;10 is abnormal and indicates presence of extra osmotically active particles (i.e. other than sodium, glucose, and urea)</div><div>e.g. glycine post TURP, mannitol post IVIG</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q%@mPc&OSR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the 4 most common causes of severe hyponatraemia (&lt;120)?", 
                "Thiazide/indapamide (41%)<div>SIADH (38%)</div><div>- 70% medication related, 40% psychotropics</div><div>Hypovolaemia (24%)</div><div>Alcohol (11%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ppWOo;icAs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Patients with hyponatraemia should not be rapidly corrected to avoid what complication?", 
                "Osmotic demyelination syndrome<div>- occurs if there is rapid correction and the hyponatraemia had been present &gt;2 days, as the brain has adapted to the hypotonicity</div><div>- higher risk at lower Na levels</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NGoNkL)QXO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How quickly can hyponatraemia be corrected, keeping in mind risk of osmotic demyelination syndrome?", 
                "Aim to correct by 4-6mmol/L per 24hrs<div>Maximum is 10mmol per 24hrs</div><div>Only correct more rapidly if definitely known to be &lt;48hrs since onset</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B9I*enk_]=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 15 drugs that can cause hyponatraemia", 
                "Thiazides<div>Indapamide</div><div>Loop diuretics</div><div><br /></div><div>Omeprazole</div><div><br /></div><div>ACEi, ARB</div><div>Amlodipine</div><div><br /></div><div>Carbamazepine</div><div><br /></div><div>SSRI</div><div>TCA</div><div>MAOI</div><div><br /></div><div>Opiates</div><div>NSAID</div><div><br /></div><div>Cyclophosphamide</div><div>Haloperidol</div><div>Amitriptyline</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cI{p=?-;EV", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do thiazides result in hyponatraemia? (3)", 
                "Sodium and potassium loss<div>Stimulation of thirst</div><div>Impaired urinary dilution</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ET-g6%x|H;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 drugs or drug classes that cause hyponatraemia by stimulated ADH release", 
                "Carbemazepine<div>SSRIs</div><div>TCAs</div><div>MAOIs</div><div>Opiates</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q(FFXI([Hc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 drugs or drug classes that cause hyponatreaemia by potentiating the action of ADH in the kidneys", 
                "NSAIDs<div>Cyclophosphamide</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m1oFM;c5oo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 investigations that may be ordered for a patient with hyponatraemia", 
                "Glucose<div>Lipids</div><div>Cortisol</div><div>Thyroid function</div><div>LFT</div><div>Paired urine and sodium osmolality</div><div>Urine Na and K</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mGV_zK%/DI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 causes of hypertonic or isotonic hyponatreaemia (osmolality &gt; 275)", 
                "Hyperglycaemia<div>Hyperproteinaemia (pseudohyponatraemia)</div><div>Hyperlipidaemia (pseudohyponatraemia)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "OdrLcK,=kJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe hyperglycaemia induced dilutional hyponatraemia", 
                "A type of hypertonic hyponatraemia<div>Omolality typically &gt; 290</div><div>High blood sugar causes water to move out of cells via osmosis, expanding extracellular fluid volume -&gt; dilutional hyponatraemia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hO[n*2U=g}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how sodium level can be corrected for hyperglycaemia", 
                "<div>Decrease sodium by 2mmol/L for every 5.5mmol/L increase in BSL</div><div><br /></div><div>Simple version: divide BSL by 3 and add to sodium</div><div><br /></div><div>e.g. Na = 120, BSL = 60</div><div>120 + 20&nbsp;</div><div>true sodium = 140 (normal!)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y-I][_:_0a", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How can hyperlipidaemia and hyperproteinaemia result in pseudohyponatraemia?", 
                "Lab error - different proportion to usual for lipids and protein stuffs up the lab equation<div>Can circumvent by doing VBG which does not use this formula</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s7O?&Ld_cd", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Most causes of hyponatraemia are hypotonic, isotonic, or hypertonic?", 
                "Hypotonic (90%)", 
                ""
            ], 
            "flags": 0, 
            "guid": "pb-Dbh-}LZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What does a low urinary sodium usually mean about the patient's circulating volume, in patients with hypotonic hyponatraemia?", 
                "Low circulating volume<div>Body is conserving sodium to increase intravascular volume</div><div><br /></div><div>Can occur if diarrhoea, sweating, vomiting, other losses</div><div>Can occur if deficiency in intravascular volume/high extravascular fluid in CCF, cirrhosis, nephrotic syndrome</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "IiD!QTg&+Y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What does a high urinary sodium (&gt;20) usually indicate in patients with hypotonic hyponatraemia?", 
                "<div>Implies presence of ADH causing water reabsorption</div><div><br /></div><div>e.g.</div>SIADH<div>Diuretics, renal failure, cerebral salt wasting, hypocortisolaemia (Addisonian crisis)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g`+asU)v@b", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 causes of hypovolaemic hyponatraemia with low urinary sodium", 
                "These patients have low sodium due to low fluid state/low circulating volume, and they are appropriately retaining sodium (low urine sodium) to try to retain fluid and increase intravascular volume<div><div><br /></div><div>e.g.</div><div>GI losses</div><div>Excessive sweating</div><div>Third spacing (burns, bowel obstruction, pancreatitis, trauma)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h>0LQ[w6|5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 causes of hypovolaemic hyponatraemia with high urinary sodium (&gt;20)", 
                "These patients have low sodium due to low volume with inappropriate ADH mediated water reabsorption<div><br /></div><div>e.g.</div><div>Diuretics (thiazides)</div><div>Salt-losing nephropathy</div><div>Cerebral salt wasting syndrome</div><div>Hypocortisolaemia (Addison's crisis)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JVQ6<|`9xv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with hypotonic hypovolaemic hyponatraemia, by how much should 1 litre of normal saline increase the sodium?", 
                "1L = 1mmol/L increase in sodium", 
                ""
            ], 
            "flags": 0, 
            "guid": "P+eT,-*FPi", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 causes of hypotonic hypervolaemic hyponatraemia with low urinary sodium (&lt;20)", 
                "<div>These patients have intravscular volume depletion despite overall too much water, resulting in dilutional hyponatraemia and low tonicity</div><div><div>Low urine sodium as they try to retain it to increase circulating volume<br /><div><br /></div><div>e.g.</div><div>Heart failure</div><div>Cirrhosis</div><div>Nephrotic syndrome</div></div></div><div><br /></div><div>Management is treatment of underlying cause</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x]:ahCs0x.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 causes of hypotonic hypervolaemic hyponatraemia with high urinary sodium (&gt;20)", 
                "<div>Diuretics (early)</div><div>Renal failure - nephrogenic SIADH</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sWTY]d#%to", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of hypotonic hypervolaemic hyponatraemia", 
                "Treat underlying cause (e.g. heart failure, cirrhosis)<div>Fluid restrict</div><div>+/- diuresis</div><div>+/- conc albumin (if cirrhosis)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Gy}3mHIr)l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the renin-angiotensin system (7)", 
                "Renin is synthesised in juxtaglomerular cells<div>Secreted in response to renal hypoperfusion<br /><div>Renin cleaves angiotensin I from angiotensinogen</div></div><div>ACE catalyses conversion of angiotensin I to angiotensin II (mostly in the lung)</div><div>Angiotensin II causes arteriolar vasoconstriction and sodium reabsorption by the kidney</div><div>Aldosterone is secreted from the adrenal cortex in response to angiotensin II</div><div>Aldosterone binds to mineralocorticoid receptors, causing salt and water retention and potassium secretion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j,_:)Z1K|s", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-1", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-1-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "F<nLy_jW+;", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-2", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-2-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "rf2<dg#>(;", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-3", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-3-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "BBK0s9F`?f", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-4", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-4-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Mw[:IB`tz$", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-5", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-5-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "J_j1YG|lHl", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-6", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-6-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "FtU!K-.wu-", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-7", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-7-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "P~1xh#]~(j", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-8", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-8-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Pu|x)b0|^C", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-9", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-9-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Dk`U,OeJ@{", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-10", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-10-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "w7GRp/.%h3", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-11", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-11-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Jo4@c{T,>(", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-12", 
                "", 
                "<img src=\"tmputftcr.png\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-12-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-12-A.svg\" />", 
                "<img src=\"2e2f2edcafd6405fa6fd9bcdcfe0cca1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "CBq3EG|u&2", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the actions of aldosterone", 
                "Secreted by the adrenal cortex in response to angiotensin II<div>Binds to minteralocorticoid receptors</div><div>--&gt; increases the expression of epithelial sodium channels in the distal tubule, causing salt and water retention, potassium wasting&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J)QM4+|{)b", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe secondary hyperaldosteronism", 
                "Occurs in chronic low effective arterial blood volume states, e.g. CCF, cirrhosis, CKD<div>Instead of normal attenuation of effect of aldosterone (salt/water retaning, potassium wasting), the effect continues</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m<Q?/d)t}i", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 causes of hypotonic euvolaemic hyponatraemia with low urinary sodium", 
                "Water intoxication (psychogenic, NMDA use, marathons)<div>Poor solute intake (malnutrition - ETOH dependance, elderly on tea and toast diet)</div><div>Hypothyroid (very rare)</div><div>Hypotonic fluid infusion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lf%4l+s~Aj", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 causes of hypotonic euvolaemic hyponatraemia with high urinary sodium", 
                "SIADH<div>Nonosmotic physiological ADH release (stress, pain, nausea)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rMc1N6NfUj", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 criteria for SIADH", 
                "<div>SIADH is a diagnosis of exclusion where:</div><div><br /></div>Euvolaemic<div>Low serum osmolality &lt; 275</div><div>High urine osmolality &gt; 100</div><div>High urine sodium &gt;20</div><div>Inappropriately concentrated urine for serum osmolality</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n+%}W<gX`-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 10 causes of SIADH", 
                "<div>CNS disturbance (any; e.g. stroke, haemorrhage, infection, trauma, psychosis)</div><div>Malignancy with ectopic ADH production (e.g. SCLC)</div><div>Drugs (e.g. carbamazepine, cyclophosphamide)</div><div>Surgery</div><div>Pulmonary disease (e.g.&nbsp;pneumonia, asthma, atelectasis, acute respiratory failure, pneumothorax)</div><div>Hypopituitarism and hypothyroidism</div><div>Hormone administration (oxytocin, vasopressin)</div><div>HIV</div><div>Hereditary</div><div>Idiopathic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mTK-pT>qJ<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 symptoms of slow onset (chronic) hyponatraemia", 
                "Fatigue, nausea, dizziness, gait disturbance, confusion", 
                ""
            ], 
            "flags": 0, 
            "guid": "x=.@/?Z=7Z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 symptoms or signs of sudden onset hyponatraemia (acute)", 
                "Obtundation<div>Seizure</div><div>Coma</div><div>Respiratory arrest</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ktNUk]7?(<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of hyponatraemia where duration is unknown, not severe or symptomatic (4)", 
                "Aim to raise sodium by 4-6mmol per 24hrs<div>Treat underlying cause</div><div>Give normal saline if hypovolaemic</div><div>Fluid restrict if SIADH or hypervolaemia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ic<8zq6AD=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of symptomatic or severe hyponatraemia (5)", 
                "Move to HDU<div>Consider hypertonic saline</div><div>- 2ml/kg 3% saline IV over 15min (raises sodium by 2-3mmol/L)</div><div>- assess response and repeat at 20min</div><div>- aim to increase by 4-6mmol over 2-3hrs (avoids cerebral oedema; still need to correct less than 10mmol per 24hrs)</div><div>- recheck every 2-4hrs</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BS91S3]0gY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 risk factors for osmotic demyelination syndrome", 
                "Lower serum sodium &lt; 115<div>Rapid correction &gt;12mmol/24hrs</div><div>ETOH use</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B>5s`_,<lj", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the test of choice for&nbsp;osmotic demyelination syndrome (central pontine demyelination)", 
                "MRI brain<div><br /></div><div>May not be present on initial scans</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h#NTuL?iKu", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of&nbsp;osmotic demyelination syndrome (5)", 
                "Confusion<div>Seizure</div><div>Drowsiness</div><div>Pseudobulbar palsy</div><div>Tetraparesis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JE`lrR%5ah", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is onset of symptoms of&nbsp;osmotic demyelination syndrome typically seen?", 
                "Delayed onset; 2 - 6 days after presentation", 
                ""
            ], 
            "flags": 0, 
            "guid": "k;t|8#U6xK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with hyponatraemia has overrapid correction of their sodium by 14mmol/L in 24hrs. What can be done to reduce risk of&nbsp;osmotic demyelination syndrome?", 
                "Relower the sodium&nbsp;<div>- give dextrose infusion (based on case reports only) ,or</div><div>- desmopression</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hewkC&t&j3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the use of vasopression receptor antagonists", 
                "Selective V2 receptor antagonists (tolvaptan, conivaptan)<br />Can be used in treatment of hypervolaemic or euvolaemic hyponatraemia<div>Very expensive, poor side effect profile, can cause overrapid correction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ep-3u);JpD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of HIV patients are diagnosed late (CD4 count &lt;350)?", 
                "33%", 
                ""
            ], 
            "flags": 0, 
            "guid": "BU,]p{jyAs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of HIV patients have advanced disease at diagnosis (CD4 &lt; 200)", 
                "20%", 
                ""
            ], 
            "flags": 0, 
            "guid": "z*$T`~Jw,.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients with HIV in Australia have undetectable viral load?", 
                "72%", 
                ""
            ], 
            "flags": 0, 
            "guid": "wOIAm#P*XO", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the differences between HIV 1 and HIV 2", 
                "Different area affected:&nbsp;HIV 1 worldwide, HIV 2 in West Africa and Europe<div>HIV1: higher viral load, faster disease progression, lower CD4 counts, faster replication rate</div><div>HIV2: resistant to all NNRTIs, many PIs, and T-20</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g{wZ0K2q9+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the life cycle of HIV (7)", 
                "Binding: binds to CD4 and one of to co-receptors, CXCR4 or CCR5<div>Fusion: fuses with the host cell and release RNA into it</div><div>Reverse transcription: single stranded RNA is converted to HIV DNA by reverse transcriptase</div><div>Integration: HIV DNA enters the nucleus, integrase (an enzyme) cuts the cell's DNA and inserts HIV DNA</div><div>Transcription and translation: RNA polymerase makes RNA copies of DNA. HIV RNA is inserted into new virus particles or processed and translated into HIV proteins.</div><div>Assembly: gag molecules, viral RNA, and envelope proteins are packaged into the growing virus that buds off from the host cell</div><div>Release and maturation: viral protease cleaves the gag molecules into individual functional proteins. Mature virus can now infect other cells.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "twxvImN1k(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f9752605f61461fbc2f126347688db1-ao-1", 
                "Describe the life cycle of HIV", 
                "<img src=\"tmpht4sim.png\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-1-A.svg\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "jAiv[bQmci", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f9752605f61461fbc2f126347688db1-ao-2", 
                "Describe the life cycle of HIV", 
                "<img src=\"tmpht4sim.png\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-2-A.svg\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GhQA|RVGi8", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f9752605f61461fbc2f126347688db1-ao-3", 
                "Describe the life cycle of HIV", 
                "<img src=\"tmpht4sim.png\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-3-A.svg\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ntU[J+XsS^", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f9752605f61461fbc2f126347688db1-ao-4", 
                "Describe the life cycle of HIV", 
                "<img src=\"tmpht4sim.png\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-4-A.svg\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "m1@7z$M>n,", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f9752605f61461fbc2f126347688db1-ao-5", 
                "Describe the life cycle of HIV", 
                "<img src=\"tmpht4sim.png\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-5-A.svg\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ia^#Puy9_v", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f9752605f61461fbc2f126347688db1-ao-6", 
                "Describe the life cycle of HIV", 
                "<img src=\"tmpht4sim.png\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-6-A.svg\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Nec%zR`4gl", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2f9752605f61461fbc2f126347688db1-ao-7", 
                "Describe the life cycle of HIV", 
                "<img src=\"tmpht4sim.png\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-7-A.svg\" />", 
                "<img src=\"2f9752605f61461fbc2f126347688db1-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "zw*l_(ZZ[@", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2bc20057da4e4ec1b26538aea998a79d-ao-1", 
                "", 
                "<img src=\"tmpw7n71m.png\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-1-A.svg\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "y.%5pvJq=q", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2bc20057da4e4ec1b26538aea998a79d-ao-2", 
                "", 
                "<img src=\"tmpw7n71m.png\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-2-A.svg\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "H~cKL;zZpe", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2bc20057da4e4ec1b26538aea998a79d-ao-3", 
                "", 
                "<img src=\"tmpw7n71m.png\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-3-A.svg\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "vWRkAUE}:z", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2bc20057da4e4ec1b26538aea998a79d-ao-4", 
                "", 
                "<img src=\"tmpw7n71m.png\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-4-A.svg\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "h|ejamR7Wj", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2bc20057da4e4ec1b26538aea998a79d-ao-5", 
                "", 
                "<img src=\"tmpw7n71m.png\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-5-A.svg\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "yEwCsc@X[<", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2bc20057da4e4ec1b26538aea998a79d-ao-6", 
                "", 
                "<img src=\"tmpw7n71m.png\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-6-A.svg\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "n~BFRAbPoT", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2bc20057da4e4ec1b26538aea998a79d-ao-7", 
                "", 
                "<img src=\"tmpw7n71m.png\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-7-A.svg\" />", 
                "<img src=\"2bc20057da4e4ec1b26538aea998a79d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "H4~._6tjZ#", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "988f2a4be17449eda5b5289d45856744-ao-1", 
                "", 
                "<img src=\"tmpwjvd9h.png\" />", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-1-A.svg\" />", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "yl%izM3yEv", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "988f2a4be17449eda5b5289d45856744-ao-2", 
                "", 
                "<img src=\"tmpwjvd9h.png\" />", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-2-A.svg\" />", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Bx[0,<+cvM", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "988f2a4be17449eda5b5289d45856744-ao-3", 
                "", 
                "<img src=\"tmpwjvd9h.png\" />", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-3-A.svg\" />", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kA/LQC~vBf", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "988f2a4be17449eda5b5289d45856744-ao-4", 
                "", 
                "<img src=\"tmpwjvd9h.png\" />", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-4-A.svg\" />", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "N%L+x_4gKb", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "988f2a4be17449eda5b5289d45856744-ao-5", 
                "", 
                "<img src=\"tmpwjvd9h.png\" />", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-5-A.svg\" />", 
                "<img src=\"988f2a4be17449eda5b5289d45856744-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "cy5QR}/~n]", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which cells are the primary reservoir of HIV?", 
                "Memory cells", 
                ""
            ], 
            "flags": 0, 
            "guid": "nYA7iYySd}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of HIV infection on lymphoid tissue?", 
                "Leads to progressive fibrosis and marked CD4 depletion<div>Persists despite ART</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Rr5c}u!*B", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the significance of delta32 mutation in CCR5 in HIV patients?", 
                "<div>32 base pair deletion within the coding region results in frameshift, generates a nonfunctioning receptor</div><div>This receptor is required for HIV to bind to CD4 cells (is a co-binding site)</div><div>Present in 10% of europeans, absent in blacks and Japanese</div><div>Confers resistance to HIV1 if homozygous (1% of Europeans)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J6B|Vb85&Z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe 3 mutations/HLA types that confer resistance to HIV", 
                "delta32 mutation in CCR5<div>HLA B57 (protective early)</div><div>HLAB27 (protective late)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "n#B$3/Tr@#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 HLA subtype that confers susceptibility to HIV", 
                "HLAB3503", 
                ""
            ], 
            "flags": 0, 
            "guid": "f3u!06c}v@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should antiretrovirals be commenced for patients in HIV?", 
                "At diagnosis", 
                ""
            ], 
            "flags": 0, 
            "guid": "l<L6Ri.H}p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe immune activation in HIV (3)", 
                "Immune activation is associated with increased morbidity and mortality, poor CD4 recovery<div>Associated with atherosclerosis</div><div>Immune activation is also seen in HIV controllers and elite controllers</div><div>Can be reduced with ART</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fqO|j,nR6-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the benefits of early ART in HIV patients? (3)", 
                "<div>Reduce AIDS diagnosis/disease progression/opportunistic infections/death</div>Reduced immune activation<div>Reduce HIV reservoir</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Op=(Rw8|{j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is the reservoir established in HIV?", 
                "During initial acute infection (first 30 days)", 
                ""
            ], 
            "flags": 0, 
            "guid": "v)>r[?Up5d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "40370c712deb41489d993bc97a4ed075-ao-1", 
                "", 
                "<img src=\"tmp3mhsu_.png\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-1-A.svg\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Avm8b+tC`T", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "40370c712deb41489d993bc97a4ed075-ao-2", 
                "", 
                "<img src=\"tmp3mhsu_.png\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-2-A.svg\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "LEb(<wZV7r", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "40370c712deb41489d993bc97a4ed075-ao-3", 
                "", 
                "<img src=\"tmp3mhsu_.png\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-3-A.svg\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "hyK%Z^c/#", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "40370c712deb41489d993bc97a4ed075-ao-4", 
                "", 
                "<img src=\"tmp3mhsu_.png\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-4-A.svg\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "euOtOBYKO{", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "40370c712deb41489d993bc97a4ed075-ao-5", 
                "", 
                "<img src=\"tmp3mhsu_.png\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-5-A.svg\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "s{HvhR]/7Z", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "40370c712deb41489d993bc97a4ed075-ao-6", 
                "", 
                "<img src=\"tmp3mhsu_.png\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-6-A.svg\" />", 
                "<img src=\"40370c712deb41489d993bc97a4ed075-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "c236RE,5LI", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the story of the Berlin Patient, Timothy Brown (5)", 
                "Diagnosed with HIV in 1995<div>4 years of ART</div><div>AML diagnosed in 2006 - chemotherapy</div><div>HLA identical donor by delta 32 homozygous donor, x2, then total body irradiation</div><div>Aviremic since then despite off ART since 2007</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q]Rj>78njh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a HIV 'elite controller'?", 
                "Patient able to maintain HIV viral load &lt;50copies spontaneously (without any therapy)<div>Tend to be HLAB27 or B57</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HPg[EUo_$J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is a long term nonprogressor in HIV?", 
                "Long-standing HIV infection who are not on ART do not develop clinical progression and have stable CD4 cell counts and low levels of detectable viremia", 
                ""
            ], 
            "flags": 0, 
            "guid": "dgzr&HFG86", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the expected outcome if a HIV patient ceases ART?", 
                "Rapid viral rebound with rise in viral load, drop in CD4", 
                ""
            ], 
            "flags": 0, 
            "guid": "D:fJvbs?@7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe immune reconstitution inflammatory syndrome (IRIS)", 
                "<div>Inflammatory reaction to latent or subclinical infection</div><div>- 'paradoxical' subtype: worsening of a recognised pre-existing infection</div><div>- 'unmasking' subctype: worsening/appearance of an unrecognised pre-existing infection</div><div>May occur 1 week to 1 month after starting any ART</div><div>Clincial features relate to the type and location of the pre-existing infection</div><div>Higher risk with low CD4 count (&lt;100 cells mircoL)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "cG]RM^I:Gy", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the non-infective&nbsp;immune reconstitution inflammatory syndrome (IRIS) in HIV patients", 
                "Rarely, instead of worsening of a pre-existing infection, ART can be associated with dramatic onset or worsening of an autoimmune condition<div>e.g. sarcoidosis, autoimmune thyroiditis, graves' disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q7pDry`sxa", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of TB and HIV co-infection (which should be treated first)", 
                "<div>Start TB treatment first.</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>-&nbsp;If CD4 count &lt;50, start ART &lt; 2 weeks (to minimise AIDS progression and death)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>-&nbsp;If CD4 &gt;50, start ART between 2 - 8 weeks (to minimise IRIS risk)</div><div><br /></div><div>In TB meningitis, wait at least 8 weeks regardless of CD4, as severe IRIS can be fatal</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GOP,FKJCKW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How can IRIS be differentiated from worsening immunodeficiency-related infection?", 
                "In IRIS:&nbsp;<div>- HIV RNA low, inflammation high, evidence of immune response on histopathology, may resolve without treatment<div>in immunodeficiency:&nbsp;</div><div>- HIV RNA high, inflammation low, impaired immune response on histopathology, requires antimicrobials</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nK^8sE=l|`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 aromatase inhibitors", 
                "Anastrozole<div>Letrozole</div><div>Exemestane</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P.eot.[)g2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Oncology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-1", 
                "Describe the natural history of HIV", 
                "<img src=\"tmp7gtalh.png\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-1-A.svg\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "D)Y%o4sdu-", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-2", 
                "Describe the natural history of HIV", 
                "<img src=\"tmp7gtalh.png\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-2-A.svg\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "AbV_T,[ZL8", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-3", 
                "Describe the natural history of HIV", 
                "<img src=\"tmp7gtalh.png\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-3-A.svg\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "H#.K6j$[TS", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-4", 
                "Describe the natural history of HIV", 
                "<img src=\"tmp7gtalh.png\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-4-A.svg\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q23dFwAEtn", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-5", 
                "Describe the natural history of HIV", 
                "<img src=\"tmp7gtalh.png\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-5-A.svg\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Rg*f*!+p=g", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-6", 
                "Describe the natural history of HIV", 
                "<img src=\"tmp7gtalh.png\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-6-A.svg\" />", 
                "<img src=\"7addb3f5cfaf4f9d81cffb0e9d0710fd-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Cx.8)c)mV}", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "32f45114f3f941aeaea0049234da3262-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients", 
                "<img src=\"tmpca8v12.png\" />", 
                "<img src=\"32f45114f3f941aeaea0049234da3262-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"32f45114f3f941aeaea0049234da3262-ao-1-A.svg\" />", 
                "<img src=\"32f45114f3f941aeaea0049234da3262-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "tMqlFgV{}r", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "32f45114f3f941aeaea0049234da3262-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients", 
                "<img src=\"tmpca8v12.png\" />", 
                "<img src=\"32f45114f3f941aeaea0049234da3262-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"32f45114f3f941aeaea0049234da3262-ao-2-A.svg\" />", 
                "<img src=\"32f45114f3f941aeaea0049234da3262-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "eX?qjPqnlD", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "32f45114f3f941aeaea0049234da3262-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients", 
                "<img src=\"tmpca8v12.png\" />", 
                "<img src=\"32f45114f3f941aeaea0049234da3262-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"32f45114f3f941aeaea0049234da3262-ao-3-A.svg\" />", 
                "<img src=\"32f45114f3f941aeaea0049234da3262-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "M8OM|ePsic", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "6218b815d3914801b563c39312b32585-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis", 
                "<img src=\"tmpkvknuj.png\" />", 
                "<img src=\"6218b815d3914801b563c39312b32585-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"6218b815d3914801b563c39312b32585-ao-1-A.svg\" />", 
                "<img src=\"6218b815d3914801b563c39312b32585-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "l2!IA]J.b,", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "6218b815d3914801b563c39312b32585-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis", 
                "<img src=\"tmpkvknuj.png\" />", 
                "<img src=\"6218b815d3914801b563c39312b32585-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"6218b815d3914801b563c39312b32585-ao-2-A.svg\" />", 
                "<img src=\"6218b815d3914801b563c39312b32585-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Oynh9T.:EJ", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "6218b815d3914801b563c39312b32585-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis", 
                "<img src=\"tmpkvknuj.png\" />", 
                "<img src=\"6218b815d3914801b563c39312b32585-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"6218b815d3914801b563c39312b32585-ao-3-A.svg\" />", 
                "<img src=\"6218b815d3914801b563c39312b32585-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "OkEq9?#EV+", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9b930ae4601b43c88953957edb11298b-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis", 
                "<img src=\"tmpkvknuj.png\" />", 
                "<img src=\"9b930ae4601b43c88953957edb11298b-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9b930ae4601b43c88953957edb11298b-ao-1-A.svg\" />", 
                "<img src=\"9b930ae4601b43c88953957edb11298b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "s9c^#x5o/.", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9b930ae4601b43c88953957edb11298b-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis", 
                "<img src=\"tmpkvknuj.png\" />", 
                "<img src=\"9b930ae4601b43c88953957edb11298b-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9b930ae4601b43c88953957edb11298b-ao-2-A.svg\" />", 
                "<img src=\"9b930ae4601b43c88953957edb11298b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "PUKFN,ol9z", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "9b930ae4601b43c88953957edb11298b-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis", 
                "<img src=\"tmpkvknuj.png\" />", 
                "<img src=\"9b930ae4601b43c88953957edb11298b-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"9b930ae4601b43c88953957edb11298b-ao-3-A.svg\" />", 
                "<img src=\"9b930ae4601b43c88953957edb11298b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Dg^e??v]b(", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "69244d8c59534607afd4989bfe43930a-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis", 
                "<img src=\"tmpvtsoih.png\" />", 
                "<img src=\"69244d8c59534607afd4989bfe43930a-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"69244d8c59534607afd4989bfe43930a-ao-1-A.svg\" />", 
                "<img src=\"69244d8c59534607afd4989bfe43930a-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "eDhePMnQ&I", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "69244d8c59534607afd4989bfe43930a-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis", 
                "<img src=\"tmpvtsoih.png\" />", 
                "<img src=\"69244d8c59534607afd4989bfe43930a-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"69244d8c59534607afd4989bfe43930a-ao-2-A.svg\" />", 
                "<img src=\"69244d8c59534607afd4989bfe43930a-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "MruVXjo0w?", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "69244d8c59534607afd4989bfe43930a-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis", 
                "<img src=\"tmpvtsoih.png\" />", 
                "<img src=\"69244d8c59534607afd4989bfe43930a-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"69244d8c59534607afd4989bfe43930a-ao-3-A.svg\" />", 
                "<img src=\"69244d8c59534607afd4989bfe43930a-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ry4v27Y8&a", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "346af3bf3aba416dbf8f4f53ca163402-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpwfxdbh.png\" />", 
                "<img src=\"346af3bf3aba416dbf8f4f53ca163402-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"346af3bf3aba416dbf8f4f53ca163402-ao-1-A.svg\" />", 
                "<img src=\"346af3bf3aba416dbf8f4f53ca163402-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GQlm0.8^zq", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "346af3bf3aba416dbf8f4f53ca163402-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpwfxdbh.png\" />", 
                "<img src=\"346af3bf3aba416dbf8f4f53ca163402-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"346af3bf3aba416dbf8f4f53ca163402-ao-2-A.svg\" />", 
                "<img src=\"346af3bf3aba416dbf8f4f53ca163402-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "sa`AP>O_[(", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "346af3bf3aba416dbf8f4f53ca163402-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpwfxdbh.png\" />", 
                "<img src=\"346af3bf3aba416dbf8f4f53ca163402-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"346af3bf3aba416dbf8f4f53ca163402-ao-3-A.svg\" />", 
                "<img src=\"346af3bf3aba416dbf8f4f53ca163402-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "L9#QGC<*_d", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e4954af151fc4b6684eb3077e80ecd4d-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmp0xchjr.png\" />", 
                "<img src=\"e4954af151fc4b6684eb3077e80ecd4d-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e4954af151fc4b6684eb3077e80ecd4d-ao-1-A.svg\" />", 
                "<img src=\"e4954af151fc4b6684eb3077e80ecd4d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "MfseR~[TTv", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e4954af151fc4b6684eb3077e80ecd4d-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmp0xchjr.png\" />", 
                "<img src=\"e4954af151fc4b6684eb3077e80ecd4d-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e4954af151fc4b6684eb3077e80ecd4d-ao-2-A.svg\" />", 
                "<img src=\"e4954af151fc4b6684eb3077e80ecd4d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "n.m)-%3ZBL", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e4954af151fc4b6684eb3077e80ecd4d-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmp0xchjr.png\" />", 
                "<img src=\"e4954af151fc4b6684eb3077e80ecd4d-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e4954af151fc4b6684eb3077e80ecd4d-ao-3-A.svg\" />", 
                "<img src=\"e4954af151fc4b6684eb3077e80ecd4d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "vn`y`)V%_9", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8b9d11e55af24760a2e902d9455c078b-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpaczdmx.png\" />", 
                "<img src=\"8b9d11e55af24760a2e902d9455c078b-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8b9d11e55af24760a2e902d9455c078b-ao-1-A.svg\" />", 
                "<img src=\"8b9d11e55af24760a2e902d9455c078b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "w[V6laKzBl", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8b9d11e55af24760a2e902d9455c078b-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpaczdmx.png\" />", 
                "<img src=\"8b9d11e55af24760a2e902d9455c078b-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8b9d11e55af24760a2e902d9455c078b-ao-2-A.svg\" />", 
                "<img src=\"8b9d11e55af24760a2e902d9455c078b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "G=!LnQN12x", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8b9d11e55af24760a2e902d9455c078b-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpaczdmx.png\" />", 
                "<img src=\"8b9d11e55af24760a2e902d9455c078b-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8b9d11e55af24760a2e902d9455c078b-ao-3-A.svg\" />", 
                "<img src=\"8b9d11e55af24760a2e902d9455c078b-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Y^:*Nu(!Y", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "424dcadad47a486fa57e864f7dc532b7-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpmgx4yb.png\" />", 
                "<img src=\"424dcadad47a486fa57e864f7dc532b7-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"424dcadad47a486fa57e864f7dc532b7-ao-1-A.svg\" />", 
                "<img src=\"424dcadad47a486fa57e864f7dc532b7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Pj%crcY&D|", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "424dcadad47a486fa57e864f7dc532b7-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpmgx4yb.png\" />", 
                "<img src=\"424dcadad47a486fa57e864f7dc532b7-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"424dcadad47a486fa57e864f7dc532b7-ao-2-A.svg\" />", 
                "<img src=\"424dcadad47a486fa57e864f7dc532b7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "9/]wF6]F@", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "424dcadad47a486fa57e864f7dc532b7-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpmgx4yb.png\" />", 
                "<img src=\"424dcadad47a486fa57e864f7dc532b7-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"424dcadad47a486fa57e864f7dc532b7-ao-3-A.svg\" />", 
                "<img src=\"424dcadad47a486fa57e864f7dc532b7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "rhd.d}?NkO", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f45f83152d654f7aadc09c78cee80025-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpwmj0ut.png\" />", 
                "<img src=\"f45f83152d654f7aadc09c78cee80025-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f45f83152d654f7aadc09c78cee80025-ao-1-A.svg\" />", 
                "<img src=\"f45f83152d654f7aadc09c78cee80025-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "B7:ySLYQx?", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f45f83152d654f7aadc09c78cee80025-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpwmj0ut.png\" />", 
                "<img src=\"f45f83152d654f7aadc09c78cee80025-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f45f83152d654f7aadc09c78cee80025-ao-2-A.svg\" />", 
                "<img src=\"f45f83152d654f7aadc09c78cee80025-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q?$fg3VQ|u", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f45f83152d654f7aadc09c78cee80025-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpwmj0ut.png\" />", 
                "<img src=\"f45f83152d654f7aadc09c78cee80025-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f45f83152d654f7aadc09c78cee80025-ao-3-A.svg\" />", 
                "<img src=\"f45f83152d654f7aadc09c78cee80025-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ydBdO_gRvE", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "05e25644c8a34adda53563af5a11d2c9-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmp2ep58n.png\" />", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-1-A.svg\" />", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "sjTzz#,Z^T", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "05e25644c8a34adda53563af5a11d2c9-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmp2ep58n.png\" />", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-2-A.svg\" />", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "c&N4+45#|m", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "05e25644c8a34adda53563af5a11d2c9-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmp2ep58n.png\" />", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-3-A.svg\" />", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "yw3|([el=,", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "05e25644c8a34adda53563af5a11d2c9-ao-4", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmp2ep58n.png\" />", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-4-A.svg\" />", 
                "<img src=\"05e25644c8a34adda53563af5a11d2c9-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "M+L4HY=7I", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d286a1e9ee6547779ed0e02926655795-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpaeujxg.png\" />", 
                "<img src=\"d286a1e9ee6547779ed0e02926655795-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d286a1e9ee6547779ed0e02926655795-ao-1-A.svg\" />", 
                "<img src=\"d286a1e9ee6547779ed0e02926655795-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GxR]3*pxk}", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d286a1e9ee6547779ed0e02926655795-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpaeujxg.png\" />", 
                "<img src=\"d286a1e9ee6547779ed0e02926655795-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d286a1e9ee6547779ed0e02926655795-ao-2-A.svg\" />", 
                "<img src=\"d286a1e9ee6547779ed0e02926655795-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "x{IO-K^1wE", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "d286a1e9ee6547779ed0e02926655795-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmpaeujxg.png\" />", 
                "<img src=\"d286a1e9ee6547779ed0e02926655795-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"d286a1e9ee6547779ed0e02926655795-ao-3-A.svg\" />", 
                "<img src=\"d286a1e9ee6547779ed0e02926655795-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "hbRli5OZ$k", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a08cc10589774ec58d1813413c8b1b2d-ao-1", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmphfgmhw.png\" />", 
                "<img src=\"a08cc10589774ec58d1813413c8b1b2d-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a08cc10589774ec58d1813413c8b1b2d-ao-1-A.svg\" />", 
                "<img src=\"a08cc10589774ec58d1813413c8b1b2d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "fls22K>^MY", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a08cc10589774ec58d1813413c8b1b2d-ao-2", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmphfgmhw.png\" />", 
                "<img src=\"a08cc10589774ec58d1813413c8b1b2d-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a08cc10589774ec58d1813413c8b1b2d-ao-2-A.svg\" />", 
                "<img src=\"a08cc10589774ec58d1813413c8b1b2d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "D{f`ZWd.xP", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a08cc10589774ec58d1813413c8b1b2d-ao-3", 
                "Treatment and prophylaxis for opportunistic infection in HIV positive patients<br />Column 1: primary treatment<br />Column 2: secondary prophylaxis<br />Column 3: primary prophylaxis<br />", 
                "<img src=\"tmphfgmhw.png\" />", 
                "<img src=\"a08cc10589774ec58d1813413c8b1b2d-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a08cc10589774ec58d1813413c8b1b2d-ao-3-A.svg\" />", 
                "<img src=\"a08cc10589774ec58d1813413c8b1b2d-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "zLRj5bjmPX", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with HIV is started on prophylaxis against opportunistic infection due to a CD4 count below the required theshold. With ART, it rises above the threshold again. Should the prophylaxis be ceased or continued?", 
                "Can be ceased once CD4 count above the cutoff, provided viral load is well ocntrolled so there is no indication CD4 count will drop again", 
                ""
            ], 
            "flags": 0, 
            "guid": "O4S+}!|T+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should antiretroviral therapy be started?", 
                "At diagnosis in all patients, regardless of CD4 count<div>(some delay may be required if current opportunistic infection - see other cards)</div><div><br /></div><div>From the START study: 57% reduce risk of AIDS illness, serious non-AIDS illness or all cause mortality with immediate (vs delayed) ART</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DZx`sLIt>W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When should ART be started in HIV patients with an opportunistic infection?", 
                "Once stable on treatment for the infection - generally within 2-4 weeks (to avoid overlap of toxicity)", 
                ""
            ], 
            "flags": 0, 
            "guid": "rXGSSvPR~m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is it safe to stop ART for HIV patients?", 
                "Never. Do not stop, no breaks or holidays (unless very significant toxicity)<div>Results in higher mortality/AIDS events</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oZCb7Ug-;|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which opportunistic infection carries the highest risk of IRIS in HIV patients?", 
                "Cryptococcal meningitis", 
                ""
            ], 
            "flags": 0, 
            "guid": "x1y~]_@n#C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 5 classes of antiretroviral drugs", 
                "Reverse transcriptase inhibitors - nucleoside/nucleotide analogues<div>Reverse transcriptase inhibitors - non-nucleoside reverse transcriptase inhibitors</div><div>Protease inhibitors</div><div>Entry inhibitors (fusion inhibitor/chemokine receptor blocker)</div><div>Integrase Strand Transfer inhbitors (most potent)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Bbq?x;ni>j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the initial antriretroviral therapy for HIV infection", 
                "At least three drugs are used, typically two NRTIs + a third agent<div><img src=\"paste-590326074966017.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xFMJ$j}|8U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 nucleoside analogue reverse transcriptase inhibitors (NRTIs)", 
                "Lamivudine<div>Emtricitabine</div><div>Abacavir</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PadP9Tpkp:", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 nucleotide analogue reverse transcriptase inhibitor (NRTI)", 
                "Tenofovir", 
                ""
            ], 
            "flags": 0, 
            "guid": "D^rE05[yZG", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 toxicities of tenofovir", 
                "Renal impairment<div>Osteopenia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CZ1[/L2hD~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the medication associated with hypersensitivity in HLAB*5701 positive patients", 
                "Abacavir", 
                ""
            ], 
            "flags": 0, 
            "guid": "yCz0):Fbjh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What test must be performed prior to starting abacavir?", 
                "HLAB*5701<div>If positive, cannot use abacavir</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H.0ob|kEG,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 toxicities of tenofovir", 
                "renal tubular toxicity/renal impairment&nbsp;<div>reduced bone mineral density</div><div>acute exacerbation of hepatitis B on discontinuation in hepatitis B / HIV co-infected patients</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p!VCcvs7lK", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 toxicities of emtricitabine", 
                "hyperpigmentation of palms and soles<div>acute exacerbation of hepatitis B on discontinuation in hepatitis B / HIV co-infected patients</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hubG^,KI!0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 toxicities of efavirenz", 
                "neuropsychological reactions (insomnia, altered dreams, impaired concentration, abnormal thinking, dizziness [on starting, usually resolves after days to weeks])<div>hyperlipidaemia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J$8sQeIWvr", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 toxicities of atazanavir", 
                "unconjugated hyperbilirubinaemia and jaundice (not dangerous, cosmetic problem)<div>rash&nbsp;</div><div>prolongation of PR interval</div><div>nephrolithiasis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vN=pe!WqNI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 toxicities of dolutegravir", 
                "headache<div>diarrhoea</div><div>increased creatine kinase</div><div>increased serum creatinine due to inhibition of renal tubular creatinine secretion</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hc{%}_7(NI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 toxicities of elvitegravir", 
                "diarrhoea<div>nausea</div><div>headache</div><div>increased creatine kinase</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Bk5$9A6h6U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 toxicities of raltegravir", 
                "nausea<div>headache&nbsp;</div><div>increased creatine kinase</div><div>rash</div><div>abnormal liver function</div><div>rhabdomyolysis (rare)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zZ<F}i]a,r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 class toxicities of non-nucleoside reverse transcriptase inhibitors (NNRTIs)", 
                "nausea<div>rash (including Stevens–Johnson syndrome—more frequent with nevirapine)</div><div>abnormal liver function (more frequent with nevirapine)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "G,O#<?l/R}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 class toxicities of protease inhibitors for HIV", 
                "<div>hyperlipidaemia (all more common when ritonavir combined with lopinavir than with atazanavir and darunavir)</div><div>nausea<div>diarrhoea</div></div><div>lipodystrophy</div><div>hyperglycaemia&nbsp;</div><div>abnormal liver function</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JRJs$1|^%V", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 non-nucleoside reverse transcriptase inhibitors (NNRTIs)", 
                "<div>1st gen:</div><div>Nevirapine</div>Efavirenz<div><br /></div><div>2nd gen:<br /><div><div>Etravirine</div><div>Rilpivirine (cannot take with PPI)</div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qO&|9OEjgQ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 toxicities of nevirapine", 
                "Severe hepatotoxicity (especially in women with CD4 count greater than 250 cells/microlitre or men with CD4 count greater than 400 cells/microlitre)<div>Fever</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MfB;}F*HgZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 protease inhibitors used in HIV", 
                "Atazanavir<div>Darunavir<br /><div>Lopinavir+ritonavir</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u9$^!O+N6O", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What drug must be given together with protease inhibitors (for HIV) to increase their effect?", 
                "Ritonavir, low dose<div>Is also a protease inhibitor, reduces the metabolism of the other PI to increase its effect</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c:-*D)HhoB", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 fusion inhibitor used in HIV", 
                "Enfuvirtide", 
                ""
            ], 
            "flags": 0, 
            "guid": "c,9]6m[Y13", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 HIV entry inhibitor (CCR5 inhibitor)", 
                "Maraviroc&nbsp;<div>- only used in CCR5 HIV strain&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wzbW{2rW?o", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 integrase strand transfer inhibitors", 
                "Dolutegravir<div>Elvitegravir</div><div>Raltegravir</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P6.HnT!|8]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 preferred features of antiretroviral therapy", 
                "Once daily dose<div>Fixed drug combination</div><div>Low toxicity and long time side effects</div><div>Minimal drug drug interactions</div><div>Low selection for resistance</div><div>CNS penetration</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E0y^RQ)Y4|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe genotype testing in HIV (5)", 
                "Should be done at baseline<div>15 - 20% have resistance to at least 1 drug</div><div><div>Strongly influenced by antiretroviral drug use patterns in source patient</div><div>Early detection important as&nbsp;some mutations become undetectable over time (virus is away from selection pressure of antiretrovirals in previous host)&nbsp;</div></div><div>Most common is NNRTI resistance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JJsRQQ@O%q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 single pill combination that can be used as initial therapy for HIV", 
                "Dolutegravir + abacavir + lemivudine<div>(integrase inhibitor + NRTI + NRTI)</div><div><br /></div><div>Elvitegravir + Cobicistat + Emtricitabine + Tenofovir ('Genvoya')</div><div>(integrase + cyp450 inhibitor + NRTI + NRTI)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D!1SLwdP1H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 drug that interacts with integrase inhibitors", 
                "Metformin", 
                ""
            ], 
            "flags": 0, 
            "guid": "p7pyJV;J:.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe investigations that should ideally be done prior to starting antiretroviral therapy in HIV (7)", 
                "CD4 count<div>HIV viral load</div><div>Hepatitis B and C</div><div>HIV genotype</div><div>LFT, fasting lipids</div><div>HLAB5701</div><div>Drug review - any potential interactions</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DN#LSuo1?r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the ideal NRTI of choice in HIV and hep B co-infection?", 
                "Tenofovir - has anti hep B action", 
                ""
            ], 
            "flags": 0, 
            "guid": "l{R.L{%hs@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2edcc191e58a4bd297d1f6301de69416-ao-1", 
                "", 
                "<img src=\"tmphxefvd.png\" />", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-1-A.svg\" />", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "gnqwBY}{o$", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2edcc191e58a4bd297d1f6301de69416-ao-2", 
                "", 
                "<img src=\"tmphxefvd.png\" />", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-2-A.svg\" />", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "q;T+wl^GmO", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2edcc191e58a4bd297d1f6301de69416-ao-3", 
                "", 
                "<img src=\"tmphxefvd.png\" />", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-3-A.svg\" />", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "e:OlyAwL{0", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2edcc191e58a4bd297d1f6301de69416-ao-4", 
                "", 
                "<img src=\"tmphxefvd.png\" />", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-4-A.svg\" />", 
                "<img src=\"2edcc191e58a4bd297d1f6301de69416-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kH>3/-Qv*c", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the aim for HIV viral load with antiretroviral treatment?", 
                "&lt;20 copies/mL (undetectable)", 
                ""
            ], 
            "flags": 0, 
            "guid": "K%`&x/3HO&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define virologic suppression in HIV", 
                "HIV RNA level below limit of assay detection (&lt;20copies/mL", 
                ""
            ], 
            "flags": 0, 
            "guid": "B4VR%D9qb2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define incomplete virological response in HIV", 
                "Inability to achieve virologic suppression after 24 weeks of therapy (viral load &gt;200 on 2 consecutive samples)", 
                ""
            ], 
            "flags": 0, 
            "guid": "N{WL%;*sKr", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define virologic failure in HIV", 
                "The inability to maintain suppression of viral replication to a HIV RNA level &lt;200copies/mL", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q=/}U]i!2e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define virologic rebound in HIV", 
                "HIV RNA &gt; 200copies/mL after virologic suppression", 
                ""
            ], 
            "flags": 0, 
            "guid": "MX8FJCn$iX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Should a single increased viral load result prompt a change in ART in patients with HIV?", 
                "No<div>Need two consecutive measurements 1 month apart of &gt;200 to be termed virologic failure</div><div>A single measurement of viraemia 20 - 200copies/mL is a 'blip' and is not significant</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kH=Vfu:C@[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 causes of virologic failure in HIV on ART", 
                "<div>Noncompliance (most common)</div><div>Drug-drug or drug-food interactions</div><div>- e.g. Atazanavir or rilpivirine taken with a PPI, rilpivirine taken without a meal</div><div>Underlying malabsorptive condition</div><div>Drug resistance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k)9&k28OnL", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "You suspect a patient with HIV who has virologic failure has developed drug resistance. When should genotype testing for resistance be performed?", 
                "While on ART, or within 4 weeks of discontinuing<div>- virus tends to revert to 'wild type' in absence of ART selection pressure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uWJ@G6r-Ss", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 indications for switching ART therapy in HIV", 
                "Virologic failure<div>Toxicity</div><div><br /></div><div>Do NOT switch in immunologic failure (persistent low CD4 despite therapy) - does not work</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yOBONS74=3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A patient with HIV has persistently low CD4 despite ART. Is there evidence for switching to different therapy?", 
                "No<div>Does not improve outcomes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f)4RHvz[2l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 'archived resistance' in HIV?", 
                "Resistance to a previous ART treatment the patient has been on and developed resistance to, often long ago<div>Does not appear on genotype testing, however resistance appears if that drug is restarted</div><div><br /></div><div>Need to take thorough treatment history to avoid.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p3e{}q-pW,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When is it considered safe to switch one agent of an ART regimen in HIV patients who are having drug toxicity?", 
                "When viral load is suppressed &lt;50copies/mL", 
                ""
            ], 
            "flags": 0, 
            "guid": "b3mP~s3-2y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "When switching therapy in ART, should you switch within the drug class or to a new drug class?", 
                "Try to use a new class", 
                ""
            ], 
            "flags": 0, 
            "guid": "M<PARTQ*fa", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 10 non-infectious complications of HIV", 
                "T2DM<br /><div>Dyslipidaemia</div><div>HAND</div><div>Cardiovascular disease</div><div>Hepatic steatosis</div><div>Bone and kidney disease</div><div>Depression</div><div>Hypertension</div><div>Cancer</div><div>Sexual dysfunction</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x{,&DpNdPk", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the risk reduction with PrEP with perfect adherence?", 
                "100% reduction (no documented cases of transmission)", 
                ""
            ], 
            "flags": 0, 
            "guid": "y$_&onyGI<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is contained in pre-exposure prophylaxis for HIV (PrEP)?", 
                "Tenofovir + emtricitabine", 
                ""
            ], 
            "flags": 0, 
            "guid": "qn0`.M$[z.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients are eligible for PrEP?", 
                "Medium to high risk of HIV infection<div>Negative HIV test</div><div>eGFR &gt;60</div><div>Not on nephrotoxic medication</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F|@si+>,|h", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe postexposure prophylaxis (PEP)", 
                "Start within 72hrs of exposure<div>Two NRTIs if low risk:&nbsp;</div><div>- emtricitabine + tenofovir, or&nbsp;</div><div>- lamivudine + zidovudine)</div><div>If high risk, add to the above</div><div>- lopinavir + ritonavir (protease inhibitor), or</div><div>- raltegravir (integrase inhibitor)</div><div><br /></div><div>Continue for 4 weeks.</div><div><br /></div><div>HIV test at baseline, 4-6 weeks, and 3 months after exposure.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m<ywWtHAi*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe early HIV infection (first 6 months) (6)", 
                "May have acute HIV infection (refers to symptomatic patients/acute retroviral syndrome)<div>Viral load very high, &gt;100,000 copies/mL (may be &gt;1 million copies)</div><div>CD4 count drops transiently</div><div>Seroconversion occurs</div><div>Virus 'set point' reached - steady state of plasma viraemia, stable CD4 count</div><div>- higher virus set point = poorer prognosis, faster progression</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w)n)KN??cj", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe chronic HIV infection (without ART) (4)", 
                "Stable viral load with slow progressive CD4 decline<div>Average viral load 30,000 - 50,000 copies/mL</div><div>Average 10<sup>9</sup>&nbsp;CD4 cells destroyed daily without treatment, which are mostly replaced leading to slow decline</div><div>Average 50cells/microL decline per year; faster/slower decline with higher/lower viral load</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uMC--nt>;z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Without treatment, what is the average time between HIV infection and CD4 &lt;200?", 
                "8 - 10 years", 
                ""
            ], 
            "flags": 0, 
            "guid": "D;b>[JuWNf", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What signs or symptoms may be seen in a patient with chronic untreated HIV infection without AIDS?", 
                "Majority asymptomatic<div>May have nonspecific constitutional symptoms</div><div>Majority have generalised lymphadenopathy - symmetrical, modest enlargement, painless</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sc+.Eqe+%y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What HIV-associated complications begin to appear at CD4 count 200 - 499? (5)", 
                "<div>Skin and mucosal: thrush, oral hairy leukoplakia, seborrheic dermatitis, bacterial folliculitis (particularly due to staph aureus)</div><div>Viral reactivation: HSV, VZV, HPV (may have rapid progression)</div><div>Strep pneumoniae</div><div>Hep B and C</div><div>Syphilis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "?_HMHtH|Z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define AIDS", 
                "HIV infection with CD4 count &lt; 200, or presence of an AIDS defining illness", 
                ""
            ], 
            "flags": 0, 
            "guid": "uWc2)+nex-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mean CD4 count at AIDS-definining illness diagnosis?", 
                "67", 
                ""
            ], 
            "flags": 0, 
            "guid": "p.w~986eAr", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients develop AIDS with a CD4 count &gt; 200?", 
                "10%", 
                ""
            ], 
            "flags": 0, 
            "guid": "b?wwQT9=!H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the average time from CD4 &lt; 200 to diagnosis of an AIDS defining illness?", 
                "12 - 18 months", 
                ""
            ], 
            "flags": 0, 
            "guid": "mQ}T1_D~lT", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where is the viral reservoir for HSV and VZV?", 
                "Episomal DNA ganglia", 
                ""
            ], 
            "flags": 0, 
            "guid": "bv_ny|XjZC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do antivirus drugs virucidal or virustatic?", 
                "All are virustatic<div>Hence no action against nonreplicating or latent virus</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kl9?a68G>E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do nucleoside and nucleotide analogue antivirals work?", 
                "False analogues of the building blocks the virus need to make new RNA or DNA, causing chain termination of the new strand<div><br /></div><div><img src=\"paste-623358668439553.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "C@2(9y^/Y$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How do protease inhibitor antivirals work?", 
                "Interfere with enzymes essential for cleavage of proteins required to form a new viral particle<div><br /></div><div><img src=\"paste-623453157720065.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DKrIm8@(rC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the action of neuraminidase inhibitor antivirals", 
                "Bind the neuraminidase spike to prevent the passage of the virus through the cell membrane, thus preventing formation of the new viral particle<div>e.g. oseltamivir</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yB%3k2Mi+C", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does HIV develop drug resistance?", 
                "When reverse transcriptase synthesises DNA from HIV viral RNA, this is an error-prone process and mutation can give rise to resistance", 
                ""
            ], 
            "flags": 0, 
            "guid": "zYr|g67*Pe", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does acyclovir work?", 
                "It is an analogue of deoxyguanosine (a nucleoside analogue) (i.e. the 'G' base in DNA)<div>Missing 3' hydroxyl sugar, which means no further bases can be added, thereby disrupting synethesis of new virus DNA</div><div><br /></div><div><img src=\"paste-625201209409537.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "PSi`+/nH)u", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is ID50?", 
                "Infectious doe required to produce infection in 50% of subjects", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q5G=V(D.~-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is IC50?", 
                "Concentration of drug (e.g. gentamicin) required ot inhibit the growth of half of an inoculum of a bug (e.g. pseudomonas)", 
                ""
            ], 
            "flags": 0, 
            "guid": "i1H+vY-dX_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the relationship between acyclovir and valacyclovir", 
                "Acyclovir has poor bioavailability (20%)<div>Valacyclovir is a prodrug of acyclovir, better bioavailabilty (55%)</div><div>Can achieve much higher AUC and therefore treat infections that require higher drug concentrations (e.g. CMV)</div><div><br /></div><div><img src=\"paste-629650795528193.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sBj%H@p6vi", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism or action of penciclovir?", 
                "A nucleoside analogue of the deoxyguanosine base (same as acyclovir)<div>Crucial difference from deoxygyanosine at the end of the molecule no further bases can be added, thereby disrupting synethesis of new virus DNA</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B,KWMpg|P2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A first episode of genital herpes is usually caused by HSV 1 or 2?", 
                "HSV 1", 
                ""
            ], 
            "flags": 0, 
            "guid": "x?K.#;:F>,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Recurrent genital herpes is usually due to HSV 1 or 2?", 
                "HSV 2", 
                ""
            ], 
            "flags": 0, 
            "guid": "hkV-#.9m</", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of a first episode of genital herpes (herpes simplex virus)", 
                "<img src=\"paste-631536286171137.jpg\" /><div><br /></div><div>Start within 72hrs of symptoms for best results.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p.u;Y1GvY[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of recurrent/episode genital herpes (herpes simplex virus)", 
                "<img src=\"paste-631622185517057.jpg\" />", 
                ""
            ], 
            "flags": 0, 
            "guid": "O7c$+?A:j$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the suppressive treatment of genital herpes (herpes simplex virus) for patients with frequent severe recurrences", 
                "<img src=\"paste-631716674797569.jpg\" /><div><br /></div><div>Treatment may be ongoing, or it may be interrupted every 6 months to determine the natural history of the disease and restarted in the event of recurrence.&nbsp;</div><div>Long-term suppressive antiviral therapy is considered safe.&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lb=4NoNny9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of a minor primary episode of oral mucovutaneous herpes simplex virus (2)", 
                "Supportive management (ie oral fluids, antipyretic drugs and analgesia)<div>Topical lignocaine 2%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nzM:+=yGXr", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of severe primary skin or oral mucocutaneous herpes simplex virus infection", 
                "<img src=\"paste-632008732573697.jpg\" />", 
                ""
            ], 
            "flags": 0, 
            "guid": "J8(^^9*a^J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of minor recurrence of oral mucocutaneous herpes simplex virus (cold sore)", 
                "Topical aciclovir 5%, 5 times a day for 5 days at first sign of recurrence", 
                ""
            ], 
            "flags": 0, 
            "guid": "zxa8mq~Q$E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of herpes zoster (reactivated varicella zoster virus/shingles)", 
                "If presents within 72hrs of onset, or if immunocompromised regardless of duration, use:<div><img src=\"paste-633237093220353.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "F]}oiR#@.!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the benefits of antiviral ltherapy in shingles (reactivated varicella zoster virus)?", 
                "If commenced within 72hrs, reduces acute pain, duration of the rash, viral shedding and ophthalmic complications.&nbsp;<div>Whether antiviral therapy reduces the incidence of postherpetic neuralgia is contentious.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A92Uh%s?:`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the classic appearance the retina in CMV retinitis", 
                "Haemorrhage and exudates tracking along blood vessels<div>'tomato sauce on cottage cheese'</div><div><img src=\"paste-633310107664385.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b6[m2U]z~~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>What is the diagnosis?</div><img src=\"paste-633305812697089.jpg\" />", 
                "CMV retinitis<div>Classic haemorrhage and exudate tracking along blood vessels ('tomato sauce on cottage cheese') appearance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "miSjTnQa;K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of ganciclovir", 
                "Analogue of nucleoside guanosine<div>Particularly potent against CMV (preferentially phosphorylated by CMV viral kinase UL97, leading to chain termination)</div><div>Terrible oral bioavailability, need to be used IV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ij8y4:0Dz<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of valganciclovir", 
                "A prodrug of ganciclovir with improved bioavailability (60% vs 6-10%)<div>Ganciclovir is an analogue of nucleoside guanosine with particularly potent action against CMV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y,n]x2}m[q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of zanamivir and oseltamivir?", 
                "<div>Neuraminidase inhibitors, used for influenza</div>Bind the neuraminidase spike to prevent the passage of the virus through the cell membrane, thus preventing formation of the new viral particle", 
                ""
            ], 
            "flags": 0, 
            "guid": "A-[W`}qPxM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of acute influenza infection", 
                "If established complications, or if requiring hospitalisation, or if at high risk for poor outcomes (e.g pregnant, elderly, co-morbidities), use:<div>- oseltamivir 75mg BD for 5 days, or</div><div>- zanamivir 10mg inhaled BD for 5 days</div><div><br /></div><div>Can also consider within 48hrs of infection in otherwise well individuals, but only shortens disease duration by 1 day</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gr.o{0NfMm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the effect of neuraminidase inhibitors (zanamivir, oseltamivir) in patients admitted with influenza?", 
                "Reduced mortality, best if within 48hrs but still benefit after this too", 
                ""
            ], 
            "flags": 0, 
            "guid": "i87{4li*;k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of foscarnet (5)", 
                "Pyrophosphate analogue<div>Directly inhibits pyrophosphate binding site of DNA polymerase (no need for phosphorylation like the nucleoside analogues), preventing viral DNA replication</div><div>Therefore active against resistant viruses that have stopped phosphorylating and uptaking the nucleoside analogue drugs like acyclovir</div><div>Broad action against many different viruses</div><div>Less virus-specific than nucleoside analogues, so more toxic (renal dysfynction, metabolic disturbance)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BzT5(U@S6H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of cidofovir", 
                "Nucleotide analogue of deoxycytidine monophosphate (dCMP)<div>Does not need viral enzymes to become activated (independent of TK/UL97 phosphorylation), therefore active against resistant virus</div><div>Active against adenovirus, HSV, EBV, HBV, HHV6, HHV8, HPV</div><div>Less viral-specific so more toxic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LV#pykj<kW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the yellow fever vaccine", 
                "<div>Live attenuated vaccine&nbsp;</div><div>Contraindicated in immunocompromised (they can get yellow fever and die)</div><div>Lifelong protection</div><div>Indicated in travellers to endemic areas, and those who live there (parts of South America and sub-Saharan Africa)</div><div>Do not give over age 60</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jag2R-msn@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is yellow fever", 
                "<div>Mosquito borne viral haemorrhagic fever, caused by a flavivirus</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hz@I*Qh/%t", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where is yellow fever found?", 
                "<div>Found in tropical regions of South America, and sub-Saharan Africa (ongoing outbreak in Brazil)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kocZT??q^(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the three stages of yellow fever infection", 
                "<div>Infection: nonspecific findings like fever, malaise, headache, joint pain, nausea, vomiting</div><div>Remission: abatement of symptoms for up to 48hrs</div><div>Intoxication: hepatic dysfunction, renal failure, coagulopathy, shock</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BuQ$|#0IgM", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is a diagnosis of yellow fever made? (3)", 
                "Serology (ELISA for IgM)<div>- IgM provides presumptive diagnosis, confirmed by a rise in titre between paired acute and convalescent samples<br /><div>PCR</div><div>- rapid diagnostic PCR tests</div><div>Virus isolation</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "E0<5L^S^`,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of yellow fever", 
                "Supportive care (no specific antivirals available)", 
                ""
            ], 
            "flags": 0, 
            "guid": "HuwI&MW.1e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "For how long after travel to a Zika-endemic area should a male refrain from attempting to conceive a child?", 
                "6 months", 
                ""
            ], 
            "flags": 0, 
            "guid": "ed(Uk$zm1#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "For how long after travel to a Zika-endemic area should a female refrain from attempting to conceive a child?", 
                "8 weeks", 
                ""
            ], 
            "flags": 0, 
            "guid": "yDsG<ody:t", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How can Zika be transmitted? (4)", 
                "<div>Mosquitoes</div>Blood<div>Sexual<br /><div>Organ transplant</div><div>Lab exposure</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LQ6SL5AFJa", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the manifestations of Zika virus infection (6)", 
                "Fever<div>Rash</div><div>Small joint arthritis</div><div>Conjunctivitis</div><div>Guillain-Barre</div><div>Foetal microcephaly if pregnant</div><div><br /></div><div>Typically resolives in 1 week</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hMx0.0a5bs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Is it safe to travel to a Zika area while pregnant, in any trimester?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "A4>Qlz}qFL", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of patients will be asymptomatic with Zika infection?", 
                "80%", 
                ""
            ], 
            "flags": 0, 
            "guid": "bb9(Pd($X6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can a negative Zika test exclude infection?", 
                "No", 
                ""
            ], 
            "flags": 0, 
            "guid": "ocM_B63fr;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the Zika virus (2)", 
                "Flavivirus, mosquito-borne<div>Ongoing outbreak in the Americas, also found in Africa, Southeast Asia, Pacific Islands</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ot8Bnla@Rh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe carbapenem resistance (2)", 
                "Frequently due to carbapenemase<div>Hydrolyse all beta lactams, including carbapenems</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B4*-s)?6lH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define malaria", 
                "Infection with parasite from the Plasmodium family<div>Transmitted to humans through the bites of infected mosquitoes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j]E#7YuC._", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 5 species of plasmodium parasite that cause malaria, and their features", 
                "P. falciparum&nbsp;<div>- almost all deaths/severe disease</div><div>- no dormant liver stage, no late relapses</div><div>- almost always chloroquinolone resistant</div><div>- need to exclude rapidly when malaria is suspected<br /><div>P. knowlesi</div><div>- Can be severe, but looks like malariae on testing</div><div>P. vivax and P. ovale</div><div>- Can lie dormant and have late relapses</div><div>P. malariae</div><div>- Usually benign</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lgY:I6YIND", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe diagnostic testing for malaria", 
                "<div>FBE</div><div>- haemolytic anaemia</div><div>- WCC low or normal</div><div>- thrombocytopenia (95%)</div>Microscopy (thick and thin film)&nbsp;<div><div>Rapid diagnostic testing/antigen capture tests, e.g. immunochromatographic assay (ICT)&nbsp;</div><div><br /></div><div><div>Thick and thin films are much more sensitive for falciparum than for&nbsp;vivax and ovale</div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oKbycL`|<m", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of uncomplicated malaria", 
                "Artemether + lumefantrine (1st line)<div>or</div><div>Atovaquone + proguanil</div><div>or</div><div>Quinine sulfate + doxycycline or clindamycin</div><div><br /></div><div>Do not use the same thing they had for prophylaxis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "MJbX=MaP6d", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe severe malaria", 
                "<div>Altered consciousness, jaundice, oliguria, respiratory distress, severe anaemia or hypoglycaemia</div><div>Parasite count &gt; 100 000/mm3 (more than 2% of red blood cells parasitised)</div><div>Vomiting</div><div>Clinical acidosis or metabolic acidosis on blood biochemistry</div><div>Acute kidney injury</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uJ*k3RWP,V", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Severe malaria is usually due to which species?", 
                "Plasmodium falciparum", 
                ""
            ], 
            "flags": 0, 
            "guid": "Cj3)tX&n=*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of severe malaria (3)", 
                "Artesunate IV<div>Switch to oral artemether-lumefantrine when well/able to take oral therapy<br /><div>Likely to need ICU</div></div><div><br /></div><div>Can use IV quinine if artesunate not available (not as good)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sFGaSQl%W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mortality in severe malaria?", 
                "15 - 20% with treatment", 
                ""
            ], 
            "flags": 0, 
            "guid": "g)S(%-)`Il", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe 1 delayed toxicity of artesunate therapy for severe malaria", 
                "Delayed haemolysis (weeks after therapy)", 
                ""
            ], 
            "flags": 0, 
            "guid": "br#Q^=,~$w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe anti-relapse therapy in malaria with vivax and ovale", 
                "P. vivax and ovale can exist as dormant parasites(hypnozites) in the liver, which do not show up on testing<div>Require therapy to eliminate</div><div><br /></div><div>Use the below concurrently with usual uncomplicated malaria treatment:</div><div>- primaquine</div><div><br /></div><div>Need to exclude G6PD deficiency prior to use of primaquine (haemolysis)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I0I<EseB[<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What condition needs to be excluded prior to use of primaquine?", 
                "G6PD<div>Use can cause severe haemolysis</div><div><br /></div><div>Primaquine is used to eradicate dormant parasites in plasmodium vivax and ovale (malaria) infection</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nL)M]p?m#&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe malaria prophylaxis (3)", 
                "Atovaquone + proguanil (start 1 day prior, continue 1 week after leaving)<div>or</div><div>Doxycycline (start 1-2 days prior, continue 4 weeks after leaving</div><div>or</div><div>Mefloquine (start 2 weeks prior, continue 4 weeks after leaving)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Ky<z/XPH/g", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the malaria prophylaxis of choice in pregnancy", 
                "Mefloquine (safe in 2nd and 3rd trimesters)<div><br /></div><div>In general malaria-endemic areas should be avoided in pregnancy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P=8zlq{%^*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the side effects of doxycycline (4)", 
                "Photosensitivity (10%)<div>GI upset</div><div>Vaginal thrush</div><div>OCP becomes ineffective</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O1OXZQ:z&U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe dengue fever (2)", 
                "Flavivirus, mosquito-borne<div>Incubation 3 - 10 days</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vDg,hKmE{{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the 4 classic dengue fever syndromes", 
                "Undifferentiated fever<div>Classic dengue fever</div><div>Dengue haemorrhagic fever</div><div>Dengue shock syndrome</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P~?SvU=%O>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the general biochemical findings in dengue fever (3)", 
                "FBE<div>- neutropenia, later lymphocytosis</div><div>- thrombocytopenia (&lt;100 = severe disease)</div><div>- haematocrit: rising haematocrit indicates fluid leakage, warning sign for shock</div><div>LFT</div><div>- mildly raised ALT, AST (3-5x ULN = severe)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Nrx~3QM#3f", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the diagnostic testing for dengue fever", 
                "Serology (1st test)<div>NS1 antigen&nbsp;</div><div>Flavivirus PCR</div><div><br /></div><div><br /></div><div><img src=\"paste-666578924339201.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vbWM~eiK?6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe traveller's diarrhoea", 
                "A syndrome, causes largely by bacteria<div>Commonest travel related symptom (20 - 50% in developing countries)</div><div>Usually abrupt onset and self-limiting without treatment</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NHRB8OH<y9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of traveller's diarrhoea", 
                "Azithromycin 1g as a single dose or 500mg daily for 3 days", 
                ""
            ], 
            "flags": 0, 
            "guid": "O~nx*0OK6)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the formula for positive liklihood ratio", 
                "sensitivity/1 - specificity", 
                ""
            ], 
            "flags": 0, 
            "guid": "dYH5.|+S^e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Statistics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the negative likelihood ratio equation?", 
                "1 - sensitivity/specificity", 
                ""
            ], 
            "flags": 0, 
            "guid": "Cpiyo:S0g>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Statistics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the formula for sensitivity?", 
                "Sens = true pos/(true pos + false neg)", 
                ""
            ], 
            "flags": 0, 
            "guid": "bz?:m}81+k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Statistics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the formula for specificity?", 
                "Spec = true neg/(true neg + false pos)&nbsp;", 
                ""
            ], 
            "flags": 0, 
            "guid": "AVJ=pO$e=v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Statistics"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 opportunistic bacterial infections", 
                "Nocardia<div>Legionella</div><div>Mycobacterium tuberculosis</div><div>Atypical mycobacterium</div><div>Clostridium difficile</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fplWz~v.&-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 opportunistic fungal infections", 
                "Aspergillus<div>Cryptococcus</div><div>Mucormycosis</div><div>Pneumocystis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m|5#po*e[[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-1", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-1-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "cR{]+KpL$J", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-2", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-2-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "FoN-p6s/)w", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-3", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-3-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "t>[-NN-]M$", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-4", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-4-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "h$ZyC(cZ]?", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-5", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-5-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "w7@-g$2ko7", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-6", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-6-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kD<uoP;nCm", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-7", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-7-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "IAbk{66zjn", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-8", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-8-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Ot_E2tIOJJ", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-9", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-9-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "n=GU2~/mF~", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-10", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-10-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "j!@zov,r/i", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-11", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-11-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "e<@R-59ZK,", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-12", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-12-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-12-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "I)osPbM+H:", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "445e1ae2761d405fb6b7b389d7553e8f-ao-13", 
                "", 
                "<img src=\"tmp53sjtz.png\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-13-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-13-A.svg\" />", 
                "<img src=\"445e1ae2761d405fb6b7b389d7553e8f-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "u@sNPgq4O`", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fb9ac26aca0842e0a7bc0774c629ca27-ao-1", 
                "", 
                "<img src=\"tmpkhv23b.png\" />", 
                "<img src=\"fb9ac26aca0842e0a7bc0774c629ca27-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fb9ac26aca0842e0a7bc0774c629ca27-ao-1-A.svg\" />", 
                "<img src=\"fb9ac26aca0842e0a7bc0774c629ca27-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "B=<LKe-dcI", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fb9ac26aca0842e0a7bc0774c629ca27-ao-2", 
                "", 
                "<img src=\"tmpkhv23b.png\" />", 
                "<img src=\"fb9ac26aca0842e0a7bc0774c629ca27-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fb9ac26aca0842e0a7bc0774c629ca27-ao-2-A.svg\" />", 
                "<img src=\"fb9ac26aca0842e0a7bc0774c629ca27-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "MCR(B||K0l", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fb9ac26aca0842e0a7bc0774c629ca27-ao-3", 
                "", 
                "<img src=\"tmpkhv23b.png\" />", 
                "<img src=\"fb9ac26aca0842e0a7bc0774c629ca27-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fb9ac26aca0842e0a7bc0774c629ca27-ao-3-A.svg\" />", 
                "<img src=\"fb9ac26aca0842e0a7bc0774c629ca27-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "B)hdTnO7{e", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Anti B-cell therapies such as rituximab increase risk of what type of infection (2)", 
                "Viral reactivation<div>Respiratory infections</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rpJhe7(Um%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Anti T-cell therapies increase risk of what type of infection (11)", 
                "<div>Mainly intracellular pathogens</div><div><br /></div>PJP<div>Moulds</div><div>Cryptococcus</div><div>Endemic fungi</div><div>Viral reactivation</div><div>Intracellular bacteria: TB, atypical mycobacteria, legionella, nocardia, listeria, salmonella</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fivK.~+8i?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 immunosuppressives that are primarily anti-T cell", 
                "Corticosteroids<div>Purine analogues (fludarabine)</div><div>Calcineurin inhibitors (cyclosporin, tacrolimus)</div><div>mTOR inhibitors (everolimus, sirolimus)</div><div>Antimetabolites (mycophenolate, azathioprine)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d0=4m.!%e0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Hyposplenism and hypogammaglobulinaemia increase risk of infection with what type of organism?", 
                "Encapsulated organisms (inability to opsonise)", 
                ""
            ], 
            "flags": 0, 
            "guid": "J>/#~c<I=c", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 patient groups at incresed risk of infection with encapsulated organisms", 
                "Hyposplenism/asplenism<div>Hypogammaglobulinaemia</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mR??rz-<T;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "TNF alpha inhibitors increase risk of infection with what organism(s) (1)", 
                "Invasive fungal infections", 
                ""
            ], 
            "flags": 0, 
            "guid": "GYfhGA[Gq?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which has higher mortality, gram postive or gram negative bacteraemia in patients with febrile neutropenia?", 
                "Gram negative (18%) is higher.<div>Gram positive (5%)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q+4uCT0/48", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the MASCC score in febrile neutropenia? (7)", 
                "<div>Mild or no symptoms: 5 points</div><div>Moderate symptoms: 3 points</div><div>No COPD: 4 points</div><div>Solid tumour OR haem with no prior invasive fungal infection: 4 points</div><div>No dehydration 3 points</div><div>Outpatient: 3 points</div><div>Age &lt; 60: 2 points</div><div><br /></div>Score &gt;21 = can consider outpatient PO antibiotics", 
                ""
            ], 
            "flags": 0, 
            "guid": "l0nk:>}3m)", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of ipilimumab", 
                "anti-CTL4", 
                ""
            ], 
            "flags": 0, 
            "guid": "c1s`Kp7I2G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of pembrolizumab", 
                "PD-1 inhibitor", 
                ""
            ], 
            "flags": 0, 
            "guid": "v}nfc?O31^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are ESBLs?", 
                "Extended spectrum beta-lactamases<div><div>Enzymes that inactivate and confer resistance to most beta-lactam antibiotics, including penicillins and cephalosporins</div><div>Coded for on plasmids, which can be transmitted between bacteria</div><div>Found exclusively in gram-negative organisms, primarily Klebsiella pneumoniae, Klebsiella oxytoca, and Escherichia coli.</div></div><div><br /></div><div>Treat with meropenem or trimethoprim/sulfamethoxazole</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lu%=%nNf}|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How does the quantiferon gold assay work (4)", 
                "Measures host lymphocyte gamma-interferon response to specific antigens for MTB complex<div>Tests reactivity to TB antigens (ESAT6 and CFP10), which are potent antigens that cause T cells to produce interferon gamma</div><div>Control test of reaction mitogen - the mitogen is the 'control' to test if the patient is able to mount a sufficient immune response, and should be positive.</div><div>- an indeterminate result can occur in&nbsp;in immunosuppressed patients who fail to test positive in the mitogen control</div><div><br /></div><div>Specificity 98 - 100%, sensitvity 80 - 85%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "t7HrEY-0B]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>Name 5 risk factors for pneumocystis pneumonia</div>", 
                "HIV<div>Glucocorticoidss, particularly if + another immunosuppressive therapy</div><div>Defect in cell-mediated immunity</div><div>Cancer (haematologic &gt; solid)</div><div>Transplant</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "rbACk1WVK.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of pneumocystis pneumonia in patients without HIV", 
                "<div>Fulminant respiratory failure</div><div>Fever</div><div>Dry cough</div><div><br /></div><div>Typically in an immunosuppressed patient</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ez`F>/oB$Z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the typical radiographic features of pneumocystis pneumonia in patients without HIV", 
                "Diffuse, bilateral, interstital infiltrates<div>Ground glass pattern on CT</div><div><br /></div><div><img src=\"939d75215998468259a6ab7ca34f23_big_gallery.jpeg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dx9~Zx_@H^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe investigations for suspected PJP infection (5)", 
                "<div>CD4 count (if HIV)</div><div>1-3-beta-d-glucan level (elevated in infection)</div><div>CXR and/or CT chest</div><div><br /></div><div>Diagnostic tests:</div>Induced sputum<div>if negative, bronchoscopy with bronchoalveolar lavage</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BE_w&5IbiS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What type of organism is pneumocystis jirovecii?", 
                "An atypical yeast-like fungus", 
                ""
            ], 
            "flags": 0, 
            "guid": "cr5,_K}?2G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 risk factors for PJP in HIV patients", 
                "Not receiving ART<div>CD4 &lt; 200</div><div>CD4 &lt; 14%</div><div>Previous PJP</div><div>Oral thrush</div><div>Recurrent bacterial pneumonia</div><div>Unintentional LOW</div><div>HIgh viral load</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "HnM|#=$v^M", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of PJP in HIV patients", 
                "Indolent onset of fever, cough, dyspnoea over days to weeks", 
                ""
            ], 
            "flags": 0, 
            "guid": "RfCJ_W]|K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment for mild to moderate pneumocystis jiroveci pneumonia (4)", 
                "Trimethoprim/sulfamethoxazole 5/25 mg/kg TDS for 21 days (preferred), or<div>Clindamycin, or</div><div>Dapsone, or</div><div>Atovaquone</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l<6$3Gw]<6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of severe pneumocystis jiroveci pneumonia (4)", 
                "Trimethoprim/sulfamethoxazole 5/25mg/kg IV, 6-8hrly until improved, then switch to orals (preferred)<div>or, if hypersensitive to the above,</div><div>Clindamycin IV</div><div>or</div><div>Pentamidine IV</div><div><br /></div><div>Also, if HIV positve, ADD:</div><div>Prednisolone 40mg BD</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k]Y7,EUe$3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 diagnostic tests for herpes virus infection&nbsp;", 
                "Herpes multiplex PCR<div>Histology showing tissue inclusions (gold standard)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "lM)kjByofx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the diagnostic test of choice in suspected CMV infection?", 
                "CMV viral load", 
                ""
            ], 
            "flags": 0, 
            "guid": "Kk]?`}CgDo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a6ef346cdd714beeba506139f702194c-ao-1", 
                "Hepatitis B", 
                "<img src=\"tmpful3du.png\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-1-A.svg\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "c|{P!<s^dV", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a6ef346cdd714beeba506139f702194c-ao-2", 
                "Hepatitis B", 
                "<img src=\"tmpful3du.png\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-2-A.svg\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "muC*k-{=,|", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a6ef346cdd714beeba506139f702194c-ao-3", 
                "Hepatitis B", 
                "<img src=\"tmpful3du.png\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-3-A.svg\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "eMHxS1CGOY", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a6ef346cdd714beeba506139f702194c-ao-4", 
                "Hepatitis B", 
                "<img src=\"tmpful3du.png\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-4-A.svg\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Fs!xv9xhaN", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a6ef346cdd714beeba506139f702194c-ao-5", 
                "Hepatitis B", 
                "<img src=\"tmpful3du.png\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-5-A.svg\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Jr9Pm.UXt)", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a6ef346cdd714beeba506139f702194c-ao-6", 
                "Hepatitis B", 
                "<img src=\"tmpful3du.png\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-6-A.svg\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "OtA29%i3c]", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a6ef346cdd714beeba506139f702194c-ao-7", 
                "Hepatitis B", 
                "<img src=\"tmpful3du.png\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-7-A.svg\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GV91~y)rpT", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a6ef346cdd714beeba506139f702194c-ao-8", 
                "Hepatitis B", 
                "<img src=\"tmpful3du.png\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-8-A.svg\" />", 
                "<img src=\"a6ef346cdd714beeba506139f702194c-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ESr>?.Bywu", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Which patients undergoing immunosuppressive patients should be screened for hepatitis B? What should be tested?", 
                "All patients<div><br /></div><div>Hep B surface antigen</div><div>Anti-hep B core</div><div><br /></div><div>If the above are positive, complete the remaining serology for hep B</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "CgFM]hb0Xv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of hep B surface antigen positve patients who are about to start immunosuppression", 
                "Antiviral prophylaxis, ideally 1 week before starting therapy<div>Continue for 6-12 months after stopping therapy (if rituximab, at least 12 months)<br /><div><br /></div><div>Tenofovir, or</div><div>Entecavir</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KIX_5sYm66", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of hep B surface antigen negative, hep B core antibody positive patients who are about to start immunosuppression", 
                "Low risk of reactivation, unless rituximab<div><br /></div><div>Either:<br /><div>Use prophylxis (tenofovir or entecavir), or&nbsp;</div><div>Monitor closely and start if anti-HBs level decreases, or hep B surface antigen or HBV DNA become positive</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "s&4He*?*S>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the preferred hep B treatment in pregnancy?", 
                "Tenofovir<div><br /></div><div>Decision of whether to continue or not is expect advice (continue if advanced liver disease)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fE?Q{nY`6q", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe strategies to reduce risk of mother-baby transmission of hepatitis B (2)", 
                "Tenofovir commenced at 30-32 weeks to reduce viral load (if high load)<div>Hep B vaccination and hep B immunoglobulin to the infant within 12 hours of birth<br /><div><br /></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vxlu~ab.u<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe progressive multifocal leukoencephalopathy", 
                "Caused by reactivation of JC virus (John Cunningham virus)<div>Deadly demyelinating disease of the CNS<br /><div>Occurs only in immunosuppression</div><div>Associated with HIV and AIDS, also rarely in lymphoproliferative and myeloproliferative dieases, solid organ malignancy, organ transplant</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D&g*(jN_)H", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of&nbsp;progressive multifocal leukoencephalopathy (5)", 
                "subacute neurologic deficits including&nbsp;<div>- altered mental status</div><div>- visual symptoms such as hemianopia and diplopia</div><div>- hemiparesis or monoparesis</div><div>- appendicular or gait ataxia</div><div>- &nbsp;Seizures (18%)</div><div><br /></div><div>Can be a manifestation of IRIS (i.e. after starting ART for HIV)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sYQklY|q>B", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the imaging findings in progressive multifocal leukoencephalopathy", 
                "Multifocal process limited to the white matter&nbsp;<div>Does not conform to vascular territories&nbsp;</div><div>Exhibits neither mass effect nor contrast enhancement.</div><div><br /></div><div><img src=\"paste-695694507638785.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D+v3yl!d7.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Reactivation of the JC virus results in what disease?", 
                "Progressive multifocal leukoencephalopathy", 
                ""
            ], 
            "flags": 0, 
            "guid": "iLv@A)~s6I", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is progressive multifocal leukoencephalopathy diagnosed?", 
                "Brain biopsy (gold standard) (not always necessary)<div>PCR for JC virus DNA in the CSF</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nHMo/_5C->", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the BK virus and its effects (4)", 
                "A polyomavirus, only causes disease in immunosuppression<div><br /><div><div>Reactivation causes</div><div>- tubulointersitial nephritis (in renal transplant, rarely in other transplants)</div><div>- ureteral stenosis (in renal transplant, rarely in other transplants)</div></div><div>- haemorrhagic cystitis (in allogeneic stem cell transplant)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pi~v^&>p|2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of strongyloides hyperinfection syndrome (2)", 
                "Ivermectin +/- albendazole<div>Reduce immunosuppression if possible</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wkD_uH9t1?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of strongyloides hyperinfection syndrome (5)", 
                "Fever<div>Nausea/vomiting, anorexia, diarrhoea, abdo pain&nbsp;</div><div>Dyspnoea, wheeze, haemoptysis, cough</div><div>CXR showing pulmonary infiltrates with foci of haemorrhage, pneumonitis, and oedema</div><div>Bacteraemia (typically gram negative) due to bloodstream seeding from the GI tract or lungs</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "goKYAQ#83k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is this?<div><img src=\"paste-698632265269249.jpg\" /></div>", 
                "Sputum sample shows stronyloides larvae being attacked by eosinophils", 
                ""
            ], 
            "flags": 0, 
            "guid": "m9M)rixZxh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Toxoplasmosis is typically seen in which patint group? (4)", 
                "<div>Condiutions with T cell deficits:</div><div><br /></div>HIV infection (most common CNS infection in AIDS not on appropriate prophylaxis)<div>Allogeneic haematopoetic cell transplant<br /><div>Heart transplant</div></div><div>Haematological malignancy with profound T cell deficit</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i3cA<R$W`g", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is toxoplasma gondii? (2)", 
                "Causative pathogen in toxoplasmosis<div>Intracellular protozoan parasite</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P^)rG!d*T]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Does toxoplasma gondii cause disease in immunocompetent patients?", 
                "No, typically only immunocompromised get toxoplasmosis<div>If infected, are asymptomatic</div><div>Latent infection can persist for life</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Jk4THEZ&{E", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "At what CD4 count is toxoplasmosis typically seen in HIV patients?", 
                "CD4 &lt; 100", 
                ""
            ], 
            "flags": 0, 
            "guid": "w/#a3[^]f7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the clinical features of cerebral toxoplasmosis", 
                "Toxoplasmic encephalitis.<div>- headache</div><div>- fever</div><div>- neurologic symptoms, confusion - may have focal deficits or seizure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kPcE~BwjMX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 clinical syndromes of extracerebral toxoplasmosis", 
                "Pneumonitis<div>Chorioretinitis</div><div>Disseminated disease with septic shock</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pjd&go`R^(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe pneumonitis seen in toxoplasmosis (4)", 
                "Fever<div>SOB</div><div>Nonproductive cough&nbsp;</div><div>Reticulonodular infiltrates on CXR</div><div><br /></div><div>Can be indistinguishable from PJP<div><br /></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "i-~,CcR+hR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe toxoplasmosis chorioretinitis (3)", 
                "<div>Eye pain</div><div>Decreased visual acuity</div><div>Raised yellow-white cottony lesions in nonvascular distribution (as opposed to CMV which is vascular distribution)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tUe7[/VXja", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>When may a presumptive diagnosis of toxoplasmosis be made? (3)</div>", 
                "Compatible clinical syndrome (e.g. toxoplasmic encephalitis)<div>Positive T gondii IgG antibody</div><div>Brain imaging shows typical appearance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "A]Cml-`rSC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the typical appearance on MRI in toxoplasmosis", 
                "Multiple ring-enhancing lesions<div>Associated oedema</div><div><br /></div><div><img src=\"paste-700586475388929.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mS]}f{VWGI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe investigations for suspected toxoplasmosis (5)", 
                "Serology for T gondii IgG (IgM usually absent)<div>MRI brain</div><div><br /></div><div>Occasionally:</div><div>Lumbar puncture - PCR for T gondii (highly specific, variable sensitivity 50 - 98%)</div><div>Brain biopsy + visualisation of organism</div><div>SPECT (good for lymphoma vs toxo, e.g. single lesion and poor candidate for biopsy)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h||0a/voUj", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do cervical nerve roots emerge above or below the corresponding vertebra (e.g. does C6 nerve root emerge at C5/6 or C6/7)?", 
                "Emerge above<div>e.g. C6 emerges at C5/6</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h}fl<zF,m(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Do thoracic and lumbar nerve roots emerge above or below the corresponding vertebra (e.g. does T6 nerve root emerge at T5/6 or T6/7)?", 
                "Emerge below<div>e.g. T6 emerges at T6/7</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "iQk-Dk&9qZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Where does the spinal cord end?", 
                "L1/2", 
                ""
            ], 
            "flags": 0, 
            "guid": "JN*H|?ODM~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Can lumbar level pathology give upper motor neuron signs?", 
                "No<div>Cord ends at L1-2</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zEI9B%@AB.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the path of the corticospinal tract", 
                "<div>Contain upper motor neurones that original at M1 of the primary motor cortex in the posterior frontal lobe</div><div>Fibres run to the internal capsule, become more closely packed</div><div>Go down through the brainstem</div><div>Decussate at the lower medulla (80 - 85% of fibres decussate and become the lateral corticospinal tract; the remainder do not and are the anterior corticospinal tract)</div><div>Synapse on the anterior horn cells</div><div><br /></div><div>Lateral corticospinal tract contains majority of fibres (80 - 85%)</div><div><br /></div><div><img src=\"paste-704164183146497.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p!t6*5T~`^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The dorsal columns control what sensory modalities (2)", 
                "Joint position<div>Vibration</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "srWz]h)wTw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the path of the dorsal columns", 
                "<div>Input from large sensory fibres in peripheral nerve</div>Enter through the dorsal horn, into the dorsal column ipsilaterally<div>Decussate at the cervicomedullary junction</div><div>Up to the thalamus and into the sensory cortex</div><div><br /></div><div><img src=\"paste-705048946409473.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "N$NmPBSZ-j", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The anterior and lateral spinothalamic tracts carry what three sensory modalities?", 
                "Pain<div>Temperature</div><div>Touch</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kioPdmX8?8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the path of the spinothalamic tract", 
                "Input from small sensory fibres in peripheral nerves<div>Enter through the dorsal root ganglion<br /><div>Decussate almost immediately (within 1-2 segments)</div></div><div>Terminate in the thalamus (and a little to the cortex)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O^KaYGZIWw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8ff6f95822174b37946fdecf76625f13-ao-1", 
                "", 
                "<img src=\"tmpbtmppw.png\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-1-A.svg\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "v2(,w`9Va(", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8ff6f95822174b37946fdecf76625f13-ao-2", 
                "", 
                "<img src=\"tmpbtmppw.png\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-2-A.svg\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "ng#rJ}:bDq", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8ff6f95822174b37946fdecf76625f13-ao-3", 
                "", 
                "<img src=\"tmpbtmppw.png\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-3-A.svg\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "O|_:A[!Ug<", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8ff6f95822174b37946fdecf76625f13-ao-4", 
                "", 
                "<img src=\"tmpbtmppw.png\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-4-A.svg\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "EX76$3#>#/", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8ff6f95822174b37946fdecf76625f13-ao-5", 
                "", 
                "<img src=\"tmpbtmppw.png\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-5-A.svg\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "IcYt#<V]xE", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8ff6f95822174b37946fdecf76625f13-ao-6", 
                "", 
                "<img src=\"tmpbtmppw.png\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-6-A.svg\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "bwD@I=iHrw", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8ff6f95822174b37946fdecf76625f13-ao-7", 
                "", 
                "<img src=\"tmpbtmppw.png\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-7-A.svg\" />", 
                "<img src=\"8ff6f95822174b37946fdecf76625f13-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "B(ZD[SOY`U", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "47491ca45543444fb1b398bbb5eaafe6-ao-1", 
                "", 
                "<img src=\"tmpmrkxyw.png\" />", 
                "<img src=\"47491ca45543444fb1b398bbb5eaafe6-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"47491ca45543444fb1b398bbb5eaafe6-ao-1-A.svg\" />", 
                "<img src=\"47491ca45543444fb1b398bbb5eaafe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "h~@(E{!-f_", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "47491ca45543444fb1b398bbb5eaafe6-ao-2", 
                "", 
                "<img src=\"tmpmrkxyw.png\" />", 
                "<img src=\"47491ca45543444fb1b398bbb5eaafe6-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"47491ca45543444fb1b398bbb5eaafe6-ao-2-A.svg\" />", 
                "<img src=\"47491ca45543444fb1b398bbb5eaafe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "PD:|baMj>b", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "47491ca45543444fb1b398bbb5eaafe6-ao-3", 
                "", 
                "<img src=\"tmpmrkxyw.png\" />", 
                "<img src=\"47491ca45543444fb1b398bbb5eaafe6-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"47491ca45543444fb1b398bbb5eaafe6-ao-3-A.svg\" />", 
                "<img src=\"47491ca45543444fb1b398bbb5eaafe6-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Pza@sAv/|}", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 3 major white matter tracts of clinical importance", 
                "<div>Corticospinal tract</div>Dorsal colum<div>Anterior and lateral spinothalamic tracts</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JCT7^,`:&r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>This is an example of an intramedullary, intradural, or extradural mass of the spinal cord?</div><img src=\"paste-710018223570945.jpg\" />", 
                "Intramedullary (i.e. mass is whithin the spinal cord itself)", 
                ""
            ], 
            "flags": 0, 
            "guid": "w`;)kWcG_J", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "<div>This is an example of an intramedullary, intradural, or extradural mass of the spinal cord?</div><img src=\"paste-710185727295489.jpg\" />", 
                "Extradural mass<div>This is a mass from outside the spinal cord that is pushing on it</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "y+vM1fB}Sq", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "This is an example of an intramedullary, intradural, or extradural mass of the spinal cord?<div><img src=\"paste-711663196045313.jpg\" /></div>", 
                "Intradural mass, e.g. fibroma or meningioma", 
                ""
            ], 
            "flags": 0, 
            "guid": "wAD_i,iowX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 'lamination' of the spinal cord and how is it clincally relevent?", 
                "<div>The lateral tracts (lateral corticospinal tract, lateral spinothalamic tract) have their fibres ordered laterally to medially from lowest (sacral) to highest (cervical)</div><div>This means extrinsic compression will affect the lower levels more, have a vague upper limit of the sensory level</div><div>Intrinsic compression will affect the upper levels more, have a crisp upper limit of involvement and attenuated lower level involvement with sacral sparing</div><div><br /></div><div><img src=\"paste-723706284343297.jpg\" /></div><br /><div><img src=\"paste-711792045064193.jpg\" /></div><div><img src=\"paste-723719169245185.jpg\" /></div><div><img src=\"paste-723852313231361.jpg\" /></div><div><img src=\"paste-723899557871617.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "4Krvx*zV0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the classic cause of a 'central cord pattern' of involvement?", 
                "Syringomyelia -&nbsp;fluid-filled, gliosis-lined cavity within the spinal cord", 
                ""
            ], 
            "flags": 0, 
            "guid": "AF.YmSz&j-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the pattern of involvement in syringomyelia", 
                "Central spinal cord lesion<div>Involves decussating fibres of the spinothalamic tract (so they lesion will cause sensory loss at and above the level of the lesion)</div><div>- sensory loss of only pain and temperature</div><div>- sparing of dorsal column (joint position, vibration)</div><div>May have direct involvement of the anterior horn cells causing lower motor involvement</div><div><br /></div><div><img src=\"paste-729023453855745.jpg\" /></div><div><img src=\"paste-729044928692225.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B27@,;n]I=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Finger jerk reflex corresponds to what level?", 
                "C8", 
                ""
            ], 
            "flags": 0, 
            "guid": "K>|B+#JnR;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Triceps jerk reflex corresponds to what level?", 
                "C7", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q^019@puJ4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is brown-seqard syndrome?", 
                "Also called hemi-cord syndrome<div>Unilateral involvement of the dorsal column, corticospinal tract, and spinothalamic tract</div><div>Weakness, loss of vibration, and loss of proprioception on ipsilateral side below the level of the lesion</div><div>Loss of pain and temperature on the opposite side below the level of the lesion (the spinothalamic tract, because it decussates almost immediately)</div><div><br /></div><div>Causes include knife/bullet wounds, demyelination.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M{.%YFl[6Z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Most spinal cord blood supply within the cord is provided by?", 
                "Anterior spinal artery<div>However the posterior columns (including the dorsal column) are supplied by the posterior spinal arteries)<br /><div><div><br /></div><div><img src=\"paste-744889063047169.jpg\" /></div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sosm8ix8I3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What clincal picture would you expect with occlusion of the anterior spinal artery?", 
                "Dense paraplegia involving motor (corticospinal) and spinothalamic tracts, as these are supplied by the anterior spinal artery<div>May spare the posterior columns (including the dorsal column), as supply is by the posterior spinal arteries</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Jn7k2K_w23", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe subactue combined degeneration of the cord", 
                "<div>Caused by pernicious anaemia with B12 deficiency</div><div>&nbsp;- Similar picture rarely caused by copper deficiency, viamint E deficiency, nitrous oxide intoxication</div><div>Degeneration of dorsal and lateral white matter (dorsal column, corticospinal tract)</div><div>Results in slowly progressive weakness, sensory ataxia, and paraesthesia</div><div>Ultimately results in spasticity, paraplegia, incontinence</div><div>Not all patients have anaemia or macrocytosis</div><div>B12 supplementation halts or reverses progression</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "opjTOgXN7p", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 causes of neoplasia in the intradural/extramedullary space of the spine", 
                "Meningeal metastases (e.g. leptomeningeal disease)<div>Neurofibroma</div><div>Meningioma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pr)z6C3q,<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 clinical presentations of meningeal cancer", 
                "Encephalopathy<div>Multifocal lesions, randomly scattered, with focal neurological signs (nerve roots, cranial nerves, spinal cord)</div><div>e.g. right L5 nerve root syndrome, left C7 nerve root syndrome, a numb chin on the left and deafness on the right</div><div><br /></div><div><img src=\"paste-752224867188737.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Adh>C$L(!V", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common cause of acute myelopathy?", 
                "Demyelination", 
                ""
            ], 
            "flags": 0, 
            "guid": "vHqs|l!Ql`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 causes of acute myelopathy", 
                "Demyelination (most common)<div>Infection</div><div>Inflammatory process</div><div>Vascular</div><div>Neoplastic/paraneoplastic</div><div>Compression/surgical</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k@VY7va8g~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the diagnostic criteria for idiopathic transverse myelitis (5)", 
                "Bilateral, not not necessarily symmetric, sensorimotor and autonomic spinal cord dysfunction<div>Clearly defined sensory level</div><div>Progression to nadir of deficits between 4hrs and 21 days from onset</div><div>Demonstraction of spinal cord inflammation (CSF pleocytosis or elevated IgG indec, or MRI shows gadolinium enhancing cord lesion)</div><div>Exclusion of compressive, post-RT, neoplastic, vascular causes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "I{2af.o<$P", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe transverse myelitis (6)", 
                "Segmental spinal cord injury caused by acute inflammation<div>Usually idiopathic, presumed autoimmune</div><div>50% have preceding infection</div><div>Can be presenting event in multiple sclerosis</div><div>Can be part of the presentatin of neuromyelitis optica</div><div>Associated with connective tissue disease</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H25D2qG[lg", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the clinical features of transverse myelitis", 
                "Inflammation in 1-2 spinal cord segments, usually in the thoraic cord<div>Symptoms develop rapidly over hours (though can be slowly over weeks)</div><div>Bilateral weakness and multimodality sensory disturbance below level of the lesion</div><div>May have pain or tingling, also tight banding/girdle-like sensation around the trunk</div><div>May have autonomic dysfunction (bowel and bladder)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vPA^1AR[~=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the expected investigation results in transverse myelitis (2)", 
                "MRI: Gadolinium-enhancing signal abnormality, usually extending over one or more cord segments. The cord often appears swollen at these levels.&nbsp;<div>CSF:&nbsp;abnormal in 50%; elevated protein (usually 100 to 120 mg/100 mL) and moderate lymphocytosis (usually &lt;100/mm3). Glucose levels are normal.&nbsp;Oligoclonal bands are usually not present in isolated TM, and when present suggest a higher risk of subsequent MS</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "t)#;*6.1Cs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the expected prognosis in transverse myelitis?", 
                "Recovery begins after 1 - 3 months<div>40% have persistent deficit</div><div>Recurrence is rare</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Rc=Yi^>JMh", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of transverse myelitis", 
                "Corticosteroids or other immunosuppression, though minimal evidence that it works", 
                ""
            ], 
            "flags": 0, 
            "guid": "e?2SjY{65T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of dural arteriovenous fistula (4)", 
                "Typically presents with gradual progressive myelopathy, sometimes stepwise<div>Symptoms may fluctuate but eventually permanent and progressive paraparesis and sensory disturbance with sphincter dysfunction occurs<br /><div>Age &gt;50-60</div><div>More common in men</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "J{}8rr}h:*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe epidural abscess (6)", 
                "Infection via continutous spread from skin/soft tissue, post surgery, or via haematogenous spread<div>Risk factors: HIV, diabetes, IVDU, ETOH</div><div>Staph aureus most common pathogen (66%)</div><div>Classic triad of pain, fever, and neurological deficit, however neuro deficit is a very late sign</div><div>MRI is highly sensitive</div><div>Treatment is surgical drainage and IV antibiotics (genamicin and flucloxacillin)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "b/(Q_1-U&K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-1", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-1-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "v_!dv5whN", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-2", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-2-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Rbjlb=8Sr/", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-3", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-3-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "jx<tr|;MQ8", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-4", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-4-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "uvR+0-Qd!^", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-5", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-5-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Al3RebPESz", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-6", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-6-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Na?HbywV(Q", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-7", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-7-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "l6v]sH+MUV", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-8", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-8-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "w5lQ7]:~_)", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-9", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-9-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Kk[1e:^]e.", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-10", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-10-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "r1BhO-rVT[", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-11", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-11-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "KLC(,@C}C(", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-12", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-12-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-12-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "d:GxZ(ZUNb", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-13", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-13-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-13-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "m+THQz~i2*", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-14", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-14-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-14-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "bVT^z^_~sS", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-15", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-15-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-15-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "x[q%I1zD3.", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-16", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-16-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-16-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "IBL}VGX?XG", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-17", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-17-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-17-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "D)%v<lTEe:", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-18", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-18-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-18-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "o=d]F,EPD:", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "8d4d2f247cc0446abc16fbcf15ced780-ao-19", 
                "", 
                "<img src=\"tmp1c9ml9.png\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-19-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-19-A.svg\" />", 
                "<img src=\"8d4d2f247cc0446abc16fbcf15ced780-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GQu0H8R!O%", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 differential diagnoses for apparent C5 or C6 radiculopathy", 
                "Neuralgic amyotrophy<div>Suprascapular nerve palsy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "DC:7v`2vc2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 differential diagnoses for apparent C7 radiculopathy", 
                "Radial nerve palsy (Saturday night palsy)", 
                ""
            ], 
            "flags": 0, 
            "guid": "nT@rx}jUwZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 differential diagnoses for apparent C8 or T1 radiculopathy", 
                "Lower brachal plexus problem (radiation plexopathy, neoplastic infiltration)<div>Ulnar nerve palsy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kQrq;g?>k}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 differential diagnoses for apparent L2, L3, or L4 radiculopathy", 
                "Femoral nerve palsy<div>Lumbar plexopathy</div><div>Psoas haematoma (cannot bear to straighten the leg due to pain)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pj3a5`w_-|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 differential diagnoses for apparent L5 adiculopathy", 
                "Common peroneal nerve palsy&nbsp;<div>- inversion of the foot may be supplied by L5 root but not the common peroneal nerve</div><div>- hip abduction is supplied by L5 but never by the common peroneal nerve (weak hip abduction will be L5 root)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AB1ua8WD]u", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 differential diagnoses for apparent S1 radiculopathy", 
                "Sciatic nerve palsy", 
                ""
            ], 
            "flags": 0, 
            "guid": "jl,jV-tp89", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the most common cause of foot drop after hip replacement under spinal anaesthetic?", 
                "Stretch or injury of sciatic nerve due to hip joint manipulation<div>- not due to anaesthetics messing up the L5 nerve root during the spinal anaesthetic</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fhJh-=^#0;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe motor neuron disease, and its 3 subtypes", 
                "Progressive degenerative condition involving both upper and lower motor neurons<div>Subtypes include</div><div>- amyotrophic lateral sclerosis (most common)</div><div>- primary lateral sclerosis (3 - 4%)</div><div>- progressive musclar atrophy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d;[Vv,([.@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe amyotrophic lateral sclerosis (5)", 
                "The most common form of motor neuron disease<div>Clinical hallmark is combination of upper motor and lower motor neuron signs and symptoms<br /><div>Presentations include&nbsp;asymmetric limb weakness (80%) or&nbsp;bulbar onset (20%)</div><div>- bulbar onset worse prognosis</div><div>Associated frontotemporal dementia in 10 - 15%</div><div>Autonomic symptoms, parkinsonism, supranuclear gaze paresis, and/or sensory loss can occur</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "yvbC.m+WDD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the natural history of amyotrophic lateral scerosis (subtype of motor neuron disease) (2)", 
                "<div><div>Highly variable presentation and disease course between patients</div></div><div>Relentlessly progressive linear course, eventually resulting in neuromusclar respiratory failure and dysphagia which cause death</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sErAJ}&F^;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe primary lateral sclerosis (5)", 
                "A less common type of motor neuron disease (2 - 4% cases)<div>Progressive isolated upper motor neuron disorder</div><div>Slower progression than amyotrophic lateral sclerosis, with lack of weight loss, and absence of lower motor neuron findings in first 4 years</div><div>Most eventually develop lower motor signs, at which point it is called upper motor neuron onset ALS</div><div>Longer survival than ALS</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Cv6T]rR>Sk", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe progressive muscular atrophy (3)", 
                "Type of motor neuron disease<div>Progressive lower motor neuron disorder</div><div>Many eventually develop upper motor neuron signs later in the disease course (at which point it is called lower motor neuron onset ALS)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "eAWte77w7u", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the diagnostic criteria for motor neuron disease (3)", 
                "Evidence of lower motor neuron degeneration on clinical, electrophysiological, or neuropathological examiantion<div>Evidence of upper motor neuron degeneration by clinical examination</div><div><br /></div><div>The above in &gt;4 regions.</div><div><br /></div><div>And:</div><div>Progressive spread to symptoms or signs within a region or to other regions</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gjO(tIZQ7r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the investigations for suspected motor neuron disease (4)", 
                "History and examination<div>Electrodiagnostic studies (electromyography and nerve conduction)</div><div>MRI to exclude other causes (normal in ALS)</div><div>CSF if suspicion for chronic inflammatory demyelinating polyneuropathy, HIV, lymphoma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h^L8OP9/8w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the expected nerve conduction findings in motor neuron disease", 
                "<div>Nerve conduction usually normal, may have reduced compound muscle action potential amplitudes if severe</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mN;j&[(mdo", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the expected electromyography findings in motor neuron disease (3)", 
                "<div>Features of acute and chronic denervation and reinnervation:</div><div>- Acute denervation findings: fibrillations, positive sharp waves</div><div>- Chronic denervation and reinnervation findings: large-amplitude, long-duration, complex motor unit action potentials (MUAPs) with neurogenic recruitment and a reduced interference pattern.</div><div><br /></div><div>Fasciculation potentials may also appear in denervated muscle and represent spontaneous firing of motor units that are not voluntarily recruited. Fasciculations may be visible to the naked eye when they occur on the surface of muscles</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "g,7RBWMc}6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the examination findings in motor neuron disease, including relevent negatives (7)", 
                "<div>Multifocal distribution</div><div>Mixed upper and lower motor neuron signs in the same area</div><div>- e.g. a wasted arm with hyperreflexia</div><div><div>Wasting and fasciculation of the tongue (if bulbar)</div>Wasting of the side of the thumb and the index finger more than the little finger (split hand sign)</div><div>No sensory symptoms</div><div>No eye movement involvement</div><div>No bladder/bowel involvement</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K%M5JKd7jC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the pathological findings in motor neuron disease with frontotemporal dementia (2)", 
                "Neuronal loss in brainstem nuclei and anterior horns of psinal cord<div>Ubiquitin-positive inclusions</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B{Q6YH%to5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of motor neuron disease patients have a familial syndrome? What is the most common mutation?", 
                "5%<div>C9orf72 (24% of mutations)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "L0;o*Wz=2z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Neurology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of polyenes", 
                "A type of antifungal<div>Create pores in the fungus cell membrane</div><div>e.g. amphotericin B, nystatin&nbsp;</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "GfN#L`U^d3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 toxicities of amphotericin B", 
                "Nephrotoxicity<div>Infusion reaction (fevers, hypotension, bronchospasm, myalgia, nausea/vomiting, tachycardia)</div><div><br /></div><div>These can be dose-limiting toxicities.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h$kLRhM>Ze", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 uses of amphotericin B", 
                "<div>Selected cases of invasive candidiasis</div><div>Cryptococcal meningitis in HIV</div><div>Empiric therapy, selected cases</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Lb)A!eQpO|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 polyenes", 
                "A type of antifungal that targets the cell wall membrane<div><div>Amphotericin B, nystatin (older formations)</div><div>Liposomal amphotericin (ambisome), amphotericin B lipid complex (abelcet) (newer formations)</div></div><div><br /></div><div>Amphotericin B is rarely used due to toxicity; the newer formulations are used instead.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ql5#Q[Pyv&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of mucormycosis", 
                "Urgent surgical debridement<div>Liposomal amphotericin B, IV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kOfs2Q|8sR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 agents that would be a good choice for presumed invasive fungal infection as empiric therapy", 
                "Liposomal amphotericin B - 1st line<div>Voriconazole - 2nd line</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "mL4lU#~8x_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of invasive pulmonary aspergillosis, in patients with no neutropenia and mild disease.", 
                "Voriconazole PO, or<div>Itraconazole PO</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "vgFmhc^q&|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of invasive pulmonary aspergillosis (2)", 
                "Voriconazole IV (preferred), or<div>Amphotericin B liposomal IV</div><div><br /></div><div>Avoid using the same agent that was used for prophylaxis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "u+Fz^]J}1K", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of mild to moderate cryptococcal pneumonia caused by C neoformans in immunocompetent patients, who do not have meningitis", 
                "Fluconazole IV or PO for first dose, then PO for 6 - 12 months", 
                ""
            ], 
            "flags": 0, 
            "guid": "gs@VC_$).A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of cryptococcal pneumonia caused by C neoformans in immunocompromised patients, or those with severe infection", 
                "Amphotericin B + flycytosine for 2 weeks<div>Then fluconazole maintenance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Clzp%H?.L_", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of cryptococcal pneumonia caused by C Gatii", 
                "Amphotericin B (desoxycholate, liposomal, or lipid complex) IV<div>PLUS</div><div>Flucytosine IV</div><div><br /></div><div>After 2 weeks, switch to PO fluconazole for 6 &nbsp;- 12 months</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "fUyf]-$|m{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe fusariosis (8)", 
                "Infection with fusarium species<div>Most common invasive species is fusarium solani<br /><div>Locally invasive or disseminated infection in immunocompromised&nbsp;</div><div>Supsect when:</div><div>- persistent fever refractory to antibiotics and antifungals in setting of prolonged neutropenia</div><div>- positive fungal blood culture</div><div>- presence of skin involvement (cellulitis, interdigital intertrigo, onychomycosis, metastatic lesions)</div><div>Diagnose by isolating the fungus in secretions, blood, or skin scrapings</div><div>Treat with liposomal amphotericin B if invasive disease</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "wjU^i_xIY7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of cryptococcal meningitis", 
                "Subacute onset of headache, fever, altered mental state<div><div>May have cerebral mass lesions (cryptococcomas)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xG4-1WZ~j>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 species implicated in cryptococcal meningitis", 
                "Cryptococcus gatii (typically in immunocompetent)<div>cryptococcus neoformans (typically in immunocompromised)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jhra+L^cj=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe investigations for suspected cryptococcal meningitis (4)", 
                "<div>CT or MRI to look for raised ICP or space-occupying lesion (cryptococcoma)</div>CSF: low WCC (&lt;50cells/microL) with mononuclear predominance, slightly elevated protein, low glucose (may be completely normal, 25 - 30%)<div>CSF culture of organism (takes 3- 5 days)<div>Positive cryptococcal polysaccharide in serum or CSF (much faster than culture, strongly suggests the diagnosis)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P#0$~3N}Dm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Cryptococcal meningitis in non-HIV infected immunocompromised patients is usually caused by what organism?", 
                "C gattii", 
                ""
            ], 
            "flags": 0, 
            "guid": "jG%Ds%eDcr", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Cryptococcal meningitis in HIV infected immunocompromised patients is usually caused by what organism?", 
                "C. neoformans<div>Can also be C. Gattii</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AORWo1<JaW", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the induction therapy management of cryptococcal meningitis in non-HIV infected immunocompromised patients, and immunocompetent patients", 
                "Amphotericin B (desoxycholate, liposomal, or lipid complex) IV<div>PLUS</div><div>Flucytosine IV</div><div><br /></div><div>Continue for at least 2 weeks, then repeat lumbar puncture to check for viable cryptococci to assess for ongoing need for induction therapy</div><div>Need at least 2 weeks induction for C neoformans, 4 - 6 weeks for C gattii</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "h1GaYPM}`1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe consolidation therapy management of cryptococcal meningitis in non-HIV infected immunocompromised patients, and immunocompetent patients", 
                "PO fluconazole for at least 8 weeks", 
                ""
            ], 
            "flags": 0, 
            "guid": "{JgK]$Aht", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe eradication therapy management of cryptococcal meningitis in non-HIV infected immunocompromised patients, and immunocompetent patients", 
                "Fluconazole PO daily for 6 - 12 months", 
                ""
            ], 
            "flags": 0, 
            "guid": "FV48@^aMIX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe induction therapy management of cryptococcal meningitis in HIV infected immunocompromised patients", 
                "Amphotericin B (desoxycholate, liposomal, or lipid complex) IV<div>PLUS</div><div>Flucytosine IV</div><div><br /></div><div>For at least 2 weeks</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "l3(oLN;D;1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe consolidation therapy management of cryptococcal meningitis in HIV infected immunocompromised patients", 
                "Fluconazole 400mg PO daily for 8 weeks", 
                ""
            ], 
            "flags": 0, 
            "guid": "D1}G~Cw8&r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe maintenance therapy management of cryptococcal meningitis in HIV infected immunocompromised patients", 
                "Fluconazole 200mg daily for at least 1 year, and until CD4 &gt; 100 for 3 months or longer", 
                ""
            ], 
            "flags": 0, 
            "guid": "k]+m!,&N0a", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of triazole antifungals (fluconazole, itraconazole, etc)", 
                "Impact on endoplasmic reticulum of the fungus - inhibit C12alpha demethylase<div>This is required for ergosterol synthesis to make the cell membrane</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "IXi}o)=i8a", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the spectrum of activity of voriconazole (4)", 
                "Fluconazole resistant candida<div>Many moulds, including aspergillus, fusarium, scedosporium apiospermum</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M&{Q2dRDT(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Voriconazole has what effect on CYP?", 
                "CYP inhibitor", 
                ""
            ], 
            "flags": 0, 
            "guid": "dU/9CTTCX9", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe toxicities or voriconazole (5)", 
                "<div>Elevated LFTs (30%)</div><div>Rash (19%)</div><div>Transient visual disturbance</div><div>Worsening of CKD (cannot use CrCl &lt; 50)</div><div>Lung SCC in lung transplant patients</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "f6*y|pbV-v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is 1st line therapy for suspected or definite invasive aspergillosis?", 
                "Voriconazole IV", 
                ""
            ], 
            "flags": 0, 
            "guid": "DOlNvfq!,8", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of oesophageal candidiasis (2)", 
                "Asymptomatic and not immunocompromised: nystatin<div>All other patients: fluconazole</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "oT(4]l;1kx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 5 indications for prophylaxis against mould infection (aspergillus, scedosporium)", 
                "<div>higher-risk allogeneic HSCT</div><div>–<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>pre-engraftment—neutropenia expected to last for more than 14 days, or previous Aspergillus infection or colonisation</div><div>–<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>post-engraftment—severe graft-versus-host disease (GVHD)</div><div>acute myeloid leukaemia—high-intensity chemotherapy</div><div>acute lymphocytic leukaemia—high-intensity chemotherapy</div><div>lung and heart–lung transplantation—post-transplantation airway colonisation with Aspergillus</div><div>liver transplantation—some high-risk patients</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "NIrmOpaK`A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe prophylaxis against mould infection (aspergillus, scedosporium)", 
                "<div>posaconazole liquid 200 mg orally with fatty food or an acidic beverage, 8-hourly [Note 8] [Note 9]</div><div>OR</div><div>voriconazole 200 mg orally, 12-hourly</div><div>OR</div><div>itraconazole liquid 2.5 mg/kg orally, 12-hourly</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "jcAihImZ&<", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the indications for prophylaxis against yeast infection (candida) (5)", 
                "<div>allogeneic HSCT—neutropenia expected to last for less than 14 days</div><div>autologous HSCT—chemotherapy associated with mucositis</div><div>acute myeloid leukaemia—less intensive chemotherapy</div><div>lymphoma—high-intensity chemotherapy</div><div>liver transplantation—some high-risk patients (criteria vary between centres, and some centres use mould prophylaxis instead).</div><div><br /></div><div>Patients who are already taking prophylaxis against mould infection do not need yeast prophylaxis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "P;A7WSinDx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe prophylaxis against yeast infection (candida)", 
                "Fluconazole 400mg PO daily", 
                ""
            ], 
            "flags": 0, 
            "guid": "IE?0[EdC(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe prophylaxis against herpes simplex virus", 
                "<div>aciclovir 400 mg orally, 12-hourly</div><div>OR</div><div>valaciclovir 500 mg orally, daily (12-hourly in highly immunosuppressed patients)</div><div>OR (if unable to tolerate oral therapy)</div><div>aciclovir 5 mg/kg IV, 8-hourly.</div><div><br /></div><div>Not required if already on prophylaxis for CMV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x([iB`}8Z(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe prophylaxis for varicella zoster virus", 
                "<div>aciclovir 800 mg orally, 12-hourly</div><div>OR</div><div>valaciclovir 500 mg orally, 12-hourly</div><div>OR (if unable to tolerate oral therapy)</div><div>aciclovir 5 mg/kg IV, 8-hourly.</div><div><br /></div><div>Not required if already taking CMV prophylaxis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "hn%]cHaak0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe universal prophylaxis, and pre-emptive treatment, for CMV", 
                "Valganciclovir 900mg PO daily<div><br /></div><div>If active graft vs host disease of the gut, or severe diarrhoea, use</div><div>Ganciclovir IV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d{uLazZyBI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of echinocandins (caspofungin, micafungin)", 
                "inhibit beta 1,3-d-glucan synthesis inhibitors, thereby inhibiting fungal cell wall synthesis", 
                ""
            ], 
            "flags": 0, 
            "guid": "v`>YEYnfC`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the spectrum of activity of&nbsp;echinocandins (caspofungin, micafungin)", 
                "<div>Very narrow spectrum:</div>Fungostatic against aspergillus<div>Fungocidal against candida</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "IER<1X5Px!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 antifungal class that may be used for severe invasive candida infection or candidaemia", 
                "Echinocandins: anidulafungin, caspofungin and micafungin (because fungocidal)", 
                ""
            ], 
            "flags": 0, 
            "guid": "iw?j>X3!{k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 antifungals that require drug level monitoring", 
                "Voriconazole<div>Posaconazole</div><div><br /></div><div>Improves response/treatment success, reduces toxicity</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KV@-ca<GQ5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "How is mycobacterium tubercolosis transmitted?", 
                "1-5 micrometer airborne particles<div>Low infectious dose (1-10 organisms)</div><div>Prolonged close contact in poorly ventilated surrounds results in transmission</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ciQ_tvb|MJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the natural history of mycobacterium TB infection", 
                "Exposure (20-30% of close contacts infected) --&gt;<div>Latent TB infection --&gt;</div><div>10% at some point reactivate, usually in setting of precipitating factors (HIV, immunosuppression, low body weight, diabetes, renal impairment, smoking, etc)</div><div><br /></div><div><img src=\"paste-36704790511617.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zh(M#jm7SF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the impact of HIV infection of mycobacterium TB infection, in terms of risk of reactivation?", 
                "Drastically increased risk of reactivation<div>Instead of lifetime risk of 10%, becomes 10% per year</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "dbl~_q3KeX", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Control of replication and establishing latent infection in mycobacterium TB (as opposed to active infection) is mediated by what factors?", 
                "T cell immunity<div>Interferon gamma</div><div>TNF alpha</div><div><br /></div><div>Hence anti-TNF, things that interfere with interferon gamma, greatly increase risk of reactivation</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "K/6s;uxPSF", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the role of quantiferon gold in TB diagnosis and management", 
                "<div>NOT recommended for diagnosing active TB</div><div>Can tell if exposed to TB or not; cannot differentiate between active and latent infection</div><div>Cannot be used to determine if successful treatment (remains positive for life)</div><div>Negative result does not rule out TB</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "El;m]mS-/W", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the classical presentation of TB", 
                "Subacute presentation (&gt;3 weeks) of cough and sputum<div>Haemoptysis<br /><div>Fever, night sweats, weight loss</div><div>Pleuritic pain</div><div>Upper lobe predominance, presence of cavitation or pleural effusion</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M`ANs.W9%2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the non-pulmonary manifestations of TB (6)", 
                "<div>Tuberculous lymphadenitis (30%), most commonly cervical - diagnosis with biopsy/aspirate</div><div>Bone/joint (particularly spinal) TB with chronic unrelenting back pain - need biopsy</div><div>Genitourinary TB -- sterile pyuria, need early morning urine mycobacterial culture</div><div>Chronic epididymo-orchitis</div><div>Pelvic TB in women with infertility and chronic pain</div><div>CNS TB with meningitis, tuberculoma</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "d(Lw#>109N", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe tuberculosis meningitis", 
                "1% of TB<div>Peak incidence in children &lt;4 and immunosuppressed adults</div><div>1 week to 1 month of symptoms - fever, meningism, culminating in focal neurology and seizures</div><div>May or may not have pulmonary involvement</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "q@jTJH>7N0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe investigations for tuberculosis meningitis", 
                "<div>CSF: lymphocytic pleocytosis, low glucose (ddx for this: cryptococcal meningitis)</div><div>MRI: basal meningitis</div><div>AFB and TB-PCR have poor sensitivity (20 - 50%), often treat as culture negative</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w$xuB>b8n(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of tuberculosis meningitis", 
                "<div>Isoniazid</div><div>Rifampicin</div>Moxifloxacin (rather than ethambutol - better CNS penetration)<div>Pyrazinamide<br /><div>Dexamethasone for 6 - 8 weeks</div></div><div><br /></div><div>9 - 12 months total treatment</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "nbi7ZwvVd-", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 diagnostic tests for TB", 
                "PCR (rapid)<div>Acid fast bacilli</div><div>Culture (takes 2 - 6 weeks, antibiotic sensitivities take 8 weeks)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sYZC<vj[zJ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the standard short course treatment of TB", 
                "<div>Isoniazid</div><div>PLUS</div><div>rifampicin</div><div>PLUS</div><div>ethambutol&nbsp;</div><div>PLUS</div><div>pyrazinamide</div><div><br /></div><div>All four agents for 2 months (initial phase), then isoniazid and rifampicin for further 4 months (continuation phase) (total 6 months)</div><div><br /></div><div>98% cure</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "gu?7Nyr{vP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe 3 toxicities of isoniazid", 
                "Hepatitis<div>Rash&nbsp;</div><div>Neuropathy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JN(;@dw1>V", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe 2 toxicities of rifampicin", 
                "Drug interactions<div>Hepatitis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kK~_cmXwtP", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe 3 toxicities of pyrazinamide", 
                "Hepatitis<div>Rash<br /><div>Gout, joint pain</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kUkWksv7,;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe 1 toxicity of ethambutol", 
                "Optic neuropathy", 
                ""
            ], 
            "flags": 0, 
            "guid": "lv]taqKj}v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of TB therapy patients will develop hepatitis as a drug toxicity, and which agents are to blame?", 
                "5%<div>Pyrazinamide &gt; isoniazid &gt; rifampicin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "5u_8O.fpY", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the management of TB therapy induced hepatitis", 
                "If ALT 2 - 5x ULN and asymptomatic - monitor<div>If &gt;5x ULN or symptoms, cease all therapy</div><div>- if can't interrupt, use ethambutol, moxiflocacin, amikacin</div><div>Restart once ALT &lt; 2x ULT</div><div>- restart ethambutol + rifampicin, then isoniazid. If tolerated, it was probably the pyrazinamide; do not restart this, and extend therapy to 9 months instead.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "x8e6V#/lHN", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is primary drug resistance in TB?", 
                "Infection with a drug resistent strain of TB", 
                ""
            ], 
            "flags": 0, 
            "guid": "uqbd<0KK?k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is secondary drug resistance in TB?", 
                "Development of resistance in an initially susceptible strain", 
                ""
            ], 
            "flags": 0, 
            "guid": "l%Scg;@g,n", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the commonest mono-drug resistance in TB?", 
                "Isoniazid (4.6% in australia)", 
                ""
            ], 
            "flags": 0, 
            "guid": "!@Q$x?x:(", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Why do we use combination therapy in TB?", 
                "Large number of TB bacteria (10<sup>9</sup> - 10<sup>10</sup> bacteria), because of this at least a few will be resistant to any given drug due to spontaneous mutation<div>- isoniazid, 1 in 10<sup>6</sup></div><div>- rifampicin, 1 in 10<sup>8</sup><br /><div>However chance of spontaneous mutation to more than one drug is highly unlikely</div><div>Use multiple drugs to kill off the resistant clones (may be resistant to one drug, but will not be to the other)</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "H:|VxkMZ[`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of isoniazid-resistant TB", 
                "Rifampicin, pyrazinamide, ethambutol for 6 - 9 months", 
                ""
            ], 
            "flags": 0, 
            "guid": "Kq9|4IaEa0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the treatment of pyrazinamide resistant TB", 
                "Isoniazid + rifampicin for 9 months", 
                ""
            ], 
            "flags": 0, 
            "guid": "tJpM}W={Q|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define multi-drug resistant TB", 
                "Resistance to isoniazid and rifampicin (+/- other resistance)<div>1.7% of Australian cases</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JMb!L6,h.;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Define extensively drug resistant TB", 
                "Resistance to rifapicin AND isoniazid AND quinolones AND at least one injectable (amikacin, kanamycin, or capreomycin)<div>Morality &gt;20%</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ke4s>INW-.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 risk factors for multi drug resistant TB", 
                "Previous TB treatment<div>-&nbsp;60 - 70% have no history of prior treatment</div><div>Contact with multi drug resistant TB or residence in a 'hot zone'</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "j{aK*jXu):", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how testing for multi drug resistant TB is performed", 
                "Rapid drug resistance detection: genotypic detection of rifampicin by analysis of rifampicin resistance determining region, rpoB, via PCR (GeneXpert)<div>- Can detect TB, and also if resistant</div><div>- Sensitivity 98% if smear positive, 75% if smear negative (improve to 90% with 3 sputums)<br /><div>Rifampicin resistance is highly predictive of multi-drug resistant TB</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BkE=&9~:dm", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the test of choice for rapid diagnosis of TB in HIV positive patients?", 
                "GeneXpert (cartridge-based PCR for rpoB)<div>30% more sensitive than smear in HIV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "D#}ABg3y5|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the Bangladeshi regimen management of multi drug resistant TB", 
                "<div>4 months: Isoniazid (double dose) + moxifloxacin + pyrazinamide + ethambutol + amikacin + prothionamide + clofazimine</div><div>5 - 8 months: pyrazinamide, ethambutol, moxiflocaxin</div><div><br /></div><div>Success 80 - 90%</div><div>Cannot use in pregnancy, extrapulmonary TB</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O&X0_%nd;y", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe treatment of multi drug resistant TB", 
                "<div>Aim for 5 drugs, at least 12 months treatment</div><div><br /></div>An injectable (amikacin or capreomycin)<div>A fluoroquinolone (moxiflocacin)</div><div>Two drugs from group C (linezolid, clofazimine)</div><div>Then one from group D1, D2, or D3</div><div><br /></div><div>Consider surgical resection in selected cases</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "m33.,w,<PR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of TB in HIV patients with CD4 &lt; 200", 
                "Cavitation rare<div>Atypical CXR<br /><div>Smear negative more common</div><div>Extrapulmonary more common (40 - 80%)</div><div>- nodes</div><div>- miliary</div><div>- meningitis</div><div>- dissemination, bacteraemia</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "AwmxilkdU1", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the presentation of TB in HIV patients with CD4 count &gt; 200", 
                "Same as non-HIV patients", 
                ""
            ], 
            "flags": 0, 
            "guid": "ze@QVR@;1*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the drug interactions between rifampicin and HIV antiretrovirals (5)", 
                "<div>Do not use</div>Tenofovir alafenamide + rifampicin (old tenofovir, tenofovir disoproxil is OK)<div>Protease inhibitors + rifampicin</div><div>Elvitegravir/corbicistat + rifampicin</div><div>Bictegraivir + rifampicin</div><div><br /></div><div>Change dose</div><div>Double dose of raltegravir or dolutegravir if + rifampicin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "k|kqW>!F}.", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe a regimen that can be used to treat HIV in the setting of TB co-infection on standard TB therapy", 
                "Truvada (emtricitabine + tenofovir disoproxil)<div>AND</div><div>Double dose raltegravir or dolutegravir</div><div><br /></div><div>Once stopped TB therapy, wait 1 month then go back to normal therapy</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "v//&6+4{X?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What percentage of TB/HIV co-infected patients will get IRIS when they start antiretrovirals?", 
                "10 - 40%", 
                ""
            ], 
            "flags": 0, 
            "guid": "w=bkL(L|W3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "43af36f4a8a64c28a38d673fb8dab9e3-oa-1", 
                "", 
                "<img src=\"tmp4uludv.png\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-1-A.svg\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "K{=Hs=q$_O", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "43af36f4a8a64c28a38d673fb8dab9e3-oa-2", 
                "", 
                "<img src=\"tmp4uludv.png\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-2-A.svg\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "dld{ofs%96", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "43af36f4a8a64c28a38d673fb8dab9e3-oa-3", 
                "", 
                "<img src=\"tmp4uludv.png\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-3-A.svg\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "6j+na!fR@", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "43af36f4a8a64c28a38d673fb8dab9e3-oa-4", 
                "", 
                "<img src=\"tmp4uludv.png\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-4-A.svg\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "N8gcDfHi#9", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "43af36f4a8a64c28a38d673fb8dab9e3-oa-5", 
                "", 
                "<img src=\"tmp4uludv.png\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-5-A.svg\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "K,^v]4y*9(", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "43af36f4a8a64c28a38d673fb8dab9e3-oa-6", 
                "", 
                "<img src=\"tmp4uludv.png\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-6-A.svg\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "D+`;yoeiO#", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "43af36f4a8a64c28a38d673fb8dab9e3-oa-7", 
                "", 
                "<img src=\"tmp4uludv.png\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-7-A.svg\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "M{O3Ry9>Z0", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "43af36f4a8a64c28a38d673fb8dab9e3-oa-8", 
                "", 
                "<img src=\"tmp4uludv.png\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-8-A.svg\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "l)yJyYfUEX", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "43af36f4a8a64c28a38d673fb8dab9e3-oa-9", 
                "", 
                "<img src=\"tmp4uludv.png\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-9-A.svg\" />", 
                "<img src=\"43af36f4a8a64c28a38d673fb8dab9e3-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "qfjZ&uV`;z", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2a9b029671cf45dcb4656aeeae293fc5-oa-1", 
                "", 
                "<img src=\"tmpn_mh6p.png\" />", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-1-A.svg\" />", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "dN*pT`omJ_", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2a9b029671cf45dcb4656aeeae293fc5-oa-2", 
                "", 
                "<img src=\"tmpn_mh6p.png\" />", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-2-A.svg\" />", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "sKaOG8S1T*", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2a9b029671cf45dcb4656aeeae293fc5-oa-3", 
                "", 
                "<img src=\"tmpn_mh6p.png\" />", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-3-A.svg\" />", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "y3a)(DfDze", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "2a9b029671cf45dcb4656aeeae293fc5-oa-4", 
                "", 
                "<img src=\"tmpn_mh6p.png\" />", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-4-A.svg\" />", 
                "<img src=\"2a9b029671cf45dcb4656aeeae293fc5-oa-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "JfpH-adft]", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 mechanisms by which microbes can acquire antibiotic resistance", 
                "Chromosomal mutation<div>Plasmids</div><div>Transposons (free DNA)</div><div>Bacteriophage (virus)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qQF#,52hV#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 mechanisms of antibiotic resistance", 
                "Antibiotic inactivation, e.g. beta lactamases<div>Alterationo fo antibiotic target site</div><div>Decreased antibiotic permeability of the cell wall, preventing drug access to target</div><div>Active antibiotic efflux from the bacteria</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "QeXd,2q.9L", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe beta lactamases", 
                "Secreted by gram positive organisms, into the milieu surrounding the organism (they are exoenzymes)<div>Confer resistance to beta lactam antibiotics</div><div><br /></div><div>Also found in the periplasmic space in gram negative pathogens</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "OGd-iculT+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the appearance of staph aureus", 
                "Gram positive cocci in grape-like bunches (not chains)<div><br /></div><div><img src=\"paste-119464515338241.jpg\" /></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r}Tv?~s;^A", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "This is a CSF sample. What is the abnormality?<div><img src=\"paste-119541824749569.jpg\" /></div>", 
                "Large number of white blood cells<div>Inside the neutrophil in the centre are gram negative diplococci - neisseria meningitidis (meningococcal meningitis)</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "LNo2Z815oI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What does clavulanic acid do", 
                "It is a beta lactam<div>Acts as a 'suicide inhibitor' of beta lactamases - binds to beta lactamase and prevents it from inactivating the antibiotic it is co-administered with (typically amoxicillin), to overcome beta lactamase penicillin resistance</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qm@!T&v8}2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are the ESCAPPM organisms?", 
                "Organisms with inducible chromosomally-mediated beta lactamase production<div>Will appear sensitive to beta lactams on initial testing, but quickly become resistant with therapy</div><div>Beta lactam antibiotics should never be used.</div><div><br /></div><div>Enterobacter</div><div>Serratia</div><div>Citrobacter</div><div>ACinetobacter</div><div>Pseudomonas</div><div>Proteus vulgaris</div><div>Morganella morganii</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BO2ch:mY+*", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 inactivating enzymes that may be produced by a bacteria to confer antibiotic resistance", 
                "Beta lactamases<div>Aminoglycoside modifying enzymes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "JO*n`ncd.!", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What are penicillin binding proteins?", 
                "PBPs are associate with the bacterial cell membrane<div>Have functions essential for wall synethesis and remodelling</div><div>Beta lactam antibiotics bind to specific PBPs, causing cell death</div><div>Alteration in PBP target sites results in resistance to pencillin&nbsp;</div><div>- e.g. penicillin resistant strep pneumoniae</div><div>- methicillin resistant staph aureus (MRSA) via mecA gene</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "B#B-z;IuGS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 1 gene that is an absolute requirement for staph aureus to become methicillin resistant (MRSA)", 
                "mecA gene<div>Codes for penicillin binding protein 2a (PBP2a), which has a low affinity for beta lactam antibiotics, hence they cannot bind and destroy the cell wall</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p5m!uN[.-w", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of fluoroquinolones?", 
                "Direct inhibitors of bacterial DNA synthesis - target bacterial enzymes DNA gyrase and topoisomerase IV<div>Bactericidal</div><div>e.g. moxifloxacin, ciprofloxacin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "zBBDf_.r`k", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of fluoroquinolone resistance", 
                "Alteration of the target, bacterial DNA gyrase<div>No longer blocked by the fluoroquinolones, so bacteria can multiply</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w&)b1J,H5+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of resistance to streptomycin", 
                "Alteration of the target, 30s ribosomal sub-unit", 
                ""
            ], 
            "flags": 0, 
            "guid": "LJ<Q4=_D!;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of resistance to erythromycin", 
                "Alteration of the target, 50s ribosomal subunit", 
                ""
            ], 
            "flags": 0, 
            "guid": "nE`zaNJm!@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the mechanism of action of rifamycins?", 
                "<div>Inhibit bacterial DNA-dependent RNA polymerase, as a result of drug binding in the polymerase subunit deep within the DNA/RNA channel, facilitating direct blocking of the elongating RNA&nbsp;</div>E.g. rifampicin", 
                ""
            ], 
            "flags": 0, 
            "guid": "H>%LH)&Rx=", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe how gram negative bacteria can decrease their cell wall permeability to antibiotics in order to become resistant", 
                "Gram negative bacteria have porins in their cell wall, through which antibiotics enter<div>Changes in the size and hydrophobicity of these can decrease penetration by antibiotics</div><div>e.g. resistance in enterobacteriaceae and pseudomonas to trimethoprim and fluoroquinolones</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "w1&{S%CTnC", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 4 types of beta lactam antibiotic", 
                "Penicillins<div>Monobactams</div><div>Cephalosporins</div><div>Carbapenems</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "M7gE8dFO2|", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the spectrum of activity of penicillins", 
                "Gram positives e.g. enterococcus faecalis, liseria, staphylococcus aueus, coagulase negative staph, &nbsp;streptococci, strep viridans<div>Anaerobes e.g. clostridium perfringens, actinomyces, fusobacteria</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "EiZtxc:MC&", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "14ab4892fd5a49bfb60774ff4d79b1db-ao-1", 
                "", 
                "<img src=\"tmp1wkkew.png\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-1-A.svg\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "H0v8)|xC7u", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "14ab4892fd5a49bfb60774ff4d79b1db-ao-2", 
                "", 
                "<img src=\"tmp1wkkew.png\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-2-A.svg\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "RjvO`)`%X>", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "14ab4892fd5a49bfb60774ff4d79b1db-ao-3", 
                "", 
                "<img src=\"tmp1wkkew.png\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-3-A.svg\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "c&#I/UXb&>", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "14ab4892fd5a49bfb60774ff4d79b1db-ao-4", 
                "", 
                "<img src=\"tmp1wkkew.png\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-4-A.svg\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Ot-cx*mg@V", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "14ab4892fd5a49bfb60774ff4d79b1db-ao-5", 
                "", 
                "<img src=\"tmp1wkkew.png\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-5-A.svg\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "yhl?<O.~<V", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "14ab4892fd5a49bfb60774ff4d79b1db-ao-6", 
                "", 
                "<img src=\"tmp1wkkew.png\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-6-A.svg\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kmP353kxy1", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "14ab4892fd5a49bfb60774ff4d79b1db-ao-7", 
                "", 
                "<img src=\"tmp1wkkew.png\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-7-A.svg\" />", 
                "<img src=\"14ab4892fd5a49bfb60774ff4d79b1db-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "c`k>xN#Imj", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fca61051139d4a889aeec54c024fb10e-ao-1", 
                "", 
                "<img src=\"tmpmmb5et.png\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-1-A.svg\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "pG>e2a4GQY", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fca61051139d4a889aeec54c024fb10e-ao-2", 
                "", 
                "<img src=\"tmpmmb5et.png\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-2-A.svg\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "n8F#l%CJd4", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fca61051139d4a889aeec54c024fb10e-ao-3", 
                "", 
                "<img src=\"tmpmmb5et.png\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-3-A.svg\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Fw{L;sjIjM", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fca61051139d4a889aeec54c024fb10e-ao-4", 
                "", 
                "<img src=\"tmpmmb5et.png\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-4-A.svg\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "OOU!`.,gJv", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fca61051139d4a889aeec54c024fb10e-ao-5", 
                "", 
                "<img src=\"tmpmmb5et.png\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-5-A.svg\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "m)j7;R7[q0", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fca61051139d4a889aeec54c024fb10e-ao-6", 
                "", 
                "<img src=\"tmpmmb5et.png\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-6-A.svg\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "r7pBVW~kq@", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "fca61051139d4a889aeec54c024fb10e-ao-7", 
                "", 
                "<img src=\"tmpmmb5et.png\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-7-A.svg\" />", 
                "<img src=\"fca61051139d4a889aeec54c024fb10e-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "QP==O6zi6$", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "06769536f22b4e50b17c7572b9456594-ao-1", 
                "", 
                "<img src=\"tmpbfn_ik.png\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-1-A.svg\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "x1J3Gi<er8", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "06769536f22b4e50b17c7572b9456594-ao-2", 
                "", 
                "<img src=\"tmpbfn_ik.png\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-2-A.svg\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "F)<t&*j<s`", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "06769536f22b4e50b17c7572b9456594-ao-3", 
                "", 
                "<img src=\"tmpbfn_ik.png\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-3-A.svg\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "wYAsH?Z&7=", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "06769536f22b4e50b17c7572b9456594-ao-4", 
                "", 
                "<img src=\"tmpbfn_ik.png\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-4-A.svg\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "zTsQ=30}$b", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "06769536f22b4e50b17c7572b9456594-ao-5", 
                "", 
                "<img src=\"tmpbfn_ik.png\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-5-A.svg\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "v8jHSR[`P%", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "06769536f22b4e50b17c7572b9456594-ao-6", 
                "", 
                "<img src=\"tmpbfn_ik.png\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-6-A.svg\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "BEzk;~H5z6", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "06769536f22b4e50b17c7572b9456594-ao-7", 
                "", 
                "<img src=\"tmpbfn_ik.png\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-7-A.svg\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "u`lO8>{Y~$", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "06769536f22b4e50b17c7572b9456594-ao-8", 
                "", 
                "<img src=\"tmpbfn_ik.png\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-8-A.svg\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "v,v#Z8J8|M", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "06769536f22b4e50b17c7572b9456594-ao-9", 
                "", 
                "<img src=\"tmpbfn_ik.png\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-9-A.svg\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "w/]-bwYm>]", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "06769536f22b4e50b17c7572b9456594-ao-10", 
                "", 
                "<img src=\"tmpbfn_ik.png\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-10-A.svg\" />", 
                "<img src=\"06769536f22b4e50b17c7572b9456594-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "lU,LY_%W|c", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f15ba88647424e9fb28dc09e3b7e6cbe-ao-1", 
                "", 
                "<img src=\"tmpwyfkeh.png\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-1-A.svg\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "sQR]^TPG![", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f15ba88647424e9fb28dc09e3b7e6cbe-ao-2", 
                "", 
                "<img src=\"tmpwyfkeh.png\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-2-A.svg\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "DiE.,jznSd", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f15ba88647424e9fb28dc09e3b7e6cbe-ao-3", 
                "", 
                "<img src=\"tmpwyfkeh.png\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-3-A.svg\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "nae,<iWLQ7", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f15ba88647424e9fb28dc09e3b7e6cbe-ao-4", 
                "", 
                "<img src=\"tmpwyfkeh.png\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-4-A.svg\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Ch@_q0`7;{", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f15ba88647424e9fb28dc09e3b7e6cbe-ao-5", 
                "", 
                "<img src=\"tmpwyfkeh.png\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-5-A.svg\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "h_rmqrzqSB", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f15ba88647424e9fb28dc09e3b7e6cbe-ao-6", 
                "", 
                "<img src=\"tmpwyfkeh.png\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-6-A.svg\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "krZ]vfzVxB", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f15ba88647424e9fb28dc09e3b7e6cbe-ao-7", 
                "", 
                "<img src=\"tmpwyfkeh.png\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-7-A.svg\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "wQ:gxW(SR1", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f15ba88647424e9fb28dc09e3b7e6cbe-ao-8", 
                "", 
                "<img src=\"tmpwyfkeh.png\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-8-A.svg\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "J-A.U|@}Td", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f15ba88647424e9fb28dc09e3b7e6cbe-ao-9", 
                "", 
                "<img src=\"tmpwyfkeh.png\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-9-A.svg\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "utgWxHL)+B", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "f15ba88647424e9fb28dc09e3b7e6cbe-ao-10", 
                "", 
                "<img src=\"tmpwyfkeh.png\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-10-A.svg\" />", 
                "<img src=\"f15ba88647424e9fb28dc09e3b7e6cbe-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Ej;wb})~1r", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-1", 
                "", 
                "<img src=\"tmpmesev0.png\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-1-A.svg\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "d>HbIW<(SB", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-2", 
                "", 
                "<img src=\"tmpmesev0.png\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-2-A.svg\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "P%-(#^o4NT", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-3", 
                "", 
                "<img src=\"tmpmesev0.png\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-3-A.svg\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "wz4yUr?#0;", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-4", 
                "", 
                "<img src=\"tmpmesev0.png\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-4-A.svg\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "u!-wD(tFL{", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-5", 
                "", 
                "<img src=\"tmpmesev0.png\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-5-A.svg\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "rxo1v(WwgT", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-6", 
                "", 
                "<img src=\"tmpmesev0.png\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-6-A.svg\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "cYT#[Y&rPn", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-7", 
                "", 
                "<img src=\"tmpmesev0.png\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-7-A.svg\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "fD?MB8_cv9", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "cf900fe14f3f4b4ea3195ceb3e4a2727-ao-8", 
                "", 
                "<img src=\"tmpmesev0.png\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-8-A.svg\" />", 
                "<img src=\"cf900fe14f3f4b4ea3195ceb3e4a2727-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kqv&r+)&|[", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "102e08bbf5a2406d9efaf24cd9912e39-ao-1", 
                "", 
                "<img src=\"tmpwzzqaz.png\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-1-A.svg\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "QSSEj^OZP#", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "102e08bbf5a2406d9efaf24cd9912e39-ao-2", 
                "", 
                "<img src=\"tmpwzzqaz.png\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-2-A.svg\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "y*5[xLzslC", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "102e08bbf5a2406d9efaf24cd9912e39-ao-3", 
                "", 
                "<img src=\"tmpwzzqaz.png\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-3-A.svg\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "pVFP=.BqeL", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "102e08bbf5a2406d9efaf24cd9912e39-ao-4", 
                "", 
                "<img src=\"tmpwzzqaz.png\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-4-A.svg\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "d#@1XGZ<4h", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "102e08bbf5a2406d9efaf24cd9912e39-ao-5", 
                "", 
                "<img src=\"tmpwzzqaz.png\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-5-A.svg\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "rC,ml^[p0S", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "102e08bbf5a2406d9efaf24cd9912e39-ao-6", 
                "", 
                "<img src=\"tmpwzzqaz.png\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-6-A.svg\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "s2T$W`}G3]", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "102e08bbf5a2406d9efaf24cd9912e39-ao-7", 
                "", 
                "<img src=\"tmpwzzqaz.png\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-7-A.svg\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "w3~|}_:Nn@", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "102e08bbf5a2406d9efaf24cd9912e39-ao-8", 
                "", 
                "<img src=\"tmpwzzqaz.png\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-8-A.svg\" />", 
                "<img src=\"102e08bbf5a2406d9efaf24cd9912e39-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "bSuW:HA!2w", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21b949f0660f488bb7f4363b9c24d2a7-ao-1", 
                "", 
                "<img src=\"tmprztwtk.png\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-1-A.svg\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "I,p3@/X_pL", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21b949f0660f488bb7f4363b9c24d2a7-ao-2", 
                "", 
                "<img src=\"tmprztwtk.png\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-2-A.svg\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "sn8wt-*MF{", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21b949f0660f488bb7f4363b9c24d2a7-ao-3", 
                "", 
                "<img src=\"tmprztwtk.png\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-3-A.svg\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Hr(HIlp*4S", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21b949f0660f488bb7f4363b9c24d2a7-ao-4", 
                "", 
                "<img src=\"tmprztwtk.png\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-4-A.svg\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "edg>K>$w6.", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21b949f0660f488bb7f4363b9c24d2a7-ao-5", 
                "", 
                "<img src=\"tmprztwtk.png\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-5-A.svg\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "gP/&#{`tQP", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21b949f0660f488bb7f4363b9c24d2a7-ao-6", 
                "", 
                "<img src=\"tmprztwtk.png\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-6-A.svg\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "c57Za6qqou", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21b949f0660f488bb7f4363b9c24d2a7-ao-7", 
                "", 
                "<img src=\"tmprztwtk.png\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-7-A.svg\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "yC@$0i[tI&", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21b949f0660f488bb7f4363b9c24d2a7-ao-8", 
                "", 
                "<img src=\"tmprztwtk.png\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-8-A.svg\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "g>eujB+-^C", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21b949f0660f488bb7f4363b9c24d2a7-ao-9", 
                "", 
                "<img src=\"tmprztwtk.png\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-9-A.svg\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "fM|0QdN2_H", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21b949f0660f488bb7f4363b9c24d2a7-ao-10", 
                "", 
                "<img src=\"tmprztwtk.png\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-10-A.svg\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "r$Ct:Yf1VP", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "21b949f0660f488bb7f4363b9c24d2a7-ao-11", 
                "", 
                "<img src=\"tmprztwtk.png\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-11-A.svg\" />", 
                "<img src=\"21b949f0660f488bb7f4363b9c24d2a7-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Bn-~^z_m8p", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "15439e09c73b4cc38607fdfcfa984152-ao-1", 
                "", 
                "<img src=\"tmpt8_ojk.png\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-1-A.svg\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "O:{]>Dxf^m", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "15439e09c73b4cc38607fdfcfa984152-ao-2", 
                "", 
                "<img src=\"tmpt8_ojk.png\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-2-A.svg\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "M-RAG_M&!b", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "15439e09c73b4cc38607fdfcfa984152-ao-3", 
                "", 
                "<img src=\"tmpt8_ojk.png\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-3-A.svg\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "t24`<l%<RY", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "15439e09c73b4cc38607fdfcfa984152-ao-4", 
                "", 
                "<img src=\"tmpt8_ojk.png\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-4-A.svg\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GU74Lk~K2f", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "15439e09c73b4cc38607fdfcfa984152-ao-5", 
                "", 
                "<img src=\"tmpt8_ojk.png\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-5-A.svg\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "kRFBl79yg]", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "15439e09c73b4cc38607fdfcfa984152-ao-6", 
                "", 
                "<img src=\"tmpt8_ojk.png\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-6-A.svg\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "HE&u=87/Xu", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "15439e09c73b4cc38607fdfcfa984152-ao-7", 
                "", 
                "<img src=\"tmpt8_ojk.png\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-7-A.svg\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "x~pT2y:P#t", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "15439e09c73b4cc38607fdfcfa984152-ao-8", 
                "", 
                "<img src=\"tmpt8_ojk.png\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-8-A.svg\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "mI&jxd^T`]", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "15439e09c73b4cc38607fdfcfa984152-ao-9", 
                "", 
                "<img src=\"tmpt8_ojk.png\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-9-A.svg\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "J6(3W>gQ`I", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "15439e09c73b4cc38607fdfcfa984152-ao-10", 
                "", 
                "<img src=\"tmpt8_ojk.png\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-10-A.svg\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "j0e4*xW--d", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "15439e09c73b4cc38607fdfcfa984152-ao-11", 
                "", 
                "<img src=\"tmpt8_ojk.png\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-11-A.svg\" />", 
                "<img src=\"15439e09c73b4cc38607fdfcfa984152-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "Q&!X.8cmRE", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a8274d6edc5a471594aeb61f643110c5-ao-1", 
                "", 
                "<img src=\"tmp9pbyyc.png\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-1-A.svg\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "K*12TEFfJ%", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a8274d6edc5a471594aeb61f643110c5-ao-2", 
                "", 
                "<img src=\"tmp9pbyyc.png\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-2-A.svg\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "qn;)%fB~zw", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a8274d6edc5a471594aeb61f643110c5-ao-3", 
                "", 
                "<img src=\"tmp9pbyyc.png\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-3-A.svg\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "yWGh8)whpj", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a8274d6edc5a471594aeb61f643110c5-ao-4", 
                "", 
                "<img src=\"tmp9pbyyc.png\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-4-A.svg\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "JWe?}M6=kt", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a8274d6edc5a471594aeb61f643110c5-ao-5", 
                "", 
                "<img src=\"tmp9pbyyc.png\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-5-A.svg\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "BkrikQJP@A", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a8274d6edc5a471594aeb61f643110c5-ao-6", 
                "", 
                "<img src=\"tmp9pbyyc.png\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-6-A.svg\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "E;ZxYy;7JO", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a8274d6edc5a471594aeb61f643110c5-ao-7", 
                "", 
                "<img src=\"tmp9pbyyc.png\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-7-A.svg\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "tD8(Mp+6~q", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a8274d6edc5a471594aeb61f643110c5-ao-8", 
                "", 
                "<img src=\"tmp9pbyyc.png\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-8-A.svg\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GW:|sA;@}7", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a8274d6edc5a471594aeb61f643110c5-ao-9", 
                "", 
                "<img src=\"tmp9pbyyc.png\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-9-A.svg\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "DaUHtr>)K)", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "a8274d6edc5a471594aeb61f643110c5-ao-10", 
                "", 
                "<img src=\"tmp9pbyyc.png\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-10-A.svg\" />", 
                "<img src=\"a8274d6edc5a471594aeb61f643110c5-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GfvW9`jsM4", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "83cf0965978e4f59a97e34b52ee7bcfb-ao-1", 
                "", 
                "<img src=\"tmp6jfgmf.png\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-1-A.svg\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "F==2u3upC*", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "83cf0965978e4f59a97e34b52ee7bcfb-ao-2", 
                "", 
                "<img src=\"tmp6jfgmf.png\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-2-A.svg\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "l$KL2QjaBw", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "83cf0965978e4f59a97e34b52ee7bcfb-ao-3", 
                "", 
                "<img src=\"tmp6jfgmf.png\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-3-A.svg\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "hNF92h,vg-", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "83cf0965978e4f59a97e34b52ee7bcfb-ao-4", 
                "", 
                "<img src=\"tmp6jfgmf.png\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-4-A.svg\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "B7foUv@Gg9", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "83cf0965978e4f59a97e34b52ee7bcfb-ao-5", 
                "", 
                "<img src=\"tmp6jfgmf.png\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-5-A.svg\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "rrt4ydjXnp", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "83cf0965978e4f59a97e34b52ee7bcfb-ao-6", 
                "", 
                "<img src=\"tmp6jfgmf.png\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-6-A.svg\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "sA>H)V|PU_", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "83cf0965978e4f59a97e34b52ee7bcfb-ao-7", 
                "", 
                "<img src=\"tmp6jfgmf.png\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-7-A.svg\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "QD3A0ud3jM", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "83cf0965978e4f59a97e34b52ee7bcfb-ao-8", 
                "", 
                "<img src=\"tmp6jfgmf.png\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-8-A.svg\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "hZSD@2/akH", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "83cf0965978e4f59a97e34b52ee7bcfb-ao-9", 
                "", 
                "<img src=\"tmp6jfgmf.png\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-9-A.svg\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "G,JaWF$vUo", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "83cf0965978e4f59a97e34b52ee7bcfb-ao-10", 
                "", 
                "<img src=\"tmp6jfgmf.png\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-10-A.svg\" />", 
                "<img src=\"83cf0965978e4f59a97e34b52ee7bcfb-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "mN2!Q*z^0y", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e3faec01942d401cbe1516d280823959-ao-1", 
                "", 
                "<img src=\"tmpcfvxvs.png\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-1-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-1-A.svg\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "v0b9XFNTJb", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e3faec01942d401cbe1516d280823959-ao-2", 
                "", 
                "<img src=\"tmpcfvxvs.png\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-2-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-2-A.svg\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "u!9Pwy1.{.", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e3faec01942d401cbe1516d280823959-ao-3", 
                "", 
                "<img src=\"tmpcfvxvs.png\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-3-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-3-A.svg\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "cF<S3udLBR", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e3faec01942d401cbe1516d280823959-ao-4", 
                "", 
                "<img src=\"tmpcfvxvs.png\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-4-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-4-A.svg\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "wS:19ndIG/", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e3faec01942d401cbe1516d280823959-ao-5", 
                "", 
                "<img src=\"tmpcfvxvs.png\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-5-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-5-A.svg\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "GWVWCX|B+T", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e3faec01942d401cbe1516d280823959-ao-6", 
                "", 
                "<img src=\"tmpcfvxvs.png\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-6-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-6-A.svg\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "zaDD};Jo,d", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e3faec01942d401cbe1516d280823959-ao-7", 
                "", 
                "<img src=\"tmpcfvxvs.png\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-7-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-7-A.svg\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "zyR].#~OK(", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e3faec01942d401cbe1516d280823959-ao-8", 
                "", 
                "<img src=\"tmpcfvxvs.png\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-8-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-8-A.svg\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "xbQ[iB())Z", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e3faec01942d401cbe1516d280823959-ao-9", 
                "", 
                "<img src=\"tmpcfvxvs.png\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-9-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-9-A.svg\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "iKlkz;lDlL", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e3faec01942d401cbe1516d280823959-ao-10", 
                "", 
                "<img src=\"tmpcfvxvs.png\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-10-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-10-A.svg\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "mGiM7A;[L?", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "e3faec01942d401cbe1516d280823959-ao-11", 
                "", 
                "<img src=\"tmpcfvxvs.png\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-11-Q.svg\" />", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-11-A.svg\" />", 
                "<img src=\"e3faec01942d401cbe1516d280823959-ao-O.svg\" />"
            ], 
            "flags": 0, 
            "guid": "lhRDHz!iKf", 
            "note_model_uuid": "be63c1f1-c495-11e8-9855-d481d727b8af", 
            "tags": [
                "InfectiousDiseases"
            ]
        }
    ]
}